UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

___________________________________________________________________________ 
FORM 10-Q
(Mark One) 
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2017March 31, 2020
 
or
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                              to                         
 
Commission File Number: 1-13991
MFA FINANCIAL, INC.
(Exact name of registrant as specified in its charter)
_______________________________________________________________________________________________________________ 
Maryland 13-3974868
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
   
350 Park Avenue, 20th Floor
New YorkNew York 10022
(Address of principal executive offices) (Zip Code)
(212) (212) 207-6400
(Registrant’s telephone number, including area code)


Not Applicable
(Former name, former address and former fiscal year, if changed since last period)

____________________________________________________________________

Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per shareMFANew York Stock Exchange
7.50% Series B Cumulative Redeemable
Preferred Stock, par value $0.01 per share
MFA/PBNew York Stock Exchange
6.50% Series C Cumulative Redeemable
Preferred Stock, par value $0.01 per share
MFA/PCNew York Stock Exchange
8.00% Senior Notes due 2042MFONew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yesx  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yesx No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x 
Accelerated filero
Non-accelerated filerSmaller reporting company
   
Non-accelerated filer o (Do not check if a smaller reporting company)
Smaller reporting company o
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  oYes ☐ No x

396,943,263453,242,244 shares of the registrant’s common stock, $0.01 par value, were outstanding as of October 27, 2017.June 10, 2020.
 

Explanatory Note

On May 6, 2020, MFA Financial, Inc. (the “Company”) furnished information in a Current Report on Form 8-K (the “Form 8-K”) pursuant to the Order (Release No. 34-88465) of the U.S. Securities and Exchange Commission (the “SEC”), dated March 25, 2020 (the “Order”). The Order provides registrants, including the Company, with the ability to extend the dates by which certain filings are required to be made with the SEC, in light of operational challenges presented by the COVID-19 pandemic. In the Form 8-K, the Company disclosed that, while it had fully implemented its business continuity plan and had transitioned to a remote work environment in response to the operational and health risks associated with the COVID-19 pandemic, the disruption and volatility in the financial markets triggered in large part by the pandemic had a significant impact on the Company’s operations and financial position. As a result, the Company’s management had to devote significant time and attention to address such matters, which had diverted management resources from completing tasks necessary to timely file this Quarterly Report on Form 10-Q for the three months ended March 31, 2020 (the “Quarterly Report”) on or before the original filing deadline of May 11, 2020. In light of the foregoing circumstances, and in reliance on the Order, the Company disclosed in the Form 8-K that it did not intend to file the Quarterly Report by May 11, 2020. The Company, in reliance on and as permitted by the Order, is hereby timely filing this Quarterly Report within 45 days from the original filing deadline.


MFA FINANCIAL, INC.


TABLE OF CONTENTS
 
 Page
  
PART I
FINANCIAL INFORMATION
   
 
   
 
   
 
   
 
   
 
   
 
   
   
   
  
   
   
   
   
   
   
   
 



MFA FINANCIAL, INC.
CONSOLIDATED BALANCE SHEET




 (In Thousands Except Per Share Amounts) September 30,
2017
 December 31,
2016
  (Unaudited)  
Assets:  
  
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities:  
  
Agency MBS, at fair value ($2,911,353 and $3,540,401 pledged as collateral, respectively) $3,019,304
 $3,738,497
Non-Agency MBS, at fair value ($2,853,891 and $4,751,419 pledged as collateral, respectively) (1)
 3,911,660
 5,684,836
CRT securities, at fair value ($530,833 and $357,488 pledged as collateral, respectively) 653,633
 404,850
Mortgage servicing rights (“MSR”) related assets ($412,674 and $226,780 pledged as collateral, respectively) 411,840
 226,780
Residential whole loans, at carrying value ($347,906 and $427,880 pledged as collateral, respectively) (2)
 639,216
 590,540
Residential whole loans, at fair value ($903,494 and $734,331 pledged as collateral, respectively) (2)
 1,103,518
 814,682
Securities obtained and pledged as collateral, at fair value 507,318
 510,767
Cash and cash equivalents 608,173
 260,112
Restricted cash 15,440
 58,463
Other assets 233,357
 194,495
Total Assets $11,103,459
 $12,484,022
     
Liabilities:    
Repurchase agreements and other advances $6,871,443
 $8,687,268
Obligation to return securities obtained as collateral, at fair value 507,318
 510,767
8% Senior Notes due 2042 (“Senior Notes”) 96,763
 96,733
Payable for unsettled MBS and residential whole loans purchases 124,006
 
Other liabilities 246,278
 155,352
Total Liabilities $7,845,808
 $9,450,120
     
Commitments and contingencies (See Note 11) 

 

     
Stockholders’ Equity:    
Preferred stock, $.01 par value; 7.50% Series B cumulative redeemable; 8,050 shares authorized;
  8,000 shares issued and outstanding ($200,000 aggregate liquidation preference)
 $80
 $80
Common stock, $.01 par value; 886,950 shares authorized; 396,939 and 371,854 shares issued
  and outstanding, respectively
 3,969
 3,719
Additional paid-in capital, in excess of par 3,219,398
 3,029,062
Accumulated deficit (596,022) (572,641)
Accumulated other comprehensive income 630,226
 573,682
Total Stockholders’ Equity $3,257,651
 $3,033,902
Total Liabilities and Stockholders’ Equity $11,103,459
 $12,484,022
MFA FINANCIAL, INC.
CONSOLIDATED BALANCE SHEETS
 (In Thousands Except Per Share Amounts) March 31,
2020
 December 31,
2019
  (Unaudited)  
Assets:  
  
Residential whole loans:    
Residential whole loans, at carrying value ($5,055,177 and $4,847,782 pledged as collateral, respectively) (1) (2)
 $5,934,042
 $6,069,370
Residential whole loans, at fair value ($718,343 and $794,684 pledged as collateral, respectively) (1)
 1,243,792
 1,381,583
Allowance for credit and valuation losses on residential whole loans held at carrying value and held-for-sale (218,011) (3,025)
Total residential whole loans, net 6,959,823
 7,447,928
Residential mortgage securities:  
  
Non-Agency MBS, at fair value ($1,331,674 and $2,055,802 pledged as collateral, respectively) 1,119,940
 2,063,529
Agency MBS, at fair value ($568,704 and $1,658,614 pledged as collateral, respectively) 553,413
 1,664,582
Credit Risk Transfer (“CRT”) securities, at fair value ($263,225 and $252,175 pledged as collateral, respectively) 254,101
 255,408
Mortgage servicing rights (“MSR”) related assets ($877,204 and $1,217,002 pledged as collateral, respectively) 738,054
 1,217,002
Cash and cash equivalents 116,465
 70,629
Restricted cash 216,902
 64,035
Other assets 1,171,639
 784,251
Total Assets $11,130,337
 $13,567,364
     
Liabilities:    
Repurchase agreements $7,768,180
 $9,139,821
Other liabilities 921,482
 1,043,591
Total Liabilities $8,689,662
 $10,183,412
     
Commitments and contingencies (See Note 10) 


 


     
Stockholders’ Equity:    
Preferred stock, $.01 par value; 7.50% Series B cumulative redeemable; 8,050 shares authorized;
8,000 shares issued and outstanding ($200,000 aggregate liquidation preference)
 $80
 $80
Preferred stock, $.01 par value; 6.50% Series C fixed-to-floating rate cumulative redeemable;
12,650 shares authorized; 11,000 shares issued and outstanding ($275,000 aggregate liquidation preference)
 110
 
Common stock, $.01 par value; 874,300 and 886,950 shares authorized; 453,138 and 452,369 shares issued
and outstanding, respectively
 4,531
 4,524
Additional paid-in capital, in excess of par 3,906,613
 3,640,341
Accumulated deficit (1,548,361) (631,040)
Accumulated other comprehensive income 77,702
 370,047
Total Stockholders’ Equity $2,440,675
 $3,383,952
Total Liabilities and Stockholders’ Equity $11,130,337
 $13,567,364


(1)Includes approximately $174.4$185.9 million and $186.4 million of Non-Agency MBSResidential whole loans, at carrying value and $516.4 million and $567.4 million of Residential whole loans, at fair value transferred to consolidated variable interest entities (“VIEs”) at March 31, 2020 and December 31, 2016.2019, respectively. Such assets can be used only to settle the obligations of each respective VIE.
(2)Includes approximately $131.3Non-QM loans held-for-sale with an amortized cost of $965.5 million of Residential whole loans, atand a net carrying value and $40.4of $895.3 million of Residential whole loans, at fair value transferred to a consolidated VIE at September 30, 2017. Such assets can be used only to settle the obligations of the VIE.March 31, 2020.


The accompanying notes are an integral part of the consolidated financial statements.


MFA FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
  Three Months Ended
March 31,
(In Thousands, Except Per Share Amounts) 2020 2019
Interest Income:    
Residential whole loans held at carrying value $83,486
 $49,620
Non-Agency MBS 32,551
 54,001
Agency MBS 8,861
 18,441
CRT securities 2,962
 6,200
MSR-related assets 14,207
 10,620
Cash and cash equivalent investments 486
 764
Other interest-earning assets 2,907
 1,306
Interest Income $145,460
 $140,952
     
Interest Expense:  
  
Repurchase agreements $72,698
 $70,809
Other interest expense 11,061
 8,217
Interest Expense $83,759
 $79,026
     
Net Interest Income $61,701
 $61,926
     
Provision for credit and valuation losses on residential whole loans and other financial instruments $(150,827) $(805)
Net Interest Income after Provision for Credit and Valuation Losses $(89,126) $61,121
     
Other Income, net:    
Impairment and other losses on securities available-for-sale and other assets $(419,651) $
Net realized (loss)/gain on sales of residential mortgage securities and residential whole loans (238,380) 24,609
Net unrealized (loss)/gain on residential mortgage securities measured at fair value through earnings (77,961) 8,672
Net (loss)/gain on residential whole loans measured at fair value through earnings (52,760) 25,267
Net loss on Swaps not designated as hedges for accounting purposes (4,239) (8,944)
Other, net 2,228
 1,565
Other (Loss)/Income, net $(790,763) $51,169
     
Operating and Other Expense:    
Compensation and benefits $8,899
 $8,554
Other general and administrative expense 4,575
 4,645
Loan servicing and other related operating expenses 11,164
 10,234
Costs associated with restructuring/forbearance agreement 4,468
 
Operating and Other Expense $29,106
 $23,433
     
Net (Loss)/Income $(908,995) $88,857
Less Preferred Stock Dividend Requirement $5,215
 $3,750
Net (Loss)/Income Available to Common Stock and Participating Securities $(914,210) $85,107
     
Basic (Loss)/Earnings per Common Share $(2.02) $0.19
Diluted (Loss)/Earnings per Common Share $(2.02) $0.19


The accompanying notes are an integral part of the consolidated financial statements.

MFA FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
  Three Months Ended 
 September 30,
 Nine Months Ended 
 September 30,
(In Thousands, Except Per Share Amounts) 2017 2016 2017 2016
Interest Income:  
  
  
  
Agency MBS $15,533
 $18,957
 $50,014
 $64,546
Non-Agency MBS 63,252
 83,638
 212,728
 253,555
CRT securities 8,676
 3,983
 22,898
 9,897
MSR related assets 7,194
 
 17,833
 
Residential whole loans held at carrying value 9,026
 5,917
 26,219
 16,112
Cash and cash equivalent investments 1,452
 221
 2,854
 531
Interest Income $105,133
 $112,716
 $332,546
 $344,641
         
Interest Expense:        
Repurchase agreements and other advances $46,303
 $46,158
 $141,444
 $137,127
Senior Notes and other interest expense 2,972
 2,009
 7,202
 6,360
Interest Expense $49,275
 $48,167
 $148,646
 $143,487
         
Net Interest Income $55,858
 $64,549
 $183,900
 $201,154
         
Other-Than-Temporary Impairments:        
Total other-than-temporary impairment losses $
 $(1,255) $(63) $(1,255)
Portion of loss recognized in/(reclassed from) other comprehensive income 
 770
 (969) 770
Net Impairment Losses Recognized in Earnings $
 $(485) $(1,032) $(485)
         
Other Income, net:        
Net gain on residential whole loans held at fair value $18,679
 $19,639
 $48,660
 $47,729
Net gain on sales of MBS and U.S. Treasury securities 14,933
 7,083
 30,530
 26,069
Other, net (4,515) 7,179
 14,844
 9,844
Other Income, net $29,097
 $33,901
 $94,034
 $83,642
         
Operating and Other Expense:        
Compensation and benefits $10,892
 $7,078
 $26,258
 $21,507
Other general and administrative expense 4,081
 3,709
 14,060
 12,508
Loan servicing and other related operating expenses 6,177
 4,167
 14,785
 10,265
Operating and Other Expense $21,150
 $14,954
 $55,103
 $44,280
         
Net Income $63,805
 $83,011
 $221,799
 $240,031
Less Preferred Stock Dividends 3,750
 3,750
 11,250
 11,250
Net Income Available to Common Stock and Participating Securities $60,055
 $79,261
 $210,549
 $228,781
         
Earnings per Common Share - Basic and Diluted $0.15
 $0.21
 $0.54
 $0.61
         
Dividends Declared per Share of Common Stock $0.20
 $0.20
 $0.60
 $0.60

The accompanying notes are an integral part of the consolidated financial statements.

MFA FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)
(UNAUDITED)

MFA FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)
(UNAUDITED)

MFA FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)
(UNAUDITED)
 Three Months Ended 
 September 30,
 Nine Months Ended 
 September 30,
 Three Months Ended
March 31,
(In Thousands) 2017 2016 2017 2016 2020 2019
Net income $63,805
 $83,011
 $221,799
 $240,031
Net (loss)/income $(908,995) $88,857
Other Comprehensive Income/(Loss):            
Unrealized (loss)/gain on Agency MBS, net
 (3,032) (6,941) (22,241) 17,857
Unrealized gain on Non-Agency MBS, net 10,020
 71,291
 93,429
 106,906
Unrealized gains on securities available-for-sale 124,410
 22,103
Reclassification adjustment for MBS sales included in net income (14,935) (6,829) (30,283) (26,795) (23,953) (17,009)
Reclassification adjustment for other-than-temporary impairments included in net income 
 (485) (1,032) (485)
Reclassification adjustment for impairments included in net income (344,269) 
Derivative hedging instrument fair value changes, net 5,791
 22,769
 16,671
 (39,803) (50,127) (10,445)
Amortization of de-designated hedging instruments, net 1,594
 (341)
Other Comprehensive Income/(Loss) (2,156) 79,805
 56,544
 57,680
 (292,345) (5,692)
Comprehensive income before preferred stock dividends $61,649
 $162,816
 $278,343
 $297,711
 $(1,201,340) $83,165
Dividends declared on preferred stock (3,750) (3,750) (11,250) (11,250)
Dividends required on preferred stock (5,215) (3,750)
Comprehensive Income Available to Common Stock and Participating Securities $57,899
 $159,066
 $267,093
 $286,461
 $(1,206,555) $79,415
 
The accompanying notes are an integral part of the consolidated financial statements.

MFA FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(UNAUDITED)

  Nine Months Ended September 30, 2017
(In Thousands, 
Except Per Share Amounts)
 Preferred Stock
7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share
 Common Stock Additional Paid-in Capital Accumulated
Deficit
 Accumulated Other Comprehensive Income Total
 Shares Amount Shares Amount    
Balance at December 31, 2016 8,000
 $80
 371,854
 $3,719
 $3,029,062
 $(572,641) $573,682
 $3,033,902
Net income 
 
 
 
 
 221,799
 
 221,799
Issuance of common stock, net of expenses (1)
 
 
 25,726
 250
 190,265
 
 
 190,515
Repurchase of shares of common stock (1)
 
 
 (641) 
 (5,158) 
 
 (5,158)
Equity based compensation expense 
 
 
 
 5,209
 
 
 5,209
Accrued dividends attributable to stock-based awards 
 
 
 
 20
 
 
 20
Dividends declared on common stock 
 
 
 
 
 (233,244) 
 (233,244)
Dividends declared on preferred stock 
 
 
 
 
 (11,250) 
 (11,250)
Dividends attributable to dividend equivalents 
 
 
 
 
 (686) 
 (686)
Change in unrealized gains on MBS, net 
 
 
 
 
 
 39,873
 39,873
Derivative hedging instrument fair value changes, net 
 
 
 
 
 
 16,671
 16,671
Balance at September 30, 2017 8,000
 $80
 396,939
 $3,969
 $3,219,398
 $(596,022) $630,226
 $3,257,651
MFA FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(UNAUDITED)
  Three Months Ended March 31, 2020
(In Thousands, 
Except Per Share Amounts)
 Preferred Stock
6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable - Liquidation Preference $25.00 per Share
 Preferred Stock
7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share
 Common Stock Additional Paid-in Capital Accumulated
Deficit
 Accumulated Other Comprehensive Income Total
 Shares Amount Shares Amount Shares Amount    
Balance at December 31, 2019 
 $
 8,000
 $80
 452,369
 $4,524
 $3,640,341
 $(631,040) $370,047
 $3,383,952
Cumulative effect adjustment on adoption of new accounting standard ASU 2016-13 
 
 
 
 
 
 
 (8,326) 
 (8,326)
Net loss 
 
 
 
 
 
 
 (908,995) 
 (908,995)
Issuance of Series C Preferred Stock, net of expenses 11,000
 110
 
 
 
 
 265,919
 
 
 266,029
Issuance of common stock, net of expenses 
 
 
 
 1,106
 7
 680
 
 
 687
Repurchase of shares of common stock (1)
 
 
 
 
 (337) 
 (2,652) 
 
 (2,652)
Equity based compensation expense 
 
 
 
 
 
 1,266
 
 
 1,266
Accrued dividends attributable to stock-based awards 
 
 
 
 
 
 1,059
 
 
 1,059
Change in unrealized gains on MBS, net 
 
 
 
 
 
 
 
 (243,812) (243,812)
Derivative hedging instrument fair value changes and amortization, net 
 
 
 
 
 
 
 
 (48,533) (48,533)
Balance at March 31, 2020 11,000
 $110
 8,000
 $80
 453,138
 $4,531
 $3,906,613
 $(1,548,361) $77,702
 $2,440,675

  Nine Months Ended September 30, 2016
(In Thousands, 
Except Per Share Amounts)
 Preferred Stock
7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share
 Common Stock Additional Paid-in Capital Accumulated
Deficit
 Accumulated Other Comprehensive Income Total
 Shares Amount Shares Amount    
Balance at December 31, 2015 8,000
 $80
 370,584
 $3,706
 $3,019,956
 $(572,332) $515,851
 $2,967,261
Net income 
 
 
 
 
 240,031
 
 240,031
Issuance of common stock, net of expenses (1)
 
 
 716
 5
 936
 
 
 941
Repurchase of shares of common stock (1)
 
 
 (217) 
 (1,481) 
 
 (1,481)
Equity based compensation expense 
 
 
 
 4,140
 
 
 4,140
Accrued dividends attributable to stock-based awards 
 
 
 
 (518) 
 
 (518)
Dividends declared on common stock 
 
 
 
 
 (222,669) 
 (222,669)
Dividends declared on preferred stock 
 
 
 
 
 (11,250) 
 (11,250)
Dividends attributable to dividend equivalents 
 
 
 
 
 (697) 
 (697)
Change in unrealized gains on MBS, net 
 
 
 
 
 
 97,483
 97,483
Derivative hedging instruments fair value changes, net 
 
 
 
 
 
 (39,803) (39,803)
Balance at September 30, 2016 8,000
 $80
 371,083
 $3,711
 $3,023,033
 $(566,917) $573,531
 $3,033,438


(1)  For the ninethree months ended September 30, 2017 and 2016,March 31, 2020 includes approximately $5.2$2.7 million (640,748(337,026 shares) and $1.5 million (217,464 shares), respectively surrendered for tax purposes related to equity-based compensation awards.


MFA FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
  Nine Months Ended 
 September 30,
(In Thousands) 2017 2016
Cash Flows From Operating Activities:  
  
Net income $221,799
 $240,031
Adjustments to reconcile net income to net cash provided by operating activities:  
  
Gain on sales of MBS and U.S. Treasury securities (30,530) (26,069)
Gain on sales of real estate owned (2,844) (1,840)
Gain on liquidation of residential whole loans (7,178) 
Other-than-temporary impairment charges 1,032
 485
Accretion of purchase discounts on MBS and CRT securities, residential whole loans and MSR related assets (67,065) (64,093)
Amortization of purchase premiums on MBS and CRT securities 23,766
 27,748
Depreciation and amortization on real estate, fixed assets and other assets 1,199
 746
Equity-based compensation expense 5,369
 4,143
Unrealized gain on residential whole loans at fair value (12,499) (25,529)
Increase in other assets and other (3,827) (47,761)
Decrease in other liabilities (10,248) (9,025)
Net cash provided by operating activities $118,974
 $98,836
     
Cash Flows From Investing Activities:  
  
Principal payments on MBS, CRT securities and MSR related assets $3,387,673
 $2,581,507
Proceeds from sales of MBS and U.S. Treasury securities 222,143
 65,068
Purchases of MBS, CRT securities and MSR related assets (1,425,717) (1,398,606)
Purchases of residential whole loans and capitalized advances (391,613) (367,740)
Principal payments on residential whole loans 105,549
 70,729
Proceeds from sales of real estate owned 51,834
 21,833
Purchases of real estate owned and capital improvements (17,224) 
Redemption of Federal Home Loan Bank stock 10,422
 49,595
Additions to leasehold improvements, furniture and fixtures (596) (380)
Net cash provided by investing activities $1,942,471
 $1,022,006
     
Cash Flows From Financing Activities:  
  
Principal payments on repurchase agreements and other advances $(57,118,263) $(62,376,619)
Proceeds from borrowings under repurchase agreements and other advances 55,302,002
 61,685,547
Proceeds from issuance of securitized debt 147,847
 
Principal payments on securitized debt (9,140) (22,057)
Payments made for securitization related costs
 (1,520) 
Payments made for margin calls and settlements on repurchase agreements and interest rate swap agreements (“Swaps”) (51,111) (179,028)
Proceeds from reverse margin calls and settlements on repurchase agreements and Swaps 66,517
 128,700
Proceeds from issuances of common stock 190,516
 941
Dividends paid on preferred stock (11,250) (11,250)
Dividends paid on common stock and dividend equivalents (228,982) (223,385)
Net cash used in financing activities $(1,713,384) $(997,151)
Net increase in cash and cash equivalents $348,061
 $123,691
Cash and cash equivalents at beginning of period $260,112
 $165,007
Cash and cash equivalents at end of period $608,173
 $288,698
     
Non-cash Investing and Financing Activities:    
Net increase/(decrease) in securities obtained as collateral/obligation to return securities obtained as collateral $131,930
 $(13,450)
Transfer from residential whole loans to real estate owned $97,388
 $69,803
Dividends and dividend equivalents declared and unpaid $79,605
 $74,556

The accompanying notes are an integral part of the consolidated financial statements.



5
MFA FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(UNAUDITED)
  Three Months Ended March 31, 2019
(In Thousands, 
Except Per Share Amounts)
 Preferred Stock
7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share
 Common Stock Additional Paid-in Capital Accumulated
Deficit
 Accumulated Other Comprehensive Income Total
 Shares Amount Shares Amount    
Balance at December 31, 2018 8,000
 $80
 449,787
 $4,498
 $3,623,275
 $(632,040) $420,288
 $3,416,101
Net income 
 
 
 
 
 88,857
 
 88,857
Issuance of common stock, net of expenses 
 
 1,066
 7
 544
 
 
 551
Repurchase of shares of common stock (1)
 
 
 (370) 
 (2,610) 
 
 (2,610)
Equity based compensation expense 
 
 
 
 992
 
 
 992
Accrued dividends attributable to stock-based awards 
 
 
 
 435
 
 
 435
Dividends declared on common stock ($0.20 per share) 
 
 
 
 
 (90,097) 
 (90,097)
Dividends declared on preferred stock ($0.46875 per share) 
 
 
 
 
 (3,750) 
 (3,750)
Dividends attributable to dividend equivalents 
 
 
 
 
 (256) 
 (256)
Change in unrealized losses on MBS, net 
 
 
 
 
 
 5,094
 5,094
Derivative hedging instruments fair value changes, net 
 
 
 
 
 
 (10,786) (10,786)
Balance at March 31, 2019 8,000
 $80
 450,483
 $4,505
 $3,622,636
 $(637,286) $414,596
 $3,404,531

(1)  For the three months ended March 31, 2019, includes approximately $2.6 million (370,244 shares) surrendered for tax purposes related to equity-based compensation awards.

The accompanying notes are an integral part of the consolidated financial statements.


MFA FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
  Three Months Ended
March 31,
(In Thousands) 2020 2019
Cash Flows From Operating Activities:  
  
Net (loss)/income $(908,995) $88,857
Adjustments to reconcile net income to net cash provided by operating activities:  
  
Loss on sales of residential whole loans at carrying value 145,791
 
Loss/(gain) on sales of residential mortgage securities and MSR-related assets 92,589
 (24,609)
Gain on sales of real estate owned (3,107) (1,398)
Gain on liquidation of residential whole loans (1,105) (4,684)
Impairment and other losses on securities available-for-sale and other assets 419,651
 
Accretion of purchase discounts on residential mortgage securities, residential whole loans and MSR-related assets (12,114) (15,915)
Amortization of purchase premiums on residential mortgage securities and residential whole loans, and amortization of terminated hedging instruments 15,266
 7,620
Depreciation and amortization on real estate, fixed assets and other assets 3,582
 432
Equity-based compensation expense 1,273
 998
Unrealized losses on residential whole loans at fair value 74,556
 1,060
Provision for credit and valuation losses on residential whole loans and other financial instruments 150,827
 
Unrealized losses on residential mortgage securities and interest rate swap agreements (“Swaps”) and other 82,464
 200
Increase in other assets (37,811) (8,770)
Decrease in other liabilities (9,653) (6,709)
Net cash provided by operating activities $13,214
 $37,082
     
Cash Flows From Investing Activities:  
  
Purchases of residential whole loans, loan related investments and capitalized advances $(1,119,464) $(1,021,557)
Principal payments on residential whole loans 508,855
 233,724
Principal payments on residential mortgage securities and MSR-related assets 539,882
 391,641
Proceeds from sales of residential mortgage securities 1,009,316
 208,306
Purchases of residential mortgage securities and MSR-related assets (162,607) (327,221)
Proceeds from sales of real estate owned 52,042
 23,963
Purchases of real estate owned and capital improvements (5,606) (5,923)
Additions to leasehold improvements, furniture and fixtures (176) (391)
Net cash provided by/(used in) investing activities $822,242
 $(497,458)
     
Cash Flows From Financing Activities:  
  
Principal payments on repurchase agreements $(12,903,818) $(18,879,173)
Proceeds from borrowings under repurchase agreements 12,216,862
 19,509,794
Principal payments on securitized debt (37,418) (25,501)
Payments made for settlements and unwinds of Swaps (88,405) (21,478)
Proceeds from issuance of Series C Preferred Stock 275,000
 
Payments made for costs related to Series C Preferred Stock issuance (8,912) 
Proceeds from issuances of common stock 687
 551
Dividends paid on preferred stock 
 (3,750)
Dividends paid on common stock and dividend equivalents (90,749) (90,198)
Net cash (used in)/provided by financing activities $(636,753) $490,245
Net increase in cash, cash equivalents and restricted cash $198,703
 $29,869
Cash, cash equivalents and restricted cash at beginning of period $134,664
 $88,709
Cash, cash equivalents and restricted cash at end of period $333,367
 $118,578
     
Supplemental Disclosure of Cash Flow Information    
Interest Paid $80,158
 $81,435
     
Non-cash Investing and Financing Activities:    
Transfer from residential whole loans to real estate owned $50,693
 $65,160
Dividends and dividend equivalents declared and unpaid $
 $90,353
Receivable for unsettled MBS, MSR-related asset, and residential whole loan sales $419,583
 $
The accompanying notes are an integral part of the consolidated financial statements.

6

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


 
1.   Organization
 
MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998.  The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes.  In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders.  The Company has elected to treat certain of its subsidiaries as a taxable REIT subsidiarysubsidiaries (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business. (See NotesNote 2(pn) and 12))
 
2.   Summary of Significant Accounting Policies
 
(a)  Basis of Presentation and Consolidation
 
The interim unaudited consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”).  Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted according toin accordance with these SEC rules and regulations.  Management believes that the disclosures included in these interim unaudited consolidated financial statements are adequate to make the information presented not misleading.  The accompanying unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.2019.  In the opinion of management, all normal and recurring adjustments necessary to present fairly the financial condition of the Company at September 30, 2017March 31, 2020 and results of operations for all periods presented have been made.  The results of operations for the three and ninemonths ended September 30, 2017March 31, 2020 should not be construed as indicative of the results to be expected for the full year.
 
The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with GAAP.  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition.  Management has made significant estimates in several areas, including other-than-temporary impairment, (“OTTI”)valuation allowances and loss allowances on MBSresidential whole loans (See Note 3), mortgage-backed securities (“MBS”) (See Note 4) and Other Assets (See Note 5), valuation of MBS, CRT securities and MSR relatedMSR-related assets (See Notes 34 and 15)14), income recognition and valuation of residential whole loans (See Notes 43 and 15)14), valuation of derivative instruments (See Notes 5(b)5(c) and 15)14) and income recognition on certain Non-Agency MBS (defined below) purchased at a discount. (See Note 3)4)  In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest. (See Note 2(pn))  Actual results could differ from those estimates.


The Company has one1 reportable segment assince it manages its business and analyzes and reports its results of operations on the basis of one1 operating segment;segment: investing, on a leveraged basis, in residential mortgage assets.
 
The consolidated financial statements of the Company include the accounts of all subsidiaries; allsubsidiaries. All intercompany accounts and transactions have been eliminated. In addition, the Company consolidates entities established to facilitate its loan securitization transaction as well astransactions related to the acquisition and securitization of residential whole loans.loans completed in prior years. Certain prior period amounts have been reclassified to conform to the current period presentation.



67

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


(b)  MBSResidential Whole Loans (including Non-Agency MBSResidential Whole Loans transferred to consolidated VIEs)

Residential whole loans included in the Company’s consolidated balance sheets are primarily comprised of pools of fixed- and CRTadjustable-rate residential mortgage loans acquired through consolidated trusts in secondary market transactions. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below for Purchased Credit Deteriorated Loans that are held at carrying value is typically utilized by the Company for Purchased Credit Deteriorated Loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The Company also acquires Purchased Performing Loans that are typically held at carrying value, but the accounting methods for income recognition and determination and measurement of any required credit loss reserves (as discussed below) differ from those used for Purchased Credit Deteriorated Loans held at carrying value. The accounting model described below for residential whole loans held at fair value is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically.  Purchases and sales of residential whole loans that are subject to an extended period of due diligence that crosses a reporting date are recorded in our balance sheet at amounts reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Residential whole loans purchased under flow arrangements with loan origination partners are generally recorded at the transaction settlement date. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any repurchase agreement financing until the closing of the purchase transaction. Interest income, credit related losses and changes in the fair value of loans held at fair value are recorded post settlement for acquired loans and until transaction settlement for sold loans. (See Notes 3, 6, 7, 14 and 15)

Residential Whole Loans at Carrying Value

Purchased Performing Loans

Acquisitions of Purchased Performing Loans to date have been primarily comprised of: (i) loans to finance (or refinance) one-to-four family residential properties that are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (“Non-QM loans”), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (“Rehabilitation loans” or “Fix and Flip loans”), (iii) loans to finance (or refinance) non-owner occupied one-to four-family residential properties that are rented to one or more tenants (“Single-family rental loans”), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (“Seasoned performing loans”). Purchased Performing Loans are initially recorded at their purchase price. Interest income on Purchased Performing Loans acquired at par is accrued based on each loan’s current interest bearing balance and current interest rate, net of related servicing costs. Interest income on such loans purchased at a premium/discount to par is recorded each period based on the contractual coupon net of any amortization of premium or accretion of discount, adjusted for actual prepayment activity. For loans acquired with related servicing rights retained by the seller, interest income is reported net of related serving costs.

An allowance for credit losses is recorded at acquisition, and maintained on an ongoing basis, for all losses expected to be incurred over the life of the respective loan. Any required credit loss allowance would reduce the net carrying value of the loan with a corresponding charge to earnings, and may increase or decrease over time. Significant judgments are required in determining any allowance for credit loss, including assumptions regarding the loan cash flows expected to be collected, the value of the underlying collateral and the ability of the Company to collect on any other forms of security, such as a personal guaranty provided either by the borrower or an affiliate of the borrower. Income recognition is suspended for loans at the earlier of the date at which payments become 90 days past due or when, in the opinion of management, a full recovery of income and principal becomes doubtful (i.e., such loans are placed on nonaccrual status). For nonaccrual loans other than Fix and Flip loans, all payments are applied to principal under the cost recovery method. For nonaccrual Fix and Flip loans, interest income is recorded under the cash basis method as interest payments are received. Interest accruals are resumed when the loan becomes contractually current and performance is demonstrated to be resumed. A loan is written off when it is no longer realizable and/or it is legally discharged. Modified loans are considered “troubled debt restructurings” if the Company grants a concession to a borrower who is experiencing financial difficulty (including the interpretation of this definition set forth in OCC Bulletin 2020-35).


8

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

The aggregate allowance for credit losses is equal to the sum of the losses expected to be incurred over the life of each respective loan. These losses were estimated by projecting each loan’s expected cash flows based on their contractual terms, expected prepayments, and estimated default and loss severity rates. The default and severity rates were estimated based on the following steps: (i) obtained the Company’s historical experience through an entire economic cycle for each loan type or, to the extent the Company did not have sufficient historical loss experience for a given loan type, publicly available data derived from the historical loss experience of certain banks, which data the Company believes is generally representative of its portfolio, (ii) obtained historical economic data (U.S. unemployment rates and home price appreciation) over the same period, and (iii) estimated default and severity rates during three distinct future periods based on historical default and severity rates during periods when economic conditions similar to those forecasted were experienced. The three periods were as follows: (i) a one-year forecast of economic conditions based on U.S. unemployment rates and home price appreciation, followed by (ii) a two-year “reversion” period during which economic conditions (U.S. unemployment rates and home price appreciation) are projected to revert to historical averages on a straight line basis, followed by (iii) the remaining life of each loan, during which period economic conditions (U.S. unemployment rates and home price appreciation) are projected to equal historical averages. In addition, a liability is established (and recorded in Other Liabilities) each period using a similar methodology for committed but undrawn loan amounts. This methodology has not changed from the calculation of the allowance for credit losses on January 1, 2020 pursuant to the transition to ASU 2016-13 as described below under “New Accounting Standards and Interpretations,” other than a change in the reversion period from one year to two years to reflect the expected ongoing impact of current conditions. (See Note 3)

Purchased Credit Deteriorated Loans

The Company has elected to account for these loans as credit impaired as they have experienced a more-than-insignificant deterioration in credit quality since origination and were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of these loans have previously experienced payment delinquencies and the amount owed may exceed the value of the property pledged as collateral. Consequently, these loans generally have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Loans considered credit impaired are initially recorded at the purchase price on a net basis, after establishing an initial allowance for credit losses (their initial cost basis is equal to their purchase price plus the initial allowance for credit losses). Subsequent to acquisition, the gross recorded amount for these loans reflects the initial cost basis, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded cost basis reduced by any allowance for credit losses. Interest income on such loans purchased is recorded each period based on the contractual coupon net of amortization of the difference between their cost basis and unpaid principal balance (“UPB”), subject to the Company’s nonaccrual policy.

Residential Whole Loans Held-for-Sale

The Company’s residential whole loans held-for-sale are presented on the Company’s consolidated balance sheets at the lower of the current carrying amount or fair value less estimated selling costs. Interest income on the Company’s residential whole loans held-for-sale is included in Residential whole loans held at carrying value on the Company’s consolidated statements of operations.

Residential Whole Loans at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at the time of acquisition. For the majority of these loans, there is significant uncertainty associated with estimating the timing of and amount of cash flows that will be collected. Further, the cash flows ultimately collected may be dependent on the value of the property securing the loan. Consequently, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns for the majority of these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party that specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net (loss)/gain on residential whole loans measured at fair value through earnings on the Company’s consolidated statements of operations.

Cash received representing coupon interest payments on residential whole loans held at fair value is not included in Interest Income, but rather is included in Net (loss)/gain on residential whole loans measured at fair value through earnings on the Company’s

9

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

consolidated statements of operations. Cash outflows associated with loan-related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in unrealized gains or losses reported each period.

(c)  Residential Mortgage Securities
 
The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by or sponsored by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Macthe issuer and the principal payments received are baseddependent on the performance of loans in either a reference pool or an actual pool of previously securitized MBS.loans. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a principal loss if certain defined credit events occur, including, for certain CRT securities, if the loans inperformance of the actual or reference pool experience delinquencies exceeding specified thresholds.loans results in either an actual or calculated loss that exceeds the credit enhancement of the security owned by the Company.
 
Designation
 
TheMBS that the Company generally intends to hold its MBS until maturity; however,maturity, but that it may sell from time to time it may sell any of its securities as part of the overall management of its business.  As a result, all of the Company’s MBSbusiness, are designated as “available-for-sale” (“AFS”) and, accordingly,. Such MBS are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTIallowance for losses is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.
 
Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.


The Company has elected the fair value option for certain of its Agency MBS that it does not intend to hold to maturity. These securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting to more appropriately reflect the risk sharingrisk-sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.
 
Revenue Recognition, Premium Amortization and Discount Accretion
 
Interest income on securities is accrued based on thetheir outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.
 
Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs.a change in the loss allowance.  (See Note 3)4)
 
Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income.  The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors.  If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time.  Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result.


710

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


Determination of Fair Value for MBS and CRTResidential Mortgage Securities
 
In determining the fair value of the Company’s MBS and CRTresidential mortgage securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity.  (See Note 15)14)
 
Impairments/OTTIAllowance for credit losses


When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities, as well as securities for which a credit loss allowance had been previously recorded, on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.”determines whether any changes to the allowance for credit losses are required.  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTIa write-down through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the OTTIimpairment related to credit losses is recognized through chargesa loss allowance charged to earnings with the remainder recognized through AOCI on the Company’s consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Following the recognition of an OTTICredit loss allowances are subject to reversal through earnings a new cost basis is established for the security and may not be adjusted for subsequent recoveriesresulting from improvements in fair value through earnings.  However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income.expected cash flows. The determination as to whether an OTTI exists and, if so, the amount ofto record (or reverse) a credit impairment recognized in earningsloss allowance is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections.  As a result, the timing and amount of OTTIslosses constitute material estimates that are susceptible to significant change.  (See Note 3)4)


Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, Fair Isaac Corporation (“FICO”) scores at loan origination, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations as well as reports by credit rating agencies, such as Moody’s Investors Services, Inc. (“Moody’s”), Standard & Poor’s Corporation (“S&P”) or Fitch, Inc. (collectively with Moody’s and S&P, “Rating Agencies”), general market assessments, and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the OTTIallowance related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS and CRT Securities that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.
 
Balance Sheet PresentationResidential Whole Loans at Fair Value

TheCertain of the Company’s MBS and CRT Securities pledged as collateral against repurchase agreements, Federal Home Loan Bank advances and Swapsresidential whole loans are includedpresented at fair value on theits consolidated balance sheets as a result of a fair value election made at the time of acquisition. For the majority of these loans, there is significant uncertainty associated with estimating the timing of and amount of cash flows that will be collected. Further, the cash flows ultimately collected may be dependent on the value of the property securing the loan. Consequently, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns for the majority of these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party that specializes in providing valuations of residential mortgage loans and trading activity observed in the securities pledged disclosed parenthetically.  Purchasesmarket place. Subsequent changes in fair value are reported in current period earnings and sales of securities are recordedpresented in Net (loss)/gain on residential whole loans measured at fair value through earnings on the trade date. Company’s consolidated statements of operations.


(c) MSR Related Assets

The Company has investments in financial instruments whose cash flows are considered to be largely dependentCash received representing coupon interest payments on underlying MSRs that either directly or indirectly act as collateral for the investment. These financial instruments, which are referred to as MSR related assets are discussed in more detail below. The Company’s MSR related assets pledged as collateral against repurchase agreements areresidential whole loans held at fair value is not included in the consolidated balance sheets with the amounts pledged disclosed parenthetically. Purchases and sales of MSR related assets are recordedInterest Income, but rather is included in Net (loss)/gain on residential whole loans measured at fair value through earnings on the trade date. (See Notes 3, 6, 7 and 15)Company’s


89

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020



consolidated statements of operations. Cash outflows associated with loan-related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in unrealized gains or losses reported each period.
Term Notes Backed by MSR Related Collateral

(c)  Residential Mortgage Securities
The Company has investedinvestments in term notesresidential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by special purpose vehicles (“SPV”) that have acquired rights to receive cash flows representingor sponsored by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by the servicing fees and/or excess servicing spread associated with certain MSRs. The Company considers payment ofissuer and the principal and interest on these term notes to be largelypayments received are dependent on the cash flows generatedperformance of loans in either a reference pool or an actual pool of loans. As the loans in the underlying pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a principal loss if the performance of the actual or reference pool loans results in either an actual or calculated loss that exceeds the credit enhancement of the security owned by the underlying MSRsCompany.
Designation
MBS that the Company generally intends to hold until maturity, but that it may sell from time to time as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holderspart of the term notes is also mitigated by structural credit support in the formoverall management of over-collateralization. Credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.

The Company’s term notes backed by MSR related collateralits business, are reporteddesignated as “available-for-sale” (“AFS”). Such MBS are carried at their fair value on the Company’s consolidated balance sheets with unrealized gains and losses excluded from earnings (except when an allowance for losses is recognized, as discussed below) and reported in AOCI. Interest incomeAccumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.
Upon the sale of an AFS security, any unrealized gain or loss is recognized on an accrual basisreclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company has elected the fair value option for certain of its Agency MBS that it does not intend to hold to maturity. These securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.

The Company’s valuation processCompany has elected the fair value option for such notescertain of its CRT securities as it considers a numberthis method of factors, including a comparable bond analysis performed by a third-party pricing service which involves determining a pricing spread at issuance ofaccounting to more appropriately reflect the term note. The pricing spread is used at each subsequent valuation date to determine an implied yield to maturity of the term note, which is then used to derive an indicative market value for the security. This indicative market value is further reviewed by the Company and may be adjusted to ensure it reflects a realistic exit price at the valuation date given the structural featuresrisk-sharing structure of these securities. Other factors taken into consideration include indicative values provided by repurchase agreement counterparties, estimatedSuch securities are carried at their fair value with changes in fair value ofincluded in earnings for the related underlying MSR collateralperiod and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient.

Corporate Loan

The Company has entered into a loan agreement with an entity that originates loans and owns the related MSRs. Under the terms of loan agreement, the Company has committed to lend $130.0 million of which approximately $101.1 million was drawn at September 30, 2017. The loan is secured by certain U.S. Government, Agency and private-label MSRs, as well as other unencumbered assets owned by the borrower. The term loan is recorded on the Company’s consolidated balance sheets at the drawn amount, on which interest income is recognized on an accrual basisreported in Other Income, net on the Company’s consolidated statements of operations. Commitment fees received
Revenue Recognition, Premium Amortization and Discount Accretion
Interest income on securities is accrued based on their outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the undrawn amounttime of purchase are deferred and recognized asamortized into interest income over the remaining loan termlife of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.
Interest income on Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the timesecurity’s effective interest rate which is the security’s internal rate of draw. At the endreturn (“IRR”). The IRR is determined using management’s estimate of the commitment period, any remaining deferred commitment fees will be recorded as Other Incomeprojected cash flows for each security, which are based on the Company’s consolidated statementsobservation of operations. The Company evaluatescurrent information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the recoverabilitytiming and amount of the loan oncredit losses. On at least a quarterly basis, by considering various factors, including the current statusCompany reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the loan, changeslast evaluation, may result in fair value of the MSRs that secure the loan and the recent financial performance of the borrower.

(d)  Residential Whole Loans (including Residential Whole Loans transferred to consolidated VIEs)

Residential whole loans includeda prospective change in the Company’s consolidated balance sheets are comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions generally at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally basedIRR/ interest income recognized on the delinquency status of the majority of the underlying borrowersthese securities or in the package at acquisition. The accounting model described below under “Residential Whole Loans at Carrying Value” is typically utilized by the Company for loans where the underlying borrower hasrecognition of a delinquency status of less than 60 days at the acquisition date. The accounting model described below under “Residential Whole Loans at Fair Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed.

The Company’s residential whole loans pledged as collateral against repurchase agreements are includedchange in the consolidated balance sheets with amounts pledged disclosed parenthetically.  Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any repurchase agreement financing until the closing of the purchase transaction.loss allowance.  (See Notes 4, 6, 7, 15 and 16)Note 4)


910

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020



Determination of Fair Value for Residential Mortgage Securities
Residential Whole Loans at Carrying Value

Notwithstanding thatIn determining the majority of these loans are considered to be performing substantially in accordance with their current contractual terms and conditions, the Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of the borrowers have previously experienced payment delinquencies and the amount owed on the mortgage loan may exceed thefair value of the property pledgedCompany’s residential mortgage securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as collateral. Consequently,well as management’s observations of market activity.  (See Note 14)
Allowance for credit losses

When the Company has assessed that these loans have a higher likelihoodfair value of defaultan AFS security is less than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers.its amortized cost at the balance sheet date, the security is considered impaired.  The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Such loans are initiallyassesses its impaired securities, as well as securities for which a credit loss allowance had been previously recorded, at the purchase price with no allowance for loan losses. Subsequent to acquisition, the recorded amount reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition.

Under the application of this accounting model the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loans basis for loans not aggregated into pools, the Company estimates at acquisition and periodically on at least a quarterly basis and determines whether any changes to the principalallowance for credit losses are required.  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize a write-down through charges to earnings equal to the entire difference between the investment’s amortized cost and interestits fair value at the balance sheet date.  If the Company does not expect to sell an impaired security, only the portion of the impairment related to credit losses is recognized through a loss allowance charged to earnings with the remainder recognized through AOCI on the Company’s consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Credit loss allowances are subject to reversal through earnings resulting from improvements in expected cash flows. The determination as to whether to record (or reverse) a credit loss allowance is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of future performance and cash flow projections.  As a result, the timing and amount of losses constitute material estimates that are susceptible to significant change.  (See Note 4)

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the allowance related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected. The difference betweencollected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected andat the carrying amountcurrent financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and theremaining cash flows expected to be collected is referred to asagainst the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the lifeamortized cost of the underlying loans.

A decrease in expected cash flows in subsequent periods may indicate impairmentsecurity at the pool and/or individual loan level, thus requiring the establishment of an allowance for loan losses by a chargeassessment date.  The discount rate used to the provision for loan losses. The allowance for loan losses representscalculate the present value of cash flowsthe expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. A significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expectedfuture cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield.based on the instrument’s IRR.

Residential Whole Loans at Fair Value


Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at the time of acquisition. GivenFor the majority of these loans, there is significant uncertainty associated with estimating the timing of and amount of cash flows associated with these loans that will be collected, and thatcollected. Further, the cash flows ultimately collected may be dependent on the value of the property securing the loan,loan. Consequently, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns fromfor the majority of these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party whothat specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. Subsequent changes in fair value are reported in current period earnings and presented in Net (loss)/gain on residential whole loans heldmeasured at fair value through earnings on the Company’s consolidated statements of operations.


Cash received reflectingrepresenting coupon interest payments on residential whole loans held at fair value is not included in Interest Income, but rather is presentedincluded in Net (loss)/gain on residential whole loans heldmeasured at fair value through earnings on the Company’s

9

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

consolidated statements of operations. Cash outflows associated with loan-related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in Netunrealized gains or losses reported each period.

(c)  Residential Mortgage Securities
The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by or sponsored by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by the issuer and the principal payments received are dependent on the performance of loans in either a reference pool or an actual pool of loans. As the loans in the underlying pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a principal loss if the performance of the actual or reference pool loans results in either an actual or calculated loss that exceeds the credit enhancement of the security owned by the Company.
Designation
MBS that the Company generally intends to hold until maturity, but that it may sell from time to time as part of the overall management of its business, are designated as “available-for-sale” (“AFS”). Such MBS are carried at their fair value with unrealized gains and losses excluded from earnings (except when an allowance for losses is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity.
Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method.

The Company has elected the fair value option for certain of its Agency MBS that it does not intend to hold to maturity. These securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on residential whole loans heldthe Company’s consolidated statements of operations.

The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting to more appropriately reflect the risk-sharing structure of these securities. Such securities are carried at their fair value.value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statements of operations.


Revenue Recognition, Premium Amortization and Discount Accretion
Interest income on securities is accrued based on their outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity.
Interest income on Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of a change in the loss allowance.  (See Note 4)

10

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


(e)Determination of Fair Value for Residential Mortgage Securities Obtained
In determining the fair value of the Company’s residential mortgage securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and Pledgedrepurchase agreement counterparties, dialogue with market participants, as Collateral/Obligationwell as management’s observations of market activity.  (See Note 14)
Allowance for credit losses

When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired.  The Company assesses its impaired securities, as well as securities for which a credit loss allowance had been previously recorded, on at least a quarterly basis and determines whether any changes to Return Securities Obtainedthe allowance for credit losses are required.  If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize a write-down through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date.  If the Company does not expect to sell an impaired security, only the portion of the impairment related to credit losses is recognized through a loss allowance charged to earnings with the remainder recognized through AOCI on the Company’s consolidated balance sheets.  Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings.  Credit loss allowances are subject to reversal through earnings resulting from improvements in expected cash flows. The determination as to whether to record (or reverse) a credit loss allowance is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of future performance and cash flow projections.  As a result, the timing and amount of losses constitute material estimates that are susceptible to significant change.  (See Note 4)

Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS.  The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations and dialogue with market participants.  As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS.  In determining the allowance related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date.  The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes.  Impairment assessment for Non-Agency MBS that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date.  The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR.
Balance Sheet Presentation
The Company’s residential mortgage securities pledged as collateral against repurchase agreements and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically.  Purchases and sales of securities are recorded on the trade date. 

(d) MSR-Related Assets

The Company has investments in financial instruments whose cash flows are considered to be largely dependent on underlying MSRs that either directly or indirectly act as collateral for the investment. These financial instruments, which are referred to as MSR-related assets, are discussed in more detail below. The Company’s MSR-related assets pledged as collateral against repurchase agreements are included in the consolidated balance sheets with the amounts pledged disclosed parenthetically. Purchases and sales of MSR-related assets are recorded on the trade date. (See Notes 4, 6, 7 and 14)

Term Notes Backed by MSR-Related Collateral
 
The Company has invested in term notes that are issued by special purpose vehicles (“SPV”) that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. The Company

11

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

considers payment of principal and interest on these term notes to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. Credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient.

The Company’s term notes backed by MSR-related collateral are treated as AFS securities and reported at fair value on the Company’s consolidated balance sheets with unrealized gains and losses excluded from earnings and reported in AOCI, subject to impairment and loss allowances. Interest income is recognized on an accrual basis on the Company’s consolidated statements of operations. The Company’s valuation process for such notes is similar to that used for residential mortgage securities and considers a number of observable market data points, including prices obtained securitiesfrom pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. Other factors taken into consideration include estimated changes in fair value of the related underlying MSR collateral, under collateralizedas applicable, and the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient.

Corporate Loans
The Company has made or participated in loans to provide financing arrangements in connection with its financing strategy for Non-Agency MBS.  Securities obtainedto entities that originate residential mortgage loans and own the related MSRs. These corporate loans are generally secured by certain MSRs, as collateral in connection with these transactionswell as certain other unencumbered assets owned by the borrower.

Corporate loans are recorded on the Company’s consolidated balance sheets at the drawn amount, on which interest income is recognized on an accrual basis on the Company’s consolidated statements of operations, subject to loss allowances. Commitment fees received on the undrawn amount are deferred and recognized as an asset along withinterest income over the remaining loan term at the time of draw. At the end of the commitment period, any remaining deferred commitment fees are recorded as Other Income on the Company’s consolidated statements of operations. The Company evaluates the recoverability of its corporate loans on a liability representingquarterly basis considering various factors, including the obligation to returncurrent status of the collateral obtained, atloan, changes in the fair value.  While beneficial ownershipvalue of securities obtained remains with the counterparty,MSRs that secure the Company hasloan and the right to transferrecent financial performance of the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction.  (See Note 2(l) for Repurchase Agreements and Reverse Repurchase Agreements)borrower.


(f)(e)  Cash and Cash Equivalents
 
Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less.  Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement and/or Swap counterparties as a result of reverse margin calls (i.e., margin calls made by the Company).  The Company did not hold any cash pledged by its counterparties at September 30, 2017 or March 31, 2020 and December 31, 2016.  The Company’s2019. At March 31, 2020 and December 31, 2019, the Company had cash and cash equivalents of $116.5 million and $70.6 million, respectively. At March 31, 2020, the Company had 0 investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation (“FDIC”) or any other government agency, were $568.3 million and $208.9 million at September 30, 2017 andagency. As of December 31, 2016, respectively.2019, the Company had $39.6 million worth of investments in overnight money market funds. In addition, deposits in FDIC insured accounts generally exceed insured limits. (See Notes 7 and 15)14)
 
(g) (f) Restricted Cash
 
Restricted cash represents the Company’s cash held by its counterparties in connection with certain of the Company’s Swaps and/or repurchase agreements that is not available to the Company for general corporate purposes. Restricted cash may be applied against amounts due to repurchase agreement and/or Swap counterparties, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap and/or repurchase agreement.agreements.  The Company had aggregate restricted cash held as collateral or otherwise in connection with its Swaps and repurchase agreements and/or Swaps of $15.4$216.9 million and $58.5$64.0 million at September 30, 2017March 31, 2020 and December 31, 20162019, respectively.  (See Notes 5(b)5(c), 6, 7 and 15)14)
 
(h)  Goodwill

At September 30, 2017 and December
12

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2016, the Company had goodwill of $7.2 million, which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998.  Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level.  Through September 30, 2017, the Company had not recognized any impairment against its goodwill. Goodwill is included in Other assets on the Company’s consolidated balance sheets.2020


(i)(g) Real Estate Owned (“REO”)
 
REO represents real estate acquired by the Company, including through foreclosure, deed in lieu of foreclosure, or purchased in connection with the acquisition of residential whole loans. REO acquired through foreclosure or deed in lieu of foreclosure is initially recorded at fair value less estimated selling costs. REO acquired in connection with the acquisition of residential whole loans is initially recorded at its purchase price. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. The Company has acquired certain properties that it holds for investment purposes, including rentals to third parties. These properties are held at their historical basis less depreciation, and are subject to impairment. Related rental income and expenses are recorded in Other Income, net. (See Note 5(a))5)


(j)(h)  Depreciation
 
Leasehold Improvements, Real estate and Other Depreciable Assets
 
Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term.  Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase. The building component of real estate held-for-investment is depreciated over 27.5 years.
 

11

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

(k)  MBS Resecuritization,(i)  Loan Securitization and Other Debt Issuance Costs
 
MBS resecuritization and loanLoan securitization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various MBS resecuritization and loan securitizationfinancing transactions completed by the Company.  Other debt issuance and related costs include costs incurred by the Company in connection with issuing its 6.25% Convertible Senior Notes due 2024 (“Convertible Senior Notes”), 8% Senior Notes due 2042 (“Senior Notes”) and certain other repurchase agreement financings. These costs may include underwriting, rating agency, legal, accounting and other fees.  Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For the Convertible Senior Notes, Senior Notes and other repurchase agreement financings, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and, in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations.


(l)(j)  Repurchase Agreements and Other Advances
Repurchase Agreements


The Company finances the holdings of a significant portion of its residential mortgage assets with repurchase agreements.  Under repurchase agreements, the Company sells securitiesassets to a lender and agrees to repurchase the same securitiesassets in the future for a price that is higher than the original sale price.  The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender.  Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securitiesassets as collateral to secure the borrowing, in an amount which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral.  At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan including any accrued interest and concurrently receives back its pledged collateral from the lender.  With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms.  Margin calls, whereby a lender requires that the Company pledge additional securitiesassets or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBSassets pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions.  The Company also may make margin calls on counterparties when collateral values increase.
 
The Company’s repurchase financings collateralized by residential mortgage securities and MSR-related assets typically have terms ranging from one month to six months at inception, but may alsowhile a significant amount of our repurchase financings collateralized by residential whole loans have longerterms ranging from three months to twelve months or shorter terms.longer.  Should a counterparty decide not

13

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation.  If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable oron such collateral.  (See Notes 6, 7 and 15)14)
 
In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company has entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty.  Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price.  The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower.  In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement.  No net cash was exchanged between the Company and counterparty at the inception of the transactions.  Securities obtained and pledged as collateral are recorded as an asset on the Company’s consolidated balance sheets.  Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis.  Both the Company and the counterparty have the right to make daily margin calls based on changes in the value of the collateral obtained and/or pledged.  The Company’s liability to the counterparty in connection with this financing arrangement is recorded on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.”  (See Note 2(e))

12

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017


Federal Home Loan Bank (“FHLB”) Advances

In January 2016, the Federal Housing Finance Agency (the “FHFA”) released its final rule amending its regulation on FHLB membership, which, among other things, provided termination rules for then current captive insurance members. As a result of such regulation, the Company’s wholly-owned subsidiary, MFA Insurance, Inc. (“MFA Insurance”) was required to repay all of its outstanding FHLB advances by February 19, 2017 and its FHLB membership was terminated on such date. FHLB advances were secured financing transactions and were carried at their contractual amounts. Accrued interest payable on FHLB advances is included in Other liabilities on the Company’s consolidated balance sheet at December 31, 2016. (See Notes 6, 7 and 15)(k)  Equity-Based Compensation
 
(m)  Equity-Based Compensation
Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date. For certain awards granted prior to January 1, 2017, compensation expense recognized included the impact of estimated forfeitures, with any changes in estimated forfeiture rates accounted for as a change in estimate. Upon adoption of new accounting guidance that was effective for the Company on January 1, 2017, the Company made a policy election to account for forfeitures as they occur. (See Note 2(u))
 
From 2011 through 2013, the Company granted certain restricted stock units (“RSUs”) that vested annually over a one or three-year period, provided that certain criteria were met, which were based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period.  Starting in 2014, theThe Company has made annual grants of RSUsrestricted stock units (“RSUs”) certain of which cliff vest after a three-year period, subject only to continued employment, and others of which cliff vest after a three-year period, subject to both continued employment and the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholdershareholder return during that three-year period.period, as well as the total shareholder return (“TSR”) of the Company relative to the TSR of a group of peer companies (over the three-year period) selected by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) at the date of grant. The features in these awards related to the attainment of total stockholdershareholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards.  Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which is recognized as compensation expense over the relevant vesting period.  The amount of compensation expense recognized is not dependent on whether the market condition was or will be achieved.
 
The Company has awardedmakes dividend equivalentsequivalent payments in connection with certain of its equity-based awards.   A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Company’s Equity Compensation Plan (the “Equity Plan”), and they are paid in cash or other consideration at such times and in accordance with such rules, terms and conditions, as the Compensation Committee may determine in its discretion.  Payments pursuant to dividend equivalents are generally charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest.  Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards (i) do not or are not expected to vest and (ii) grantees are not required to return payments of dividends or dividend equivalents to the Company.  (See Notes 2(n)2(l) and 14)13)
 
(n)(l)  Earnings per Common Share (“EPS”)
 
Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and an estimate of other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares.  In applying the two-class method, earnings are allocated to both shares of common stock and estimated securities that participate in dividends based on their respective weighted-average shares outstanding for the period.  For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method.  Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period.  In addition, the Company’s Convertible Senior Notes are included in the calculation of diluted EPS if the assumed conversion into common shares is dilutive, using the “if-converted” method. This involves adding back the periodic interest expense associated with the Convertible Senior Notes to the numerator and by adding the shares that would be issued in an assumed conversion (regardless of whether the conversion option is in or out of the money) to the denominator for the purposes of calculating diluted EPS. (See Note 13)12)
 
(o)(m)  Comprehensive Income/(Loss)
 
The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock.
 


1314

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


(p)(n)  U.S. Federal Income Taxes


The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”), and the corresponding provisions of state law.  The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT for federal income tax purposes. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code.  As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe.  Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year.  As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no0 provision for current or deferred income taxes has been made in the accompanying consolidated financial statements.  Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% of its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations.


In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a domestic TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may beis conducted through one or more TRS, itsthe net taxable income earned by its domestic TRS, may beif any, is subject to corporate income taxation. To maintain the Company’s REIT election, no more than 25% (or, for 2018 and subsequent taxable years, 20%) of the value of a REIT’sthe Company’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U.S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. NoNaN net deferred tax benefit was recorded by the Company for the ninethree months ended September 30, 2017March 31, 2020 and 2016, as2019, related to the net taxable losses in the TRS, since a valuation allowance for the full amount of the associated deferred tax asset of approximately $73.5 million was recognized as its recovery is not considered more likely than not. The related net operating loss carryforwards generated prior to 2018 will begin to expire in 2034; those generated in 2020, 2019 and 2018 can be carried back to each of the five taxable years preceding the taxable year of such loss and thereafter can be carried forward and do not expire.


 Based on its analysis of any potentialpotentially uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of September 30, 2017,March 31, 2020, December 31, 2016,2019, or September 30, 2016. The Company filed its 2016 tax return prior to October 16, 2017. TheMarch 31, 2019. As of the date of this filing the Company’s tax returns for tax years 20132016 through 20162018 are open to examination.


(q)(o)  Derivative Financial Instruments
 
The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currentlyhave generally been comprised of Swaps, the majority of which arewere designated as cash flow hedges against the interest rate risk associated with its borrowings.


Swaps
 
The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions.  The Company assesses, both at the inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.”
 

15

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

Swaps are carried on the Company’s consolidated balance sheets at fair value, in Other assets, if their fair value is positive, or in Other liabilities, if their fair value is negative.  Beginning inSince January 2017, variation margin payments on the Company’s

14

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

Swaps that have been novated to a clearing house arehave been treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the related Swap contract. The effect of this change is to reduce what would have otherwise been reported as the fair value of the Swap. All of the Company’s Swaps were novated to a central clearing house. Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective.  ChangesPeriodic payments accrued in fair value for any ineffective amount of a Swap are recognized in earnings.  The Company has not recognized any change in the value of its existingconnection with Swaps designated as hedges through earningsare included in interest expense and are treated as a result of hedge ineffectiveness.an operating cash flow.


The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate. (See Notes 5(c), 7 and 14)


As of September 30, 2017, allChanges in the fair value of the Company’s Swaps have been novated to a central clearing house. (See Notes 5(b), 7 and 15)not designated in hedging transactions are recorded in Other income, net on the Company’s consolidated statements of operations.


(r)(p)  Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities
 
The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability.  The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability.  This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value.  In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. 


In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans, Agency MBS and CRT securities at the time of acquisition. Subsequent changes in the fair value of these loans and CRT securitiesfinancial instruments are reported in Net gain on residential whole loans held at fair value and Other income, net, respectively onin the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable. (See Notes 2(dc), 2(b), 4, 3 and 15)14)


(s)(q)  Variable Interest Entities
 
An entity is referred to as a VIE if it meets at least one of the following criteria:  (i) the entity has equity that is insufficient to permit the entity to finance its activities without the additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) the holders of the equity investment at risk have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionately few voting rights.
 
The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.   The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE.
 
The Company has in prior years entered into several MBS resecuritizationfinancing transactions and during the second quarter of 2017, completed a loan securitization transaction which resulted in the Company consolidating the VIEs that were createdforming entities to facilitate these transactions.  In determining the accounting treatment to be applied to these transactions, the Company concluded that the entities used to facilitate these transactions wereare VIEs and that they should be consolidated.  If the Company had determined that consolidation was not required, it would have then assessed whether the transfers of the underlying assets would qualify as sales or should be accounted for as secured financings under GAAP. (See Note 16)15)




1516

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


The Company also includes on its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and/or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance.


(t)(r)  Offering Costs Related to Issuance and Redemption of Preferred Stock


Offering costs related to the issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS.

(u)(s)  New Accounting Standards and Interpretations

Accounting Standards Adopted in 20172020


CompensationFinancial Instruments - Stock CompensationCredit Losses - Improvements to Employee Share-Based Payment AccountingMeasurement of Credit Losses on Financial Instruments


In MarchJune 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU” 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) 2016-09, , which has subsequently been amended by ASUs 2019-11, Codification Improvements to Employee Share-Based PaymentTopic 326, Financial Instruments - Credit Losses, 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief, 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, 2020-02 Financial Instruments-Credit Losses (Topic 326)-Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting (“ASU 2016-09”). Bulletin No. 119 and Update to SEC Section on Effective Date (SEC Update), and 2020-03 Codification Improvements to Financial Instruments. The amendments in ASU 2016-13 require entities to measure all expected credit losses (rather than incurred losses) for financial assets held at the reporting date, based on historical experience, current conditions and reasonable and supportable forecasts. ASU 2016-13 also requires enhanced financial statement disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. The amendments in this ASU were required to be applied by recording a cumulative-effect adjustment to equity as of the beginning of the first reporting period in which the guidance is effective. A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The Company adopted the new ASU on January 1, 2020. The impact of adoption was that the allowance for credit losses on Purchased Performing Loans increased by approximately $8.3 million. This transition adjustment was recorded as an increase in the Company’s allowance for credit losses and an adjustment to decrease retained earnings as of the adoption date. In addition, for Purchased Credit Deteriorated Loans, the carrying value of the portfolio was adjusted on transition to include an estimate of the allowance for credit losses as required by the new standard. For financial statement reporting purposes, this adjusted carrying value is presented net of the estimated allowance for credit losses. Consequently, the adjustments recorded on transition for Purchased Credit Deteriorated Loans do not result in any adjustment to retained earnings as of the adoption date. The Company does not consider these transition adjustments to be material to its financial position or previously reported GAAP or economic book value.

Under ASU 2016-13, credit losses for available-for-sale debt securities are measured in a manner similar to prior GAAP. However, the amendments in this ASU require all income tax effects of awardsthat credit losses be recorded through an allowance for credit losses, which will allow subsequent reversals in credit loss estimates to be recognized in current income. In addition, the income statement whenallowance on available-for-sale debt securities will be limited to the awards vest orextent that the fair value is less than the amortized cost. Under prior GAAP, credit impairment losses were generally required to be recorded as “other than temporary” impairment, which directly reduced the carrying amount of impaired securities, and was recorded in earnings and was not reversed if expected cash flows subsequently recovered. Under the new guidance, credit impairments on such securities (other than those related to expected sales) are settled. ASU 2016-09recorded as an allowance for credit losses that is also allows an employerrecorded in earnings, but the allowance can be reversed through earnings in a subsequent period if expected cash flows subsequently recover. Transition to repurchase more of an employee’s shares than it could prior to adoption of this ASU for tax withholding purposes without triggering liability accounting and to make a policy election to account for forfeitures as they occur. ASU 2016-09 was effective for the Company for annual periods, and interim periods within those annual periods, beginning after December 15, 2016. The Company’s adoption of ASU 2016-09new available-for-sale debt securities guidance did not haveresult in a significant impact on its financial position or financial statement disclosures.change to our retained earnings.





1617

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting

In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). The amendments in this ASU provide temporary optional expedients to ease the financial reporting burden of the expected transition from the London Interbank Offered Rate (“LIBOR”) to an alternative reference rate such as the Secured Overnight Financing Rate (“SOFR”). The amendments in the ASU are elective and apply to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The amendments in ASU 2020-04 were effective for all entities as of March 12, 2020 and will generally no longer be available to apply after December 31, 2022. The Company adopted this ASU as of the effective date and will utilize the optional expedients to the extent that they apply to the Company.

18

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

3.            ��MBS, CRT    Residential Whole Loans

Included on the Company’s consolidated balance sheets at March 31, 2020 and December 31, 2019 are approximately $7.0 billion and $7.4 billion, respectively, of residential whole loans arising from the Company’s interests in certain trusts established to acquire the loans and certain entities established in connection with its loan securitization transactions. The Company has assessed that these entities are required to be consolidated for financial reporting purposes.

Residential Whole Loans, at Carrying Value

The following table presents the components of the Company’s Residential whole loans, at carrying value at March 31, 2020 and December 31, 2019:
(Dollars In Thousands) March 31, 2020 December 31, 2019
Purchased Performing Loans:    
Non-QM loans (1)
 $3,538,725
 $3,707,245
Rehabilitation loans 978,965
 1,026,097
Single-family rental loans 506,352
 460,742
Seasoned performing loans 165,592
 176,569
Total Purchased Performing Loans 5,189,634
 5,370,653
Purchased Credit Deteriorated Loans (2)
 744,408
 698,717
Total Residential whole loans, at carrying value $5,934,042
 $6,069,370
Allowance for credit and valuation losses on residential whole loans held at carrying value and held-for-sale (218,011) (3,025)
Total Residential whole loans at carrying value, net $5,716,031
 $6,066,345
     
Number of loans 16,999
 17,082


(1)Includes Non-QM loans held-for-sale with an amortized cost of $965.5 million and a net carrying value of $895.3 million at March 31, 2020.
(2)The amortized cost basis of Purchased Credit Deteriorated Loans was increased by $62.6 million on January 1, 2020 in connection with the adoption of ASU 2016-13.

The following table presents the components of interest income on the Company’s Residential whole loans, at carrying value and held-for-sale for the three months ended March 31, 2020 and 2019:
  Three Months Ended
March 31,
 (In Thousands) 2020 2019
Purchased Performing Loans:    
Non-QM loans (1)
 $49,070
 $22,414
Rehabilitation loans 15,327
 9,933
Single-family rental loans 7,343
 2,701
Seasoned performing loans 2,600
 3,173
Total Purchased Performing Loans 74,340
 38,221
Purchased Credit Deteriorated Loans 9,146
 11,399
Total Residential whole loans, at carrying value $83,486
 $49,620


(1)Includes interest income on Non-QM loans held-for-sale at March 31, 2020.


19

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

The following table presents additional information regarding the Company’s Residential whole loans, at carrying value and held-for-sale at March 31, 2020:

March 31, 2020
  Carrying Value Amortized Cost Basis Unpaid Principal Balance (“UPB”) 
Weighted Average Coupon (1)
 Weighted Average Term to Maturity (Months) 
Weighted Average LTV Ratio (2)
 
Weighted Average Original FICO (3)
 Aging by Amortized Cost Basis
           Past Due Days
(Dollars In Thousands)        Current 30-59 60-89 90+
Purchased Performing Loans:                      
Non-QM loans (4)(5)
 $3,434,894
 $3,538,725
 $3,424,646
 5.84% 363 66% 717 $3,450,648
 $50,584
 $13,058
 $24,435
Rehabilitation loans (4)
 943,332
 978,965
 978,965
 7.24
 7 64
 720 806,413
 61,723
 20,973
 89,856
Single-family rental loans (4)
 498,921
 506,352
 501,925
 6.28
 322 70
 734 482,499
 17,536
 2,009
 4,308
Seasoned performing loans (4)
 165,343
 165,592
 180,421
 4.11
 178 42
 723 160,944
 1,670
 1,099
 1,879
Purchased Credit Deteriorated Loans (4)(6)
 673,541
 744,408
 858,122
 4.46
 292 80
 N/A N/M
 N/M
 N/M
 87,179
Residential whole loans, at carrying value, total or weighted average $5,716,031
 $5,934,042
 $5,944,079
 5.88% 285            

December 31, 2019
  Carrying Value Amortized Cost Basis Unpaid Principal Balance (“UPB”) 
Weighted Average Coupon (1)
 Weighted Average Term to Maturity (Months) 
Weighted Average LTV Ratio (2)
 
Weighted Average Original FICO (3)
 Aging by UPB
           Past Due Days
(Dollars In Thousands)        Current 30-59 60-89 90+
Purchased
   Performing Loans:
                      
Non-QM loans (4)
 $3,706,857
 $3,707,245
 $3,592,701
 5.96% 368 67% 716 $3,492,533
 $59,963
 $19,605
 $20,600
Rehabilitation loans (4)
 1,023,766
 1,026,097
 1,026,097
 7.30
 8 64
 717 868,281
 67,747
 27,437
 62,632
Single-family rental loans (4)
 460,679
 460,741
 457,146
 6.29
 324 70
 734 432,936
 15,948
 2,047
 6,215
Seasoned performing loans 176,569
 176,569
 192,151
 4.24
 181 46
 723 187,683
 2,164
 430
 1,874
Purchased Credit Impaired Loans (6)
 698,474
 698,718
 873,326
 4.46
 294 81
 N/A N/M
 N/M
 N/M
 108,998
Residential whole loans, at carrying value, total or weighted average $6,066,345
 $6,069,370
 $6,141,421
 5.96% 288            

(1)Weighted average is calculated based on the interest bearing principal balance of each loan within the related category. For loans acquired with servicing rights released by the seller, interest rates included in the calculation do not reflect loan servicing fees. For loans acquired with servicing rights retained by the seller, interest rates included in the calculation are net of servicing fees.
(2)LTV represents the ratio of the total unpaid principal balance of the loan to the estimated value of the collateral securing the related loan as of the most recent date available, which may be the origination date. For Rehabilitation loans, the LTV presented is the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated “after repaired” value of the collateral securing the related loan, where available. For certain Rehabilitation loans, totaling $259.4 million and $269.2 million at March 31, 2020 and December 31, 2019, respectively, an after repaired valuation was not obtained and the loan was underwritten based on an “as is” valuation. The weighted average LTV of these loans based on the current unpaid principal balance and the valuation obtained during underwriting, is 68% and 69% at March 31, 2020 and December 31, 2019, respectively. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.
(3)Excludes loans for which no Fair Isaac Corporation (“FICO”) score is available.
(4)At March 31, 2020 and December 31, 2019 the difference between the Carrying Value and Amortized Cost Basis represents the related allowance for credit losses.
(5)
Includes Non-QM loans held-for-sale with a net carrying value of $895.3 millionatMarch 31, 2020.
(6)Purchased Credit Deteriorated Loans tend to be characterized by varying performance of the underlying borrowers over time, including loans where multiple months of payments are received in a period to bring the loan to current status, followed by months where no payments are received. Accordingly, delinquency information is presented for loans that are more than 90 days past due that are considered to be seriously delinquent.


During three months ended March 31, 2020, $659.9 million of Non-QM loans were sold, realizing losses of $145.8 million.

20

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020



Allowance for Credit Losses

The following table presents a roll-forward of the allowance for credit losses on the Company’s Residential Whole Loans, at Carrying Value:
  Three Months Ended March 31, 2020
(Dollars In Thousands) 
Non-QM Loans (1)
 
Rehabilitation Loans (2)(3)
 Single-family Rental Loans Seasoned Performing Loans 
Purchased Credit Deteriorated Loans (4)
 Totals
Allowance for credit losses at beginning of period $388
 $2,331
 $62
 $
 $244
 $3,025
Transition adjustment on adoption of ASU 2016-13 (5)
 6,904
 517
 754
 19
 62,361
 70,555
Current provision 26,358
 33,213
 6,615
 230
 8,481
 74,897
Write-offs 
 (428) 
 
 (219) (647)
Valuation adjustment on loans held for sale 70,181
 
 
 
 
 70,181
Allowance for credit and valuation losses at end of period $103,831
 $35,633
 $7,431
 $249
 $70,867
 $218,011

  Three Months Ended March 31, 2019
(Dollars In Thousands) Non-QM Loans Rehabilitation Loans Single-family Rental Loans Seasoned Performing Loans Purchased Credit Deteriorated Loans Totals
Allowance for credit losses at beginning of period $
 $
 $
 $
 $968
 $968
Current provision 388
 2,843
 62
 
 (724) 2,569
Write-offs 
 (512) 
 
 
 (512)
Allowance for credit losses at end of period $388
 $2,331
 $62
 $
 $244
 $3,025

(1)
Includes Non-QM loans held-for-sale with a net carrying value of $895.3 million at March 31, 2020.
(2)In connection with purchased Rehabilitation loans, the Company had unfunded commitments of $123.1 million, with an allowance for credit losses of $3.5 million at March 31, 2020. Such allowance is included in “Other liabilities” on the Company’s Balance Sheet (see Note 9)
(3)Includes $110.8 million of loans that were assessed for credit losses based on a collateral dependent methodology.
(4)Includes $74.5 million of loans that were assessed for credit losses based on a collateral dependent methodology.
(5)Of the $70.6 million of reserves recorded on adoption of ASU 2016-13, $8.3 million was recorded as an adjustment to stockholders’ equity and $62.4 million was recorded as a “gross up” of the amortized cost basis of Purchased Credit Deteriorated Loans.

The Company adopted ASU 2016-13 (“CECL”) on January 1, 2020. (See Note 2) The anticipated impact of the COVID-19 pandemic on expected economic conditions, including forecasted unemployment, home price appreciation, and prepayment rates, for the short to medium term has resulted in significantly increased estimates of credit losses recorded under CECL for the first quarter of 2020 for residential whole loans held at carrying value. As of March 31, 2020, the Company expects relatively high rates of unemployment and other deteriorated market conditions to continue for an extended period, resulting in increased delinquencies and defaults. Estimates of credit losses under CECL are highly sensitive to changes in assumptions and current economic conditions have increased the difficulty of accurately forecasting future conditions. In addition, a valuation allowance to reduce the carrying value of Non-QM loans designated as held-for-sale at quarter-end of $70.2 million was recorded.

The amortized cost basis of Purchased Performing Loans on nonaccrual status as of March 31, 2020 and December 31, 2019 was $134.4 million and $99.9 million, respectively. The amortized cost basis of Purchased Credit Deteriorated Loans on nonaccrual status as of March 31, 2020 was $99.0 million. Because Purchase Credit Deteriorated Loans were previously accounted for in pools, there were no such loans on nonaccrual status as of December 31, 2019. No material interest income was recognized from loans on nonaccrual status during the three months ended March 31, 2020. At March 31, 2020, there were no loans on nonaccrual status that did not have an associated allowance for credit losses.


21

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

The following table presents certain additional credit-related information regarding our residential whole loans, at carrying value:
  Amortized Cost Basis by Origination Year and LTV Bands
(Dollars In Thousands) 2020 2019 2018 2017 2016 Prior Total
Non-QM loans (1)
              
LTV < 80% (2)
 $252,458
 $1,331,053
 $790,056
 $92,314
 $9,055
 $
 $2,474,936
LTV >= 80% (2)
 23,015
 33,783
 31,888
 9,494
 150
 
 98,330
Total Non-QM loans $275,473
 $1,364,836
 $821,944
 $101,808
 $9,205
 $
 $2,573,266
Three Months Ended March 31, 2020 Gross write-offs $
 $
 $
 $
 $
 $
 $
Three Months Ended March 31, 2020 Recoveries 
 
 
 
 
 
 
Three Months Ended March 31, 2020 Net write-offs $
 $
 $
 $
 $
 $
 $
               
Rehabilitation loans              
LTV < 80% (2)
 $48,534
 $735,912
 $160,334
 $8,243
 $
 $
 $953,023
LTV >= 80% (2)
 4,984
 17,470
 1,788
 1,700
 
 
 25,942
Total Rehabilitation loans $53,518
 $753,382
 $162,122
 $9,943
 $
 $
 $978,965
Three Months Ended March 31, 2020 Gross write-offs $
 $
 $334
 $
 $
 $94
 $428
Three Months Ended March 31, 2020 Recoveries 
 
 
 
 
 
 
Three Months Ended March 31, 2020 Net write-offs $
 $
 $334
 $
 $
 $94
 $428
               
Single family rental loans              
LTV < 80% (2)
 $21,623
 $305,098
 $149,270
 $14,060
 $
 $
 $490,051
LTV >= 80% (2)
 2,576
 13,514
 211
 
 
 
 16,301
Total Single family rental loans $24,199
 $318,612
 $149,481
 $14,060
 $
 $
 $506,352
Three Months Ended March 31, 2020 Gross write-offs $
 $
 $
 $
 $
 $
 $
Three Months Ended March 31, 2020 Recoveries 
 
 
 
 
 
 
Three Months Ended March 31, 2020 Net write-offs $
 $
 $
 $
 $
 $
 $
               
Seasoned performing loans              
LTV < 80% (2)
 $
 $
 $
 $
 $81
 $156,733
 $156,814
LTV >= 80% (2)
 
 
 
 
 
 8,778
 8,778
Total Seasoned performing loans $
 $
 $
 $
 $81
 $165,511
 $165,592
Three Months Ended March 31, 2020 Gross write-offs $
 $
 $
 $
 $
 $
 $
Three Months Ended March 31, 2020 Recoveries 
 
 
 
 
 
 
Three Months Ended March 31, 2020 Net write-offs $
 $
 $
 $
 $
 $
 $
               
Purchased credit deteriorated loans              
LTV < 80% (2)
 $
 $
 $
 $634
 $3,214
 $430,659
 $434,507
LTV >= 80% (2)
 
 
 
 
 3,773
 306,128
 309,901
Total Purchased credit deteriorated loans $
 $
 $
 $634
 $6,987
 $736,787
 $744,408
Three Months Ended March 31, 2020 Gross write-offs $
 $
 $
 $
 $
 $219
 $219
Three Months Ended March 31, 2020 Recoveries 
 
 
 
 
 
 
Three Months Ended March 31, 2020 Net write-offs $
 $
 $
 $
 $
 $219
 $219
               
Total LTV < 80% (2)
 $322,615
 $2,372,063
 $1,099,660
 $115,251
 $12,350
 $587,392
 $4,509,331
Total LTV >= 80% (2)
 30,575
 64,767
 33,887
 11,194
 3,923
 314,906
 459,252
Total residential whole loans, at carrying value $353,190
 $2,436,830
 $1,133,547
 $126,445
 $16,273
 $902,298
 $4,968,583
Total Gross write-offs $
 $
 $334
 $
 $
 $313
 $647
Total Recoveries 
 
 
 
 
 
 
Total Net write-offs $
 $
 $334
 $
 $
 $313
 $647


22

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

(1)Excludes Non-QM loans held-for-sale with an amortized cost of $965.5 million at March 31, 2020.
(2)LTV represents the ratio of the total unpaid principal balance of the loan to the estimated value of the collateral securing the related loan as of the most recent date available, which may be the origination date. For Rehabilitation loans, the LTV presented is the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated “after repaired” value of the collateral securing the related loan, where available. For certain Rehabilitation loans, totaling $259.4 million at March 31, 2020, an after repaired valuation was not obtained and the loan was underwritten based on an “as is” valuation. The weighted average LTV of these loans based on the current unpaid principal balance and the valuation obtained during underwriting, is 68% at March 31, 2020. Certain low value loans secured by vacant lots are categorized as LTV >= 80%.

Residential Whole Loans, at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at the time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans measured at fair value through earnings on the Company’s consolidated statements of operations.

23

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020


The following table presents information regarding the Company’s residential whole loans held at fair value at March 31, 2020 and December 31, 2019:

 (Dollars in Thousands)
 March 31, 2020 December 31, 2019
Less than 60 Days Past Due:    
Outstanding principal balance $664,362
 $666,026
Aggregate fair value $593,037
 $641,616
Weighted Average LTV Ratio (1)
 75.27% 76.69%
Number of loans 3,186
 3,159
     
60 Days to 89 Days Past Due:    
Outstanding principal balance $60,720
 $58,160
Aggregate fair value $50,999
 $53,485
Weighted Average LTV Ratio (1)
 85.06% 79.48%
Number of loans 279
 313
     
90 Days or More Past Due:    
Outstanding principal balance $693,380
 $767,320
Aggregate fair value $599,756
 $686,482
Weighted Average LTV Ratio (1)
 88.12% 89.69%
Number of loans 2,685
 2,983
    Total Residential whole loans, at fair value $1,243,792
 $1,381,583

(1)LTV represents the ratio of the total unpaid principal balance of the loan, to the estimated value of the collateral securing the related loan. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

The following table presents the components of Net (loss)/gain on residential whole loans measured at fair value through earnings for the three months ended March 31, 2020 and 2019:
  Three Months Ended
March 31,
 (In Thousands) 2020 2019
Coupon payments, realized gains, and other income received (1)
 $19,036
 $21,756
Net unrealized losses (74,556) (1,060)
Net gain on transfers to REO 2,760
 4,571
    Total $(52,760) $25,267

(1)Primarily includes gains on liquidation of non-performing loans, including the recovery of delinquent interest payments, recurring coupon interest payments received on mortgage loans that are contractually current, and cash payments received from private mortgage insurance on liquidated loans.


24

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

4.Residential Mortgage Securities and MSR RelatedMSR-Related Assets
 
Agency and Non-Agency MBS


The Company’s MBS are comprised of Agency MBS and Non-Agency MBS which include MBS issued prior to 2008 (“Legacy Non-Agency MBS”). These MBS are secured by:  (i) hybrid mortgages (“Hybrids”), which have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; (ii) adjustable-rate mortgages (“ARMs”); (iii) mortgages that, which have interest rates that reset annually or more frequently (collectively, “ARM-MBS”); and (iv)(iii) 15 and 30 year fixed-rate mortgages for Agency MBS and, for Non-Agency MBS, 30-year and longer-term fixed rate mortgages. In addition, the Company’s MBS are also comprised of MBS backed by securitized re-performing/non-performing loans (“RPL/NPL MBS”), where the cash flows of the bond may not reflect the contractual cash flows of the underlying collateral. The Company’s RPL/NPL MBS are generally structured with a contractual coupon step-up feature where the coupon increases up tofrom 300 - 400 basis points at 36 - 48 months from issuance or sooner. The Company pledges a significant portion of its MBS as collateral against its borrowings under repurchase agreements and Swaps.  (See Note 7)
 
Agency MBS:Agency MBS are guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae.  The payment of principal and/or interest on Ginnie Mae MBS is explicitly backed by the full faith and credit of the U.S. Government.  Since the third quarter of 2008, Fannie Mae and Freddie Mac have been under the conservatorship of the Federal Housing Finance Agency, which significantly strengthened the backing for these government-sponsored entities.
 
Non-Agency MBS (including Non-Agency MBS transferred to consolidated VIEs):MBS:  The Company’s Non-Agency MBS are primarily secured by pools of residential mortgages, which are not guaranteed by an agency of the U.S. Government or any federally chartered corporation.  Credit risk associated with Non-Agency MBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral.
 
CRT Securities


CRT securities are debt obligations issued by or sponsored by Fannie Mae and Freddie Mac. While theThe coupon payments on CRT securities are paid by Fannie Mae or Freddie Mac on a monthly basis, the payment ofissuer and the principal ispayments received are dependent on the performance of loans in either a reference pool or an actual pool of MBS securitized by Fannie Mae or Freddie Mac. As principal on loans in the reference pool are paid, principal payments on the securities are made and the principal balances of the securities are reduced. Consequently, CRT securities mirror the payment and prepayment behavior of the mortgage loans in the reference pool.loans. As an investor in a CRT security, the Company may incur a principal loss if certain defined credit events occur, including, for certain CRT securities, if the loans inperformance of the actual or reference pool experience delinquencies exceeding specified thresholds.loans results in either an actual or calculated loss that exceeds the credit enhancement of the security owned by the Company. The Company assesses the credit risk associated with its investments in CRT securities by assessing the current and expected future performance of the associated referenceloan pool. The Company pledges a significant portion of its CRT securities as collateral against its borrowings under repurchase agreements. (See Note 7)






1725

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


The following tables present certain information about the Company’s MBS and CRTresidential mortgage securities at September 30, 2017March 31, 2020 and December 31, 20162019:
 
September 30, 2017March 31, 2020
(In Thousands) 
Principal/ Current
Face
 
Purchase
Premiums
 
Accretable
Purchase
Discounts
 
Discount
Designated
as Credit Reserve and 
OTTI (1)
 
Amortized
Cost (2)
 Fair Value 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Net
Unrealized
Gain/(Loss)
 
Principal/ Current
Face
 
Purchase
Premiums
 
Accretable
Purchase
Discounts
 
Discount
Designated
as Credit Reserve (1)
 
Gross Amortized
Cost (2)
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Net
Unrealized
Gain/(Loss)
 
Fair 
Value
Agency MBS:(3)  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Fannie Mae $2,310,368
 $87,658
 $(41) $
 $2,397,985
 $2,404,220
 $27,518
 $(21,283) $6,235
 $433,397
 $15,384
 $(18) $(4,747) $444,016
 $4,242
 $
 $4,242
 $448,258
Freddie Mac 593,502
 22,884
 
 
 617,450
 608,349
 2,510
 (11,611) (9,101) 95,759
 3,468
 
 (121) 99,622
 1,655
 
 1,655
 101,277
Ginnie Mae 6,532
 118
 
 
 6,650
 6,735
 85
 
 85
 3,749
 69
 
 
 3,818
 60
 
 60
 3,878
Total Agency MBS 2,910,402
 110,660
 (41) 
 3,022,085
 3,019,304
 30,113
 (32,894) (2,781) 532,905
 18,921
 (18) (4,868) 547,456
 5,957
 
 5,957
 553,413
Non-Agency MBS:                                    
Expected to Recover Par (4)(5)
 1,390,412
 51
 (24,594) 
 1,365,869
 1,393,982
 28,352
 (239) 28,113
 150,181
 
 (13,191) 
 136,990
 6,175
 (21,643) (15,468) 121,522
Expected to Recover Less than Par (3)(4)
 2,710,690
 
 (220,199) (593,134) 1,897,357
 2,517,678
 620,472
 (151) 620,321
 1,305,667
 
 (77,777) (389,472) 838,418
 160,000
 
 160,000
 998,418
Total Non-Agency MBS (5)(6)
 4,101,102
 51
 (244,793) (593,134) 3,263,226
 3,911,660
 648,824
 (390) 648,434
 1,455,848
 
 (90,968) (389,472) 975,408
 166,175
 (21,643) 144,532
 1,119,940
Total MBS 7,011,504
 110,711
 (244,834) (593,134) 6,285,311
 6,930,964
 678,937
 (33,284) 645,653
 1,988,753
 18,921
 (90,986) (394,340) 1,522,864
 172,132
 (21,643) 150,489
 1,673,353
CRT securities (6)(7)
 608,146
 8,474
 (3,961) 
 612,659
 653,633
 42,919
 (1,945) 40,974
 365,762
 3,263
 (42) (47,137) 321,846
 
 (67,745) (67,745) 254,101
Total MBS and CRT securities $7,619,650
 $119,185
 $(248,795) $(593,134) $6,897,970
 $7,584,597
 $721,856
 $(35,229) $686,627
 $2,354,515
 $22,184
 $(91,028) $(441,477) $1,844,710
 $172,132
 $(89,388) $82,744
 $1,927,454


December 31, 20162019
(In Thousands) 
Principal/ Current
Face
 
Purchase
Premiums
 
Accretable
Purchase
Discounts
 
Discount
Designated
as Credit Reserve and 
OTTI (1)
 
Amortized
Cost (2)
 Fair Value 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Net
Unrealized
Gain/(Loss)
 
Principal/ Current
Face
 
Purchase
Premiums
 
Accretable
Purchase
Discounts
 
Discount
Designated
as Credit Reserve (1)
 
Gross Amortized
Cost (2)
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Net
Unrealized
Gain/(Loss)
 Fair Value
Agency MBS:(3)  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Fannie Mae $2,879,807
 $108,310
 $(51) $
 $2,988,066
 $3,014,464
 $45,706
 $(19,308) $26,398
 $1,119,708
 $43,249
 $(22) $
 $1,162,935
 $9,799
 $(14,741) $(4,942) $1,157,993
Freddie Mac 693,945
 26,736
 
 
 723,285
 716,209
 4,809
 (11,885) (7,076) 480,879
 19,468
 
 
 500,961
 5,475
 (3,968) 1,507
 502,468
Ginnie Mae 7,550
 136
 
 
 7,686
 7,824
 138
 
 138
 3,996
 73
 
 
 4,069
 52
 
 52
 4,121
Total Agency MBS 3,581,302
 135,182
 (51) 
 3,719,037
 3,738,497
 50,653
 (31,193) 19,460
 1,604,583
 62,790
 (22) 
 1,667,965
 15,326
 (18,709) (3,383) 1,664,582
Non-Agency MBS:                                    
Expected to Recover Par (4)(5)
 2,706,418
 57
 (24,273) 
 2,682,202
 2,706,311
 26,477
 (2,368) 24,109
 722,477
 
 (16,661) 
 705,816
 19,861
 (9) 19,852
 725,668
Expected to Recover Less than Par (3)(4)
 3,359,200
 
 (253,918) (694,241) 2,411,041
 2,978,525
 570,318
 (2,834) 567,484
 1,472,826
 
 (73,956) (436,598) 962,272
 375,598
 (9) 375,589
 1,337,861
Total Non-Agency MBS (5)(6)
 6,065,618
 57
 (278,191) (694,241) 5,093,243
 5,684,836
 596,795
 (5,202) 591,593
 2,195,303
 
 (90,617) (436,598) 1,668,088
 395,459
 (18) 395,441
 2,063,529
Total MBS 9,646,920
 135,239
 (278,242) (694,241) 8,812,280
 9,423,333
 647,448
 (36,395) 611,053
 3,799,886
 62,790
 (90,639) (436,598) 3,336,053
 410,785
 (18,727) 392,058
 3,728,111
CRT securities (6)(7)
 384,993
 3,312
 (5,557) 
 382,748
 404,850
 22,105
 (3) 22,102
 244,932
 4,318
 (55) 
 249,195
 6,304
 (91) 6,213
 255,408
Total MBS and CRT securities $10,031,913
 $138,551
 $(283,799) $(694,241) $9,195,028
 $9,828,183
 $669,553
 $(36,398) $633,155
 $4,044,818
 $67,108
 $(90,694) $(436,598) $3,585,248
 $417,089
 $(18,818) $398,271
 $3,983,519
 
(1)Discount designated as Credit Reserve and amounts related to OTTI areis generally not expected to be accreted into interest income. Amounts disclosed at September 30, 2017 reflect Credit Reserve of $578.3 million and OTTI of $14.8 million.  Amounts disclosed at December 31, 2016 reflect Credit Reserve of $675.6 million and OTTI of $18.6 million.
(2)Includes principal payments receivable of $1.1 million$516,000 and $2.6 million$614,000 at September 30, 2017March 31, 2020 and December 31, 2016,2019, respectively, which are not included in the Principal/Current Face.
(3)
Amounts disclosed at March 31, 2020 and December 31, 2019 include Agency MBS with a fair value of $14.5 millionand $280.3 million, respectively, for which the fair value option has been elected. Such securities had $499,000 unrealized gains and 0 gross unrealized losses at March 31, 2020, and $4.5 million unrealized gains and 0gross unrealized losses at December 31, 2019, respectively.
(4)
Based on managementmanagements current estimates of future principal cash flows expected to be received.
(4)
Includes RPL/NPL MBS, which at September 30, 2017 had a $1.2 billion Principal/Current face, $1.2 billion amortized cost and $1.2 billion fair value. At December 31, 2016, RPL/NPL MBS had a $2.5 billion Principal/Current face, $2.5 billion amortized cost and $2.5 billionfair value.
(5)
Includes RPL/NPL MBS, which at March 31, 2020 had an $101.4 millionPrincipal/Current face, $101.1 millionamortized cost and $79.5 millionfair value. At September 30, 2017December 31, 2019, RPL/NPL MBS had a $632.3 million Principal/Current face, $631.8 million amortized cost and $635.0 millionfair value.
(6)At March 31, 2020 and December 31, 2016,2019, the Company expected to recover approximately 86%73% and 89%, respectively,80% of the then-current face amount of Non-Agency MBS.MBS, respectively.
(6)(7)Amounts disclosed at September 30, 2017March 31, 2020 includes CRT securities with a fair value of $518.1$188.6 million for which the fair value option has been elected. Such securities had 0 gross unrealized gains and gross unrealized losses of approximately $67.7 million at March 31, 2020. Amounts disclosed at December 31, 2019 includes CRT securities with a fair value of $255.4 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $28.9$6.3 million and gross unrealized losses of approximately $1.9 million at September 30, 2017. Amounts disclosed$91,000 at December 31, 2016 includes CRT securities with a fair value of $271.2 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $12.7 million and gross unrealized losses of approximately $3,000 at December 31, 2016.2019.




1826

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020



Unrealized Losses on MBS and CRTSales of Residential Mortgage Securities

The following table presents information about the Company’s MBSsales of its residential mortgage securities for the three months ended March 31, 2020 and CRT2019. The Company has no continuing involvement with any of the sold MBS.

  Three Months Ended
March 31, 2020
 Three Months Ended
March 31, 2019
(In Thousands) Sales Proceeds Gains/(Losses) Sales Proceeds Gains/(Losses)
Agency MBS $965,132
 $(22,854) $
 $
Non-Agency MBS 264,385
 (43,124) 126,094
 18,153
CRT Securities 35,645
 (2,017) 83,368
 6,456
Total $1,265,162
 $(67,995) $209,462
 $24,609


Unrealized Losses on Residential Mortgage Securities

The following table presents information about the Company’s residential mortgage securities that were in an unrealized loss position at September 30, 2017:March 31, 2020, with respect to which no allowance for credit losses has been recorded:
 
Unrealized Loss Position For:
  Less than 12 Months 12 Months or more Total
 Fair Value Unrealized Losses Number of SecuritiesFair Value Unrealized Losses Number of SecuritiesFair Value Unrealized Losses
(Dollars in Thousands)
Agency MBS: 
  
  
  
  
  
  
  
  
Fannie Mae $
 $
 
 $
 $
 
 $
 $
Freddie Mac 
 
 
 
 
 
 
 
Ginnie Mae 
 
 
 
 
 
 
 
Total Agency MBS 
 
 
 
 
 
 
 
Non-Agency MBS:  
  
  
  
  
  
  
  
Expected to Recover Par (1)
 79,464
 21,643
 7
 
 
 
 79,464
 21,643
Expected to Recover Less than Par (1)
 
 
 
 
 
 
 
 
Total Non-Agency MBS 79,464
 21,643
 7
 
 
 
 79,464
 21,643
Total MBS 79,464
 21,643
 7
 
 
 
 79,464
 21,643
CRT securities (2)
 188,560
 67,745
 47
 
 
 
 188,560
 67,745
Total MBS and CRT securities $268,024
 $89,388
 54
 $
 $
 
 $268,024
 $89,388

  Less than 12 Months 12 Months or more Total
 Fair Value Unrealized Losses Number of SecuritiesFair Value Unrealized Losses Number of SecuritiesFair Value Unrealized Losses
(Dollars in Thousands)
Agency MBS:  
  
  
  
  
  
  
  
Fannie Mae $349,961
 $2,420
 92
 $859,887
 $18,863
 180
 $1,209,848
 $21,283
Freddie Mac 62,110
 519
 16
 399,874
 11,092
 98
 461,984
 11,611
Total Agency MBS 412,071
 2,939
 108
 1,259,761
 29,955
 278
 1,671,832
 32,894
Non-Agency MBS:  
  
  
  
  
  
  
  
Expected to Recover Par (1)
 
 
 
 13,013
 239
 9
 13,013
 239
Expected to Recover Less than Par (1)
 6,412
 48
 3
 7,329
 103
 1
 13,741
 151
Total Non-Agency MBS 6,412
 48
 3
 20,342
 342
 10
 26,754
 390
Total MBS 418,483
 2,987
 111
 1,280,103
 30,297
 288
 1,698,586
 33,284
CRT securities 27,179
 1,945
 9
 
 
 
 27,179
 1,945
Total MBS and CRT securities $445,662
 $4,932
 120
 $1,280,103
 $30,297
 288
 $1,725,765
 $35,229


(1)Based on management’s current estimates of future principal cash flows expected to be received.
(2)Amounts disclosed at March 31, 2020 include CRT securities with a fair value of $188.6 million for which the fair value option has been elected. Such securities had unrealized losses of $67.7 million at March 31, 2020.


At September 30, 2017March 31, 2020, as a result of the COVID-19 pandemic and its impact on the Company’s liquidity (see Note 6), the Company did not intenddetermined that it intended to sell, anyor was “more likely than not” going to be required to sell, the majority of its investmentsresidential mortgage securities that were in an unrealized loss position, and it is “more likely than not” that the Company will not be required to sell these securities before recovery of their amortized cost basis.  As a result, those securities were written down to fair value through earnings and a new amortized cost basis which may be at their maturity. was established. The write-down recorded in earnings aggregated $63.5 million for the three months ended March 31, 2020 and was included in “Impairment and other losses on securities available-for-sale and other assets” on the Consolidated Statement of Operations.
 
GrossSubsequent to these write-downs, there were 0 gross unrealized losses on the Company’s Agency MBS were $32.9 million at September 30, 2017March 31, 2020.  Agency MBS are issued by Government Sponsored Entities (“GSEs”) and enjoy either the implicit or explicit backing of the full faith and credit of the U.S. Government. While the Company’s Agency MBS are not rated by any rating agency, they are currently perceived by market participants to be of high credit quality, with risk of default limited to the unlikely event that the U.S.

27

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

Government would not continue to support the GSEs. Given the credit quality inherent in Agency MBS, the Company does not consider any of the current impairments on its Agency MBS to be credit related. In assessing whether it is more likely than not that it will be required to sell any impaired security before its anticipated recovery, which may be at its maturity, the Company considers for each impaired security, the significance of each investment, the amount of impairment, the projected future performance of such impaired securities, as well as the Company’s current and anticipated leverage capacity and liquidity position. Based on these analyses, the Company determined that at September 30, 2017 any unrealizedMarch 31, 2020 no allowance for credit losses was required on its Agency MBS were temporary.MBS.


Gross unrealized losses on the Company’s Non-Agency MBS were $390,000$21.6 million at September 30, 2017March 31, 2020. Based upon the most recent evaluation, the Company does not consider these unrealized losses to be indicative of OTTIrequire an allowance for credit losses and does not believe that these unrealized losses are credit related, but are rather a reflection of current market yields and/or marketplace bid-ask spreads.  The Company has reviewed its Non-Agency MBS that are in an unrealized loss position to identify those securities withthat require an allowance for credit losses that are other-than-temporary based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance and, where possible, expected future performance of the underlying collateral.
  
The Company did not recognize any credit-related OTTIan allowance for credit losses (or other than temporary impairment in prior periods) through earnings related to its Non-Agency MBS during the three months ended September 30, 2017. The Company recognized credit-related OTTI losses through earnings related to its Non-Agency MBS of $1.0 million during the nine months ended September 30, 2017March 31, 2020 and $485,000 during the three and nine months ended September 30, 2016.

2019. Non-Agency MBS on which OTTI iscredit losses were recognized have experienced, or are expected to experience, credit-related adverse cash flow changes.  The Company’s estimate of cash flows for these Non-Agency MBS is based on its review of the underlying mortgage loans securing these MBS.  The Company considers information available about the structure of the securitization, including

19

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

structural credit enhancement, if any, and the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, FICO scores at loan origination, year of origination, LTVs, geographic concentrations, as well as Rating Agency reports, general market assessments, and dialogue with market participants.  Changes in the Company’s evaluation of each of these factors impacts the cash flows expected to be collected at the OTTI assessment date. For Non-Agency MBS purchased at a discount to par that were assessed for and had no OTTI recorded this period, such cash flow estimates indicated that the amount of expected losses decreased compared to the previous OTTI assessment date. These positive cash flow changes are primarily driven by recent improvements in LTVs due to loan amortization and home price appreciation, which, in turn, positively impacts the Company’s estimates of default rates and loss severities for the underlying collateral. In addition, voluntary prepayments (i.e., loans that prepay in full with no loss) have generally trended higher for these MBS which also positively impacts the Company’s estimate of expected loss. Overall, the combination of higher voluntary prepayments and lower LTVs supports the Company’s assessment that such MBS are not other-than-temporarily impaired.

The following table presents the composition of OTTI charges recorded by the Company for the three and nine months ended September 30, 2017 and 2016:
  Three Months Ended 
 September 30,
 Nine Months Ended 
 September 30,
(In Thousands) 2017 2016 2017 2016
Total OTTI losses $
 $(1,255) $(63) $(1,255)
OTTI reclassified from OCI 
 770
 (969) 770
OTTI recognized in earnings $
 $(485) $(1,032) $(485)


The following table presents a roll-forward of the allowance for credit loss component of OTTIlosses on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI.  Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.Residential mortgage securities and MSR-related assets:

  Three Months Ended 
 September 30,
 Nine Months Ended 
 September 30,
(In Thousands) 2017 2017
Credit loss component of OTTI at beginning of period $38,337
 $37,305
Additions for credit related OTTI not previously recognized 
 63
Subsequent additional credit related OTTI recorded 
 969
Credit loss component of OTTI at end of period $38,337
 $38,337
  Three Months Ended March 31,
(Dollars In Thousands) 2020 2019
Allowance for credit losses at beginning of period $
 $
Current provision: 
 
Securities with no prior loss allowance 332,756
 
Securities with a prior loss allowance 
 
Write-offs, including allowance related to securities we intend to sell (332,756) 
Allowance for credit losses at end of period $
 $





2028

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


Purchase Discounts on Non-Agency MBS
 
The following tables presenttable presents the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the three and nine months ended September 30, 2017March 31, 2020 and 20162019:


  Three Months Ended
March 31, 2020
 Three Months Ended
March 31, 2019
(In Thousands) Discount
Designated as
Credit Reserve
 
Accretable
Discount
(1) 
Discount
Designated as
Credit Reserve
 
 Accretable Discount (1)
Balance at beginning of period $(436,598) $(90,617) $(516,116) $(155,025)
Impact of RMBS Issuer Settlement (2)
 
 
 
 (855)
Accretion of discount 
 9,889
 
 13,307
Realized credit losses 4,459
 
 7,504
 
Purchases 
 
 
 (118)
Sales/Redemptions 49,491
 (5,551) 3,191
 16,346
Net impairment losses recognized in earnings (11,513) 
 
 
Transfers/release of credit reserve 4,689
 (4,689) 3,802
 (3,802)
Balance at end of period $(389,472) $(90,968) $(501,619) $(130,147)

  Three Months Ended 
 September 30, 2017
 Three Months Ended 
 September 30, 2016
(In Thousands) 
Discount
Designated as
Credit Reserve and OTTI
 
Accretable
Discount (1) 
Discount
Designated as
Credit Reserve and OTTI
 
 Accretable Discount (1)
Balance at beginning of period $(626,498) $(257,967) $(724,198) $(325,548)
Accretion of discount 
 18,621
 
 20,236
Realized credit losses 13,982
 
 15,629
 
Purchases 
 (1,929) (15,124) 9,830
Sales 4,620
 11,244
 2,398
 6,523
Net impairment losses recognized in earnings 
 
 (485) 
Transfers/release of credit reserve 14,762
 (14,762) 6,822
 (6,822)
Balance at end of period $(593,134) $(244,793) $(714,958) $(295,781)

(1)Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.
(2)Includes the impact of $855,000 of cash proceeds (a one-time payment) received by the Company during the three months ended March 31, 2019 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities.



  Nine Months Ended 
 September 30, 2017
 Nine Months Ended 
 September 30, 2016
(In Thousands) Discount
Designated as
Credit Reserve and OTTI
 
Accretable
Discount
(1) 
Discount
Designated as
Credit Reserve and OTTI
 
 Accretable Discount (1)
Balance at beginning of period $(694,241) $(278,191) $(787,541) $(312,182)
Impact of RMBS Issuer Settlement (2)
 
 
 
 (52,881)
Accretion of discount 
 60,461
 
 61,153
Realized credit losses 39,445
 
 49,408
 
Purchases (484) (3,449) (25,999) 13,210
Sales 29,398
 10,166
 16,281
 28,297
Net impairment losses recognized in earnings (1,032) 
 (485) 
Transfers/release of credit reserve 33,780
 (33,780) 33,378
 (33,378)
Balance at end of period $(593,134) $(244,793) $(714,958) $(295,781)

(1)  Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.
(2) Includes the impact of approximately $61.8 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2016 in connection with the settlement of litigation related to certain Countrywide-sponsored residential mortgage backed securitization trusts.

Sales of MBS
During the three and nine months ended September 30, 2017, the Company sold certain Non-Agency MBS for $44.5 million and $83.1 million, realizing gross gains of $14.9 million and $30.8 million, respectively.  During the three and nine months ended September 30, 2016, the Company sold certain Non-Agency MBS for $13.2 million and $65.1 million, realizing gross gains of $7.1 million and $26.1 million, respectively. The Company has no continuing involvement with any of the sold MBS.


21

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

MSR RelatedMSR-Related Assets


(a)Term Notes Backed by MSR RelatedMSR-Related Collateral


At September 30, 2017March 31, 2020 and December 31, 2016,2019, the Company had $311.6$706.6 million and $141.0 million,$1.2 billion, respectively, of term notes issued by SPVs that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. Payment of principal and interest on these term notes is considered to be largely dependent on cash flows generated by the underlying MSRs, as this impacts the cash flows available to the SPV that issued the term notes.


At September 30, 2017,March 31, 2020, these term notes had an amortized cost and fair value of $311.0$706.6 million, gross unrealized gains of $563,000, a weighted average yield of 5.62%4.74% and a weighted average term to maturity of 3.75.1 years. During three months ended March 31, 2020, the Company sold certain term notes for $136.8 million, realizing losses of $24.6 million. During the three months ended March 31, 2020, the Company recognized an impairment loss related to its term notes of $280.8 million based on its intent to sell, or the likelihood it will be required to sell, such notes. At December 31, 2016,2019, the term notes had an amortized cost of $141.0 million, no$1.2 billion, gross unrealized gains of $5.2 million, a weighted average yield of 5.50%4.75% and a weighted average term to maturity of 4.65.3 years.


(b) Corporate LoanLoans


The Company has entered into a loan agreement with an entitymade or participated in loans to provide financing to entities that originatesoriginate residential mortgage loans and ownsown the related MSRs. The loan isThese corporate loans are secured by certain U.S. Government, Agency and private-label MSRs, as well as certain other unencumbered assets owned by the borrower. Under

During the terms of the loan agreement,year ended December 31, 2018, the Company hasparticipated in a loan where the Company committed to lend $130.0$100.0 million of which approximately $101.1$33.8 million was drawn at September 30, 2017.March 31, 2020. At September 30, 2017,March 31, 2020, the coupon paid by the borrower on the drawn amount is 7.74%3.93%, the remaining term associated with the loan is 2.8 years5 months and the remaining commitment period on any undrawn amount is nine5 months. During the remaining commitment period, the Company receives a commitment fee of 1% ofbetween 0.25% and 1.0% based on the undrawn amount forof the first three months, which then increases to 1.5% for the subsequent six month period. For the three months ended September 30, 2017, the Company recognized interest incomeloan.


29

Table of $2.1 million, including discount accretion and commitment fee income of $76,000. For the nine months ended September 30, 2017, the Company recognized interest income of $5.7 million including discount accretion and commitment fee income of $212,000.Contents

MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

Impact of AFS Securities on AOCI
 
The following table presents the impact of the Company’s AFS securities on its AOCI for the three and nine months ended September 30, 2017March 31, 2020 and 20162019:
  Three Months Ended March 31,
(In Thousands)2020 2019
AOCI from AFS securities:  
  
Unrealized gain on AFS securities at beginning of period $392,722
 $417,167
Unrealized gain on Agency MBS, net 4,876
 9,315
Unrealized gain on Non-Agency MBS, net 124,700
 12,276
Unrealized (loss)/gain on MSR term notes, net (5,166) 512
Reclassification adjustment for MBS sales included in net income (23,953) (17,009)
Reclassification adjustment for impairment included in net income (344,269) 
Change in AOCI from AFS securities (243,812) 5,094
Balance at end of period $148,910
 $422,261
  Three Months Ended September 30, Nine Months Ended September 30,
(In Thousands)2017 2016 2017 2016
AOCI from AFS securities:  
  
  
  
Unrealized gain on AFS securities at beginning of period $668,223
 $625,697
 $620,403
 $585,250
Unrealized (loss)/gain on Agency MBS, net (3,032) (6,941) (22,241) 17,857
Unrealized gain on Non-Agency MBS, net 10,020
 71,291
 93,429
 106,906
Reclassification adjustment for MBS sales included in net income (14,935) (6,829) (30,283) (26,795)
Reclassification adjustment for OTTI included in net income 
 (485) (1,032) (485)
Change in AOCI from AFS securities (7,947) 57,036
 39,873
 97,483
Balance at end of period $660,276
 $682,733
 $660,276
 $682,733

 



2230

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


Interest Income on MBS, CRTResidential Mortgage Securities and MSR RelatedMSR-Related Assets
 
The following table presents the components of interest income on the Company’s MBS, CRTresidential mortgage securities and MSRMSR- related assets for the three and nine months ended September 30, 2017March 31, 2020 and 20162019
 Three Months Ended September 30, Nine Months Ended September 30, Three Months Ended March 31,
(In Thousands) 2017 2016 2017 2016 2020 2019
Agency MBS            
Coupon interest $23,473
 $29,283
 $74,589
 $92,263
 $13,636
 $24,628
Effective yield adjustment (1)
 (7,940) (10,326) (24,575) (27,717) (4,775) (6,187)
Interest income $15,533
 $18,957
 $50,014
 $64,546
 $8,861
 $18,441
            
Legacy Non-Agency MBS            
Coupon interest $30,688
 $37,763
 $97,796
 $117,620
 $17,282
 $24,272
Effective yield adjustment (2)
 18,005
 20,055
 59,033
 59,270
 9,406
 13,144
Interest income $48,693
 $57,818
 $156,829
 $176,890
 $26,688
 $37,416
            
RPL/NPL MBS            
Coupon interest $13,947
 $25,630
 $54,475
 $74,773
 $5,583
 $16,443
Effective yield adjustment (1)(3)
 612
 190
 1,424
 1,892
 280
 142
Interest income $14,559
 $25,820
 $55,899
 $76,665
 $5,863
 $16,585
            
CRT securities            
Coupon interest $7,868
 $3,562
 $19,712
 $8,725
 $3,485
 $6,118
Effective yield adjustment (2)
 808
 421
 3,186
 1,172
 (523) 82
Interest income $8,676
 $3,983
 $22,898
 $9,897
 $2,962
 $6,200
            
MSR related assets        
MSR-related assets    
Coupon interest $7,117
 $
 $17,621
 $
 $14,207
 $10,619
Effective yield adjustment (1)
 77
 
 212
 
 
 1
Interest income $7,194
 $
 $17,833
 $
 $14,207
 $10,620
 
(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, RPL/NPL MBS and the corporate loan secured by MSRs, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity.
(2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.

(3) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously purchased at a discount of approximately $277,000 and $148,000 during the three months ended March 31, 2020 and 2019, respectively.

31

4.    Residential Whole Loans

Included on the Company’s consolidated balance sheets at September 30, 2017 and December 31, 2016 are approximately $1.7 billion and $1.4 billion, respectively, of residential whole loans arising from the Company’s interests in certain entities established to acquire the loans and an entity in connection with its loan securitization transaction. The Company has assessed that these entities are required to be consolidated.

Residential Whole Loans, at Carrying Value

Residential whole loans, at carrying value totaled approximately $639.2 million and $590.5 million at September 30, 2017 and December 31, 2016, respectively. The carrying value reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. The carrying value is reduced by any allowance for loan losses established subsequent to acquisition. The Company had approximately 3,700 and 3,200 Residential whole loans held at carrying value at September 30, 2017 and December 31, 2016, respectively.

As of September 30, 2017 the Company had established an allowance for loan losses of approximately $318,000 on its residential whole loan pools held at carrying value. For the three and nine months ended September 30, 2017, a net reversal of

23

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


provision for loan losses of approximately $57,000 and $672,000 was recorded, respectively, which is included in Operating and Other Expense on the Company’s consolidated statements of operations. For the three months ended September 30, 2016, there was no provision for loan losses recorded. For the nine months ended September 30, 2016, a net reversal of provision for loan losses of approximately $142,000 was recorded.

The following table presents the activity in the Company’s allowance for loan losses on its residential whole loan pools held at carrying value for the three and nine months ended September 30, 2017 and 2016:

 (In Thousands) Three Months Ended September 30, Nine Months Ended September 30,
  2017
2016 2017 2016
Balance at the beginning of period $375
 $1,023
 $990
 $1,165
Reversal of provisions for loan losses (57) 
 (672) (142)
Balance at the end of period $318
 $1,023
 $318
 $1,023

The following table presents information regarding estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the residential whole loans held at carrying value acquired by the Company for the three and nine months ended September 30, 2017 and 2016:

 (In Thousands) Three Months Ended September 30, Nine Months Ended September 30,
  
2017 (1)
 
2016 (2)
 
2017 (1)
 
2016 (2)
Contractually required principal and interest $185,234
 $121,818
 $185,234
 $363,144
Contractual cash flows not expected to be collected (non-accretable yield) (33,448) (31,648) (33,448) (66,685)
Expected cash flows to be collected 151,786
 90,170
 151,786
 296,459
Interest component of expected cash flows (accretable yield) (53,916) (28,801) (53,916) (98,550)
Fair value at the date of acquisition $97,870
 $61,369
 $97,870
 $197,909

(1) Included in the activity presented for the three and nine months ended September 30, 2017 are approximately $97.9 million of loans the Company committed to purchase during the three months ended June 30, 2017, but for which the closing of the purchase transaction occurred during the three months ended September 30, 2017.
(2) Excluded from the table above are approximately $111.2 million of residential whole loans held at carrying value for which the closing of the purchase transaction had not occurred as of September 30, 2016.


24

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

The following table presents accretable yield activity for the Company’s residential whole loans held at carrying value for the three and nine months ended September 30, 2017 and 2016:

 (In Thousands) Three Months Ended September 30, Nine Months Ended September 30,
  
2017 (1)
 
2016 (2)
 
2017 (1)
 
2016 (2)
Balance at beginning of period $318,125
 $234,527
 $334,379
 $175,271
  Additions 53,916
 28,801
 53,916
 98,550
  Accretion (9,026) (5,917) (26,219) (16,112)
  Reclassifications from/(to) non-accretable difference, net 303
 218
 1,242
 (80)
Balance at end of period $363,318
 $257,629
 $363,318
 $257,629

(1) Included in the activity presented for the three and nine months ended September 30, 2017 are approximately $97.9 million of loans the Company committed to purchase during the three months ended June 30, 2017, but for which the closing of the purchase transaction occurred during the three months ended September 30, 2017.
(2) Excluded from the table above are approximately $111.2 million of residential whole loans held at carrying value for which the closing of the purchase transaction had not occurred as of September 30, 2016.

Accretable yield for residential whole loans is the excess of loan cash flows expected to be collected over the purchase price. The cash flows expected to be collected represent the Company’s estimate of the amount and timing of undiscounted principal and interest cash flows. Additions include accretable yield estimates for purchases made during the period and reclassification to accretable yield from non-accretable yield. Accretable yield is reduced by accretion during the period. The reclassifications between accretable and non-accretable yield and the accretion of interest income are based on changes in estimates regarding loan performance and the value of the underlying real estate securing the loans. In future periods, as the Company updates estimates of cash flows expected to be collected from the loans and the underlying collateral, the accretable yield may change. Therefore, the amount of accretable income recorded during the three and nine months ended September 30, 2017 is not necessarily indicative of future results.

Residential Whole Loans, at Fair Value

Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations.

The following table presents information regarding the Company’s residential whole loans held at fair value at September 30, 2017 and December 31, 2016:
 (Dollars in Thousands)
 
September 30, 2017 (1)
 December 31, 2016
Outstanding principal balance $1,178,866
 $966,174
Aggregate fair value $983,150
 $814,682
Number of loans 4,834
 3,812

(1) Excluded from the table above are approximately $120.4 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2017.

During the three and nine months ended September 30, 2017, the Company recorded net gains on residential whole loans held at fair value of $18.7 million and $48.7 million, respectively. During the three and nine months ended September 30, 2016, the Company recorded net gains on residential whole loans held at fair value of $19.6 million and $47.7 million, respectively.

25

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

The following table presents the components of Net gain on residential whole loans held at fair value for the three and nine months ended September 30, 2017 and 2016:
 (In Thousands) Three Months Ended September 30, Nine Months Ended September 30,
  2017 2016 2017 2016
Coupon payments and other income received $9,824
 $6,253
 $27,971
 $15,987
Net unrealized gains 5,289
 10,913
 12,499
 25,529
Net gain on payoff/liquidation of loans 1,456
 1,535
 3,076
 3,536
Net gain on transfer to REO 2,110
 938
 5,114
 2,677
    Total $18,679
 $19,639
 $48,660
 $47,729


5.    Other Assets


The following table presents the components of the Company’s Other assets at September 30, 2017March 31, 2020 and December 31, 2016:2019:


(In Thousands) March 31, 2020 December 31, 2019
REO (1)
 $411,473
 $411,659
Receivable for unsettled MBS sales 392,597
 
Capital contributions made to loan origination partners 113,923
 147,992
Other interest-earning assets 73,443
 70,468
Interest receivable 65,977
 70,986
Other MBS and loan related receivables 55,789
 43,842
Other 58,437
 39,304
Total Other Assets $1,171,639
 $784,251

(In Thousands) September 30, 2017 December 31, 2016
REO $137,979
 $80,503
Interest receivable 25,319
 27,795
Swaps, at fair value 
 233
Goodwill 7,189
 7,189
Prepaid and other assets 62,870
 78,775
Total Other Assets $233,357
 $194,495

(1)Includes $39.5 million and $27.3 million of REO that is held-for-investment at March 31, 2020 and December 31, 2019, respectively.


(a) Real Estate Owned


At September 30, 2017,March 31, 2020, the Company had 6711,622 REO properties with an aggregate carrying value of $138.0$411.5 million. At December 31, 2016,2019, the Company had 4471,652 REO properties with an aggregate carrying value of $80.5$411.7 million.
 
During the three and nine months ended September 30, 2017, the Company reclassified 174 and 521 mortgage loans to REO at an aggregate estimated fair value less estimated selling costs of $38.9 million and $97.4 million, respectively, at the time of transfer. During the three and nine months ended September 30, 2016, the Company reclassified 122 and 385 mortgage loans to REO at an aggregate estimated fair value less estimated selling costs of $24.8 million and $69.8 million, respectively, at the time of transfer. Such transfers occur when the Company takes possession of the property by foreclosing on the borrower or completes a “deed-in-lieu of foreclosure” transaction. From time to time, the Company also acquires REO in connection with transactions to acquire residential whole loans.

At September 30, 2017, $125.2March 31, 2020, $406.9 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, excluding unsettled residential whole loans, formal foreclosure proceedings were in process with respect to $31.4$98.2 million of residential whole loans held at carrying value and $538.5$514.4 million of residential whole loans held at fair value at September 30, 2017.March 31, 2020.


DuringThe following table presents the activity in the Company’s REO for the three and nine months ended September 30, 2017, the Company sold 139March 31, 2020 and 368 REO properties for consideration of $18.4 million and $53.02019:
  Three Months Ended March 31,
(In Thousands) 2020 2019
Balance at beginning of period $411,659
 $249,413
Adjustments to record at lower of cost or fair value (4,750) (4,072)
Transfer from residential whole loans (1)
 50,693
 65,160
Purchases and capital improvements, net 5,606
 5,923
Disposals (2)
 (51,735) (25,837)
Balance at end of period $411,473
 $290,587
     
Number of properties 1,622
 1,233

(1)Includes net gain recorded on transfer of approximately $3.0 million and $4.6 million for the three months ended March 31, 2020 and 2019, respectively.
(2)During the three months ended March 31, 2020 and 2019, the Company sold 249 and 137 REO properties for consideration of $54.8 million and $27.8 million, realizing net gains of approximately $3.1 million and $1.4 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations.


(b) Capital Contributions Made to Loan Origination Partners

The Company has made investments in several loan originators as part of its strategy to be a reliable source of capital to select partners from whom it sources residential mortgage loans through both flow arrangements and bulk purchases. To date, such contributions of capital have included the acquisition of approximately $805,000 and $2.8$28.5 million respectively. During the three and nine months ended September 30, 2016, the Company sold 57 and 179 REO properties for consideration of $7.9common equity, $69.4 million and $24.0 million, realizing net gains of approximately $733,000 and $1.8 million, respectively. These amounts are included in Other, net on the Company’s consolidated statements of operations. In addition, following an updated assessment of liquidation amounts expected to be realized that was performed on all REO held at the end of the third quarters of 2017 and 2016, downward adjustments of approximately $3.1 million and $1.7 million were recorded to reflect certain REO properties at the lower of cost or estimated fair value as of September 30, 2017 and 2016, respectively.preferred



2632

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


The following table presentsequity and $75.0 million of convertible notes. In addition, for certain partners, options or warrants may have also been acquired that provide the activityCompany the ability to increase the level of its investment if certain conditions are met. At the end of each reporting period, or earlier if circumstances warrant, the Company evaluates whether the nature of its interests and other involvement with the investee entity requires the Company to apply equity method accounting or consolidate the results of the investee entity with the Company’s financial results. To date, the nature of the Company’s interests and/or involvement with investee companies has not resulted in consolidation. Further, to the extent that the nature of the Company’s interests has resulted in the Company’s REOneed for the threeCompany to apply equity method accounting, the impact of such accounting on the Company’s results for periods subsequent to that in which the Company was determined to have significant influence over the investee company was not material for any period. As the interests acquired to date by the Company generally do not have a readily determinable fair value, the Company accounts for its non-equity method interests (including any acquired options and nine months ended September 30, 2017 and 2016:
(In Thousands) Three Months Ended September 30, Nine Months Ended September 30,
  2017 2016 2017 2016
Balance at beginning of period $104,443
 $56,784
 $80,503
 $28,026
Adjustments to record at lower of cost or fair value (3,129) (1,659) (7,306) (4,655)
Transfer from residential whole loans (1)
 38,944
 24,812
 97,388
 69,803
Purchases and capital improvements 15,342
 415
 17,224
 2,204
Disposals (17,621) (7,163) (49,830) (22,189)
Balance at end of period $137,979
 $73,189
 $137,979
 $73,189

(1)  Includes net gainwarrants) in loan originators initially at cost. The carrying value of these investments will be adjusted if it is determined that an impairment has occurred or if there has been a subsequent observable transaction in either the investee company’s equity securities or a similar security that provides evidence to support an adjustment to the carrying value. Following an evaluation of the anticipated impact of the COVID-19 pandemic on economic conditions for the short to medium term, the Company recorded impairment charges of $58.1 million on transfer of approximately $2.8 million and $845,000 forinvestments in certain loan origination partners during the three months ended September 30, 2017March 31, 2020, which was included in “Impairment and 2016, respectively;other losses on securities available-for-sale and other assets” on the consolidated statements of operations. At March 31, 2020, approximately $5.3 million and $2.5 million for$2.0 billion of the nine months ended September 30, 2017 and 2016, respectively.Company’s Residential whole loans, at carrying value were serviced by entities in which the Company has an investment.




33

(b)
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

(c)Derivative Instruments
 
The Company’s derivative instruments are currentlyhave generally been comprised of Swaps, the majority of which are designated as cash flow hedges against the interest rate risk associated with its borrowings. In addition, in connection with managing risks associated with purchases of longer duration Agency MBS, the Company has also entered into Swaps that are not designated as hedges for accounting purposes.

In response to the turmoil in the financial markets resulting from the COVID-19 pandemic experienced during the three months ended March 31, 2020 and given that management no longer considered these transactions to be effective hedges in the prevailing interest rate environment, the Company unwound all of its approximately $4.1 billion of Swap hedging transactions late in the first quarter in order to recover previously posted margin. At March 31, 2020, losses of $71.2 million on unwound Swaps previously designated as hedges for accounting purposes continue to be included in AOCI. As the underlying hedged financing transactions are still considered probable of occurring, these losses will be amortized to interest expense over the remaining lives of the associated Swaps, which averaged 20 months at March 31, 2020.

The following table presents the fair value of the Company’s derivative instruments at March 31, 2020 and their balance sheet location at September 30, 2017 and December 31, 2016:2019:
 
 September 30, 2017 December 31, 2016 March 31, 2020 December 31, 2019
Derivative Instrument(1) Designation  Balance Sheet Location Notional Amount Fair Value Notional Amount Fair Value Designation  Notional Amount Fair Value Notional Amount Fair Value
(In Thousands)                      
Non-cleared legacy Swaps (1)
 Hedging Assets $
 $
 $350,000
 $233
Cleared Swaps (2)
 Hedging Liabilities $2,550,000
 $
 $2,550,000
 $(46,954)
Swaps Hedging $
 $
 $2,942,000
 $
Swaps Non-Hedging $
 $
 $230,000
 $
 
(1) Non-cleared legacy Swaps include Swaps executed and settled bilaterally with counterparties without the use of an organized exchange or central clearing house. The Company’s final non-cleared legacy Swaps expired during the three months ended June 30, 2017.
(2) Cleared Swaps includeRepresents Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties. As of September 30, 2017, all of the Company’s Swaps have been novated to and are cleared by a central clearing house are subject to initial margin requirements. Beginning in January 2017, variation margin payments on the Company’s cleared Swaps are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap.

Swaps
 
The following table presents the assets pledged as collateral against the Company’s Swap contracts at September 30, 2017March 31, 2020 and December 31, 20162019:
 
(In Thousands) March 31, 2020 December 31, 2019
Agency MBS, at fair value $
 $2,241
Restricted cash 
 16,777
Total assets pledged against Swaps $
 $19,018
(In Thousands) September 30, 2017 December 31, 2016
Agency MBS, at fair value $23,197
 $32,468
Restricted cash 6,524
 53,849
Total assets pledged against Swaps $29,721
 $86,317

 
The Company’s derivative hedging instruments,Swaps designated as hedges, or a portion thereof, could become ineffective in the future if the associated repurchase agreements that such derivatives hedge fail to exist or if expected payments under the Swaps fail to have terms that match those ofadequately offset expected payments under the derivatives that hedge such borrowings.  At September 30, 2017, all of the Company’s derivatives were deemed effective for hedging purposes and no derivatives were terminated during the three and nine months ended September 30, 2017 and 2016.repurchase agreements.
 

27

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

The Company’s Swaps designated as hedging transactions have the effect of modifying the repricing characteristics of the Company’s repurchase agreements and cash flows for such liabilities.  To date, no cost has been incurred at the inception of a Swap (except for certain transaction fees related to entering into Swaps cleared though a central clearing house), pursuant to which the Company agrees to pay a fixed rate of interest and receive a variable interest rate, generally based on one-month or three-month London Interbank Offered Rate (“LIBOR”),LIBOR, on the notional amount of the Swap. TheDuring the three months ended March 31, 2019, the Company did not recognizede-designated and re-designated any change in the value of its existing Swaps previously designated as hedges through earnings as a resulthedge in order to benefit from the simplified assessment requirements under ASU 2017-12. This de-designation and re-designation had no net impact on the Company’s financial condition or results of hedge ineffectiveness during the three and nine months ended September 30, 2017 and 2016.operations.
 
At September 30, 2017, the Company had Swaps designated in hedging relationships with an aggregate notional amount

34

Table of $2.6 billion and extended 30 months on average with a maximum term of approximately 71 months. Contents

MFA FINANCIAL, INC.
The following table presents certain information with respect to the Company’s Swap activity during the three and nine months ended September 30, 2017:NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2020
(Dollars in Thousands) Three Months Ended 
 September 30, 2017
 Nine Months Ended 
 September 30, 2017
New Swaps:    
Number of new Swaps 
 
Aggregate notional amount $
 $
Swaps amortized/expired:    
Aggregate notional amount $
 $350,000
Weighted average fixed-pay rate % 0.58%



The following table presents information about the Company’s Swaps at September 30, 2017March 31, 2020 and December 31, 20162019:
 
   September 30, 2017 December 31, 2016
  Notional Amount 
Weighted Average Fixed-Pay
Interest Rate
 
Weighted Average Variable
Interest Rate (2) 
Notional Amount  
Weighted Average Fixed-Pay
Interest Rate
 
 Weighted Average Variable
Interest Rate (2)
 
 
Maturity (1)
 (Dollars in Thousands)            
 Within 30 days $
 % % $
 % %
 Over 30 days to 3 months 
 
 
 50,000
 0.67
 0.64
 Over 3 months to 6 months 
 
 
 300,000
 0.57
 0.66
 Over 6 months to 12 months 550,000
 1.49
 1.23
 
 
 
 Over 12 months to 24 months 200,000
 1.71
 1.24
 550,000
 1.49
 0.71
 Over 24 months to 36 months 1,500,000
 2.22
 1.24
 200,000
 1.71
 0.76
 Over 36 months to 48 months 200,000
 2.20
 1.23
 1,500,000
 2.22
 0.74
 Over 48 months to 60 months 
 
 
 200,000
 2.20
 0.75
 Over 60 months to 72 months 100,000
 2.75
 1.24
 
 
 
 
Over 72 months to 84 months (3)
 
 
 
 100,000
 2.75
 0.74
 Total Swaps $2,550,000
 2.04% 1.24% $2,900,000
 1.87% 0.72%
   March 31, 2020 December 31, 2019
  Notional Amount 
Weighted Average Fixed-Pay
Interest Rate
 
Weighted Average Variable
Interest Rate (2) 
Notional Amount  
Weighted Average Fixed-Pay
Interest Rate
 
 Weighted Average Variable
Interest Rate (2)
 
 
Maturity (1)
 (Dollars in Thousands)        
 Over 3 months to 6 months $
 % % $200,000
 2.05% 1.70%
 Over 6 months to 12 months 
 
 
 1,430,000
 2.30
 1.77
 Over 12 months to 24 months 
 
 
 1,300,000
 2.11
 1.86
 Over 24 months to 36 months 
 
 
 20,000
 1.38
 1.90
 Over 36 months to 48 months 
 
 
 222,000
 2.88
 1.84
 Total Swaps $
 % % $3,172,000
 2.24% 1.81%


(1)  Each maturity category reflects contractual amortization and/or maturity of notional amounts.
(2)  Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively.
(3) Reflects one Swap with a maturity date of July 2023.
 

28

MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

The following table presents the net impact of the Company’s derivative hedging instruments on its net interest expense and the weighted average interest rate paid and received for such Swaps for the three and nine months ended September 30, 2017March 31, 2020 and 20162019:
 
  Three Months Ended
March 31,
(Dollars in Thousands) 2020 2019
Interest (expense)/income attributable to Swaps $(3,359) $1,191
Weighted average Swap rate paid 2.09% 2.31%
Weighted average Swap rate received 1.65% 2.49%
  Three Months Ended 
 September 30,
 Nine Months Ended 
 September 30,
(Dollars in Thousands) 2017 2016 2017 2016
Interest expense attributable to Swaps $5,310
 $10,170
 $19,606
 $31,279
Weighted average Swap rate paid 2.04% 1.82% 1.96% 1.82%
Weighted average Swap rate received 1.23% 0.49% 1.00% 0.45%

 
During the three months ended March 31, 2020 and 2019, the Company recorded net losses on Swaps not designated in hedging relationships of approximately $4.3 million and $8.9 million, respectively, which included $9.4 million and $7.8 million of losses realized on the unwind of certain Swaps. These amounts are included in Other income, net on the Company’s consolidated statements of operations.

Impact of Derivative Hedging Instruments on AOCI
 
The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the three and nine months ended September 30, 2017March 31, 2020 and 20162019:
 
  Three Months Ended
March 31,
(In Thousands) 2020 2019
AOCI from derivative hedging instruments:    
Balance at beginning of period $(22,675) $3,121
Net loss on Swaps (50,127) (10,445)
Amortization of de-designated hedging instruments, net 1,594
 (341)
Balance at end of period $(71,208) $(7,665)


The estimated net amount of the existing losses that are reported in AOCI as of March 31, 2020 that are expected to be reclassified into earnings within the next 12 months is $44.5 million.

35

MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020
  Three Months Ended 
 September 30,
 Nine Months Ended 
 September 30,
(In Thousands) 2017 2016 2017 2016
AOCI from derivative hedging instruments:        
Balance at beginning of period $(35,841)
$(131,971) $(46,721) $(69,399)
Net gain/(loss) on Swaps 5,791
 22,769
 16,671
 (39,803)
Balance at end of period $(30,050) $(109,202) $(30,050) $(109,202)






6.      Repurchase Agreements and Other Advances
 
Repurchase Agreements

The Company’s repurchase agreements are accounted for as secured borrowings and bear interest that is generally LIBOR-based.  (See Notes 2(l)2(j) and 7)  At September 30, 2017,March 31, 2020, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 1928 days and an effective repricing period of eleven months,11 months.  Late in the first quarter, due to the severe market volatility and price dislocations resulting from concerns driven by the COVID-19 pandemic, the Company was unable to meet all of it margin call obligations with respect to its repurchase obligations, which effectively triggered a default under the numerous repurchase agreements it has with its counterparties. The Company initiated discussions with its counterparties regarding entering into a forbearance agreement that would provide the Company relief from compliance with certain of the requirements of these agreements, including the impactneed to make margin calls, for an agreed period. Subsequent to quarter end, the Company entered into a forbearance agreement with the majority of related Swaps.its repurchase agreement counterparties and eliminated the amounts outstanding with other repurchase agreement counterparties with whom it did not enter into a forbearance agreement. See Note 16 “Subsequent Events” for further details. At December 31, 2016,2019, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 1940 days and an effective repricing period of 1210 months, including the impact of related Swaps.


2936

MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


 
The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at September 30, 2017March 31, 2020 and December 31, 20162019:
(Dollars in Thousands) September 30,
2017
 December 31,
2016
Repurchase agreement borrowings secured by Agency MBS $2,671,245
 $3,095,020
Fair value of Agency MBS pledged as collateral under repurchase agreements $2,888,156
 $3,280,689
Weighted average haircut on Agency MBS (1)
 4.62% 4.67%
Repurchase agreement borrowings secured by Legacy Non-Agency MBS $1,361,866
 $1,690,937
Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase agreements (2)
 $1,848,134
 $2,317,708
Weighted average haircut on Legacy Non-Agency MBS (1)
 22.40% 24.01%
Repurchase agreement borrowings secured by RPL/NPL MBS $798,508
 $1,943,572
Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements $1,005,757
 $2,433,711
Weighted average haircut on RPL/NPL MBS (1)
 21.58% 20.98%
Repurchase agreements secured by U.S. Treasuries $474,726
 $504,572
Fair value of U.S. Treasuries pledged as collateral under repurchase agreements $475,688
 $510,767
Weighted average haircut on U.S. Treasuries (1)
 1.39% 1.60%
Repurchase agreements secured by CRT securities 
 $413,172
 $271,205
Fair value of CRT securities pledged as collateral under repurchase agreements $530,833
 $357,488
Weighted average haircut on CRT securities (1)
 22.05% 23.22%
Repurchase agreements secured by MSR related assets $268,819
 $135,112
Fair value of MSR related assets pledged as collateral under repurchase agreements $412,674
 $226,780
Weighted average haircut on MSR related assets (1)
 33.76% 41.40%
Repurchase agreements secured by residential whole loans (3)
 $883,366
 $832,060
Fair value of residential whole loans pledged as collateral under repurchase agreements $1,273,955
 $1,175,088
Weighted average haircut on residential whole loans (1)
 28.35% 25.03%
(Dollars in Thousands) March 31,
2020
 December 31,
2019
Repurchase agreements secured by residential whole loans (1)
 $4,700,931
 $4,743,094
Fair value of residential whole loans pledged as collateral under repurchase agreements (2)(3)
 $5,665,277
 $5,986,267
Weighted average haircut on residential whole loans (4)
 19.17% 20.07%
Repurchase agreement borrowings secured by Agency MBS $522,209
 $1,557,675
Fair value of Agency MBS pledged as collateral under repurchase agreements $568,704
 $1,656,373
Weighted average haircut on Agency MBS (4)
 4.99% 4.46%
Repurchase agreement borrowings secured by Legacy Non-Agency MBS $1,003,122
 $1,121,802
Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase agreements $1,088,549
 $1,420,797
Weighted average haircut on Legacy Non-Agency MBS (4)
 21.60% 20.27%
Repurchase agreement borrowings secured by RPL/NPL MBS $255,409
 $495,091
Fair value of RPL/NPL MBS pledged as collateral under repurchase agreements $243,125
 $635,005
Weighted average haircut on RPL/NPL MBS (4)
 20.30% 21.52%
Repurchase agreements secured by CRT securities 
 $297,628
 $203,569
Fair value of CRT securities pledged as collateral under repurchase agreements $263,225
 $252,175
Weighted average haircut on CRT securities (4)
 20.89% 18.84%
Repurchase agreements secured by MSR-related assets $929,915
 $962,515
Fair value of MSR-related assets pledged as collateral under repurchase agreements $877,204
 $1,217,002
Weighted average haircut on MSR-related assets (4)
 22.11% 21.18%
Repurchase agreements secured by other interest-earning assets $59,777
 $57,198
Fair value of other interest-earning assets pledged as collateral under repurchase agreements $71,837
 $61,708
Weighted average haircut on other interest-earning assets (4)
 21.88% 22.01%
 
(1)Haircut representsExcludes $811,000 and $1.1 million of unamortized debt issuance costs at March 31, 2020 and December 31, 2019, respectively.
(2)At March 31, 2020 and December 31, 2019, includes RPL/NPL MBS with an aggregate fair value of $193.9 million and $238.8 million, respectively, obtained in connection with the percentage amount by which the collateral value is contractually required to exceed theCompany’s loan amount.securitization transactions that are eliminated in consolidation.
(2) Includes $172.4 million of Legacy Non-Agency MBS acquired from consolidated VIEs that are eliminated from the Company’s consolidated balance sheets at December(3) At March 31, 2016.
(3) Excludes $259,000 and $210,000 of unamortized debt issuance costs at September 30, 20172020 and December 31, 2016,2019, includes residential whole loans held at carrying value with an aggregate fair value of $4.8 billion and $5.0 billion and aggregate amortized cost of $5.1 billion and $4.8 billion, respectively and residential whole loans held at fair value with an aggregate fair value and amortized cost of $718.3 million and $794.7 million, respectively.

(4) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount.

In addition, the Company had cash pledged as collateral in connection with its repurchase agreements of $213.1 million and $25.2 million at March 31, 2020 and December 31, 2019, respectively.


37

MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at September 30, 2017March 31, 2020 and December 31, 2016:2019:


  March 31, 2020 December 31, 2019
 Balance 
 Weighted Average Interest RateBalance Weighted Average Interest Rate
Time Until Interest Rate Reset
(Dollars in Thousands)        
Within 30 days $2,504,628
 1.96% $4,472,120
 2.55%
Over 30 days to 3 months 2,993,905
 2.96
 2,746,384
 3.43
Over 3 months to 12 months 1,392,318
 4.06
 1,014,441
 3.36
Over 12 months 878,140
 5.65
 907,999
 3.44
Total repurchase agreements $7,768,991
 3.14% $9,140,944
 2.99%
Less debt issuance costs 811
   1,123
  
Total repurchase agreements less debt
  issuance costs
 $7,768,180
   $9,139,821
  

  September 30, 2017 December 31, 2016
 Balance 
 Weighted Average Interest RateBalance Weighted Average Interest Rate
Time Until Interest Rate Reset
(Dollars in Thousands)        
Within 30 days $6,378,566
 2.15% $7,284,062
 1.77%
Over 30 days to 3 months 493,136
 2.42
 1,188,416
 1.91
Total repurchase agreements 6,871,702
 2.17% 8,472,478
 1.79%
Less debt issuance costs 259
   210
  
Total repurchase agreements less debt
  issuance costs
 $6,871,443
   $8,472,268
  


Undrawn Financing Commitment


30

MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

The following table presents contractual maturity information aboutMSR-related assets, the Company’s borrowings under repurchase agreements, allCompany has obtained a financing commitment of up to $75.0 million, of which are accounted for$25.4 million was utilized and was outstanding as secured borrowings, at September 30, 2017, and does not reflectof March 31, 2020. The Company pays a commitment fee ranging from 0.125% to 0.5% of the impactundrawn amount, depending on the amount of derivative contracts that hedge such repurchase agreements:financing utilized.

  September 30, 2017
Contractual Maturity Overnight Within 30 Days Over 30 Days to 3 Months Over 3 Months to 12 Months Over 12 months Total
(Dollars in Thousands)            
Agency MBS $
 $2,590,020
 $81,225
 $
 $
 $2,671,245
Legacy Non-Agency MBS 
 746,798
 478,331
 136,737
 
 1,361,866
RPL/NPL MBS 
 359,471
 316,638
 122,399
 
 798,508
U.S. Treasuries 
 474,726
 
 
 
 474,726
CRT securities 
 409,123
 4,049
 
 
 413,172
MSR related assets 
 268,819
 
 
 
 268,819
Residential whole loans 
 
 
 821,770
 61,596
 883,366
Total (1)
 $
 $4,848,957
 $880,243
 $1,080,906
 $61,596
 $6,871,702
             
Weighted Average Interest Rate % 1.83% 2.56% 3.31% 3.68% 2.17%
             
Gross amount of recognized liabilities for repurchase agreements in Note 8 $6,871,702
Amounts related to repurchase agreements not included in offsetting disclosure in Note 8 $

(1)Excludes $259,000 of unamortized debt issuance costs at September 30, 2017.


The Company had repurchase agreementsagreement borrowings with 3126 and 28 counterparties at both September 30, 2017March 31, 2020 and December 31, 2016.2019, respectively. The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at September 30, 2017:March 31, 2020:
 
 September 30, 2017 March 31, 2020
 
Counterparty
Rating (1)
 
Amount 
at Risk (2)
 
Weighted 
Average Months 
to Maturity for
Repurchase Agreements
 
Percent of
Stockholders’ Equity
 
Counterparty
Rating (1)
 
Amount 
at Risk (2)
 
Weighted 
Average Months 
to Maturity for
Repurchase Agreements (3)
 
Percent of
Stockholders’ Equity
Counterparty  
(Dollars in Thousands)                
Wells Fargo (3)
 AA-/Aa2/AA- $325,023
 6 10.0%
Credit Suisse (4)
 BBB+/Aa2/A- 235,579
 2 7.2
 BBB+/Baa2/A- $421,642
 2 17.3%
UBS (5)
 A+/A1/A+ 167,329
 8 5.1
Barclays Bank BBB/Aa3/A 386,620
 2 15.8
Goldman Sachs (5)
 BBB+/A3/A 256,550
 5 10.5
Wells Fargo (6)
 A+/Aa2/AA- 246,865
 16 10.1


(1)As rated at September 30, 2017March 31, 2020 by S&P, Moody’s and Fitch, Inc., respectively.  The counterparty rating presented is the lowest published for these entities.
(2)The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities.
(3)See Note 16 “Subsequent Events” for details regarding the Company’s Forbearance Agreements, which impacts the maturity dates of the Company’s repurchase agreement financings.
(4)Includes $313.8$369.0 million at risk with Credit Suisse and $52.6 million at risk with Credit Suisse Cayman.
(5)Includes $118.1 million at risk with Goldman Sachs Lending Partners and $138.4 million at risk with Goldman Sachs Bank USA.
(6)Includes $240.9 million at risk with Wells Fargo Bank, NA and $11.2approximately $6.0 million at risk with Wells Fargo Securities LLC.
(4)Includes $9.7 million at risk with Credit Suisse AG, Cayman Islands and $225.9 million at risk with Credit Suisse. Counterparty ratings are not published for Credit Suisse AG, Cayman Islands.
(5) Includes Non-Agency MBS pledged as collateral with contemporaneous repurchase and reverse repurchase agreements.



31

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

FHLB Advances

In January 2016, the FHFA released its final rule amending its regulation on FHLB membership, which, among other things, provided termination rules for then current captive insurance members. As a result of such regulation, MFA Insurance was required to repay all of its outstanding FHLB advances by February 19, 2017 and its FHLB membership was terminated on such date. At December 31, 2016, MFA Insurance had $215.0 million in outstanding long-term secured FHLB advances with a weighted average borrowing rate of 0.78%. Interest payable on outstanding FHLB advances at December 31, 2016 totaled approximately $42,000 and was included in Other liabilities on the Company’s consolidated balance sheets.


7. Collateral Positions
 
The Company pledges securities or cash as collateral to its counterparties pursuant to its borrowings under repurchase agreements and for initial margin payments on centrally cleared Swaps. In addition, the Company receives securities or cash as collateral pursuant to financing provided under reverse repurchase agreements.  The Company exchanges collateral with its

38

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

counterparties based on changes in the fair value, notional amount and term of the associated repurchase agreements and Swap contracts, as applicable.  In connection with these margining practices, either the Company or its counterparty may be required to pledge cash or securities as collateral.  When the Company’s pledged collateral exceeds the required margin, the Company may initiate a reverse margin call, at which time the counterparty may either return the excess collateral or provide collateral to the Company in the form of cash or equivalent securities.



32

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements, derivative hedging instruments and FHLB advances at September 30, 2017 and December 31, 2016
  September 30, 2017 December 31, 2016
(In Thousands) Assets Pledged Collateral Held Assets Pledged Collateral Held
Derivative Hedging Instruments:  
  
  
  
Agency MBS $23,197
 $
 $32,468
 $
Cash (1)
 6,524
 
 53,849
 
  29,721
 
 86,317
 
Repurchase Agreement Borrowings:        
Agency MBS 2,888,156
 
 3,280,689
 
Legacy Non-Agency MBS (2)(3)
 1,848,134
 
 2,317,708
 
RPL/NPL MBS 1,005,757
 
 2,433,711
 
U.S. Treasury securities 475,688
 
 510,767
 
CRT securities 530,833
 
 357,488
 
MSR related assets 412,674
 
 226,780
 
Residential whole loans 1,273,955
 
 1,175,088
 
Cash (1)
 8,916
 
 4,614
 
  8,444,113
 
 10,306,845
 
         
FHLB Advances:        
Agency MBS 
 
 227,244
 
  
 
 227,244
 
         
Reverse Repurchase Agreements:        
U.S. Treasury securities 
 507,318
 
 510,767
  
 507,318
 
 510,767
Total $8,473,834
 $507,318
 $10,620,406
 $510,767
(1)  Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.
(2)  Includes $172.4 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs that are eliminated from the Company’s consolidated balance sheets at December 31, 2016.
(3)  In addition, at September 30, 2017 and December 31, 2016, $689.3 million and $688.2 million of Legacy Non-Agency MBS, respectively, are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.


33

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

The following table presents detailed information about the Company’s assets pledged as collateral pursuantare described in Notes 2(f) - Restricted Cash, 5(c) - Derivative Instruments and 6 - Repurchase Agreements. The total fair value of assets pledged as collateral with respect to itsthe Company’s borrowings under repurchase agreements andand/or derivative hedging instruments was $9.0 billion and $11.3 billion at September 30, 2017:March 31, 2020 and December 31, 2019, respectively. An aggregate of $56.0 million and $57.2 million of accrued interest on those assets had also been pledged as of March 31, 2020 and December 31, 2019, respectively.

  September 30, 2017
  
Assets Pledged Under Repurchase 
Agreements
 
Assets Pledged Against Derivative
Hedging Instruments
 
Total Fair
Value of Assets Pledged and Accrued Interest
(In Thousands) Fair Value 
Amortized
Cost
 
Accrued 
Interest on
Pledged 
Assets
 
Fair Value/ 
Carrying 
Value
 
Amortized
Cost
 
Accrued Interest on 
Pledged 
Assets
 
Agency MBS $2,888,156
 $2,890,386
 $7,461
 $23,197
 $23,763
 $48
 $2,918,862
Legacy Non-Agency MBS (1)
 1,848,134
 1,432,145
 6,711
 
 
 
 1,854,845
RPL/NPL MBS 1,005,757
 1,001,548
 757
 
 
 
 1,006,514
U.S. Treasuries 475,688
 475,342
 
 
 
 
 475,688
CRT securities 530,833
 491,490
 418
 
 
 
 531,251
MSR related assets 412,674
 411,277
 942
 
 
 
 413,616
Residential whole loans (2)
 1,273,955
 1,251,400
 2,974
 
 
 
 1,276,929
Cash (3)
 8,916
 8,916
 
 6,524
 6,524
 
 15,440
Total $8,444,113
 $7,962,504
 $19,263
 $29,721
 $30,287
 $48
 $8,493,145

(1)In addition, at September 30, 2017, $689.3 million of Legacy Non-Agency MBS are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty.
(2)Includes residential whole loans held at carrying value with an aggregate fair value of $370.5 million and aggregate amortized cost of $347.9 million and residential whole loans held at fair value with an aggregate fair value and amortized cost of $903.5 million.
(3)Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets.

34

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

8.    Offsetting Assets and Liabilities
The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at September 30, 2017 and December 31, 2016:
Offsetting of Financial Assets and Derivative Assets
  Gross Amounts of Recognized Assets Gross Amounts Offset in the Consolidated Balance Sheets Net Amounts of Assets Presented in the Consolidated Balance Sheets 
Gross Amounts Not Offset in 
the Consolidated Balance Sheets
  Net Amount
(In Thousands) 
Financial
Instruments
 
Cash 
Collateral 
Received
September 30, 2017            
Swaps, at fair value $
 $
 $
 $
 $
 $
Total $
 $
 $
 $
 $
 $
             
December 31, 2016            
Swaps, at fair value $233
 $
 $233
 $(233) $
 $
Total $233
 $
 $233
 $(233) $
 $
Offsetting of Financial Liabilities and Derivative Liabilities
  Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Consolidated Balance Sheets Net Amounts of Liabilities Presented in the Consolidated Balance Sheets 
Gross Amounts Not Offset in the 
Consolidated Balance Sheets
 Net Amount 
(In Thousands)
Financial 
Instruments (1)
 
Cash 
Collateral 
Pledged (1)
September 30, 2017            
Swaps, at fair value (2)
 $
 $
 $
 $
 $
 $
Repurchase agreements and other advances (3)(4)
 6,871,702
 
 6,871,702
 (6,862,786) (8,916) 
Total $6,871,702
 $
 $6,871,702
 $(6,862,786) $(8,916) $
             
December 31, 2016            
Swaps, at fair value (2)
 $46,954
 $
 $46,954
 $
 $(46,954) $
Repurchase agreements and other advances (3)(4)
 8,687,478
 
 8,687,478
 (8,682,864) (4,614) 
Total $8,734,432
 $
 $8,734,432
 $(8,682,864) $(51,568) $
(1) Amounts disclosed in the Financial Instruments column of the table above represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements and other advances, and derivative transactions.  Amounts disclosed in the Cash Collateral Pledged column of the table above represent amounts pledged as collateral against derivative transactions and repurchase agreements, and exclude excess collateral of $6.5 million and $6.9 million at September 30, 2017 and December 31, 2016, respectively.
(2) The fair value of securities pledged against the Company’s Swaps was $23.2 million and $32.5 million at September 30, 2017 and December 31, 2016, respectively. Beginning in January 2017, variation margin payments on the Company’s cleared Swaps are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap.
(3) The fair value of financial instruments pledged against the Company’s repurchase agreements and other advances was $8.4 billion and $10.5 billion at September 30, 2017 and December 31, 2016, respectively.
(4) Excludes $259,000 and $210,000 of unamortized debt issuance costs at September 30, 2017 and December 31, 2016, respectively.

35

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

Nature of Setoff Rights
In the Company’s consolidated balance sheets, all balances associated with the repurchase agreement and Swap transactions that are not centrally cleared are presented on a gross basis.

Certain of the Company’s repurchase agreement and derivative transactions are governed by underlying agreements that generally provide for a right of setoff in the event of default or in the event of a bankruptcy of either party to the transaction. For oneIn the Company’s consolidated balance sheets, all balances associated with repurchase agreement counterparty,agreements are presented on a gross basis.

The fair value of financial instruments pledged against the underlyingCompany’s repurchase agreements provide for an unconditional rightwas $8.8 billion and $11.2 billion at March 31, 2020 and December 31, 2019, respectively. Since January 2017, variation margin payments on the Company’s cleared Swaps have been treated as a legal settlement of setoff.  the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the related Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap. As previously discussed, in response to the turmoil in the financial markets resulting from the COVID-19 pandemic experienced during the three months ended March 31, 2020, the Company unwound all of its Swaps late in the quarter. The fair value of financial instruments pledged against the Company’s Swaps at December 31, 2019 was $2.2 million. In addition, cash that has been pledged as collateral against repurchase agreements and Swaps is reported as Restricted cash on the Company’s consolidated balance sheets. (See Notes 2(f), 5(c) and 6). See Note 6 regarding the Company’s inability to meet its margin requirements at March 31, 2020.


9.
9. Other Liabilities

The following table presents the components of the Company’s Other liabilities at March 31, 2020 and December 31, 2019:

(In Thousands) March 31, 2020 December 31, 2019
Securitized debt (1)
 $533,733
 $570,952
Convertible Senior Notes 224,264
 223,971
Senior Notes 96,874
 96,862
Dividends and dividend equivalents payable 
 90,749
Accrued interest payable 21,840
 18,238
Accrued expenses and other 44,771
 42,819
Total Other Liabilities $921,482
 $1,043,591

(1)Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that are eliminated in consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 10 and 15 for further discussion.)

(a) Convertible Senior Notes

On June 3, 2019, the Company issued $230.0 million in aggregate principal amount of its Convertible Senior Notes in an underwritten public offering, including an additional $30.0 million issued pursuant to the exercise of the underwriters’ option to purchase additional Convertible Senior Notes. The total net proceeds the Company received from the offering were approximately $223.3 million, after deducting offering expenses and the underwriting discount.  The Convertible Senior Notes bear interest at a fixed rate of 6.25% per year, paid semiannually on June 15 and December 15 of each year commencing December 15, 2019 and

39

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

will mature on June 15, 2024, unless earlier converted, redeemed or repurchased in accordance with their terms. The Convertible Senior Notes are convertible at the option of the holders at any time until the close of business on the business day immediately preceding the maturity date into shares of the Company’s common stock based on an initial conversion rate of 125.7387 shares of the Company’s common stock for each $1,000 principal amount of the Convertible Senior Notes, which is equivalent to an initial conversion price of approximately $7.95 per share of common stock. The Convertible Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 6.94%. The Company does not have the right to redeem the Convertible Senior Notes prior to maturity, except to the extent necessary to preserve its status as a REIT, in which case the Company may redeem the Convertible Senior Notes, in whole or in part, at a redemption price equal to the principal amount redeemed plus accrued and unpaid interest.

The Convertible Senior Notes are the Company’s senior unsecured obligations and are effectively junior to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements and other financing arrangements, to the extent of the value of the collateral securing such indebtedness and equal in right of payment to the Company’s existing and future senior unsecured obligations, including the Senior Notes.

(b) Senior Notes
 
On April 11, 2012, the Company issued $100.0 million in aggregate principal amount of its Senior Notes in an underwritten public offering.  The total net proceeds to the Company received from the offering of the Senior Notes were approximately $96.6 million, after deducting offering expenses and the underwriting discount.  The Senior Notes bear interest at a fixed rate of 8.00% per year, paid quarterly in arrears on January 15, April 15, July 15 and October 15 of each year and will mature on April 15, 2042.  The Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 8.31%. The Company may redeem the Senior Notes, in whole or in part, at any time, on or after April 15, 2017, at a redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest to, but not excluding, the redemption date.interest.


The Senior Notes are the Company’s senior unsecured obligations and are subordinateeffectively junior to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements obligation to return securities obtained as collateral and other financing arrangements, to the extent of the value of the collateral securing such indebtedness.indebtedness and equal in right of payment to the Company’s existing and future senior unsecured obligations, including the Convertible Senior Notes.

 
10. Other Liabilities

The following table presents the components of the Company’s Other liabilities at September 30, 2017 and December 31, 2016:

(In Thousands) September 30, 2017 December 31, 2016
Securitized debt (1)
 $137,327
 $
Dividends and dividend equivalents payable 79,605
 74,657
Accrued interest payable 11,223
 14,129
Swaps, at fair value (2)
 
 46,954
Accrued expenses and other liabilities 18,123
 19,612
Total Other Liabilities $246,278
 $155,352
(1)Securitized debt represents third-party liabilities of consolidated VIEs and excludes liabilities of the VIEs acquired by the Company that are eliminated in consolidation. The third-party beneficial interest holders in the VIEs have no recourse to the general credit of the Company. (See Notes 11 and 16 for further discussion.)
(2)Beginning in January 2017, variation margin payments on the Company’s cleared Swaps are treated as a legal settlement of the exposure under the Swap contract. Previously such payments were treated as collateral pledged against the exposure under the Swap contract. The effect of this change is to reduce what would have otherwise been reported as fair value of the Swap.


11.10.    Commitments and Contingencies
 
(a) Lease Commitments
 
The Company pays monthly rent pursuant to two operating3 office leases.  TheIn November 2018, the Company amended the lease term for the Company’sits corporate headquarters in New York, New York, extendsunder the same terms and conditions, to extend the expiration date for the lease by up to one year, through June 30, 2020.2021, with a mutual option to terminate in February 2021.  For the three months ended March 31, 2020, the Company recorded expense of approximately $666,000 in connection with the lease for its current corporate headquarters.

In addition, in November 2018, the Company executed a lease agreement on new office space in New York, New York. The Company plans to relocate its corporate headquarters to this new office space upon the substantial completion of the building. The lease provides for aggregate cash payments ranging over time of approximately $2.5 million per year, paid on a monthly basis, exclusive of escalation charges.  In addition, as part of this lease agreement, the Company has provided the landlord a $785,000 irrevocable standby letter of credit fully collateralized by cash.  The letter of credit may be drawn upon by the landlordterm specified in the event thatagreement is fifteen years with an option to renew for an additional five years. The Company’s current estimate of annual lease rental expense under the Company defaults under certain terms of the lease.  In addition, the

36

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

Company has anew lease, through December 31, 2021 for its off-site back-up facility located in Rockville Centre, New York,excluding escalation charges which provides for, among other things, lease payments totaling $32,000, annually.

(b) Corporate Loan

at this point are unknown, is approximately $4.6 million. The Company has entered into a loan agreement with an entity that originates loans and ownscurrently expects to relocate to the related MSRs. The loan is secured by certain U.S. Government, Agency and private-label MSRs,space in the fourth quarter of 2020, but this timing, as well as when it is required to begin making payments and recognize rental and other unencumbered assets owned byexpenses under the borrower. Undernew lease, is dependent on when the terms of the loan agreement, the Company has committed to lend $130.0 million of which approximately $101.1 million was drawn at September 30, 2017.space is actually available for use.


(c)(b)Representations and Warranties in Connection with Loan Securitization TransactionTransactions


In connection with the loan securitization transactiontransactions entered into by the Company, in June 2017 (See Note 16 for further discussion), the Company has the obligation under certain circumstances to repurchase assets previously transferred to a securitization vehiclevehicles upon breach of certain representations and warranties. As of September 30, 2017,March 31, 2020, the Company had no0 reserve established for repurchases of loans and was not aware of any material unsettled repurchase claims that would require the establishment of such a reserve.  (See Note 15)


(d)MBS Purchase Commitments

40

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

(c) Corporate Loans

The Company has participated in loans to provide financing to entities that originate loans and own MSRs, as well as certain other unencumbered assets owned by the borrower. Under the terms of the respective lending agreements, the Company has committed to lend $150.0 million of which approximately $108.8 million was drawn at March 31, 2020. (See Note 4)

(d)Rehabilitation Loan Commitments

At September 30, 2017,March 31, 2020, the Company had unfunded commitments to purchase Non-Agency MBS at an estimated price of $3.6 million. The expected settlement amounts are included$123.1 million in the Non-Agency MBS balances presented at fair value on the Company’s consolidated balance sheets,connection with a corresponding liability included in Payable for unsettled MBS and residential whole loan purchases.its purchased Rehabilitation loans. (See Note 3)

(e)Residential Whole Loan Purchase Commitments

At September 30, 2017, the Company has agreed, subject to the completion of due diligence, and customary closing conditions, to purchase residential whole loans at fair value at an aggregate estimated purchase price of $120.4 million. The expected settlement amounts are included in the Company’s consolidated balance sheets in Residential whole loans, at fair value, with a corresponding liability included in Payable for unsettled MBS and residential whole loan purchases.



12.11.    Stockholders’ Equity
 
(a) Preferred Stock
 
Issuance of 7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”)

On April 15, 2013, the Company completed the issuance of 8.0 million shares of its Series B Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The Company’s Series B Preferred Stock is entitled to receive a dividend at a rate of 7.50% per year on the $25.00 liquidation preference before the Company’s common stock is paid any dividends and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series B Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends (whether or not authorized or declared) exclusively at the Company’s option commencing on April 15, 2018 (subject to the Company’s right, under limited circumstances, to redeem the Series B Preferred Stock prior to that date in order to preserve its qualification as a REIT) and upon certain specified change in control transactions in which the Company’s common stock and the acquiring or surviving entity common securities would not be listed on the New York Stock Exchange (the “NYSE”), the NYSE American LLC or NASDAQ, or any successor exchange.option.

The Series B Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six6 or more quarterly periods (whether or not consecutive).  Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two2 additional directors to the Company’s Board of Directors (the “Board”), until all unpaid dividends have been paid or declared and set apart for payment.  In addition, certain material and adverse changes to the terms of the Series B Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock.


As a result of the turmoil in the financial markets resulting from the spread of the novel coronavirus and the global COVID-19 pandemic, and in order to preserve liquidity, on March 25, 2020, the Company revoked the previously announced first quarter 2020 quarterly cash dividends on each of the Company's common stock and Series B Preferred Stock. The Series B Preferred Stock dividend of $0.46875 per share had been declared on February 14, 2020, and was to be paid on March 31, 2020, to stockholders of record as of the close of business March 2, 2020. Unpaid dividends on the Company's Series B Preferred Stock will accrue without interest. No dividends may be paid or set apart on shares of the Company's common stock unless full cumulative dividends on the Series B Preferred Stock for all past dividend periods that have ended have been or contemporaneously are paid in cash, or a sum sufficient for such payment is set apart for payment. In addition, pursuant to the forbearance agreements that the Company entered into subsequent to quarter end, the Company is prohibited from paying dividends on its Series B Preferred Stock during the forbearance period (see Note 16). The Company will continue to monitor market conditions and the potential impact the ongoing volatility and uncertainty may have on its business. Related thereto, the Company's Board of Directors will continue to evaluate liquidity and the payment of dividends as market conditions evolve.

At March 31, 2020, the unpaid cumulative dividends in arrears on the Company’s Series B Preferred Stock were $3.8 million ($0.46875 per share).

3741

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBERMARCH 31, 2020


Issuance of 6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series C Preferred Stock”)

On February 28, 2020, the Company amended its charter through the filing of articles supplementary to reclassify 12,650,000 shares of the Company’s authorized but unissued common stock as shares of the Company’s Series C Preferred Stock. On March 2, 2020, the Company completed the issuance of 11.0 million shares of its Series C Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The total net proceeds the Company received from the offering were approximately $266.0 million, after deducting offering expenses and the underwriting discount.

The Company’s Series C Preferred Stock is entitled to receive dividends (i) from and including the original issue date to, but excluding, March 31, 2025, at a fixed rate of 6.50% per year on the $25.00 liquidation preference and (ii) from and including March 31, 2025, at a floating rate equal to three-month LIBOR plus a spread of 5.345% per year of the $25.00 per share liquidation preference before the Company’s common stock is paid any dividends, and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series C Preferred Stock are payable quarterly in arrears on or about March 31, June 30, 2017

September 30 and December 31 of each year. The following table presents cash dividends declaredSeries C Preferred Stock is not redeemable by the Company prior to March 31, 2025, except under circumstances where it is necessary to preserve the Company’s qualification as a REIT for U.S. federal income tax purposes and upon the occurrence of certain specified change in control transactions. On or after March 31, 2025, the Company may, at its option, subject to certain procedural requirements, redeem any or all of the shares of the Series C Preferred Stock for cash at a redemption price of $25.00 per share, plus any accrued and unpaid dividends thereon (whether or not authorized or declared) to, but excluding, the redemption date.

The Series C Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for 6 or more quarterly periods (whether or not consecutive).  Under such circumstances, the Series Preferred Stock will be entitled to vote to elect 2 additional directors to the Company’s Board, until all unpaid dividends have been paid or declared and set apart for payment. In addition, certain material and adverse changes to the terms of the Series C Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3 of the outstanding shares of Series C Preferred Stock.

At March 31, 2020, the unpaid cumulative dividends in arrears on the Company’s Series C Preferred Stock were $1.4 million ($0.12639 per share). Pursuant to the forbearance agreements that the Company entered into subsequent to quarter end, the Company is prohibited from paying dividends on its Series C Preferred Stock during the forbearance period (see Note 16).

(b)  Dividends on Common Stock
As discussed above, on March 25, 2020, the Company revoked its previously announced first quarter 2020 quarterly cash dividends on each of the Company's common stock and Series B Preferred Stock. The quarterly cash dividend of $0.20 per share on the Company's common stock had been declared on March 11, 2020, and was to be paid on April 30, 2020, to all stockholders of record as of the close of business March 31, 2020. No dividends may be paid or set apart on shares of the Company's common stock unless full cumulative dividends on the Series B Preferred Stock from January 1, 2017 through September 30, 2017:

Declaration Date Record Date Payment Date Dividend Per Share
August 10, 2017 September 1, 2017 September 29, 2017 $0.46875
May 16, 2017 June 2, 2017 June 30, 2017 0.46875
February 17, 2017 March 6, 2017 March 31, 2017 0.46875

(b)  Dividends on Commonand Series C Preferred Stock
The following table presents for all past dividend periods that have ended have been or contemporaneously are paid in cash, dividends declared byor a sum sufficient for such payment is set apart for payment. In addition, pursuant to the forbearance agreements that the Company entered into subsequent to quarter end, the Company is prohibited from paying dividends on its common stock from January 1, 2017 through September 30, 2017:
Declaration Date (1)
 Record Date Payment Date Dividend Per Share
September 14, 2017 September 28, 2017 October 31, 2017 $0.20
(1)
June 12, 2017 June 29, 2017 July 28, 2017 0.20
 
March 8, 2017 March 29, 2017 April 28, 2017 0.20
 
(1)  At September 30, 2017, the Company had accrued dividends and dividend equivalents payable of $79.6 million related to the common stock dividend declared on September 14, 2017.
(c) Public Offering of Common Stock

The table below presents information with respect to shares of the Company’s common stock issued through public offerings during the nine months ended September 30, 2017. The Company did not issue any common stock through public offerings during the nine months ended September 30, 2016.forbearance period (see Note 16).


Share Issue Date Shares Issued Gross Proceeds Per Share Gross Proceeds
(In Thousands, Except Per Share Amounts)       
May 10, 2017 23,000
 $7.85
 $180,550
(1)

(1) The Company incurred approximately $412,000 of expenses in connection with this equity offering.

(d)(c) Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (“DRSPP”)
 
On September 16, 2016,October 15, 2019, the Company filed a shelf registration statement on Form S-3 with the SEC under the Securities Act of 1933, as amended (the “1933 Act”), for the purpose of registering additional common stock for sale through its DRSPP.  Pursuant to Rule 462(e) ofunder the 1933 Act, this shelf registration statement became effective automatically upon filing with the SEC and, when combined with the unused portion of the Company’s previous DRSPP shelf registration statements, registered an aggregate of 159.0 million shares of common stock.  The Company’s DRSPP is designed to provide existing stockholders and new investors with a convenient and economical way to purchase shares of common stock through the automatic reinvestment of dividends and/or optional cash investments.  At September 30, 2017March 31, 2020, 13.0approximately 8.8 million shares of common stock remained available for issuance pursuant to the DRSPP shelf registration statement.
 

42

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

During the three and nine months ended September 30, 2017,March 31, 2020, the Company issued 513,509 and 1,516,307106,949 shares of common stock through the DRSPP, raising net proceeds of approximately $4.3 million and $12.2 million, respectively.  From$691,979.  Since the inception of the DRSPP in September 2003 through September 30, 2017,March 31, 2020, the Company issued 32,899,09234,485,717 shares pursuant to the DRSPP, raising net proceeds of $275.1$287.3 million.


(d) At-the-Market Offering Program

38

TableOn August 16, 2019 the Company entered into a distribution agreement under the terms of Contentswhich the Company may offer and sell shares of its common stock having an aggregate gross sales price of up to $400.0 million (the “ATM Shares”), from time to time, through various sales agents, pursuant to an at-the-market equity offering program (the “ATM Program”). Sales of the ATM Shares, if any, may be made in negotiated transactions or by transactions that are deemed to be “at-the-market” offerings, as defined in Rule 415 under the 1933 Act, including sales made directly on the New York Stock Exchange (“NYSE”) or sales made to or through a market maker other than an exchange. The sales agents are entitled to compensation of up to two percent of the gross sales price per share for any shares of common stock sold under the distribution agreement.
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTSDuring the three months ended March 31, 2020, the Company did 0t sell any shares of common stock through the ATM Program. At March 31, 2020, approximately $390.0 million remained outstanding for future offerings under this program.
SEPTEMBER 30, 2017


(e)  Stock Repurchase Program
 
As previously disclosed, in August 2005, the Company’s Board authorized a stock repurchase program (the “Repurchase Program”) to repurchase up to 4.0 million shares of its outstanding common stock.  The Board reaffirmed such authorization in May 2010.  In December 2013, the Board increased the number of shares authorized under the Repurchase Program to an aggregate of 10.0 million. Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization.  Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as the Company deems appropriate (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) using available cash resources.  Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock.  The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice. The Company did not repurchase any shares of its common stock during the ninethree months ended September 30, 2017.March 31, 2020.  At September 30, 2017,March 31, 2020, 6,616,355 shares remained authorized for repurchase under the Repurchase Program.


(f) Accumulated Other Comprehensive Income/(Loss)


The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2017:March 31, 2020:
 Three Months Ended 
 September 30, 2017
 Nine Months Ended 
 September 30, 2017
 Three Months Ended
March 31, 2020
(In Thousands) 
Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
(Loss)/Gain
on Swaps
 Total AOCI Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
(Loss)/Gain
on Swaps
 Total AOCI 
Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
(Loss)
on Swaps
 Total AOCI
Balance at beginning of period $668,223
 $(35,841) $632,382
 $620,403
 $(46,721) $573,682
 $392,722
 $(22,675) $370,047
OCI before reclassifications 6,988
 5,791
 12,779
 71,188
 16,671
 87,859
 124,410
 (50,127) 74,283
Amounts reclassified from AOCI (1)
 (14,935) 
 (14,935) (31,315) 
 (31,315) (368,222) 1,594
 (366,628)
Net OCI during the period (2)
 (7,947) 5,791
 (2,156) 39,873
 16,671
 56,544
 (243,812) (48,533) (292,345)
Balance at end of period $660,276
 $(30,050) $630,226
 $660,276
 $(30,050) $630,226
 $148,910
 $(71,208) $77,702


(1)  See separate table below for details about these reclassifications.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
 


43

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020


The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2016March 31, 2019:
 Three Months Ended 
 September 30, 2016
 Nine Months Ended 
 September 30, 2016
 Three Months Ended
March 31, 2019
(In Thousands) 
Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
(Loss)/Gain
on Swaps
 Total AOCI Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
(Loss)/Gain
on Swaps
 Total AOCI 
Net Unrealized
Gain/(Loss) on
AFS Securities
 
Net 
Gain
on Swaps
 Total AOCI
Balance at beginning of period $625,697
 $(131,971) $493,726
 $585,250
 $(69,399) $515,851
 $417,167
 $3,121
 $420,288
OCI before reclassifications 64,350
 22,769
 87,119
 124,763
 (39,803) 84,960
 22,103
 (10,445) 11,658
Amounts reclassified from AOCI (1)
 (7,314) 
 (7,314) (27,280) 
 (27,280) (17,009) (341) (17,350)
Net OCI during the period (2)
 57,036
 22,769
 79,805
 97,483
 (39,803) 57,680
 5,094
 (10,786) (5,692)
Balance at end of period $682,733
 $(109,202) $573,531
 $682,733
 $(109,202) $573,531
 $422,261
 $(7,665) $414,596


(1)  See separate table below for details about these reclassifications.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
 

39

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2017March 31, 2020:
 Three Months Ended 
 September 30, 2017
 Nine Months Ended 
 September 30, 2017
  Three Months Ended
March 31, 2020
 
Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item in the Statement
Where Net Income is Presented
 Amounts Reclassified from AOCIAffected Line Item in the Statement
Where Net Income is Presented
(In Thousands)          
AFS Securities:        
Realized gain on sale of securities $(14,935) $(30,283) Net gain on sales of MBS and U.S. Treasury securities $(23,953) Net realized (loss)/gain on sales of residential mortgage securities and residential whole loans
OTTI recognized in earnings 
 (1,032) Net impairment losses recognized in earnings
Impairment recognized in earnings (344,269) Other, net
Total AFS Securities $(14,935) $(31,315)  $(368,222) 
Swaps designated as cash flow hedges:   
Amortization of de-designated hedging instruments 1,594
 Other, net
Total Swaps designated as cash flow hedges $1,594
 
Total reclassifications for period $(14,935) $(31,315)  $(366,628) 
 
The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2016March 31, 2019:
  Three Months Ended
March 31, 2019
  
Details about AOCI Components Amounts Reclassified from AOCIAffected Line Item in the Statement
Where Net Income is Presented
(In Thousands)    
AFS Securities:    
Realized gain on sale of securities $(17,009) Net realized (loss)/gain on sales of residential mortgage securities and residential whole loans
Total AFS Securities $(17,009)  
Amortization of de-designated hedging instruments (341)  
Total reclassifications for period $(17,350)  

  Three Months Ended 
 September 30, 2016
 Nine Months Ended 
 September 30, 2016
  
Details about AOCI Components Amounts Reclassified from AOCI Affected Line Item in the Statement
Where Net Income is Presented
(In Thousands)      
AFS Securities:      
Realized gain on sale of securities $(6,829) $(26,795) Net gain on sales of MBS and U.S. Treasury securities
OTTI recognized in earnings (485) (485) Net impairment losses recognized in earnings
Total AFS Securities $(7,314) $(27,280)  
Total reclassifications for period $(7,314) $(27,280)  



At September 30, 2017 and December 31, 2016, the Company had unrealized losses recorded in AOCI of approximately $103,000 and $1.7 million, respectively, on securities for which OTTI had been recognized in earnings in prior periods.


4044

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020




13.12.    EPS Calculation
 
The following table presents a reconciliation of the (loss)/earnings and shares used in calculating basic and diluted EPS(loss)/earnings per share for the three and nine months ended September 30, 2017March 31, 2020 and 20162019:
 
  Three Months Ended
March 31,
(In Thousands, Except Per Share Amounts) 2020 2019
Basic (Loss)/Earnings per Share:    
Net (loss)/income to common stockholders $(908,995) $88,857
Dividends declared on preferred stock (5,215) (3,750)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities 
 (256)
Net (loss)/income to common stockholders - basic $(914,210) $84,851
Basic weighted average common shares outstanding 452,979
 450,358
Basic (Loss)/ Earnings per Share $(2.02) $0.19
     
Diluted (Loss)/Earnings per Share:    
Net (loss)/income to common stockholders - basic $(914,210) $84,851
Interest expense on Convertible Senior Notes 
 
Net (loss)/income to common stockholders - diluted $(914,210) $84,851
Basic weighted average common shares outstanding 452,979
 450,358
Effect of assumed Convertible Senior Notes conversion to common shares 
 
Diluted weighted average common shares outstanding (1)
 452,979
 450,358
Diluted (Loss)/Earnings per Share $(2.02) $0.19

  Three Months Ended 
 September 30,
 Nine Months Ended 
 September 30,
(In Thousands, Except Per Share Amounts) 2017 2016 2017 2016
Numerator:        
Net income $63,805
 $83,011
 $221,799
 $240,031
Dividends declared on preferred stock (3,750) (3,750) (11,250) (11,250)
Dividends, dividend equivalents and undistributed earnings allocated to participating securities (409) (442) (1,299) (1,255)
Net income to common stockholders - basic and diluted $59,646
 $78,819
 $209,250
 $227,526
         
Denominator:        
Weighted average common shares for basic and diluted earnings per share (1)
 396,698
 373,141
 385,282
 373,011
Basic and diluted earnings per share $0.15
 $0.21
 $0.54
 $0.61


(1)
At September 30, 2017,March 31, 2020, the Company had an aggregate of 2.5approximately 2.3 million equity instruments outstanding that were not included in the calculation of diluted EPS for the three and nine months ended September 30, 2017,March 31, 2020, as their inclusion would have been anti-dilutive.  These equity instruments were comprised of approximately 4,000 shares of restricted common stock with a weighted average grant date fair value of $7.12 and approximately 2.5 millionreflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $6.49.$7.73. These equity instruments may have a dilutive impact on future EPS.


During the three months ended March 31, 2020, the Convertible Senior Notes were determined to be anti-dilutive and were not included in the calculation of diluted EPS under the “if-converted” method. Under this method, the periodic interest expense for dilutive notes is added back to the numerator and the weighted average number of shares that the notes are entitled to (if converted, regardless of whether the conversion option is in or out of the money) is included in the denominator for the purpose of calculating diluted EPS. The Convertible Senior Notes may have a dilutive impact on future EPS.

14.13.    Equity Compensation, Employment Agreements and Other Benefit Plans
 
(a)  Equity Compensation Plan
 
In accordance with the terms of the Company’s Equity Compensation Plan, (the “Equity Plan”), which was adopted by the Company’s stockholders on May 21, 2015 (and which amended and restated the Company’s 2010 Equity Compensation Plan), directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan.
 
Subject to certain exceptions, stock-based awards relating to a maximum of 12.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count towardstoward this limit.  At September 30, 2017,March 31, 2020, approximately 6.92.0 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan.  A participant may generally not receive stock-based awards in excess of 1.5 million shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards

45

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock.  Unless previously terminated by the Board, awards may be granted under the Equity Plan until May 20, 2025.
 
Restricted Stock Units


Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee of the Board (the “Compensation Committee”) at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date.  Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of September 30, 2017March 31, 2020 are designated to be settled in shares of the Company’s common stock.  The Company did not grant anygranted 1,204,713 and 752,500 RSUs during the three months ended September 30, 2017March 31, 2020 and 2016 and granted 898,945 and 728,195 RSUs during the nine months ended September 30, 2017 and 2016,2019, respectively. There were no0 RSUs forfeited during the ninethree months ended September 30,

41

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

2017. DuringMarch 31, 2020 and 20,000 RSUs forfeited during the ninethree months ended September 30, 2016 an aggregate of 10,000 RSUs were forfeited.March 31, 2019. All RSUs outstanding at September 30, 2017March 31, 2020 may be entitled to receive dividend equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled.  At September 30, 2017March 31, 2020 and December 31, 2016,2019, the Company had unrecognized compensation expense of $5.0$11.8 million and $3.6$5.5 million, respectively, related to RSUs.  The unrecognized compensation expense at September 30, 2017March 31, 2020 is expected to be recognized over a weighted average period of 1.92.3 years.


Restricted Stock
 
The Company did not0t award any shares of restricted common stock during the ninethree months ended September 30, 2017March 31, 2020 and 2016.2019. At September 30, 2017 and DecemberMarch 31, 2016,2020, the Company had unrecognized compensation expense of approximately $28,000 and $203,000, respectively, related to thedid 0t have any unvested shares of restricted common stock.  The Company had accrued dividends payable of approximately $13,000 and $55,000 on unvested shares of restricted stock at September 30, 2017 and December 31, 2016, respectively.  The unrecognized compensation expense at September 30, 2017 is expected to be recognized over a weighted average period of three months.outstanding.


Dividend Equivalents
 
A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock.  Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules as the Compensation Committee of the Board shall determine in its discretion.  Payments made on the Company’s outstanding dividend equivalent rights that have been granted as a separate instrument are generally charged to Stockholders’ Equity when common stock dividends are declared to the extent that such equivalents are expected to vest.  The Company did not make any payments in respect of such instruments during the nine months ended September 30, 2017 and made dividend equivalent payments of approximately $2,000$276,000 and $5,000 in respect of such separate instruments$241,000 during the three and nine months ended September 30, 2016,March 31, 2020 and 2019, respectively. At September 30, 2017, there were no dividend equivalent rights outstanding, which had been awarded separately from, but in connection with, grants of RSUs made in prior years.
 
Options
The Company did not grant any stock options during the nine months ended September 30, 2017 and 2016. At September 30, 2017, the Company had no stock options outstanding.
Expense Recognized for Equity-Based Compensation Instruments
 
The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2017March 31, 2020 and 20162019:
  Three Months Ended
March 31,
(In Thousands) 2020 2019
RSUs $1,273
 $998
Total $1,273
 $998

  Three Months Ended 
 September 30,
 Nine Months Ended 
 September 30,
(In Thousands) 
2017 (1)
 2016 
2017 (1)
 2016
RSUs $1,836
 $948
 $5,194
 $3,642
Restricted shares of common stock 74
 153
 175
 457
Dividend equivalent rights 
 
 
 44
Total $1,910
 $1,101
 $5,369
 $4,143


(1) Equity-based compensation expense for the three and nine months ended September 30, 2017 includes a one-time expense of approximately $900,000 for the accelerated vesting of certain time-based equity awards arising from the death of the Company’s former Chief Executive Officer.

(b)  Employment Agreements
 
At September 30, 2017,March 31, 2020, the Company had employment agreements with three4 of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events.



42

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

(c)  Deferred Compensation Plans
 
The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation.  The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders.
 

46

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company.  Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock.  Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time.  The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded.  Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company.
 
The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date.  The following table presents the Company’s expenses related to its Deferred Plans for its non-employee directors and senior officers for the three and nine months ended September 30, 2017March 31, 2020 and 20162019:
 
  Three Months Ended
March 31,
(In Thousands) 2020 2019
Non-employee directors $(1,906) $286
Total $(1,906) $286
  Three Months Ended 
 September 30,
 Nine Months Ended 
 September 30,
(In Thousands) 2017 2016 2017 2016
Non-employee directors $125
 $52
 $339
 $173
Total $125
 $52
 $339
 $173

 
The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2017March 31, 2020 and December 31, 20162019 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2017March 31, 2020 and December 31, 20162019:
 
 September 30, 2017 December 31, 2016 March 31, 2020 December 31, 2019
(In Thousands)
Undistributed Income Deferred (1)
  Liability Under Deferred Plans
Undistributed Income Deferred (1)
  Liability Under Deferred Plans
Undistributed Income Deferred (1)
  Liability Under Deferred Plans
Undistributed Income Deferred (1)
  Liability Under Deferred Plans
Non-employee directors $1,525
 $2,061
 $1,066
 $1,263
 $1,881
 $498
 $2,349
 $3,071
Total $1,525
 $2,061
 $1,066
 $1,263
 $1,881
 $498
 $2,349
 $3,071


(1)  Represents the cumulative amounts that were deferred by participants through September 30, 2017March 31, 2020 and December 31, 20162019, which had not been distributed through such respective date.
 
(d)  Savings Plan
 
The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code.  Subject to certain restrictions, all of the Company’s employees are eligible to make tax-deferred contributions to the Savings Plan subject to limitations under applicable law.  Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan.  The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code.  The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%.  For the three months ended September 30, 2017March 31, 2020 and 2016,2019, the Company recognized expenses for matching contributions of $87,500$120,000 and $86,000, respectively, and $262,500 and $259,000 and for the nine months ended September 30, 2017 and 2016, respectively.$104,000.


43

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

15.14.  Fair Value of Financial Instruments
 
GAAP requires the categorization of fair value measurements into three broad levels that form a hierarchy. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The three levels of valuation hierarchy are defined as follows:
 
Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
 
Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
 

47

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
 
The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy.
 
Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as CollateralResidential Whole Loans, at Fair Value
 
The Company determines the fair value of U.S. Treasury securities obtained as collateral and the associated obligation to return securities obtained as collateral are based upon pricesits residential whole loans held at fair value after considering valuations obtained from a third-party pricing service, whichthat specializes in providing valuations of residential mortgage loans. The valuation approach applied generally depends on whether the loan is considered performing or non-performing at the date the valuation is performed. For performing loans, estimates of fair value are indicativederived using a discounted cash flow approach, where estimates of cash flows are determined from the scheduled payments, adjusted using forecasted prepayment, default and loss given default rates. For non-performing loans, asset liquidation cash flows are derived based on the estimated time to liquidate the loan, the estimated value of the collateral, expected costs and estimated home price appreciation. Estimated cash flows for both performing and non-performing loans are discounted at yields considered appropriate to arrive at a reasonable exit price for the asset. Indications of loan value such as actual trades, bids, offers and generic market activity.  Securities obtained as collateralcolor may be used in determining the appropriate discount yield. The Company’s residential whole loans held at fair value are classified as Level 13 in the fair value hierarchy.

MBS and CRTResidential Mortgage Securities
 
The Company determines the fair value of its Agency MBS based upon prices obtained from third-party pricing services, which are indicative of market activity, and repurchase agreement counterparties.
 
For Agency MBS, the valuation methodology of the Company’s third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the marketplace and other data inputs.  The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds.  Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the marketplace. The Company’s Agency MBS are classified as Level 2 in the fair value hierarchy.
 
In determining the fair value of itsthe Company’s Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants.  In valuing Non-Agency MBS, the Company understands that pricing services use observable inputs that include, in addition to trading activity observed in the marketplace, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions.  For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered.  The Company collects and considers current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available.
 
The Company’s Legacy Non-Agency MBS, RPL/NPL MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters.  Accordingly, these securities are classified as Level 2 in the fair value hierarchy.


Term Notes Backed by MSR RelatedMSR-Related Collateral


The Company’s valuation process for term notes backed by MSR relatedMSR-related collateral is similar to that used for residential mortgage securities and considers a number of factors,observable market data points, including indicative valuationsprices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. Other factors taken into consideration include estimated changes in fair value of the related underlying MSR collateral and, as applicable, the financial performance of the ultimate parent or sponsoring entity of the issuer, which has provided a third-party pricing serviceguarantee that are reviewedis intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the Company and mayrelated underlying MSR collateral be adjusted to ensure they reflect a realistic exit price atinsufficient. Based on its evaluation of the valuation date givenobservability of the structural features ofdata used in its fair value estimation process, these securities. As this process includes significant unobservable inputs, these securitiesassets are classified as Level 32 in the fair value hierarchy.




4448

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020

Residential Whole Loans, at Fair Value
The Company determines the fair value of its residential whole loans held at fair value after considering valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans trading activity observed in the marketplace. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy.


Swaps
 
As of September 30, 2017, allAll of the Company’s Swaps are cleared by a central clearing house. Valuations provided by the clearing house are used for purposes of determining the fair value of the Company’s Swaps. Such valuations obtained are tested with internally developed models that apply readily observable market parameters.  As the Company’s Swaps are subject to the clearing house’s margin requirements, no0 credit valuation adjustment was considered necessary in determining the fair value of such instruments.  Beginning inSince January 2017, variation margin payments on the Company’s cleared Swaps arehave been treated as a legal settlement of the exposure under the related Swap contract. Previously such payments were treated as collateral pledged against the exposure under the related Swap contract. The effect of this change is to reduce what would have otherwise been reported as the fair value of the Swap. Swaps are classified as Level 2 in the fair value hierarchy.

Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes result in appropriate exit price valuations.  The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve.  The methods described above may produce fair value estimates that may not be indicative of net realizable value or reflective of future fair values.  Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.  The Company uses inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.  The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future.
 

45

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of September 30, 2017March 31, 2020 and December 31, 2016,2019, on the consolidated balance sheets by the valuation hierarchy, as previously described:


Fair Value at September 30, 2017March 31, 2020
 
(In Thousands) Level 1 Level 2 Level 3 Total
Assets:        
Residential whole loans, at fair value $
 $
 $1,243,792
 $1,243,792
Non-Agency MBS 
 1,119,940
 
 1,119,940
Agency MBS 
 553,413
 
 553,413
CRT securities 
 254,101
 
 254,101
Term notes backed by MSR-related collateral 
 706,608
 
 706,608
Total assets carried at fair value $
 $2,634,062
 $1,243,792
 $3,877,854

(In Thousands) Level 1 Level 2 Level 3 Total
Assets:        
Agency MBS $
 $3,019,304
 $
 $3,019,304
Non-Agency MBS 
 3,911,660
 
 3,911,660
CRT securities 
 653,633
 
 653,633
Term notes backed by MSR related collateral 
 
 311,563
 311,563
Residential whole loans, at fair value 
 
 1,103,518
 1,103,518
Securities obtained and pledged as collateral 507,318
 
 
 507,318
Total assets carried at fair value $507,318
 $7,584,597
 $1,415,081
 $9,506,996
Liabilities:        
Swaps $
 $
 $
 $
Obligation to return securities obtained as collateral 507,318
 
 
 507,318
Total liabilities carried at fair value $507,318
 $
 $
 $507,318


Fair Value at December 31, 20162019
 
(In Thousands) Level 1 Level 2 Level 3 Total
Assets:  
  
  
  
Residential whole loans, at fair value $
 $
 $1,381,583
 $1,381,583
Non-Agency MBS 
 2,063,529
 
 2,063,529
Agency MBS 
 1,664,582
 
 1,664,582
CRT securities 
 255,408
 
 255,408
Term notes backed by MSR-related collateral 
 1,157,463
 
 1,157,463
Total assets carried at fair value $
 $5,140,982
 $1,381,583
 $6,522,565
(In Thousands) Level 1 Level 2 Level 3 Total
Assets:  
  
  
  
Agency MBS $
 $3,738,497
 $
 $3,738,497
Non-Agency MBS, including MBS transferred to consolidated VIEs 
 5,684,836
 
 5,684,836
CRT securities 
 404,850
 
 404,850
Term notes backed by MSR related collateral 
 140,980
 
 140,980
Residential whole loans, at fair value 
 
 814,682
 814,682
Securities obtained and pledged as collateral 510,767
 
 
 510,767
Swaps 
 233
 
 233
Total assets carried at fair value $510,767
 $9,969,396
 $814,682
 $11,294,845
Liabilities:        
Swaps $
 $46,954
 $
 $46,954
Obligation to return securities obtained as collateral 510,767
 
 
 510,767
Total liabilities carried at fair value $510,767
 $46,954
 $
 $557,721

 


4649

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis


The following table presents additional information for the three and nine months ended September 30, 2017March 31, 2020 and 20162019 about the Company’s Residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:


  Residential Whole Loans, at Fair Value
  Three Months Ended March 31,
(In Thousands) 2020 2019
Balance at beginning of period $1,381,583
 $1,471,263
Purchases and capitalized advances (1)
 3,520
 130,089
Changes in fair value recorded in Net gain on residential whole loans measured at fair value through earnings (74,556) (1,060)
Collection of principal, net of liquidation gains/(losses) (23,805) (31,751)
  Repurchases (305) (318)
  Transfer to REO (42,645) (55,886)
Balance at end of period $1,243,792
 $1,512,337

  
Residential Whole Loans, at Fair Value (1)
  Three Months Ended September 30, Nine Months Ended September 30,
(In Thousands) 
2017 (2)
 2016 
2017 (2)
 2016
Balance at beginning of period $744,072
 $684,582
 $814,682
 $623,276
Purchases and capitalized advances 284,930
 50,071
 295,094
 169,830
Changes in fair value recorded in Net gain on residential whole loans held at fair value 5,289
 10,913
 12,499
 25,529
Collection of principal, net of liquidation gains/losses (17,670) (18,119) (53,366) (48,909)
  Repurchases (257) 
 (1,013) 
  Transfer to REO (33,214) (22,985) (84,746) (65,264)
Balance at end of period $983,150
 $704,462
 $983,150
 $704,462

(1)
Included in the activity presented for the three months ended March 31, 2019is an adjustment of $70.6 million for loans the Company committed to purchase during the three months ended December 31, 2018, but for which the closing of the purchase transaction occurred during the three months ended March 31, 2019. The adjustment was required following the finalization of due diligence performed prior to the closing of the purchase transaction and resulted in a downward revision to the prior estimate of the loan purchase amount.

(1) Excluded from the table above are approximately $120.4 million and $92.8 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2017 and 2016, respectively.
(2) Included in the activity presented for the three and nine months ended September 30, 2017 are approximately $92.7 million of loans the Company committed to purchase during the three months ended June 30, 2017, but for which the closing of the purchase transaction occurred during the three months ended September 30, 2017.


The following table presents additional information for the three and nine months ended September 30, 2017 and 2016March 31, 2019 about the Company’s investments in term notes backed by MSR relatedMSR-related collateral, held at fair value, which arewere classified as Level 3 prior to September 30, 2019 and measured at fair value on a recurring basis:


  Term Notes Backed by MSR-Related Collateral
  Three Months Ended March 31,
(In Thousands) 2019
Balance at beginning of period $538,499
Purchases 219,166
Sales 
  Collection of principal (4,584)
Changes in unrealized gain/(losses) 513
Transfer to Level 2 
Balance at end of period $753,594

  Term Notes Backed by MSR Related Collateral
  Three Months Ended September 30, Nine Months Ended September 30,
(In Thousands) 2017 2016 
2017 (1)
 2016
Balance at beginning of period $273,961
 $
 $
 $
Purchases 161,000
 
 311,000
 
  Collection of principal (123,961) 
 (140,980) 
Changes in unrealized gain/losses 563
 
 563
 
  Transfers from Level 2 to Level 3 (1)
 
 
 140,980
 
Balance at end of period $311,563
 $
 $311,563
 $

(1) Investments in term notes backed by MSR related collateral were transferred from Level 2 to Level 3 during the nine months ended September 30, 2017 as there has been very limited secondary market trading in these securities since issuance. Transfers between levels are deemed to take place on the first day of the reporting period in which the transfer has taken place.


The Company did not transfer any assets or liabilities from one level to another during the three months ended September 30, 2017 and three and nine months ended September 30, 2016.March 31, 2020 or 2019.



4750

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


Fair Value Methodology for Level 3 Financial Instruments


Residential Whole Loans, at Fair Value


The following table presentstables present a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of September 30, 2017March 31, 2020 and December 31, 2016:2019:


  March 31, 2020
(Dollars in Thousands) 
Fair Value (1)
 Valuation Technique Unobservable Input 
Weighted Average (2)
 Range
           
Residential whole loans, at fair value $745,726
 Discounted cash flow Discount rate 5.6% 5.1-9.7%
      Prepayment rate 5.2% 0.1-19.9%
      Default rate 3.9% 0.0-23.5%
      Loss severity 13.0% 0.0-100.0%
           
  $497,816
 Liquidation model Discount rate 8.6% 6.2-50.0%
      Annual change in home prices 2.5% (0.5)-6.9%
      
Liquidation timeline
(in years)
 1.9
 0.1-4.8
      
Current value of underlying properties (3)
 $709
 $5-$4,500
Total $1,243,542
        


 September 30, 2017 December 31, 2019
(Dollars in Thousands) 
Fair Value (1)
 Valuation Technique Unobservable Input 
Weighted Average (2)
 Range 
Fair Value (1)
 Valuation Technique Unobservable Input 
Weighted Average (2)
 Range
          
Residential whole loans, at fair value $304,166
 Discounted cash flow Discount rate 6.1% 5.0-8.0% $829,842
 Discounted cash flow Discount rate 4.2% 3.8-8.0%
   Prepayment rate 7.7% 0.0-13.0%   Prepayment rate 4.5% 0.7-18.0%
   Default rate 4.1% 0.0-9.8%   Default rate 4.0% 0.0-23.0%
   Loss severity 12.6% 0.0-100.0%   Loss severity 12.9% 0.0-100.0%
          
 $488,654
 Liquidation model Discount rate 8.4% 6.7-50.0% $551,271
 Liquidation model Discount rate 8.0% 6.2-50.0%
   Annual change in home prices 2.7% (4.5)-9.7%   Annual change in home prices 3.7% 2.4-8.0%
   
Liquidation timeline
(in years)
 1.6
 0.1-4.5   
Liquidation timeline
(in years)
 1.8
 0.1-4.5
   
Current value of underlying properties (3)
 $669
 $15-$4,900   
Current value of underlying properties (3)
 $684
 $10-$4,500
Total $792,820
    $1,381,113
   

  December 31, 2016
(Dollars in Thousands) 
Fair Value (1)
 Valuation Technique Unobservable Input 
Weighted Average (2)
 Range
           
Residential whole loans, at fair value $253,287
 Discounted cash flow Discount rate 6.6% 5.0-7.7%
      Prepayment rate 7.6% 0.0-12.0%
      Default rate 2.9% 0.0-9.7%
      Loss severity 13.0% 0.0-77.5%
           
  $516,014
 Liquidation model Discount rate 7.7% 6.8-26.9%
      Annual change in home prices 1.7% (9.2)-7.7%
      
Liquidation timeline
(in years)
 1.6
 0.1-4.4
      
Current value of underlying properties (3)
 $634
 $5-$4,900
Total $769,301
        


(1) Excludes approximately $310.7 million$250,000 and $45.4 million$470,000 of loans for which management considers the purchase price continues to reflect the fair value of such loans at September 30, 2017March 31, 2020 and December 31, 2016,2019, respectively.
(2) Amounts are weighted based on the fair value of the underlying loan.
(3) The simple average value of the properties underlying residential whole loans held at fair value valued via a liquidation model was approximately $353,000$368,000 and $320,000$365,000 as of September 30, 2017March 31, 2020 and December 31, 2016,2019, respectively.



Changes in market conditions, as well as changes in the assumptions or methodology used to determine fair value, could result in a significant increase or decrease in the fair value of residential whole loans. Loans valued using a discounted cash flow


4851

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


The following table presents the difference between the fair value and the aggregate unpaid principal balance of the Company’s residential whole loans for which the fair value option was elected, at September 30, 2017 and December 31, 2016:

  
September 30, 2017 (1)
 December 31, 2016
(In Thousands) Fair Value Unpaid Principal Balance Difference Fair Value Unpaid Principal Balance Difference
Residential whole loans, at fair value            
Total loans $983,150
 $1,178,866
 $(195,716) $814,682
 $966,174
 $(151,492)
Loans 90 days or more past due $690,924
 $853,655
 $(162,731) $570,025
 $695,282
 $(125,257)

(1) Excludes approximately $120.4 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2017.


Term Notes Backed by MSR Related Collateral

The Company’s valuation process for term notes backed by MSR related collateral considers a number of factors, including a comparable bond analysis performed by a third-party pricing service which involves determining a pricing spread at issuance of the term note. The pricing spread is used at each subsequent valuation datemodel are most sensitive to determine an implied yield to maturity of the term note, which is used to derive an indicative market value for the security. This indicative market value is further reviewed by the Company and may be adjusted to ensure it reflects a realistic exit price at the valuation date given the structural features of these securities. At September 30, 2017, the indicative implied yields usedchanges in the valuation of these securities ranged from 5.6%discount rate assumption, while loans valued using the liquidation model technique are most sensitive to 6.1%. The weighted average indicative yield to maturity was 5.72%. Other factors taken into consideration include indicative values provided by repurchase agreement counterparties, estimated changes in fairthe current value of the related underlying MSR collateralproperties and the financial performance of the ultimate parentliquidation timeline. Increases in discount rates, default rates, loss severities, or sponsoring entity of the issuer, who has provided a guarantee that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the related underlying MSR collateral be insufficient.

Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes resultliquidation timelines, either in appropriate exit price valuations.  The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve.  The methods described above may produce fair value estimates that may not be indicative of net realizable valueisolation or reflective of future fair values.  Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments couldcollectively, would generally result in a different estimate oflower fair value atmeasurement, whereas increases in the reporting date.  The Company uses inputs that are current asor expected value of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.  The Company reviews the classification of its financial instruments within theunderlying properties, in isolation, would result in a higher fair value hierarchymeasurement. In practice, changes in valuation assumptions may not occur in isolation and the changes in any particular assumption may result in changes in other assumptions, which could offset or amplify the impact on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future.overall valuation.


49

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

The following table presents the carrying values and estimated fair values of the Company’s financial instruments at September 30, 2017March 31, 2020 and December 31, 20162019:
 
  March 31, 2020 March 31, 2020 December 31, 2019
Level in Fair Value Hierarchy
Carrying
Value
 Estimated Fair Value
Carrying
Value
 Estimated Fair Value
(In Thousands)
Financial Assets:          
Residential whole loans, at carrying value (1)
 3 $5,716,031
 $5,602,536
 $6,069,370
 $6,248,745
Residential whole loans, at fair value 3 1,243,792
 1,243,792
 1,381,583
 1,381,583
Non-Agency MBS 2 1,119,940
 1,119,940
 2,063,529
 2,063,529
Agency MBS 2 553,413
 553,413
 1,664,582
 1,664,582
CRT securities 2 254,101
 254,101
 255,408
 255,408
MSR-related assets (2)
 2 and 3 738,054
 738,054
 1,217,002
 1,217,002
Cash and cash equivalents 1 116,465
 116,465
 70,629
 70,629
Restricted cash 1 216,902
 216,902
 64,035
 64,035
Financial Liabilities (3):
          
Repurchase agreements 2 7,768,180
 7,786,911
 9,139,821
 9,156,209
Securitized debt 2 533,733
 481,808
 570,952
 575,353
Convertible Senior Notes 2 224,264
 135,700
 223,971
 244,088
Senior Notes 1 96,874
 46,551
 96,862
 103,231

  September 30, 2017 December 31, 2016
Carrying
Value
 Estimated Fair Value
Carrying
Value
 Estimated Fair Value
(In Thousands)
Financial Assets:        
Agency MBS $3,019,304
 $3,019,304
 $3,738,497
 $3,738,497
Non-Agency MBS, including MBS transferred to consolidated VIEs 3,911,660
 3,911,660
 5,684,836
 5,684,836
CRT securities 653,633
 653,633
 404,850
 404,850
MSR related assets 411,840
 412,674
 226,780
 226,780
Residential whole loans, at carrying value 639,216
 693,795
 590,540
 621,548
Residential whole loans, at fair value 1,103,518
 1,103,518
 814,682
 814,682
Securities obtained and pledged as collateral 507,318
 507,318
 510,767
 510,767
Cash and cash equivalents 608,173
 608,173
 260,112
 260,112
Restricted cash 15,440
 15,440
 58,463
 58,463
Swaps 
 
 233
 233
Financial Liabilities (1):
        
Repurchase agreements 6,871,443
 6,871,553
 8,472,268
 8,472,078
FHLB advances 
 
 215,000
 215,000
Obligation to return securities obtained as collateral 507,318
 507,318
 510,767
 510,767
Securitized debt 137,327
 139,064
 
 
Senior Notes 96,763
 102,231
 96,733
 101,111
Swaps 
 
 46,954
 46,954
(1)Includes Non-QM loans held-for-sale with a net carrying value of $895.3 million at March 31, 2020.
(2)Includes $31.4 million and $59.5 million of MSR-related assets that are measured at fair value on a non-recurring basis that are classified as Level 3 in the fair value hierarchy at March 31, 2020 and December 31, 2019, respectively.
(3)Carrying value of securitized debt, Convertible Senior Notes, Senior Notes and certain repurchase agreements is net of associated debt issuance costs.



(1) CarryingOther Assets Measured at Fair Value on a Nonrecurring Basis

The Company holds its Residential whole loans, held-for-sale at the lower of current carrying amount or fair value less estimated selling costs. At March 31, 2020, the Company had Non-QM loans held-for-sale with a net carrying value of securitized debt, Senior Notes and certain repurchase agreements is net of associated debt issuance costs.$895.3 million.


In addition to the methodologies used to determine the fair value of the Company’s financial assets and liabilities reported at fair value on a recurring basis discussed on pages 44-49, the following methods and assumptions were used by the Company in arriving at the fair value of the Company’s other financial instruments presented in the above table that are not reported at fair value on a recurring basis:
Residential Whole Loans, at Carrying Value:  The Company determines the fair value of its residential whole loans held at carrying value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the market place. The Company’s residential whole loans held at carrying value are classified as Level 3 in the fair value hierarchy.
Cash and Cash Equivalents and Restricted Cash:  Cash and cash equivalents and restricted cash are comprised of cash held in overnight money market investments and demand deposit accounts.  At September 30, 2017 and December 31, 2016, the Company’s money market funds were invested in securities issued by the U.S. Government, or its agencies, instrumentalities, and sponsored entities, and repurchase agreements involving the securities described above.  Given the overnight term and assessed credit risk, the Company’s investments in money market funds are determined to have a fair value equal to their carrying value.

Corporate Loan: The Company determines the fair value of this loan after considering recent past and expected future loan performance, recent financial performance of the borrower and estimates of the current value of the underlying collateral, which includes certain MSRs and other assets of the borrower that are pledged to secure the borrowing. The Company’s investment in this term loan is classified as Level 3 in the fair value hierarchy.

Repurchase Agreements:  The fair value of repurchase agreements reflects the present value of the contractual cash flows discounted at market interest rates at the valuation date for repurchase agreements with a term equivalent to the remaining term

50

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

to interest rate repricing, which may be at maturity.  Such interest rates are estimated based on LIBOR rates observed in the market.  The Company’s repurchase agreements are classified as Level 2 in the fair value hierarchy.

FHLB Advances: As previously discussed, the Company did not have any FHLB advances as of September 30, 2017. FHLB advances at December 31, 2016 reflected collateralized borrowings at variable market interest rates that reset on a monthly basis. Accordingly, the carrying amount of FHLB advances were considered to approximate fair value. The Company’s FHLB advances at December 31, 2016 were classified as Level 2 in the fair value hierarchy.
Securitized Debt:  In determining the fair value of securitized debt, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. Accordingly, the Company’s securitized debt is classified as Level 2 in the fair value hierarchy.

Senior Notes:  The fair value of the Senior Notes is determined using the end of day market price quoted on the NYSE at the reporting date.  The Company’s Senior Notes are classified as Level 1 in the fair value hierarchy.

The Company holds REO at the lower of the current carrying amount or fair value less estimated selling costs. At September 30, 2017During the three months ended March 31, 2020 and December 31, 20162019, the Company’sCompany recorded REO had an aggregate carrying value of $138.0 million and $80.5 million, andwith an aggregate estimated fair value, less estimated cost to sell, of $159.3$50.7 million and $91.1$65.2 million, respectively.respectively, at the time of foreclosure. The Company classifies fair value measurements of REO as Level 3 in the fair value hierarchy.




52

16.
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

15.  Use of Special Purpose Entities and Variable Interest Entities
 
A Special Purpose Entity (“SPE”) is an entity designed to fulfill a specific limited need of the company that organized it.  SPEs are often used to facilitate transactions that involve securitizing financial assets or resecuritizing previously securitized financial assets.  The objective of such transactions may include obtaining non-recourse financing, obtaining liquidity or refinancing the underlying financial assets on improved terms.  Securitization involves transferring assets to a SPE to convert all or a portion of those assets into cash before they would have been realized in the normal course of business, through the SPE’s issuance of debt or equity instruments.  Investors in ana SPE usually have recourse only to the assets in the SPE and, depending on the overall structure of the transaction, may benefit from various forms of credit enhancement such as over-collateralization in the form of excess assets in the SPE, priority with respect to receipt of cash flows relative to holders of other debt or equity instruments issued by the SPE, or a line of credit or other form of liquidity agreement that is designed with the objective of ensuring that investors receive principal and/or interest cash flow on the investment in accordance with the terms of their investment agreement. 


The Company has in prior years entered into several MBS resecuritizationfinancing transactions and during the second quarter of 2017, a loan securitization transaction that resulted in the Company consolidating as VIEs the SPEs that were created to facilitate these transactions. See Note 2(sq) for a discussion of the accounting policies applied to the consolidation of VIEs and transfers of financial assets in connection with securitization and resecuritizationfinancing transactions.
 
The Company has engaged in loan securitization and MBS resecuritization transactionssecuritizations primarily for the purpose of obtaining improved overall financing terms as well as non-recourse financing on a portion of its residential whole loan and Non-Agency MBS portfolios.portfolio. Notwithstanding the Company’s participation in these transactions, the risks facing the Company are largely unchanged as the Company remains economically exposed to the first loss position on the underlying assets transferred to the VIEs.
 
Loan Securitization TransactionTransactions


In June 2017, as partThe following table summarizes the key details of athe Company’s loan securitization transaction, the Company sold residential whole loans with an aggregate unpaid principal balancetransactions as of approximately $219.8 million, comprised of approximately $137.0 million Residential whole loans, at carrying value (with unpaid principal balance of $176.6 million)March 31, 2020 and approximately $44.4 million of Residential whole loans, at fair value (with unpaid principal balance of $43.2 million) to MFA 2017-RPL1 Trust, which the Company consolidates as a VIE. In connection with this transaction, third-party investors purchased $147.8 million face amount of fixed-rate, sequential senior and mezzanine bonds (“Sold Bonds”) issued by the VIE at a weighted average fixed-rate of 2.753% and the Company acquired $72.0 million face amount of four classes of rated and non-rated certificates issued by this trust, which together provide credit support to the Sold Bonds, and received $147.8 million in cash, excluding expenses, accrued interest and underwriting fees. The Company also acquired two non-rated, variable-rate interest-only certificates issued by the trust, each with a notional amount of $219.8 million in connection with the transaction.

December 31, 2019:
51

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017

(Dollars in Thousands) March 31, 2020 December 31, 2019 
Aggregate unpaid principal balance of residential whole loans sold $1,290,029
 $1,290,029
 
Face amount of Senior Bonds issued by the VIE and purchased by third-party investors $802,817
 $802,817
 
Outstanding amount of Senior Bonds $533,733
(1)$570,952
(1)
Weighted average fixed rate for Senior Bonds issued 3.68%(2)3.68%(2)
Weighted average contractual maturity of Senior Bonds 29 years
(2)30 years
(2)
Face amount of Senior Support Certificates received by the Company (3)
 $275,174
 $275,174
 
Cash received $802,815
 $802,815
 

(1)Net of $2.7 million and $2.9 million of deferred financing costs at March 31, 2020 and December 31, 2019, respectively.
(2)At March 31, 2020 and December 31, 2019, $459.6 million and $493.2 million, respectively, of Senior Bonds sold in securitization transactions contained a contractual coupon step-up feature whereby the coupon increases by 300 basis points at 36 months from issuance if the bond is not redeemed before such date.
(3)Provides credit support to the Senior Bonds sold to third-party investors in the securitization transactions.

As of September 30, 2017,March 31, 2020 and December 31, 2019, as a result of the transactiontransactions described above, securitized loans with a carrying value of approximately $131.3$185.9 million and $186.4 million are included in “Residential whole loans, at carrying value” andvalue,” securitized loans with a fair value of approximately $40.4$516.4 million and $567.4 million are included in “Residential whole loans, at fair value,” and REO with a carrying value approximately $129.1 million and $137.8 million are included in “Other assets” on the Company’s consolidated balance sheets.sheets, respectively. As of September 30, 2017,March 31, 2020 and December 31, 2019, the aggregate carrying value of SoldSenior Bonds issued by consolidated VIEs was $137.3 million.$533.7 million and $571.0 million, respectively.  These SoldSenior Bonds are disclosed as “Securitized debt” and are included in Other liabilities on the Company’s consolidated balance sheets.  The holders of the Sold Bondssecuritized debt have no recourse to the general credit of the Company, but the Company does have the obligation, under certain circumstances to repurchase assets from the VIE upon the breach of certain representations and warranties in relationwith respect to the residential whole loans sold to the VIE.  In the absence of such a breach, the Company has no obligation to provide any other explicit or implicit support to any VIE.


Resecuritization Transactions

53

Table of Contents
During the first quarter of 2017, the Company entered into a transaction to exchange the remaining beneficial interests issued by the WFMLT 2012-RR1 (the “Trust”) and held by the Company for the underlying securities that had previously been transferred to and held by the Trust.  Following the completion of this transaction, the remaining beneficial interests were cancelled and the Trust was terminated.MFA FINANCIAL, INC.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
For financial reporting purposes, the exchange transaction and termination of this financing structure did not result in any gain or loss to the Company as this resecuritization was accounted for as a financing transaction.  However, for purposes of determining REIT taxable income, this resecuritization transaction was originally accounted for as a sale of the underlying securities to the Trust and acquisition of beneficial interests issued by the Trust.  Because the fair value of the underlying securities received exceeded the Company’s tax basis in the remaining beneficial interests at the exchange date, the unwind of this resecuritization structure resulted in the Company recognizing taxable income currently estimated to be approximately $47.1 million, or $0.12 per common share. In addition, the underlying securities originally transferred as part of this resecuritization are reported as Non-Agency MBS in the Company’s consolidated balance sheets at September 30, 2017 and interest income from the underlying securities from the date of exchange transaction through September 30, 2017 is reported as Interest income from Non-Agency MBS in the Company’s consolidated statements of operations.MARCH 31, 2020

As of September 30, 2017 the Company did not have any Non-Agency MBS that were resecuritized as described above. At December 31, 2016, the aggregate fair value of the Non-Agency MBS that were resecuritized as described above was $174.4 million.  These assets were included in the Company’s consolidated balance sheets and disclosed as “Non-Agency MBS transferred to consolidated VIEs, at fair value.”


The Company concluded that the entities created to facilitate these MBS resecuritization andthe loan securitization transactions are VIEs.  The Company then completed an analysis of whether each VIE created to facilitate the securitization and resecuritization transactions should be consolidated by the Company, based on consideration of its involvement in each VIE, including the design and purpose of the SPE, and whether its involvement reflected a controlling financial interest that resulted in the Company being deemed the primary beneficiary of each VIE.  In determining whether the Company would be considered the primary beneficiary, the following factors were assessed:
 
whether the Company has both the power to direct the activities that most significantly impact the economic performance of the VIE;  and
whether the Company has a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE.
 
Based on its evaluation of the factors discussed above, including its involvement in the purpose and design of the entity, the Company determined that it was required to consolidate each VIE created to facilitate thesethe loan securitization and MBS resecuritization transactions.


PriorResidential Whole Loans and REO (including Residential Whole Loans and REO transferred to consolidated VIEs)

Included on the completionCompany’s consolidated balance sheets as of March 31, 2020 and December 31, 2019 are a total of $7.0 billion and $7.4 billion, respectively, of residential whole loans, of which approximately $5.7 billion and $6.1 billion, respectively, are reported at carrying value and $1.2 billion and $1.4 billion, respectively, are reported at fair value. These assets, and certain of the Company’s first MBS resecuritization transaction in October 2010,REO assets, are directly owned by certain trusts established by the Company had not transferred assets to VIEs or QSPEsacquire the loans and other than acquiring MBS issued by such entities had no other involvementestablished in connection with VIEs or QSPEs.the Company’s loan securitization transactions. The Company has assessed that these entities are required to be consolidated. (See Notes 3 and 5(a))




5254

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2017MARCH 31, 2020


Residential Whole Loans (including Residential Whole Loans transferred16. Subsequent Events

Forbearance Agreements

On March 24, 2020, the Company announced that due to consolidated VIEs)turmoil in the financial markets resulting from the spread of the novel coronavirus and the global COVID-19 pandemic, the Company and its subsidiaries had received an unusually high number of margin calls starting approximately in mid-March. The Company’s announcement indicated that on March 23, 2020, the Company did not meet its margin calls and had notified its financing counterparties that it did not expect to be in a position to fund the anticipated volume of margin calls under its financing arrangements in the near term. In its announcement the Company also indicated that it was engaged in discussions with its financing counterparties with regard to entering into forbearance agreements pursuant to which each counterparty would agree to forbear from exercising its rights and remedies with respect to an event of default under its applicable financing arrangement(s) with the Company for an agreed upon period, including refraining from selling collateral to enforce margin calls. At the time of this announcement the Company’s obligations under its repurchase agreement financing arrangements were approximately $9.5 billion.


IncludedOn April 10, 2020, the Company announced that it had entered into a Forbearance Agreement (“Initial FBA”) with repurchase agreement counterparties holding a significant majority of its outstanding repurchase obligations. At the date of that announcement, the Company’s obligations under its repurchase agreement financing arrangements had decreased to approximately $5.8 billion.

Significant details regarding the Initial FBA were as follows:

Participating counterparties to the Initial FBA represented repurchase obligations of an aggregate of $4.8 billion, or 83% of repurchase agreement obligations outstanding as of the date of the Initial FBA;

In connection with the Initial FBA, the Company also granted the participating counterparties a security interest in Company assets that were unencumbered prior to the Initial FBA, including residential whole loans, real estate owned (REO), unrestricted cash and other assets, with an estimated aggregate market value as of the date of the Initial FBA of approximately $1.3 billion; and

Counterparties agreed to forbear from exercising any rights or remedies through the close of business on April 27, 2020s (unless terminated sooner upon the occurrence of certain events) under their respective repurchase agreements, including refraining from selling collateral to enforce margin calls.

Extended Forbearance Agreement (“Second FBA”)

On April 27, 2020, the Company entered into a Second FBA with certain counterparties holding a significant majority of its outstanding repurchase obligations. Similar to the Initial FBA, the counterparties that were party to the Second FBA agreed to forbear from exercising any rights or remedies under their respective repurchase agreements with the Company, including refraining from selling collateral to enforce margin calls, through June 1, 2020 (unless terminated sooner upon the occurrence of certain events). The Second FBA essentially extended the forbearance period agreed to under the Initial FBA.

Significant details regarding the Second FBA are as follows:

The terms and conditions of the Second FBA were substantially similar to those under the Initial FBA.

Participating counterparties to the Second FBA represented repurchase obligations of an aggregate of $4.4 billion, which represented approximately 84% of the Company’s $5.3 billion repurchase obligations outstanding as of April 24, 2020. 

Under the terms of the Second FBA, the Company also agreed to make a cash payment to the participating counterparties of $150 million, which was applied to reduce the Company’s outstanding repurchase obligation balances with counterparties participating in the Second FBA.


55

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020

Additional Extended Forbearance Agreement (“Third FBA”)

On June 1, 2020, the Company entered into the Third FBA with counterparties to its repurchase agreement financings, further extending the period of forbearance. Under the Third FBA, the Company’s repurchase agreement counterparties continued to forbear from exercising any rights or remedies under their respective repurchase agreements with the Company, including refraining from selling collateral to enforce margin calls, through June 26, 2020 (unless terminated sooner upon the occurrence of certain events). All of the Company’s remaining repurchase agreement counterparties agreed to participate in the Third FBA.

Agreement to enter into a senior secured term loan and commitment to enter into an asset level debt facility

On June 15, 2020, the Company and certain of its wholly owned subsidiaries entered into a credit agreement for a $500 million senior secured term loan facility (the “Term Loan Facility”) to be funded by certain funds and accounts managed by subsidiaries of Apollo Global Management, Inc. (together with such funds and accounts, “Apollo”), including subsidiaries of Athene Holding Ltd. (“Athene”), to which Apollo provides asset management and advisory services. The loans under the Term Loan Facility are expected to be funded on or about June 26, 2020 (the “Funding Date”). The term loans will be issued with original issue discount of 1%. Interest on the outstanding principal amount of the term loans will accrue at a rate of 11% per annum until the third anniversary of the Funding Date. Prior to the third anniversary of the Funding Date, a portion of such interest, in an amount equal to up to 3% per annum, may be capitalized, compounded and added to the unpaid principal amount of the term loans. The interest rate on the term loans will increase by 1% per annum on the third anniversary of the Funding Date and by an additional 1% per annum on each subsequent anniversary of the Funding Date. Upon the occurrence and during the continuance of an event of default under the Term Loan Facility, the principal amount of all loans outstanding and, to the extent permitted by applicable law, any interest payments on such term loans or any fees or other amounts owing under the Term Loan Facility that, in either case, are then overdue, would thereafter bear interest at a rate that is 2% per annum in excess of the interest rate otherwise payable on the term loans.

Under the Term Loan Facility, the Company will be permitted to voluntarily prepay the term loans without premium or penalty at any time; provided, however, that the Company may prepay the term loans in part on only one occasion prior to the maturity date of the Term Loan Facility and in an amount of not less than $250 million. Installment payments of principal equal to 3.75% of the initial principal amount for the first three years of the Term Loan Facility and 4.50% of the initial principal amount thereafter, together with accrued and unpaid interest on such principal amount, will be required to be made on the last business day of each March, June, September and December beginning on September 30, 2020. Mandatory prepayments of the term loans will be required to be made from net cash proceeds received in connection with certain events, that are set out in the credit agreement. Upon the event of a change in control as defined in the credit agreement, the Company is also required to make an offer to repay the loan at par, plus unpaid accrued interest, plus a specified redemption premium. In addition, the Company will be required to comply with certain affirmative and negative covenants as specified in the credit agreement that, among other things, impose certain limitations on the Company to incur liens or indebtedness, to make certain non-permitted investments or enter into new businesses, to modify or waive terms on certain of the Company’s consolidated balance sheetsexisting debt or to prepay such debt, or to pay dividends in certain circumstances. The Company must also maintain a minimum level of liquidity as defined in the agreement.

In connection with, and conditioned on, the funding of the Term Loan Facility, the Company also executed on June 15, 2020, a letter with Barclays and affiliates of Athene (the “Asset Level Lenders”), pursuant to which the Asset Level Lenders have committed, subject to satisfaction of customary conditions precedent, to a non-mark-to-market term loan facility with one or more subsidiaries of the Company to provide, severally and not jointly, financing in an aggregate amount of up to $1,650,000,000 (the “Asset Level Debt Facility”). The Company’s borrowing subsidiaries will pledge, as collateral security for the Asset Level Debt Facility, certain of their residential whole loans, as well as the equity in subsidiaries that own the loans. The Asset Level Debt Facility is also expected to close on or about June 26, 2020.

In connection with these transactions, the Company also entered into an Investment Agreement with Apollo and Athene (together the “Purchasers”), under which. the Company agreed to issue to the Purchasers warrants (the “Warrants”) to purchase, in the aggregate, 37,039,106 shares (subject to adjustment in accordance with their terms) of the Company’s common stock. In addition, the Purchasers or one or more of their affiliates have agreed to purchase, prior to the first anniversary date of the Investment Agreement, in one or a series of open market or privately negotiated transactions, a number of shares of the Company’s common stock equal to the lesser of (a) such number of shares representing 4.9% of the outstanding shares of common stock as of September 30, 2017the Funding Date or (b) such number of shares as the Purchasers may purchase for an aggregate gross purchase price of $50 million. The issuance of the Warrants is subject to satisfaction of certain terms and Decemberconditions set forth in the Investment Agreement, but is expected to occur on the Funding Date.

56

Table of Contents
MFA FINANCIAL, INC.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 20162020


The completion of the transactions contemplated by the Term Loan Facility, the Asset Level Debt Facility and the Investment Agreement are subject to and conditioned on, among other things, the completion of definitive documentation relating to the Asset Level Debt Facility, completion of documentation relating to the Company’s exit from the Third FBA and other customary closing conditions.

Portfolio sales and composition changes and impact on Company liquidity
Since the end of the first quarter through May 31, 2020, the Company has taken further steps to reduce the leverage on its portfolio, generate liquidity and reduce repurchase agreement balances with its counterparties. Actions taken by the Company include the sale of residential mortgage assets, generating proceeds of approximately $3.2 billion, which along with portfolio run-off and other payments to counterparties has resulted in an overall reduction in repurchase agreement balances of approximately $3.9 billion. Details of sales that have occurred in the second quarter through May 31, 2020 include:

The Company has disposed of approximately $2.4 billion of residential mortgage securities, including $533.1 million of Agency MBS, $1.1 billion of Non-Agency MBS and $207.4 million of CRT securities. In addition, the Company sold $574.9 million of term notes backed by MSR-related collateral and $15.6 million of other interest earning assets. Improvement in market pricing since the end of the first quarter resulted in the Company recording realized gains of approximately $177.5 million to date in the second quarter. In addition, the Company has recorded $57.0 million of unrealized gains on securities (primarily CRT securities) on which it had previously elected the fair value option.

The Company also disposed of approximately $845.2 million of residential whole loans, resulting in realized losses of approximately $128.4 million. However, after the reversal of the valuation allowance associated with loans that were designated as held-for-sale at the end of the first quarter, the net impact on second quarter results is a totalloss of $1.7approximately $58.2 million.

The Company has now sold substantially all of its Agency MBS and Legacy Non-Agency MBS portfolios and greatly reduced its holdings of MSR-related assets and CRT securities. As of May 31, 2020, the Company’s $6.6 billion and $1.4residential mortgage asset portfolio was comprised of $6.2 billion of residential whole loans and REO, approximately $235.4 million of whichMSR-related assets and $136.4 million of residential mortgage securities. These investments are financed with approximately $639.2$3.8 billion of repurchase agreements. Total debt was approximately 1.9 times stockholders’ equity at May 31, 2020.

As of June 19, 2020, the Company had total cash balances of $343.6 million, and $590.5 million are reported at carrying value and $1.1 billion and $814.7 million are reported at fair value, respectively. The inclusion of these assets arises from the Company’s interests in certain entities established to acquire the loans and an entity in connectionincluding cash on deposit with repurchase agreement counterparties totaling $103.5 million. Since entering into forbearance agreements with its loan securitization transaction. The Company has assessed that these entities are required to be consolidated. During the threelenders in April, unpaid margins calls have been substantially reduced and nine months ended September 30, 2017, the Company recognized interest income from residential whole loans reported at carrying valuewere $29.1 million as of approximately $9.0 million and $26.2 million, respectively. During the three and nine months ended September 30, 2016, the Company recognized interest income from residential whole loans reported at carrying value of approximately $5.9 million and $16.1 million, respectively. These amounts are included in Interest Income on the Company’s consolidated statements of operations. In addition, the Company recognized net gains on residential whole loans held at fair value during the three and nine months ended September 30, 2017 of approximately $18.7 million and $48.7 million, respectively. During the three and nine months ended September 30, 2016, the Company recognized net gains on residential whole loans held at fair value of $19.6 million and $47.7 million, respectively. These amounts are included in Other Income, net on the Company’s consolidated statements of operations. (See Note 4)June 19, 2020.








Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
In this Quarterly Report on Form 10-Q, we refer to MFA Financial, Inc. and its subsidiaries as “the Company,” “MFA,” “we,” “us,” or “our,” unless we specifically state otherwise or the context otherwise indicates.
 
The following discussion should be read in conjunction with our financial statements and accompanying notes included in Item 1 of this Quarterly Report on Form 10-Q as well as our Annual Report on Form 10-K for the year ended December 31, 2016.2019.


Forward Looking Statements


When used in this Quarterly Report on Form 10-Q, in future filings with the SEC or in press releases or other written or oral communications, statements which are not historical in nature, including those containing words such as “will,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “continue,” “intend,” “should,” “could,” “would,” “may”“may,” the negative of these words or similar expressions, are intended to identify “forward-looking statements” within the meaning of Section 27A of the 1933 Act and Section 21E of the 1934 Act and, as such, may involve known and unknown risks, uncertainties and assumptions.


These forward-looking statements include information about possible or assumed future results with respect to our business, financial condition, liquidity, results of operations, plans and objectives.  Statements regarding the following subjects, among others, may be forward-looking: risks related to the ongoing spread of the novel coronavirus and the COVID-19 pandemic, including its effects on the general economy and our business, financial position and results of operations; uncertainties related to our recently-announced financing arrangements, including without limitation uncertainties regarding the closing and funding of such arrangements and the anticipated benefits and uses of the proceeds therefrom; our ability to meet our ongoing obligations under our current forbearance agreement with our repurchase agreement counterparties and our expectations with respect to any exit from forbearance or the ability to extend such forbearance if needed; our ability to accurately estimate information related to our operations and financial condition subsequent to the end of the first quarter (particularly in light of the highly volatile and uncertain market conditions); payments of future dividends, including payments of accumulated but unpaid dividends on our Series B Preferred Stock and Series C Preferred Stock; changes in interest rates and the market (i.e., fair) value of our MBS;residential whole loans, MBS and other assets; changes in the prepayment rates on theresidential mortgage loans securing our MBS,assets, an increase of which could result in a reduction of the yield on MBScertain investments in ourits portfolio and an increase of which could require us to reinvest the proceeds received by usit as a result of such prepayments in MBSinvestments with lower coupons;coupons, while a decrease in which could result in an increase in the interest rate duration of certain investments in our portfolio making their valuation more sensitive to changes in interest rates and could result in lower forecasted cash flows ; credit risks underlying our assets, including changes in the default rates and management’s assumptions regarding default rates on the mortgage loans securing our Non-Agency MBS and relating toin our residential whole loan portfolio; our ability to borrow to finance our assets and the terms, including the cost, maturity and other terms, of any such borrowings; implementation of or changes in government regulations or programs affecting our business; our estimates regarding taxable income the actual amount of which is dependent on a number of factors, including, but not limited to, changes in the amount of interest income and financing costs, the method elected by us to accrete the market discount on Non-Agency MBS and residential whole loans and the extent of prepayments, realized losses and changes in the composition of our Agency MBS, Non-Agency MBS and residential whole loan portfolios that may occur during the applicable tax period, including gain or loss on any MBS disposals and whole loan modification foreclosuremodifications, foreclosures and liquidation;liquidations; the timing and amount of distributions to stockholders, which are declared and paid at the discretion of our Board and will depend on, among other things, our taxable income, our financial results and overall financial condition and liquidity, maintenance of our REIT qualification and such other factors as the Board deems relevant; our ability to maintain our qualification as a REIT for federal income tax purposes; our ability to maintain our exemption from registration under the Investment Company Act of 1940, as amended (or the Investment Company Act), including statements regarding the concept release issued by the SEC relating to interpretive issues under the Investment Company Act with respect to the status under the Investment Company Act of certain companies that are engaged in the business of acquiring mortgages and mortgage-related interests; our ability to successfully implement our strategy to growcontinue growing our residential whole loan portfolio, which is dependent on, among other things, the supply of loans offered for sale in the market; expected returns on our investments in nonperforming residential whole loans (or NPLs), which are affected by, among other things, the length of time required to foreclose upon, sell, liquidate or otherwise reach a resolution of the property underlying the NPL, home price values, amounts advanced to carry the asset (e.g., taxes, insurance, maintenance expenses, etc. on the underlying property) and the amount ultimately realized upon resolution of the asset; targeted or expected returns on our investments in recently-originated loans, the performance of which is, similar to our other mortgage loan investments, subject to, among other things, differences in prepayment risk, credit risk and financing cost associated with such investments; risks associated with our investments in MSR-related assets, including servicing, regulatory and economic risks, and risks associated with investing in real estate assets, including changes in business conditions and the general economy.  These and other risks, uncertainties and factors, including those described in the annual, quarterly and current reports that we file with the SEC, could cause our actual results to differ materially from those projected in any forward-looking statements we make.  All forward-looking statements are based on beliefs, assumptions and

expectations of our future performance, taking into account all information currently available.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.  New risks and uncertainties arise over time and it is not possible to predict those events or how they may affect us.  Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


 
Business/General
 
We are aan internally-managed REIT primarily engaged in the business of investing, on a leveraged basis, in residential mortgage assets, including Agency MBS, Non-Agency MBS, residential whole loans, CRTresidential mortgage securities and MSR relatedMSR-related assets.  Our principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential

mortgage credit fundamentals. We selectively invest in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return.

As discussed below under “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Portfolio sales and composition changes and impact on our liquidity” and in Note 16 to our consolidated financial statements, since the end of the first quarter we have engaged in asset sales and taken other actions that significantly changed our asset composition subsequent to March 31, 2020. In particular, subsequent to the end of the first quarter, we sold the vast majority of our remaining Agency MBS and Legacy Non-Agency MBS portfolios, and substantially reduced our investments in MSR-related assets and CRT securities. As a result of these actions, our primary investment asset as of the date hereof is our residential whole loan portfolio. Any discussion herein of our assets at March 31, 2020 should be read in conjunction with the description of these asset sales and other actions.
 
At September 30, 2017,March 31, 2020, we had total assets of approximately $11.1 billion, of which $6.9$7.0 billion, or 62.4%63%, represented residential whole loans acquired through interests in certain trusts established to acquire the loans. Our Purchased Performing Loans, which as of March 31, 2020 comprised approximately 72% of our MBS portfolio.residential whole loans, include: (i) loans to finance (or refinance) one-to-four family residential properties that are not considered to meet the definition of a “Qualified Mortgage” in accordance with guidelines adopted by the Consumer Financial Protection Bureau (or Non-QM loans), (ii) short-term business purpose loans collateralized by residential properties made to non-occupant borrowers who intend to rehabilitate and sell the property for a profit (or Rehabilitation loans or Fix and Flip loans), (iii) loans to finance (or refinance) non-owner occupied one-to-four family residential properties that are rented to one or more tenants (or Single-family rental loans), and (iv) previously originated loans secured by residential real estate that is generally owner occupied (or Seasoned performing loans). In addition, at March 31, 2020, we had approximately $1.9 billion in investments in residential mortgage securities, which represented approximately 17% of our total assets.  At such date, our MBS portfolio was comprised of $3.0 billionincludes $553.4 million of Agency MBS, and $3.9$1.1 billion of Non-Agency MBS which includes $2.7and $254.1 million of CRT securities. Non-Agency MBS is comprised of $1.0 billion of Legacy Non-Agency MBS and $1.2 billion$79.5 million of RPL/NPL MBS. These RPL/NPL MBS that are primarilybacked by securitized re-performing and non-performing loans and are generally structured with a contractual coupon step-up feature where the coupon increases up tofrom 300 - 400 basis points at 36 - 48 months from issuance or sooner. These securities are primarily backed by securitized re-performing and non-performing loans. In addition, at September 30, 2017, we had approximately $1.7 billionAt March 31, 2020, our investments in residential whole loans acquired through our consolidated trusts, which represented approximately 15.7%MSR-related assets were $738.1 million, or 7% of our total assets. Our MSR-related assets include term notes whose cash flows are considered to be largely dependent on MSR collateral and loan participations to provide financing to mortgage originators that own MSRs. Our remaining investment-related assets, which represent approximately 6% of our total assets at March 31, 2020, were primarily comprised of collateral obtained in connection with reverse repurchase agreements, cash and cash equivalents (including restricted cash), CRT securities, MSR relatedREO, capital contributions made to loan origination partners, other interest-earning assets REO and MBS relatedand loan-related receivables.


The results of our business operations are affected by a number of factors, many of which are beyond our control, and primarily depend on, among other things, the level of our net interest income and the market value of our assets, which is driven by numerous factors, including the supply and demand for residential mortgage assets in the marketplace, the terms and availability of adequate financing, general economic and real estate conditions (both on a national and local level), the impact of government actions in the real estate and mortgage sector, and the credit performance of our credit sensitive residential mortgage assets.  Changes in these factors, or uncertainty in the market regarding the potential for changes in these factors, can result in significant changes in the value and/or performance of our investment portfolio. Further, our GAAP results may be impacted by market volatility, resulting in changes in market values of certain financial instruments for which changes in fair value are recorded in net income each period, such as CRT securities, certain residential whole loans, Agency MBS, and Swaps not designated as hedges. Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds, on our MBS, the behavior of which involves various risks and uncertainties.  Interest rates and conditional prepayment rates (or CPRs) (which measure the amount of unscheduled principal prepayment on a bondan asset as a percentage of the bondasset balance), vary according to the type of investment, conditions in the financial markets, competition and other factors, none of which can be predicted with any certainty. With the adoption in January 2020 of new accounting standards for the measurement and recognition of credit losses, and given

the extent of current and anticipated future investments in residential whole loans, our financial results are impacted by estimates of credit losses that are required to be recorded when loans that are not accounted for at fair value through net income are acquired or originated, as well as changes in these credit loss estimates that will be required to be made periodically.
 
With respect to our business operations, increases in interest rates, in general, may over time cause:  (i) the interest expense associated with our borrowings to increase; (ii) the value of certain of our MBS portfolioresidential mortgage assets and, correspondingly, our stockholders’ equity to decline; (iii) coupons on our ARM-MBSadjustable-rate assets to reset, on a delayed basis, to higher interest rates; (iv) prepayments on our MBSassets to decline, thereby slowing the amortization of our MBS purchase premiums and the accretion of our purchase discounts;discounts, and slowing our ability to redeploy capital to generally higher yielding investments; and (v) the value of our derivative hedging instruments and, correspondingly, our stockholders’ equity to increase.  Conversely, decreases in interest rates, in general, may over time cause:  (i) the interest expense associated with our borrowings to decrease; (ii) the value of certain of our MBS portfolioresidential mortgage assets and, correspondingly, our stockholders’ equity to increase; (iii) coupons on our ARM-MBS to reset,adjustable-rate assets, on a delayed basis, to lower interest rates; (iv) prepayments on our MBSassets to increase, thereby accelerating the amortization of our MBS purchase premiums and the accretion of our purchase discounts;discounts, and accelerating the redeployment of our capital to generally lower yielding investments; and (v) the value of our derivative hedging instruments and, correspondingly, our stockholders’ equity to decrease.  In addition, our borrowing costs and credit lines are further affected by the type of collateral we pledge and general conditions in the credit market.
 
Our investments in residential mortgage assets, particularly investments in residential mortgage loans and Non-Agency MBS, expose us to credit risk, generally meaning that we are generally subject to credit losses due to the risk of delinquency, default and foreclosure on the underlying real estate collateral.  WeOur investment process for credit sensitive assets focuses primarily on quantifying and pricing credit risk. With respect to investments in Purchased Performing Loans, we believe that sound underwriting standards, including low LTVs at origination, significantly mitigate our risk of loss. Further, we believe the discounted purchase prices paid on certain of these investmentsnon performing and Purchased Credit Deteriorated Loans mitigate our risk of loss in the event that, as we expect on most such investments, we receive less than 100% of the par value of these investments. Our investment process for credit sensitive assets focuses primarily on quantifying and pricing credit risk. 

As of September 30, 2017, approximately $3.9 billion, or 56.8%, of our MBS portfolio was in its contractual fixed-rate period or were fixed-rate MBS and approximately $3.0 billion, or 43.2%, was in its contractual adjustable-rate period, or were floating rate MBS with interest rates that reset monthly.  Our ARM-MBS in their contractual adjustable-rate period primarily include MBS collateralized by Hybrids for which the initial fixed-rate period has elapsed, such that the interest rate will typically adjust on an annual or semiannual basis. 

Premiums arise when we acquire an MBS at a price in excess of the aggregate principal balance of the mortgages securing the MBS (i.e., par value). or when we acquire residential whole loans at a price in excess of their aggregate principal balance.  Conversely, discounts arise when we acquire an MBS at a price below the aggregate principal balance of the mortgages securing the MBS or when we acquire residential whole loans at a price below their aggregate principal balance.  Premiums paid on our MBS are amortized against interest income and accretableAccretable purchase discounts on these investments are accreted to interest income.  Purchase premiums, which are primarily carried on our Agency MBS, and certain CRT securities and Non-QM loans, are amortized against interest income over the life of each securitythe investment using the effective yield method, adjusted for actual prepayment activity.  An increase in the prepayment rate, as measured by the CPR, will typically accelerate the amortization of purchase premiums, thereby reducing the IRR/interest income earned on these assets. 
 

CPR levels are impacted by, among other things, conditions in the housing market, new regulations, government and private sector initiatives, interest rates, availability of credit to home borrowers, underwriting standards and the economy in general.  In particular, CPR reflects the conditional repayment rate (or CRR), which measures voluntary prepayments of mortgages collateralizing a particular MBS,loan, and the conditional default rate (or CDR), which measures involuntary prepayments resulting from defaults.  CPRs on Agency MBSour residential mortgage securities and Legacy Non-Agency MBSwhole loans may differ significantly.  For the three months ended September 30, 2017,March 31, 2020, our Agency MBS portfolio experienced a weighted average CPR of 16.2%12.6%, and our Legacy Non-Agency MBS portfolio experienced a weighted average CPR of 18.7%13.6%. Over the last consecutive eight quarters, ending with September 30, 2017,March 31, 2020, the monthly weighted average CPR on our Agency and Legacy Non-Agency MBS portfolios ranged from a high of 18.4%18.6% experienced during the month ended July 31, 2017September 30, 2019 to a low of 11.3%8.8%, experienced during the month ended February 29, 2016,March 31, 2020, with an average CPR over such quarters of 15.3%15.4%. In addition, for the three months ended March 31, 2020, the weighted average CPR on our Non-QM loan portfolio was 22.2%.
 
Our method of accounting for Non-Agency MBS purchased at significant discounts to par value requires us to make assumptions with respect to each security.  These assumptions include, but are not limited to, future interest rates, voluntary prepayment rates, default rates, mortgage modifications and loss severities.  As part of our Non-Agency MBS surveillance process, we track and compare each security’s actual performance over time to the performance expected at the time of purchase or, if we have modified our original purchase assumptions, to our revised performance expectations.  To the extent that actual performance or our expectation of future performance of our Non-Agency MBS deviates materially from our expected performance parameters, we may revise our performance expectations, suchso that the amount of purchase discount designated as credit discountthat reflects principal that is not expected to be collected may be increasedincrease or decreaseddecrease over time.  Nevertheless, credittime, which could require us to record (or reverse) loss allowances.  Credit losses greater than those anticipated or in excess of the recorded purchase discount could occur, which could materially adversely impact our operating results.
 

It is generally our business strategy to hold our residential mortgage assets as long-term investments.  On at least a quarterly basis, excluding investments for which the fair value option has been elected or for which specialized loan accounting is otherwise applied, we assess our ability and intent to continue to hold each asset and, as part of this process, we monitor our MBS, CRTresidential mortgage securities and MSR relatedMSR-related assets that are designated as AFS for other-than-temporary impairment. A change in our ability and/or intent to continue to hold any of these securities that are in an unrealized loss position, or a deterioration in the underlying characteristics of these securities, could result in our recognizing future impairment charges or a loss upon the sale of any such security.  At September 30, 2017,March 31, 2020, we had net unrealized gains on our Non-Agency MBS of $648.4$144.5 million, comprised of gross unrealized gains of $648.8$166.2 million and gross unrealized losses of $390,000 and net unrealized losses of $2.8 million on our Agency MBS, comprised of gross unrealized losses of $32.9$21.6 million and gross unrealized gains of $30.1 million. At September 30, 2017, we did not intend to sell any of$6.0 million on our MBS or CRT securities that were in an unrealized loss position, and we believe it is more likely than not that we will not be required to sell those securities before recovery of their amortized cost basis, which may be at their maturity.Agency MBS.
 
We rely primarilyheavily on borrowings under repurchase agreements to finance our residential mortgage assets.assets, although, as discussed below, we entered into agreements to obtain significant non-repurchase agreement financing in June 2020.  Our residential mortgage investments have longer-term contractual maturities than our borrowings under repurchase agreements.  Even though the majority of our investments have interest rates that adjust over time based on short-term changes in corresponding interest rate indices (typically following an initial fixed-rate period for our Hybrids), the interest rates we pay on our borrowings will typically change at a faster pace than the interest rates we earn on our investments.  In order to reduce this interest rate risk exposure, we may enter into derivative instruments, which at September 30, 2017 werehave generally been comprised of Swaps.
Our The majority of our Swap derivative instruments arehave generally been designated as cash-flow hedges against a portion of our then current and forecasted LIBOR-based repurchase agreements.  OurWhile these Swaps dodid not extend the maturities of ourthe associated repurchase agreements;agreements being hedged, they do,did, however, lock in a fixed rate of interest over their term (while they were outstanding) for the notional amount of the Swap corresponding to the hedged item. DuringFollowing the nine months ended September 30, 2017,significant interest rate decreases that occurred late in the first quarter of 2020, we did not enter into any newconsider that these Swaps and had Swaps withcontinued to be an aggregate notional amounteffective economic hedge of $350.0 million and a weighted average fixed-pay rateour portfolio. Consequently, we unwound all of 0.58% amortize and/or expire. At September 30, 2017, we had Swaps designated in hedging relationships with an aggregate notional amountour Swap transactions at the end of $2.6 billion with a weighted average fixed-pay rate of 2.04% and a weighted average variable interest rate received of 1.24%.the quarter.



Recent Market Conditions and Our Strategy
 
Sadly, during the thirdCOVID-19 impact on first quarter of 2017 we lost our former chief executive officer, William S. Gorin, who passed away in August 2017 following a two-year battle with cancer. Shortly prior to Mr. Gorin’s passing, our Board of Directors appointed our President2020 Portfolio Activity and Chief Operating Officer, Craig L. Knutson, as co-CEO, and Mr. Knutson was appointed as our sole CEO following Mr. Gorin’s death. In connection with Mr. Gorin’s death, we recorded a one-time expense of approximately $5.1 million, which related to our contractual obligations to accelerate the vesting of certain share-based awards previously made to Mr. Gorin and a death benefit payment made to his estate.impact on financial results:


At September 30, 2017,March 31, 2020, our residential mortgage asset portfolio, which includes MBS, residential whole loans CRTand REO, residential mortgage securities and MSR relatedMSR-related assets, was approximately $9.7$10.0 billion compared to $11.5$13.1 billion at December 31, 2016. During2019. Beginning in mid-March 2020, conditions related to the COVID-19 pandemic created unprecedented market volatility, widening of spreads and related liquidity pressure as counterparties sought higher margin requirements. As a result, and as pricing dislocations in markets for residential mortgage assets accelerated in the last two weeks of March 2020, we sold approximately $2.1 billion of residential mortgage securities and residential whole loans to generate liquidity, satisfy margin calls and reduce our financial leverage, which resulted in realized losses of $238.4 million for the three months

ended September 30, 2017,March 31, 2020. In addition, overall asset prices declined materially during this period, resulting in significant unrealized losses and impairment charges in the amount of $496.9 million for the quarter relating to investments in residential mortgage securities and residential whole loans. Prior to the onset of the COVID-19 pandemic, we purchased or committed to purchase, through consolidated trusts, forhad acquired approximately $187.7 million,$1.0 billion of residential whole loans with an unpaid principal balance of approximately $245.2 million. In addition, we acquired approximately $183.7 million of RPL/NPL MBS, $161.0 million of MSR related assets and $29.1 million of CRT securities.during the quarter.


At September 30, 2017, $3.9 billion, or 40.2% ofThe following table presents the activity for our residential mortgage asset portfolio was invested in Non-Agency MBS.  Duringfor the three months ended September 30, 2017,March 31, 2020*:
(In Millions) December 31, 2019 
Runoff (1)
 Acquisitions Sales 
Other (2)
 March 31, 2020 Change
Residential whole loans and REO (3)
 $7,860
 $(541) $1,091
 $(806) $(233) $7,371
 $(489)
RPL/NPL MBS 635
 (320) 
 (211) (24) 80
 (555)
MSR-related assets 1,217
 (33) 4
 (161) (289) 738
 (479)
CRT securities 255
 (1) 159
 (38) (121) 254
 (1)
Legacy Non-Agency MBS 1,429
 (68) 
 (96) (225) 1,040
 (389)
Agency MBS 1,665
 (123) 
 (988) (1) 553
 (1,112)
Totals $13,061
 $(1,086) $1,254
 $(2,300) $(893) $10,036
 $(3,025)

* As discussed below under “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Portfolio sales and composition changes and impact on our liquidity” and in Note 16 to our consolidated financial statements, since the fair valueend of the first quarter, we have engaged in asset sales and taken other actions that have significantly changed the asset composition of our balance sheet. In particular, subsequent to the end of the first quarter, we sold the vast majority of our remaining Agency MBS and Legacy Non-Agency MBS holdings decreased by $406.7 million. Theportfolios and substantially reduced our investments in MSR-related assets and CRT securities. As a result of these actions, our primary componentsinvestment asset as of the change duringdate hereof is our residential whole loan portfolio. Any discussion herein, including the quartertable above, of our assets at March 31, 2020, should be read in conjunction with the description of these Non-Agency MBS include $582.0 million of principal repaymentsasset sales and other principal reductions and the sale of Non-Agency MBS with a fair value of $44.5 million partially offset by $187.4 million of purchases (at a weighted average purchase price of 99% of par), and an increase reflecting Non-Agency MBS price changes of $32.4 million.actions.


(1)
Primarily includes principal repayments, cash collections on Purchased Credit Deteriorated Loans and sales of REO.
(2)Primarily includes changes in fair value, net premium amortization/discount accretion and adjustments to record lower of cost or estimated fair value adjustments on REO and loans held-for-sale.
(3)Includes Non-QM loans held-for-sale with a net carrying value of $895.3 million at March 31, 2020.

At September 30, 2017, $3.0 billion, or 31.0% of our residential mortgage asset portfolio, was invested in Agency MBS.  During the three months ended September 30, 2017, the fair value of our Agency MBS decreased by $228.7 million. This was due to $217.8 million of principal repayments, $7.9 million of premium amortization, and $3.0 million in net unrealized losses.

At September 30, 2017,March 31, 2020, our total recorded investment in residential whole loans and REO was $1.7$7.4 billion, or 17.9%73.4% of our residential mortgage asset portfolio. Of this amount, $639.2 million(i) $5.7 billion is presented as Residential whole loans, at carrying value (of which $5.0 billion were Purchased Performing Loans (including $895.3 million of Non-QM loans that were designated as held-for-sale) and $1.1$673.5 million were Purchased Credit Deteriorated Loans, and (ii) $1.2 billion is presented as Residential whole loans, at fair value, in our consolidated balance sheets. For the three months ended September 30, 2017,March 31, 2020, we recognized approximately $9.0$83.5 million of income on residentialResidential whole loans, held at carrying value in Interest Income on our consolidated statements of operations, representing an effective yield of 5.92%5.07% (excluding servicing costs), with Purchased Performing Loans generating an effective yield of 5.10% and Purchased Credit Impaired Loans generating an effective yield of 4.84%. In addition, we recorded a net gainloss on residential whole loans heldmeasured at fair value through earnings of $18.7$52.8 million in Other Income, net in our consolidated statements of operations for the three months ended September 30, 2017.March 31, 2020. At March 31, 2020 and December 31, 2019, we had REO with an aggregate carrying value of $411.5 million and $411.7 million, respectively, which is included in Other assets on our consolidated balance sheets.


At September 30, 2017 our total investment in MSR related assets was $411.8 million. During the three months ended September 30, 2017 we acquired $161.0 millionAs of and had $124.0 million of principal repayments on term notes backed by MSR related collateral. We also acquired $29.1 million of CRT securities, bringing our total investment in these securities to $653.6 million. During the quarter, our CRT portfolio experienced significant price volatility, as markets reacted to concerns related to seasonal hurricanes and other factors. While unrealized losses recognized in net income on this portfolio for the quarter were $5.2 million, our CRT portfolio at September 30, 2017 was in an overall unrealized gain position of $41.0 million.

We will continue to seek investments in residential mortgage assets during the remainder of 2017. The investment landscape is challenging, as market pricing for all asset classes remains high, thereby making it difficult to purchase assets at attractive risk/reward levels. In addition, unlike Agency MBS, certain of our other asset classes are not always available for purchase, as sellers offer these investments from time to time as opposed to more liquid markets which feature active buyers and sellers at nearly all times. We expect that our purchase focus will be primarily on additional credit sensitive residential whole loans, RPL/NPL MBS and MSR related assets. While the third quarter runoff of RPL/NPL MBS slowed considerably from the runoff we experienced in the second quarter (approximately $400 million versus $1.3 billion), we could experience further reduction in this portfolio if issuers continue to call these securities.

Our book value per common share was $7.70 as of September 30, 2017, a decline from book value per common share of $7.76 as of June 30, 2017. This decrease was primarily due to dividends declared during the quarter that exceeded our net income.
At the end of the third quarter of 2017, the average coupon on mortgages underlyingMarch 31, 2020, our Agency MBS was higher compared toportfolio totaled $553.4 million. Following the endonset of the third quarterCOVID-19-related market disruptions in March, we sold $965.1 million of 2016, due to upward resets on Hybrid and ARM-MBS within the portfolio.  AsAgency MBS, realizing a result, theloss of $22.9 million. The coupon yield on our Agency MBS portfolio increaseddecreased to 2.98%3.57% for the three months ended September 30, 2017,March 31, 2020, from 2.83%3.69% for the three months ended September 30, 2016March 31, 2019, and the net Agency MBS yield increaseddecreased to 1.97%2.32% for the three months ended September 30, 2017March 31, 2020 from 1.83%2.77% for the three months ended September 30, 2016. The net yield for ourMarch 31, 2019. Our Legacy Non-Agency MBS portfolio was 8.93% forhad a face amount of $1.4 billion with an amortized cost of $874.3 million and a net purchase discount of $480.1 million at March 31, 2020. This discount consists of a $389.5 million credit reserve (reflecting principal not expected to be recovered) and a $90.7 million net accretable discount. During the three months ended September 30, 2017 compared to 8.09% for the three months ended September 30, 2016.March 31, 2020, we disposed of approximately $100.7 million of Legacy Non-Agency, MBS, realizing net gains of $4.4 million. The increase in the net yield on our Legacy Non-Agency MBS portfolio reflectswas 10.55% for the impactthree months ended March 31, 2020, compared to 10.45% for the three months ended March 31, 2019. Subsequent to the end of the cash proceeds received during 2016 in connection withfirst quarter, we sold the settlementvast majority of litigation related to certain Countrywideour remaining Agency MBS and Citigroup sponsored residential mortgage backed securitization trusts and the improved performance of loans underlying the Legacy Non-Agency MBS portfolios. 

As of March 31, 2020, our RPL/NPL MBS portfolio which have resulted in credit reserve releases.totaled $80.0 million. During the three months ended March 31, 2020, we sold $163.7 million of these securities, realizing a loss of $47.5 million. The net yield foron our RPL/NPL MBS portfolio was 4.43%5.21% for the three months ended September 30, 2017March 31, 2020, compared to 3.86%4.90% for the three months ended September 30, 2016.March 31, 2019.  The increase in the net yield reflects an increase in the average coupon yield to 4.24%4.96% for the three months ended September 30, 2017March 31, 2020 from 3.83%4.86% for the three months ended September 30, 2016 and higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount.
We believe that our $593.1 million Credit Reserve and OTTI appropriately factors in remaining uncertainties regarding underlying mortgage performance and the potential impact on future cash flows for our existing Legacy Non-Agency MBS

portfolio.March 31, 2019. In addition, while the majority of our Legacy Non-Agency MBS will not return their full face value due to loan defaults, we believe that they will deliver attractive loss adjusted yields due to our discounted amortized cost of 71% of face valueinvestments in MSR-related assets at September 30, 2017. Home price appreciation and underlying mortgage loan amortization have decreased the LTV for many of the mortgages underlying our Legacy Non-Agency portfolio. Home price appreciation during the past few years has generally been driven by a combination of limited housing supply, low mortgage rates and demographic-driven U.S. household formation. Lower LTVs lessen the likelihood of defaults and simultaneously decrease loss severities. Further, during 2016 and the nine months ended September 30, 2017, we have also observed faster voluntary prepayment (i.e., prepayment of loans in full with no loss) speeds than originally projected. The yields on our Legacy Non-Agency MBS that were purchased at a discount are generally positively impacted if prepayment rates on these securities exceed our prepayment assumptions. Based on these current conditions, we have reduced estimated future losses within our Legacy Non-Agency portfolio. As a result, duringMarch 31, 2020 totaled $738.1 million. During the three months ended September 30, 2017, $14.8March 31, 2020, we sold $136.8 million of term notes backed by MSR-related collateral, realizing a loss of $24.6 million. Our investments in CRT securities totaled $254.1 million at March 31, 2020. During the quarter

we sold $35.6 million of CRT securities, realizing a loss of $2.0 million. Subsequent to the end of the first quarter, we have substantially reduced our investments in MSR-related assets and CRT securities.

Our first quarter results also include impairment and other charges totaling $419.7 million on securities available-for-sale and Other assets. Of this amount, $280.8 million is related to unrealized losses on term notes backed by MSR-related collateral and $63.5 million is related to residential mortgage securities (primarily CRT securities), as a lack of liquidity resulted in pricing dislocations in the markets for these assets in the last two weeks of March. As we had determined at March 31, 2020, that we committed to dispose of our investments in these asset classes, GAAP requires that these unrealized losses be recorded in net income for the period and reduce the amortized cost basis of the associated assets.

We adopted a new accounting standard addressing the measurement of credit losses on financial instruments (CECL) on January 1, 2020. With respect to our residential whole loans held at carrying value, CECL requires that reserves for credit losses be estimated at the reporting date based on life of loan expected cash flows, including anticipated prepayments and reasonable and supportable forecasts of future economic conditions. While the adjustments recorded at the transition date to adopt CECL did not have a material impact on our financial position, in light of the anticipated impact of the COVID-19 pandemic on expected economic conditions for the short- to medium-term, estimates of credit losses recorded under CECL for the first quarter are significantly higher than would have been recorded under prior accounting standards, where reserves for credit losses were recorded only when assessed as being incurred. For the first quarter, a provision for credit losses of $74.9 million was transferredrecorded on residential whole loans held at carrying value. In addition, a valuation allowance to reduce the carrying value of Non-QM loans designated as held-for-sale at quarter-end of $70.2 million was recorded. This valuation allowance is included, along with CECL credit loss estimates, in the provision for credit losses in our income statement. The total allowance for credit and valuation losses recorded on residential whole loans held at carrying value at March 31, 2020 was $218.0 million. In addition, as of March 31, 2020, CECL reserves for credit losses totaling approximately $5.9 million were recorded related to undrawn commitments on loans held at carrying value as well as certain other interest earning assets.

In addition, following an evaluation of the anticipated impact of the COVID-19 pandemic on economic conditions for the short- to medium-term, impairment charges of $58.1 million were recorded on investments in certain loan originators. As these investments include equity and debt investments in several private entities for which limited pricing transparency exists, particularly in light of the anticipated economic disruption associated with the COVID-19 pandemic, valuation and associated impairment considerations for these investments require significant judgment. Further, in light of the prevailing market and economic conditions that existed at March 31, 2020, management determined that it was appropriate to record an impairment charge against our goodwill intangible asset of $7.2 million, reducing the carrying value of that asset to zero.

The unprecedented market conditions that affected our first quarter 2020 results are also reflected in our book value per common share. Our GAAP book value per common share decreased to $4.34 as of March 31, 2020 from Credit Reserve$7.04 as of December 31, 2019. Economic book value per common share, a non-GAAP financial measure of our financial position that adjusts GAAP book value by the amount of unrealized mark to accretable discount.  This increasemarket gains on our residential whole loans held at carrying value, was $4.09 at March 31, 2020, a decrease from $7.44 as of December 31, 2019. For additional information regarding the calculation of Economic book value per share including a reconciliation to GAAP book value per share, refer to page 82 under the heading “Economic Book Value”.

Senior Secured Financing and Exit from Forbearance

On March 24, 2020, we announced that due to turmoil in accretable discountthe financial markets resulting from the spread of the novel coronavirus and the global COVID-19 pandemic, we had received an unusually high number of margin calls starting approximately in mid-March. In our announcement, we stated that, on March 23, 2020, we did not meet our margin calls and had notified our financing counterparties that we did not expect to be in a position to fund the anticipated volume of margin calls under our financing arrangements in the near term. As a result of these events, we initiated forbearance discussions with our financing counterparties with regard to entering into forbearance agreements pursuant to which each counterparty would agree to forbear from exercising its rights and remedies with respect to an event of default under its applicable financing arrangement(s) with the Company for an agreed upon period, including refraining from selling collateral to enforce margin calls. Following these discussions, we entered into a series of Forbearance Agreements: an initial Forbearance Agreement, or Initial FBA, on April 10, 2020; a second Forbearance Agreement on April 27, 2020, or Second FBA, that extended the Initial FBA; and a third Forbearance Agreement on June 1, 2020, or Third FBA, which is set to expire on June 26, 2020. Pursuant to these Forbearance Agreements, which are substantially similar to one another, certain of our repurchase agreement counterparties agreed to forbear from exercising their rights and remedies with respect to an event of default, including refraining from selling collateral to enforce margin calls. The primary purpose of the Forbearance Agreements was to permit us to seek, in an orderly manner, mutually beneficial solutions with our counterparties in light of the liquidity issues we faced following the onset of the COVID-19 pandemic.


During the forbearance period discussed above, we explored other potential transactions to further reduce our obligations under our existing repurchase agreements, source financing that is generally more durable than our existing funding alternatives and raise cash to bolster our liquidity. Following various discussions with potential financing sources, on June 15, 2020, we and certain of our wholly owned subsidiaries entered into a credit agreement for a $500 million senior secured term loan facility (or Term Loan Facility) to be funded by certain funds and accounts managed by subsidiaries of Apollo Global Management, Inc. (together with such funds and accounts, “Apollo”), including subsidiaries of Athene Holding Ltd. (“Athene”), to which Apollo provides asset management and advisory services. In connection with, and conditioned on, the funding of the Term Loan Facility, the Company also executed on June 15, 2020, a letter with Barclays and affiliates of Athene (the “Asset Level Lenders”), pursuant to which the Asset Level Lenders have committed, subject to satisfaction of customary conditions precedent, to a non-mark-to-market term loan facility with one or more subsidiaries of the Company to provide, severally and not jointly, financing in an aggregate amount of up to $1,650,000,000 (the “Asset Level Debt Facility”). Further details related to the Term Loan Facility and the Asset Level Debt Facility are discussed in “Note 16. Subsequent Events” in our interim financial statements as of and for the three months ended March 31, 2020.

In connection with the Term Loan Facility and the Asset Level Debt Facility, the Company also entered into an Investment Agreement with Apollo and Athene (together the “Purchasers”), under which. the Company agreed to issue to the Purchasers warrants (the “Warrants”) to purchase, in the aggregate, 37,039,106 shares (subject to adjustment in accordance with their terms) of the Company’s common stock. In addition, the Purchasers or one or more of their affiliates have agreed to purchase, prior to the first anniversary date of the Investment Agreement, in one or a series of open market or privately negotiated transactions, a number of shares of the Company’s common stock equal to the lesser of (a) such number of shares representing 4.9% of the outstanding shares of common stock as of the Funding Date or (b) such number of shares as the Purchasers may purchase for an aggregate gross purchase price of $50 million. The issuance of the Warrants is subject to satisfaction of certain terms and conditions set forth in the Investment Agreement, but is expected to increaseoccur on the interest income realized overFunding Date.

Following the remaining life of our Legacy Non-Agency MBS. The remaining average contractual life of such assets is approximately 19 years, but based on scheduled loan amortizationclosing and prepayments (both voluntary and involuntary), loan balances will decline substantially over time. Consequently, we believe that the majorityfunding of the impact on interest income fromTerm Loan Facility and the reduction in Credit Reserve will occur over the next ten years.
At September 30, 2017,Asset Level Debt Facility, we have access to various sources of liquidity which we estimateexpect to be in excessposition to exit forbearance. This will be facilitated via execution of $1.2a reinstatement agreement with all counterparties to the Third FBA, pursuant to which we will exit forbearance and terminate the Third FBA. Under the Reinstatement Agreement, if completed as expected, counterparties will waive any past defaults under the applicable repurchase agreements, terminate the Third FBA, release any security interest in our assets held by the counterparties, and reinstate the repurchase agreements on a go forward basis (subject to certain modifications, that will be agreed with these counterparties).

The completion of the transactions contemplated by the Term Loan Facility, the Asset Level Debt Facility and the Investment Agreement are subject to and conditioned on, among other things, the completion of definitive documentation relating to the Asset Level Debt Facility, completion of documentation relating to the Company’s exit from the Third FBA and other customary closing conditions.

Following completion of the transactions discussed above, we expect to be in compliance with the terms and conditions of all of our material financing arrangements, including all of our repurchase agreements, and expect to have resolved all issues with our counterparties related to the events in March 2020, including our failure to satisfy margin calls.

Portfolio sales and composition changes and impact on our liquidity

Since the end of the first quarter through May 31, 2020, we have taken further steps to reduce the leverage on our portfolio, generate liquidity and reduce repurchase agreement balances with our counterparties. Actions taken by us include the sale of residential mortgage assets, generating proceeds of approximately $3.2 billion, which along with portfolio run-off and other payments to counterparties has resulted in an overall reduction in repurchase agreement balances of approximately $3.9 billion. This amount includes (i) $608.2Details of sales that have occurred in the second quarter through May 31, 2020 include:

We have disposed of approximately $2.4 billion of residential mortgage securities, including $533.1 million of cashAgency MBS, $1.1 billion of Non-Agency MBS and cash equivalents; (ii) $186.0$207.4 million of CRT securities. In addition, we sold $574.9 million of term notes backed by MSR-related collateral and $15.6 million of other interest earning assets. Improvement in estimated financing available from unpledgedmarket pricing since the end of the first quarter resulted in us recording realized gains of approximately $177.5 million to date in the second quarter. In addition, we recorded $57.0 million of unrealized gains on securities (primarily CRT securities) on which we had previously elected the fair value option.


We also disposed of approximately $845.2 million of residential whole loans, resulting in realized losses of approximately $128.4 million. However, after the reversal of the valuation allowance associated with loans that were designated as held-for-sale at the end of the first quarter, the net impact on second quarter results is a loss of approximately $58.2 million.

We have now sold substantially all of our Agency MBS and from other AgencyLegacy Non-Agency MBS collateral that is currently pledged in excessportfolios and greatly reduced our holdings of contractual requirements;MSR-related assets and (iii) $363.4 million in estimated financing available from unpledged Non-Agency MBS. Our sourcesCRT securities. As of liquidity do not include restricted cash. We believe that we are positioned to continue to take advantage of investment opportunities within theMay 31, 2020, our $6.6 billion residential mortgage marketplace. 
Repurchase agreement funding for ourasset portfolio was comprised of $6.2 billion of residential whole loans and REO, approximately $235.4 million of MSR-related assets and $136.4 million of residential mortgage securities. These investments continued to be available to us from multiple counterparties duringare financed with approximately $3.8 billion of repurchase agreements. Total debt was approximately 1.9 times stockholders’ equity at May 31, 2020.

As of June 19, 2020, the third quarterCompany had total cash balances of 2017.  Typically,$343.6 million, including cash on deposit with repurchase agreement funding involving credit-sensitive investments is available at terms requiring higher collateralization and higher interest rates, than for repurchase agreement funding involving Agency MBS.  At September 30, 2017, our debt consisted of borrowings under repurchasecounterparties totaling $103.5 million. Since entering into forbearance agreements with 31 counterparties, securitized debt, Senior Notes outstanding, obligation to return securities obtainedits lenders in April, unpaid margins calls have been substantially reduced and were $29.1 million as collateral and payable for unsettled purchases, resulting in a debt-to-equity multiple of 2.4 times.  (See table on page 75 under Results of Operations that presents our quarterly leverage multiples since September 30, 2016.)June 19, 2020.



Information About Our Assets


The tablestable below presentpresents certain information about our asset allocation at September 30, 2017March 31, 2020:
 
ASSET ALLOCATIONALLOCATION*
 Agency MBS 
Legacy
Non-Agency MBS
 
RPL/NPL MBS (1)
 Credit Risk Transfer Securities MSR Related Assets 
Residential Whole Loans, at Carrying Value (2)
 Residential Whole Loans, at Fair Value 
Other,
net (3)
 Total
(Dollars in Millions)  
  
          
  
  
 
Residential Whole Loans, at Carrying Value (1)
 Residential Whole Loans, at Fair Value Agency MBS Legacy
Non-Agency MBS
 
RPL/NPL MBS (2)
 Credit Risk Transfer Securities MSR-Related Assets 
Other,
net
(3)
 Total
Fair Value/Carrying Value $3,019
 $2,717
 $1,195
 $654
 $412
 $639
 $1,103
 $748
 $10,487
 $5,716
 $1,244
 $553
 $1,040
 $80
 $254
 $738
 $1,019
 $10,644
Less Payable for Unsettled Purchases 
 (4) 
 
 
 
 (120) 
 (124)
Plus Receivable for Unsettled Sales 27
 
 28
 53
 164
 11
 137
 
 420
Less Repurchase Agreements (2,671) (1,837) (798) (413) (269) (273) (610) 
 (6,871) (4,092) (609) (522) (1,003) (255) (298) (930) (59) (7,768)
Less Securitized Debt (123) (411) 
 
 
 
 
 
 (534)
Less Convertible Senior Notes 
 
 
 
 
 
 
 (224) (224)
Less Senior Notes 
 
 
 
 
 
 
 (97) (97) 
 
 
 
 
 
 
 (97) (97)
Less Securitized Debt 
 
 
 
 
 (111) (26) 
 (137)
Net Equity Allocated $348
 $876
 $397
 $241
 $143
 $255
 $347
 $651
 $3,258
 $1,528
 $224
 $59
 $90
 $(11) $(33) $(55) $639
 $2,441
Debt/Net Equity Ratio (4)
 7.7x 2.1x 2.0x 1.7x 1.9x 1.5x 2.2x   2.4x 2.7x 4.6x 8.4x 10.6x N/M
 N/M
 N/M
   3.4x


* As discussed above under “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Portfolio sales and composition changes and impact on our liquidity” and in Note 16 to our consolidated financial statements, since the end of the first quarter we have engaged in asset sales and taken other actions that significantly changed our asset composition subsequent to March 31, 2020. In particular, subsequent to the end of the first quarter, we sold the vast majority of our remaining Agency MBS and Legacy Non-Agency MBS portfolios and substantially reduced our investments in MSR-related assets and CRT securities. As a result of these actions, our primary investment asset as of the date hereof is our residential whole loan portfolio. Any discussion herein, including the table above, of our assets at March 31, 2020 should be read in conjunction with the description of these asset sales and other actions.

(1)Includes $3.4 billion of Non-QM loans (including $895.3 million held-for-sale), $943.3 million of Rehabilitation loans, $498.9 million of Single-family rental loans, $165.3 million of Seasoned performing loans, and $673.5 million of Purchased Credit Deteriorated Loans. At March 31, 2020, the total fair value of these loans is estimated to be approximately $5.6 billion.
(2)RPL/NPL MBS are backed primarily by securitized re-performing and non-performing loans. The securities are generally structured such that the coupon increases up tofrom 300 - 400 basis points at 36 - 48 months from issuance or sooner. Included with the balance of Non-Agency MBS reported on our consolidated balance sheets.
(2)The carrying value of such loans reflects the purchase price, accretion of income, cash received and provision for loan losses since acquisition. At September 30, 2017, the fair value of such loans is estimated to be approximately $693.8 million.
(3)Includes cash and cash equivalents and restricted cash, securities obtained and pledged as collateral, other assets obligation to return securities obtained as collateral and other liabilities.     
(4)Represents the sum of borrowings under repurchase agreements and securitized debt and payable for unsettled purchases as a multiple of net equity allocated.  The numerator of our Total Debt/Net Equity Ratio also includes the obligation to return securities obtained as collateral of $507.3 millionConvertible Senior Notes and Senior Notes.


Residential Whole Loans

The following table presents the contractual maturities of our residential whole loan portfolios at March 31, 2020. Amounts presented do not reflect estimates of prepayments or scheduled amortization.

(In Thousands) 
Purchased
Performing Loans
 (1)
 
Purchased Credit
Deteriorated Loans
(2)
 Residential Whole Loans, at Fair Value
Amount due:      
Within one year $780,632
 $737
 $4,212
After one year:      
Over one to five years 239,496
 4,302
 5,687
Over five years 4,169,506
 739,369
 1,233,893
Total due after one year $4,409,002
 $743,671
 $1,239,580
Total residential whole loans $5,189,634
 $744,408
 $1,243,792

(1)Excludes an allowance for credit and valuation losses of $147.1 million at March 31, 2020.
(2)Excludes an allowance for credit losses of $70.9 million at March 31, 2020.


The following table presents, at March 31, 2020, the dollar amount of certain of our residential whole loans, contractually maturing after one year, and indicates whether the loans have fixed interest rates or adjustable interest rates:

(In Thousands) 
Purchased
Performing Loans
(1)(2)
 
Purchased Credit
 Deteriorated Loans (1)(3)
 
Residential Whole Loans, at Fair Value (1)
Interest rates:      
Fixed $1,434,688
 $501,139
 $879,535
Adjustable 2,974,314
 242,532
 360,045
Total $4,409,002
 $743,671
 $1,239,580

(1)Includes loans on which borrowers have defaulted and are not making payments of principal and/or interest as of March 31, 2020.
(2)Excludes an allowance for credit and valuation losses of $147.1 million at March 31, 2020.
(3)Excludes an allowance for credit losses of $70.9 million at March 31, 2020.





Agency MBS
 
The following table presentstables present certain information regarding the composition of our Agency MBS portfolio as of September 30, 2017March 31, 2020 and December 31, 2016:2019. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Agency MBS:
 
September 30, 2017March 31, 2020
(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Coupon (2)
 
3 Month
Average
CPR
15-Year Fixed Rate:  
  
  
  
  
  
  
Low Loan Balance (3)
 $125,543
 103.8% 105.3% $132,204
 110
 3.90% 8.6%
Generic 36,157
 104.0
 105.3
 38,086
 113
 4.10
 7.2
Total 15-Year Fixed Rate $161,700
 103.8% 105.3% $170,290
 111
 3.95% 8.3%
               
30-Year Fixed Rate:              
Generic $13,461
 104.0% 107.7% $14,499
 21
 4.50% 25.1%
Total 30-Year Fixed Rate $13,461
 104.0% 107.7% $14,499
 21
 4.50% 25.1%
               
Hybrid $315,351
 103.5% 102.8% $324,197
 120
 3.67% 11.4%
CMO/Other $42,393
 102.6% 103.6% $43,911
 215
 4.03% 13.5%
Total Portfolio $532,905
 103.5% 103.8% $552,897
 122
 3.80% 12.6%

December 31, 2019

(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Coupon (2)
 
3 Month
Average
CPR
15-Year Fixed Rate:  
  
  
  
  
  
  
Low Loan Balance (3)
 $1,000,583
 104.3% 102.5% $1,025,730
 64
 2.95% 11.1%
HARP (4)
 95,571
 104.7
 102.6
 98,095
 63
 2.95
 14.7
Other (Post June 2009) (5)
 87,314
 104.0
 105.2
 91,890
 84
 4.14
 11.9
Other (Pre June 2009) (6)
 315
 104.9
 105.2
 332
 100
 4.50
 28.8
Total 15-Year Fixed Rate $1,183,783
 104.3% 102.7% $1,216,047
 65
 3.04% 11.4%
               
Hybrid:  
  
  
  
  
  
  
Other (Post June 2009) (5)
 $1,092,102
 104.4% 104.2% $1,137,631
 76
 3.16% 20.1%
Other (Pre June 2009) (6)
 553,753
 101.7
 105.0
 581,390
 129
 3.35
 18.8
Total Hybrid $1,645,855
 103.5% 104.4% $1,719,021
 94
 3.23% 19.7%
CMO/Other $80,764
 102.5% 103.0% $83,172
 196
 3.04% 16.1%
Total Portfolio $2,910,402
 103.8% 103.7% $3,018,240
 85
 3.15% 16.2%
(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Coupon (2)
 3 Month
Average
CPR
15-Year Fixed Rate:  
  
  
  
  
  
  
Low Loan Balance (3)
 $460,094
 104.5% 102.4% $471,123
 93
 3.04% 10.5%
Generic 100,886
 104.5
 103.1
 104,060
 99
 3.45
 10.7
Total 15-Year Fixed Rate $560,980
 104.5% 102.5% $575,183
 94
 3.11% 10.6%
               
30-Year Fixed Rate:              
Generic $264,760
 104.2% 105.9% $280,303
 18
 4.50% 34.4%
Total 30-Year Fixed Rate $264,760
 104.2% 105.9% $280,303
 18
 4.50% 34.4%
               
Hybrid $732,968
 103.5% 103.8% $760,836
 121
 4.11% 18.3%
CMO/Other $45,875
 102.6% 103.9% $47,646
 211
 4.23% 11.7%
Total Portfolio $1,604,583
 103.9% 103.7% $1,663,968
 97
 3.83% 18.1%


(1)Does not include principal payments receivable of $516,000 and $614,000 at March 31, 2020 and December 31, 2019, respectively.
(2)Weighted average is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.
(3)Low loan balance represents MBS collateralized by mortgages with an original loan balance of less than or equal to $175,000.
December 31, 2016

(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Coupon (2)
 3 Month
Average
CPR
15-Year Fixed Rate:  
  
  
  
  
  
  
Low Loan Balance (3)
 $1,170,788
 104.3% 103.0% $1,206,174
 55
 2.97% 11.2%
HARP (4)
 116,790
 104.7
 103.0
 120,290
 54
 2.96
 12.1
Other (Post June 2009) (5)
 106,343
 104.0
 105.7
 112,400
 75
 4.14
 14.3
Other (Pre June 2009) (6)
 564
 104.9
 105.9
 597
 91
 4.50
 28.8
Total 15-Year Fixed Rate $1,394,485
 104.3% 103.2% $1,439,461
 57
 3.06% 11.5%
               
Hybrid:  
  
  
  
  
  
  
Other (Post June 2009) (5)
 $1,370,019
 104.4% 104.8% $1,436,184
 67
 2.99% 19.9%
Other (Pre June 2009) (6)
 720,419
 101.7
 105.6
 761,052
 120
 3.03
 17.0
Total Hybrid $2,090,438
 103.5% 105.1% $2,197,236
 86
 3.01% 18.9%
CMO/Other $96,379
 102.5% 102.9% $99,196
 187
 2.81% 14.7%
Total Portfolio $3,581,302
 103.8% 104.3% $3,735,893
 77
 3.02% 15.9%

(1)  Does not include principal payments receivable of $1.1 million and $2.6 million at September 30, 2017 and December 31, 2016, respectively.
(2)  Weighted average is based on MBS current face at September 30, 2017 and December 31, 2016, respectively.
(3)  Low loan balance represents MBS collateralized by mortgages with an original loan balance of less than or equal to $175,000.
(4)  Home Affordable Refinance Program (or HARP) MBS are backed by refinanced loans with LTVs greater than or equal to 80% at origination.
(5)  MBS issued in June 2009 or later. Majority of underlying loans are ineligible to refinance through the HARP program.
(6)  MBS issued before June 2009.
 

The following table presentstables present certain information regarding our 15-year fixed-rate Agency MBS as of September 30, 2017March 31, 2020 and December 31, 2016:2019. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Agency MBS:
 
September 30, 2017March 31, 2020


Coupon 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Loan Rate
 
Low Loan
Balance
and/or
HARP (3)
 3 Month
Average
CPR
 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Loan Rate
 
Low Loan
Balance
and/or
HARP (3)
 3 Month
Average
CPR
(Dollars in Thousands)                                
15-Year Fixed Rate:  
  
  
  
    
  
  
  
  
  
  
    
  
  
2.5% $608,076
 104.0% 101.3% $616,008
 57 3.04% 100% 10.6% $4,319
 104.8% 104.1% $4,497
 88 3.08% 100% 6.8%
3.0% 243,604
 105.9
 103.0
 250,902
 63 3.49
 100
 11.5
 8,509
 105.5
 104.8
 8,919
 92 3.61
 100
 6.5
3.5% 5,944
 103.5
 104.5
 6,211
 83 4.18
 100
 6.2
 2,525
 103.5
 105.3
 2,658
 113 4.19
 100
 15.3
4.0% 281,506
 103.5
 105.0
 295,672
 82 4.40
 80
 13.3
 131,275
 103.5
 105.4
 138,325
 112 4.40
 82
 12.6
4.5% 44,653
 105.2
 105.8
 47,254
 86 4.88
 34
 11.8
 15,072
 105.3
 105.4
 15,891
 117 4.89
 52
 9.1
Total 15-Year Fixed Rate $1,183,783
 104.3% 102.7% $1,216,047
 65 3.53% 93% 11.4% $161,700
 103.8% 105.3% $170,290
 111 4.37% 81% 8.3%
              
30-Year Fixed Rate:                
4.5% $13,461
 104.0% 107.7% $14,499
 21 4.86% % 25.1%
Total 30-Year Fixed Rate $13,461
 104.0% 107.7% $14,499
 21 4.86% % 25.1%
Total Fixed Rate Portfolio $175,161
 103.9% 105.5% $184,789
 104 4.41% 75% 13.6%


December 31, 20162019


Coupon 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Loan Rate
 
Low Loan
Balance
and/or
HARP (3)
 3 Month
Average
CPR
 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Loan Rate
 
Low Loan
Balance
and/or
HARP (3)
 3 Month
Average
CPR
(Dollars in Thousands)                                
15-Year Fixed Rate:  
  
  
  
    
  
  
  
  
  
  
    
  
  
2.5% $700,388
 104.0% 101.6% $711,696
 48 3.04% 100% 9.9% $241,045
 104.1% 101.2% $243,946
 85 3.06% 100% 9.3%
3.0% 288,648
 105.9
 103.3
 298,311
 54 3.49
 100
 11.3
 147,665
 105.9
 102.6
 151,470
 89 3.49
 100
 10.0
3.5% 7,244
 103.5
 104.6
 7,576
 74 4.18
 100
 15.7
 2,761
 103.5
 103.6
 2,862
 110 4.19
 100
 7.5
4.0% 343,105
 103.5
 105.9
 363,258
 73 4.40
 80
 14.2
 145,910
 103.5
 104.3
 152,234
 109 4.40
 81
 13.0
4.5% 55,100
 105.2
 106.4
 58,620
 77 4.88
 34
 14.5
 23,599
 105.3
 104.5
 24,671
 113 4.89
 36
 11.2
Total 15-Year Fixed Rate $1,394,485
 104.3% 103.2% $1,439,461
 57 3.54% 92% 11.5% $560,980
 104.5% 102.5% $575,183
 94 3.60% 92% 10.6%
              
30-Year Fixed Rate:              
4.5% $264,760
 104.2% 105.9% $280,303
 18 5.16% % 34.4%
Total 30-Year Fixed Rate $264,760
 104.2% 105.9% $280,303
 18 5.16% % 34.4%
Total Fixed Rate Portfolio $825,740
 104.4% 103.6% $855,486
 70 4.10% 63% 18.3%

(1)Does not include principal payments receivable of $516,000 and $614,000 at March 31, 2020 and December 31, 2019, respectively.
(2)Weighted average is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.
(3)Low Loan Balance represents MBS collateralized by mortgages with an original loan balance less than or equal to $175,000.  Home Affordable Refinance Program (or HARP) MBS are backed by refinanced loans with LTVs greater than or equal to 80% at origination.


(1)  Does not include principal payments receivable of $1.1 million and $2.6 million at September 30, 2017 and December 31, 2016, respectively.
(2)  Weighted average is based on MBS current face at September 30, 2017 and December 31, 2016, respectively.
(3)  Low Loan Balance represents MBS collateralized by mortgages with an original loan balance less than or equal to $175,000.  HARP MBS are backed by refinanced loans with LTVs greater than or equal to 80% at origination.


The following table presentstables present certain information regarding our Hybrid Agency MBS as of September 30, 2017March 31, 2020 and December 31, 2016:2019. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Agency MBS:
 
September 30, 2017March 31, 2020
(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Coupon (2)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Months to
Reset (3)
 
Interest
Only (4)
 3 Month
Average
CPR
Hybrid Post June 2009:                  
Agency 5/1 $425,236
 104.3% 104.7% $445,304
 3.44% 86 6 27% 23.3%
Agency 7/1 486,038
 104.4
 103.8
 504,745
 2.95
 71 14 25
 20.2
Agency 10/1 180,828
 104.6
 103.7
 187,582
 3.08
 65 54 64
 12.0
Total Hybrids Post June 2009 $1,092,102
 104.4% 104.2% $1,137,631
 3.16% 76 17 32% 20.1%
                   
Hybrid Pre June 2009:                  
Coupon < 4.5% (5)
 $545,851
 101.7% 105.0% $573,132
 3.32% 130 6 24% 18.9%
Coupon >= 4.5% (6)
 7,902
 101.8
 104.5
 8,258
 5.50
 118 6 44
 12.0
Total Hybrids Pre June 2009 $553,753
 101.7% 105.0% $581,390
 3.35% 129 6 24% 18.8%
Total Hybrids $1,645,855
 103.5% 104.4% $1,719,021
 3.23% 94 14 29% 19.7%
(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Coupon (2)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Months to
Reset (3)
 
Interest
Only (4)
 3 Month
Average
CPR
Hybrid                  
Agency 3/1 $43,650
 102.6% 103.7% $45,277
 4.13% 168 5 % 8.0%
Agency 5/1 70,169
 102.7
 102.8
 72,142
 4.10
 140 3 41
 11.0
Agency 7/1 74,565
 103.6
 102.8
 76,645
 3.89
 105 9 55
 12.7
Agency 10/1 126,967
 104.2
 102.5
 130,133
 3.12
 101 23 61
 11.6
Total Hybrids $315,351
 103.5% 102.8% $324,197
 3.67% 120 13 47% 11.4%


December 31, 20162019


(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Coupon (2)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Months to
Reset (3)
 
Interest
Only (4)
 3 Month
Average
CPR
Hybrid Post June 2009:                  
Agency 5/1 $551,736
 104.3% 105.7% $583,318
 2.93% 76 6 25% 17.7%
Agency 7/1 618,414
 104.5
 104.3
 645,200
 3.00
 62 21 24
 22.8
Agency 10/1 199,869
 104.7
 103.9
 207,666
 3.13
 58 61 64
 17.1
Total Hybrids Post June 2009 $1,370,019
 104.4% 104.8% $1,436,184
 2.99% 67 21 30% 19.9%
                   
Hybrid Pre June 2009:  
  
  
  
  
      
  
Coupon < 4.5% (5)
 $691,572
 101.7% 105.6% $730,626
 2.92% 121 6 33% 16.9%
Coupon >= 4.5% (6)
 28,847
 101.4
 105.5
 30,426
 5.71
 112 7 69
 18.1
Total Hybrids Pre June 2009 $720,419
 101.7% 105.6% $761,052
 3.03% 120 6 34% 17.0%
Total Hybrids $2,090,438
 103.5% 105.1% $2,197,236
 3.01% 86 15 32% 18.9%
(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Coupon (2)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Months to
Reset (3)
 
Interest
Only (4)
 3 Month
Average
CPR
Hybrid                  
Agency 3/1 $46,530
 102.5% 104.6% $48,686
 4.28% 165 6 % 16.6%
Agency 5/1 318,843
 103.3
 104.2
 332,234
 4.35
 131 5 15
 20.1
Agency 7/1 232,565
 103.5
 103.9
 241,552
 4.29
 111 6 20
 18.6
Agency 10/1 135,030
 104.2
 102.5
 138,364
 3.17
 98 25 60
 14.2
Total Hybrids $732,968
 103.5% 103.8% $760,836
 4.11% 121 9 24% 18.3%

(1)Does not include principal payments receivable of $516,000 and $614,000 at March 31, 2020 and December 31, 2019, respectively.
(2)Weighted average is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.
(3)Weighted average months to reset is the number of months remaining before the coupon interest rate resets.  At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic or lifetime caps.  The months to reset do not reflect scheduled amortization or prepayments.
(4)Interest only represents MBS backed by mortgages currently in their interest-only period.  Percentage is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.



(1)  Does not include principal payments receivable of $1.1 million and $2.6 million at September 30, 2017 and December 31, 2016, respectively.
(2)  Weighted average is based on MBS current face at September 30, 2017 and December 31, 2016, respectively.
(3)  Weighted average months to reset is the number of months remaining before the coupon interest rate resets.  At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic or lifetime caps.  The months to reset do not reflect scheduled amortization or prepayments.
(4)  Interest only represents MBS backed by mortgages currently in their interest-only period.  Percentage is based on MBS current face at September 30, 2017 and December 31, 2016, respectively.
(5)  Agency 3/1, 5/1, 7/1 and 10/1 Hybrid ARM-MBS with coupon less than 4.5%.
(6)  Agency 3/1, 5/1, 7/1 and 10/1 Hybrid ARM-MBS with coupon greater than or equal to 4.5%.


Non-Agency MBSResidential Whole Loans

The following table presents the contractual maturities of our residential whole loan portfolios at March 31, 2020. Amounts presented do not reflect estimates of prepayments or scheduled amortization.

(In Thousands) 
Purchased
Performing Loans
 (1)
 
Purchased Credit
Deteriorated Loans
(2)
 Residential Whole Loans, at Fair Value
Amount due:      
Within one year $780,632
 $737
 $4,212
After one year:      
Over one to five years 239,496
 4,302
 5,687
Over five years 4,169,506
 739,369
 1,233,893
Total due after one year $4,409,002
 $743,671
 $1,239,580
Total residential whole loans $5,189,634
 $744,408
 $1,243,792

(1)Excludes an allowance for credit and valuation losses of $147.1 million at March 31, 2020.
(2)Excludes an allowance for credit losses of $70.9 million at March 31, 2020.


The following table presents, information with respect toat March 31, 2020, the dollar amount of certain of our Non-Agency MBS at September 30, 2017residential whole loans, contractually maturing after one year, and December 31, 2016:indicates whether the loans have fixed interest rates or adjustable interest rates:

(In Thousands) September 30, 2017 December 31, 2016 
 Non-Agency MBS  
  
 
Face/Par $4,101,102
 $6,065,618
 
Fair Value 3,911,660
 5,684,836
 
Amortized Cost 3,263,226
 5,093,243
 
Purchase Discount Designated as Credit Reserve and OTTI (593,134)(1)(694,241)(2)
Purchase Discount Designated as Accretable (244,793) (278,191) 
Purchase Premiums 51
 57
 
(In Thousands) 
Purchased
Performing Loans
(1)(2)
 
Purchased Credit
 Deteriorated Loans (1)(3)
 
Residential Whole Loans, at Fair Value (1)
Interest rates:      
Fixed $1,434,688
 $501,139
 $879,535
Adjustable 2,974,314
 242,532
 360,045
Total $4,409,002
 $743,671
 $1,239,580

(1)Includes loans on which borrowers have defaulted and are not making payments of principal and/or interest as of March 31, 2020.
(2)Excludes an allowance for credit and valuation losses of $147.1 million at March 31, 2020.
(3)Excludes an allowance for credit losses of $70.9 million at March 31, 2020.





(1)  Includes discount designated as Credit Reserve of $578.3 million and OTTI of $14.8 million.
(2)  Includes discount designated as Credit Reserve of $675.6 million and OTTI of $18.6 million.

Purchase Discounts on Non-AgencyAgency MBS
 
The following table presents the changes in the components of purchase discount on Non-Agency MBS with respect to purchase discount designated as Credit Reserve and OTTI, and accretable purchase discount, for the three and nine months ended September 30, 2017 and 2016:
  Three Months Ended 
 September 30, 2017
 Three Months Ended 
 September 30, 2016
(In Thousands) Discount
Designated as
Credit Reserve and OTTI
 
Accretable
Discount
(1) 
 Discount
Designated as
Credit Reserve and OTTI
 
 Accretable Discount (1)
Balance at beginning of period $(626,498) $(257,967) $(724,198) $(325,548)
Accretion of discount 
 18,621
 
 20,236
Realized credit losses 13,982
 
 15,629
 
Purchases 
 (1,929) (15,124) 9,830
Sales 4,620
 11,244
 2,398
 6,523
Net impairment losses recognized in earnings 
 
 (485) 
Transfers/release of credit reserve 14,762
 (14,762) 6,822
 (6,822)
Balance at end of period $(593,134) $(244,793) $(714,958) $(295,781)

  Nine Months Ended 
 September 30, 2017
 Nine Months Ended 
 September 30, 2016
(In Thousands) Discount
Designated as
Credit Reserve and OTTI
 
Accretable
Discount
(1) 
Discount
Designated as
Credit Reserve and OTTI
 
 Accretable Discount (1)
Balance at beginning of period $(694,241) $(278,191) $(787,541) $(312,182)
Impact of RMBS Issuer Settlement (2)
 
 
 
 (52,881)
Accretion of discount 
 60,461
 
 61,153
Realized credit losses 39,445
 
 49,408
 
Purchases (484) (3,449) (25,999) 13,210
Sales 29,398
 10,166
 16,281
 28,297
Net impairment losses recognized in earnings (1,032) 
 (485) 
Transfers/release of credit reserve 33,780
 (33,780) 33,378
 (33,378)
Balance at end of period $(593,134) $(244,793) $(714,958) $(295,781)

(1)  Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.
(2) Includes the impact of approximately $61.8 million of cash proceeds (a one-time payment) received by the Company during the nine months ended September 30, 2016 in connection with the settlement of litigation related to certain Countrywide sponsored residential mortgage backed securitization trusts.


The following table presents information with respect to the yield components of our Non-Agency MBS for the three months ended September 30, 2017 and 2016:
  Three Months Ended September 30, 2017 Three Months Ended September 30, 2016
  
Legacy
Non-Agency MBS
 RPL/NPL MBS 
Legacy
Non-Agency MBS
 RPL/NPL MBS
Non-Agency MBS        
Coupon Yield (1)
 5.63% 4.24% 5.28% 3.83%
Effective Yield Adjustment (2)
 3.30
 0.19
 2.81
 0.03
Net Yield 8.93% 4.43% 8.09% 3.86%

(1) Reflects the annualized coupon interest income divided by the average amortized cost.  The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate.
(2) The effective yield adjustment is the difference between the net yield, calculated utilizing management’s estimates of timing and amount of future cash flows for Legacy Non-Agency MBS and RPL/NPL MBS, less the current coupon yield.

Actual maturities of MBS are generally shorter than stated contractual maturities because actual maturities of MBS are affected by the contractual lives of the underlying mortgage loans, periodic payments of principal and prepayments of principal.  The following table presentstables present certain information regarding the amortized costs, weighted average yields and contractual maturitiescomposition of our Agency MBS at September 30, 2017portfolio as of March 31, 2020 and does not reflectDecember 31, 2019. Subsequent to March 31, 2020, we disposed of the effectvast majority of prepayments or scheduled principal amortization on our investments in Agency MBS:
March 31, 2020
(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Coupon (2)
 
3 Month
Average
CPR
15-Year Fixed Rate:  
  
  
  
  
  
  
Low Loan Balance (3)
 $125,543
 103.8% 105.3% $132,204
 110
 3.90% 8.6%
Generic 36,157
 104.0
 105.3
 38,086
 113
 4.10
 7.2
Total 15-Year Fixed Rate $161,700
 103.8% 105.3% $170,290
 111
 3.95% 8.3%
               
30-Year Fixed Rate:              
Generic $13,461
 104.0% 107.7% $14,499
 21
 4.50% 25.1%
Total 30-Year Fixed Rate $13,461
 104.0% 107.7% $14,499
 21
 4.50% 25.1%
               
Hybrid $315,351
 103.5% 102.8% $324,197
 120
 3.67% 11.4%
CMO/Other $42,393
 102.6% 103.6% $43,911
 215
 4.03% 13.5%
Total Portfolio $532,905
 103.5% 103.8% $552,897
 122
 3.80% 12.6%

December 31, 2019

(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Coupon (2)
 3 Month
Average
CPR
15-Year Fixed Rate:  
  
  
  
  
  
  
Low Loan Balance (3)
 $460,094
 104.5% 102.4% $471,123
 93
 3.04% 10.5%
Generic 100,886
 104.5
 103.1
 104,060
 99
 3.45
 10.7
Total 15-Year Fixed Rate $560,980
 104.5% 102.5% $575,183
 94
 3.11% 10.6%
               
30-Year Fixed Rate:              
Generic $264,760
 104.2% 105.9% $280,303
 18
 4.50% 34.4%
Total 30-Year Fixed Rate $264,760
 104.2% 105.9% $280,303
 18
 4.50% 34.4%
               
Hybrid $732,968
 103.5% 103.8% $760,836
 121
 4.11% 18.3%
CMO/Other $45,875
 102.6% 103.9% $47,646
 211
 4.23% 11.7%
Total Portfolio $1,604,583
 103.9% 103.7% $1,663,968
 97
 3.83% 18.1%

(1)Does not include principal payments receivable of $516,000 and $614,000 at March 31, 2020 and December 31, 2019, respectively.
(2)Weighted average is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.
(3)Low loan balance represents MBS collateralized by mortgages with an original loan balance of less than or equal to $175,000.


The following tables present certain information regarding our fixed-rate Agency MBS as of March 31, 2020 and December 31, 2019. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Agency MBS:
 
March 31, 2020

  Within One Year One to Five Years Five to Ten Years Over Ten Years Total MBS
(Dollars in Thousands) 
Amortized
Cost
 
Weighted
Average
Yield
 
Amortized
Cost
 
Weighted
Average
Yield
 
Amortized
Cost
 
Weighted
Average
Yield
 
Amortized
Cost
 
Weighted
Average
Yield
 
Total
Amortized
Cost
 
Total Fair
Value
 
Weighted
Average
Yield
Agency MBS:      
  
  
  
  
  
  
  
  
Fannie Mae $
 % $173
 2.05% $563,126
 2.00% $1,834,686
 1.99% $2,397,985
 $2,404,220
 1.99%
Freddie Mac 
 
 
 
 143,086
 2.29
 474,364
 1.82
 617,450
 608,349
 1.93
Ginnie Mae 
 
 
 
 100
 2.32
 6,550
 2.13
 6,650
 6,735
 2.13
Total Agency MBS $
 % $173
 2.05% $706,312
 2.06% $2,315,600
 1.95% $3,022,085
 $3,019,304
 1.98%
Non-Agency MBS $
 
 $306,082
 3.98% $53
 1.16% $2,957,091
 7.74% $3,263,226
 $3,911,660
 7.39%
Total MBS $
 % $306,255
 3.98% $706,365
 2.06% $5,272,691
 5.20% $6,285,311
 $6,930,964
 4.79%
Coupon 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Loan Rate
 
Low Loan
Balance
and/or
HARP (3)
 3 Month
Average
CPR
(Dollars in Thousands)                
15-Year Fixed Rate:  
  
  
  
    
  
  
2.5% $4,319
 104.8% 104.1% $4,497
 88 3.08% 100% 6.8%
3.0% 8,509
 105.5
 104.8
 8,919
 92 3.61
 100
 6.5
3.5% 2,525
 103.5
 105.3
 2,658
 113 4.19
 100
 15.3
4.0% 131,275
 103.5
 105.4
 138,325
 112 4.40
 82
 12.6
4.5% 15,072
 105.3
 105.4
 15,891
 117 4.89
 52
 9.1
Total 15-Year Fixed Rate $161,700
 103.8% 105.3% $170,290
 111 4.37% 81% 8.3%
                 
30-Year Fixed Rate:                
4.5% $13,461
 104.0% 107.7% $14,499
 21 4.86% % 25.1%
Total 30-Year Fixed Rate $13,461
 104.0% 107.7% $14,499
 21 4.86% % 25.1%
Total Fixed Rate Portfolio $175,161
 103.9% 105.5% $184,789
 104 4.41% 75% 13.6%

December 31, 2019

Coupon 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Loan Rate
 
Low Loan
Balance
and/or
HARP (3)
 3 Month
Average
CPR
(Dollars in Thousands)                
15-Year Fixed Rate:  
  
  
  
    
  
  
2.5% $241,045
 104.1% 101.2% $243,946
 85 3.06% 100% 9.3%
3.0% 147,665
 105.9
 102.6
 151,470
 89 3.49
 100
 10.0
3.5% 2,761
 103.5
 103.6
 2,862
 110 4.19
 100
 7.5
4.0% 145,910
 103.5
 104.3
 152,234
 109 4.40
 81
 13.0
4.5% 23,599
 105.3
 104.5
 24,671
 113 4.89
 36
 11.2
Total 15-Year Fixed Rate $560,980
 104.5% 102.5% $575,183
 94 3.60% 92% 10.6%
                 
30-Year Fixed Rate:                
4.5% $264,760
 104.2% 105.9% $280,303
 18 5.16% % 34.4%
Total 30-Year Fixed Rate $264,760
 104.2% 105.9% $280,303
 18 5.16% % 34.4%
Total Fixed Rate Portfolio $825,740
 104.4% 103.6% $855,486
 70 4.10% 63% 18.3%

(1)Does not include principal payments receivable of $516,000 and $614,000 at March 31, 2020 and December 31, 2019, respectively.
(2)Weighted average is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.
(3)Low Loan Balance represents MBS collateralized by mortgages with an original loan balance less than or equal to $175,000.  Home Affordable Refinance Program (or HARP) MBS are backed by refinanced loans with LTVs greater than or equal to 80% at origination.



The following tables present certain information regarding our Hybrid Agency MBS as of March 31, 2020 and December 31, 2019. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Agency MBS:
CRT SecuritiesMarch 31, 2020
(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Coupon (2)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Months to
Reset (3)
 
Interest
Only (4)
 3 Month
Average
CPR
Hybrid                  
Agency 3/1 $43,650
 102.6% 103.7% $45,277
 4.13% 168 5 % 8.0%
Agency 5/1 70,169
 102.7
 102.8
 72,142
 4.10
 140 3 41
 11.0
Agency 7/1 74,565
 103.6
 102.8
 76,645
 3.89
 105 9 55
 12.7
Agency 10/1 126,967
 104.2
 102.5
 130,133
 3.12
 101 23 61
 11.6
Total Hybrids $315,351
 103.5% 102.8% $324,197
 3.67% 120 13 47% 11.4%

December 31, 2019

(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Coupon (2)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Months to
Reset (3)
 
Interest
Only (4)
 3 Month
Average
CPR
Hybrid                  
Agency 3/1 $46,530
 102.5% 104.6% $48,686
 4.28% 165 6 % 16.6%
Agency 5/1 318,843
 103.3
 104.2
 332,234
 4.35
 131 5 15
 20.1
Agency 7/1 232,565
 103.5
 103.9
 241,552
 4.29
 111 6 20
 18.6
Agency 10/1 135,030
 104.2
 102.5
 138,364
 3.17
 98 25 60
 14.2
Total Hybrids $732,968
 103.5% 103.8% $760,836
 4.11% 121 9 24% 18.3%

(1)Does not include principal payments receivable of $516,000 and $614,000 at March 31, 2020 and December 31, 2019, respectively.
(2)Weighted average is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.
(3)Weighted average months to reset is the number of months remaining before the coupon interest rate resets.  At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic or lifetime caps.  The months to reset do not reflect scheduled amortization or prepayments.
(4)Interest only represents MBS backed by mortgages currently in their interest-only period.  Percentage is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.



At September 30, 2017, our CRT securities had an amortized cost of $612.7 million, a fair value of $653.6 million, a weighted average yield of 5.67% and a weighted average time to maturity of 9.4 years. At December 31, 2016, our CRT securities had an amortized cost of $382.7 million, a fair value of $404.9 million, a weighted average yield of 5.86% and weighted average time to maturity of 9.0 years.



Residential Whole Loans


The following table presents the contractual maturities of our residential whole loans held by consolidated trustsloan portfolios at September 30, 2017 and doesMarch 31, 2020. Amounts presented do not reflect estimates of prepayments or scheduled amortization. For residential whole loans held at carrying value, amounts presented are estimated based on the underlying loan contractual amounts.


(In Thousands) 
Residential Whole Loans,
at Carrying Value
 
Residential Whole Loans,
at Fair Value (1)
 
Purchased
Performing Loans
 (1)
 
Purchased Credit
Deteriorated Loans
(2)
 Residential Whole Loans, at Fair Value
Amount due:    
      
Within one year $1,471
 $7,981
 $780,632
 $737
 $4,212
After one year:          
Over one to five years 4,002
 12,577
 239,496
 4,302
 5,687
Over five years 633,743
 962,592
 4,169,506
 739,369
 1,233,893
Total due after one year $637,745
 $975,169
 $4,409,002
 $743,671
 $1,239,580
Total residential whole loans $639,216
 $983,150
 $5,189,634
 $744,408
 $1,243,792


(1)Excludes an allowance for credit and valuation losses of $147.1 million at March 31, 2020.
(2)Excludes an allowance for credit losses of $70.9 million at March 31, 2020.

(1) Excludes approximately $120.4 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2017.


The following table presents, at September 30, 2017,March 31, 2020, the dollar amount of certain of our residential whole loans, held at fair value, contractually maturing after one year, and indicates whether the loans have fixed interest rates or adjustable interest rates:


(In Thousands) 
Residential Whole Loans,
at Fair Value (1)(2)
 
Purchased
Performing Loans
(1)(2)
 
Purchased Credit
 Deteriorated Loans (1)(3)
 
Residential Whole Loans, at Fair Value (1)
Interest rates:  
      
Fixed $561,122
 $1,434,688
 $501,139
 $879,535
Adjustable 414,047
 2,974,314
 242,532
 360,045
Total $975,169
 $4,409,002
 $743,671
 $1,239,580

(1)  Includes loans on which borrowers have defaulted and are not making payments of principal and/or interest as of September 30, 2017.
(2) Excludes approximately $120.4 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2017.

Information is not presented for residential whole loans held at carrying value as income is recognized based on pools of assets with similar risk characteristics using an estimated yield based on cash flows expected to be collected over the lives of the loans in such pools rather than on the contractual coupons of the underlying loans.

The following table presents additional information regarding our residential whole loans held at fair value at September 30, 2017 and December 31, 2016:
  
Residential Whole Loans,
at Fair Value
(Dollars in Thousands) September 30, 2017 December 31, 2016
Loans 90 days or more past due (1):
    
Number of Loans 3,276
 2,560
Aggregate Amount Outstanding $690,924
 $570,025

(1) Excludes loans which are 90 or more days past due at September 30, 2017 from the $120.4 million of residential whole loans held at fair value for which the closing of the purchase transaction had not occurred as of September 30, 2017.

Income on residential whole loans held at carrying value is recognized based on pools of assets with similar credit risk characteristics using an estimated yield based on cash flows expected to be collected over the lives of the loans in such pools rather than the contractual coupons of the underlying loans. As the unit of account is at the pool level rather than the individual loan level, none of our residential whole loans held at carrying value are currently considered 90 days or more past due.


Exposure to Financial Counterparties
We finance a significant portion of our residential mortgage assets with repurchase agreements and other advances. In connection with these financing arrangements, we pledge our assets as collateral to secure the borrowing. The amount of collateral pledged will typically exceed the amount of the financing with the extent of over-collateralization ranging from 1% - 5% of the amount borrowed (U.S. Treasury and Agency MBS collateral) to up to 35% (Non-Agency MBS collateral). Consequently, while repurchase agreement financing results in us recording a liability to the counterparty in our consolidated balance sheets, we are exposed to the counterparty, if during the term of the repurchase agreement financing, a lender should default on its obligation and we are not able to recover our pledged assets. The amount of this exposure is the difference between the amount loaned to us plus interest due to the counterparty and the fair value of the collateral pledged by us to the lender including accrued interest receivable on such collateral.



The table below summarizes our exposure to our counterparties at September 30, 2017, by country:
Country 
Number of
Counterparties
 
Repurchase
Agreement
Financing
 
Exposure (1)
 
Exposure as a
Percentage of
MFA Total
Assets
(Dollars in Thousands)        
European Countries:  (2)
    
  
  
Switzerland (3)
 3 $1,216,558
 $451,176
 4.06%
France 2 633,669
 164,412
 1.48
United Kingdom 2 389,142
 118,615
 1.07
Holland 1 128,838
 10,898
 0.10
Total European 8 2,368,207
 745,101
 6.71%
Other Countries:    
  
  
United States 14 $3,393,888
 $822,352
 7.41%
Canada (4)
 3 546,052
 138,114
 1.24
Japan (5)
 3 458,915
 39,246
 0.35
China (5)
 1 412,410
 13,115
 0.12
South Korea 1 192,229
 12,931
 0.12
Total Other 22 5,003,494
 1,025,758
 9.24%
Total 30 $7,371,701
(6)$1,770,859
 15.95%


(1)RepresentsIncludes loans on which borrowers have defaulted and are not making payments of principal and/or interest as of March 31, 2020.
(2)Excludes an allowance for each counterpartycredit and valuation losses of $147.1 million at March 31, 2020.
(3)Excludes an allowance for credit losses of $70.9 million at March 31, 2020.





Agency MBS
The following tables present certain information regarding the composition of our Agency MBS portfolio as of March 31, 2020 and December 31, 2019. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Agency MBS:
March 31, 2020
(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Coupon (2)
 
3 Month
Average
CPR
15-Year Fixed Rate:  
  
  
  
  
  
  
Low Loan Balance (3)
 $125,543
 103.8% 105.3% $132,204
 110
 3.90% 8.6%
Generic 36,157
 104.0
 105.3
 38,086
 113
 4.10
 7.2
Total 15-Year Fixed Rate $161,700
 103.8% 105.3% $170,290
 111
 3.95% 8.3%
               
30-Year Fixed Rate:              
Generic $13,461
 104.0% 107.7% $14,499
 21
 4.50% 25.1%
Total 30-Year Fixed Rate $13,461
 104.0% 107.7% $14,499
 21
 4.50% 25.1%
               
Hybrid $315,351
 103.5% 102.8% $324,197
 120
 3.67% 11.4%
CMO/Other $42,393
 102.6% 103.6% $43,911
 215
 4.03% 13.5%
Total Portfolio $532,905
 103.5% 103.8% $552,897
 122
 3.80% 12.6%

December 31, 2019

(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Coupon (2)
 3 Month
Average
CPR
15-Year Fixed Rate:  
  
  
  
  
  
  
Low Loan Balance (3)
 $460,094
 104.5% 102.4% $471,123
 93
 3.04% 10.5%
Generic 100,886
 104.5
 103.1
 104,060
 99
 3.45
 10.7
Total 15-Year Fixed Rate $560,980
 104.5% 102.5% $575,183
 94
 3.11% 10.6%
               
30-Year Fixed Rate:              
Generic $264,760
 104.2% 105.9% $280,303
 18
 4.50% 34.4%
Total 30-Year Fixed Rate $264,760
 104.2% 105.9% $280,303
 18
 4.50% 34.4%
               
Hybrid $732,968
 103.5% 103.8% $760,836
 121
 4.11% 18.3%
CMO/Other $45,875
 102.6% 103.9% $47,646
 211
 4.23% 11.7%
Total Portfolio $1,604,583
 103.9% 103.7% $1,663,968
 97
 3.83% 18.1%

(1)Does not include principal payments receivable of $516,000 and $614,000 at March 31, 2020 and December 31, 2019, respectively.
(2)Weighted average is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.
(3)Low loan balance represents MBS collateralized by mortgages with an original loan balance of less than or equal to $175,000.


The following tables present certain information regarding our fixed-rate Agency MBS as of March 31, 2020 and December 31, 2019. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Agency MBS:
March 31, 2020

Coupon 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Loan Rate
 
Low Loan
Balance
and/or
HARP (3)
 3 Month
Average
CPR
(Dollars in Thousands)                
15-Year Fixed Rate:  
  
  
  
    
  
  
2.5% $4,319
 104.8% 104.1% $4,497
 88 3.08% 100% 6.8%
3.0% 8,509
 105.5
 104.8
 8,919
 92 3.61
 100
 6.5
3.5% 2,525
 103.5
 105.3
 2,658
 113 4.19
 100
 15.3
4.0% 131,275
 103.5
 105.4
 138,325
 112 4.40
 82
 12.6
4.5% 15,072
 105.3
 105.4
 15,891
 117 4.89
 52
 9.1
Total 15-Year Fixed Rate $161,700
 103.8% 105.3% $170,290
 111 4.37% 81% 8.3%
                 
30-Year Fixed Rate:                
4.5% $13,461
 104.0% 107.7% $14,499
 21 4.86% % 25.1%
Total 30-Year Fixed Rate $13,461
 104.0% 107.7% $14,499
 21 4.86% % 25.1%
Total Fixed Rate Portfolio $175,161
 103.9% 105.5% $184,789
 104 4.41% 75% 13.6%

December 31, 2019

Coupon 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Loan Rate
 
Low Loan
Balance
and/or
HARP (3)
 3 Month
Average
CPR
(Dollars in Thousands)                
15-Year Fixed Rate:  
  
  
  
    
  
  
2.5% $241,045
 104.1% 101.2% $243,946
 85 3.06% 100% 9.3%
3.0% 147,665
 105.9
 102.6
 151,470
 89 3.49
 100
 10.0
3.5% 2,761
 103.5
 103.6
 2,862
 110 4.19
 100
 7.5
4.0% 145,910
 103.5
 104.3
 152,234
 109 4.40
 81
 13.0
4.5% 23,599
 105.3
 104.5
 24,671
 113 4.89
 36
 11.2
Total 15-Year Fixed Rate $560,980
 104.5% 102.5% $575,183
 94 3.60% 92% 10.6%
                 
30-Year Fixed Rate:                
4.5% $264,760
 104.2% 105.9% $280,303
 18 5.16% % 34.4%
Total 30-Year Fixed Rate $264,760
 104.2% 105.9% $280,303
 18 5.16% % 34.4%
Total Fixed Rate Portfolio $825,740
 104.4% 103.6% $855,486
 70 4.10% 63% 18.3%

(1)Does not include principal payments receivable of $516,000 and $614,000 at March 31, 2020 and December 31, 2019, respectively.
(2)Weighted average is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.
(3)Low Loan Balance represents MBS collateralized by mortgages with an original loan balance less than or equal to $175,000.  Home Affordable Refinance Program (or HARP) MBS are backed by refinanced loans with LTVs greater than or equal to 80% at origination.


The following tables present certain information regarding our Hybrid Agency MBS as of March 31, 2020 and December 31, 2019. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Agency MBS:
March 31, 2020
(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Coupon (2)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Months to
Reset (3)
 
Interest
Only (4)
 3 Month
Average
CPR
Hybrid                  
Agency 3/1 $43,650
 102.6% 103.7% $45,277
 4.13% 168 5 % 8.0%
Agency 5/1 70,169
 102.7
 102.8
 72,142
 4.10
 140 3 41
 11.0
Agency 7/1 74,565
 103.6
 102.8
 76,645
 3.89
 105 9 55
 12.7
Agency 10/1 126,967
 104.2
 102.5
 130,133
 3.12
 101 23 61
 11.6
Total Hybrids $315,351
 103.5% 102.8% $324,197
 3.67% 120 13 47% 11.4%

December 31, 2019

(Dollars in Thousands) 
Current
Face
 
Weighted
Average
Purchase
Price
 
Weighted
Average
Market
Price
 
Fair
Value (1)
 
Weighted
Average
Coupon (2)
 
Weighted
Average
Loan Age
(Months) (2)
 
Weighted
Average
Months to
Reset (3)
 
Interest
Only (4)
 3 Month
Average
CPR
Hybrid                  
Agency 3/1 $46,530
 102.5% 104.6% $48,686
 4.28% 165 6 % 16.6%
Agency 5/1 318,843
 103.3
 104.2
 332,234
 4.35
 131 5 15
 20.1
Agency 7/1 232,565
 103.5
 103.9
 241,552
 4.29
 111 6 20
 18.6
Agency 10/1 135,030
 104.2
 102.5
 138,364
 3.17
 98 25 60
 14.2
Total Hybrids $732,968
 103.5% 103.8% $760,836
 4.11% 121 9 24% 18.3%

(1)Does not include principal payments receivable of $516,000 and $614,000 at March 31, 2020 and December 31, 2019, respectively.
(2)Weighted average is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.
(3)Weighted average months to reset is the amountnumber of cash and/months remaining before the coupon interest rate resets.  At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic or securities pledgedlifetime caps.  The months to reset do not reflect scheduled amortization or prepayments.
(4)Interest only represents MBS backed by mortgages currently in their interest-only period.  Percentage is based on MBS current face at March 31, 2020 and December 31, 2019, respectively.



Non-Agency MBS
The following table presents information with respect to our Non-Agency MBS at March 31, 2020 and December 31, 2019. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Legacy Non-Agency MBS:
(In Thousands) March 31, 2020 December 31, 2019
Non-Agency MBS  
  
Face/Par $1,455,848
 $2,195,303
Fair Value 1,119,940
 2,063,529
Amortized Cost 975,408
 1,668,088
Purchase Discount Designated as Credit Reserve (389,472) (436,598)
Purchase Discount Designated as Accretable (90,968) (90,617)
Purchase Premiums 
 

Purchase Discounts on Non-Agency MBS
The following table presents the changes in the components of purchase discount on our Non-Agency MBS between purchase discount designated as Credit Reserve and accretable purchase discount for the three months ended March 31, 2020 and 2019:
  Three Months Ended
March 31, 2020
 Three Months Ended
March 31, 2019
(In Thousands) Discount
Designated as
Credit Reserve
 
Accretable
Discount
(1) 
 Discount
Designated as
Credit Reserve
 
 Accretable Discount (1)
Balance at beginning of period $(436,598) $(90,617) $(516,116) $(155,025)
Impact of RMBS Issuer Settlement (2)
 
 
 
 (855)
Accretion of discount 
 9,889
 
 13,307
Realized credit losses 4,459
 
 7,504
 
Purchases 
 
 
 (118)
Sales/Redemptions 49,491
 (5,551) 3,191
 16,346
Net impairment losses recognized in earnings (11,513) 
 
 
Transfers/release of credit reserve 4,689
 (4,689) 3,802
 (3,802)
Balance at end of period $(389,472) $(90,968) $(501,619) $(130,147)

(1)Together with coupon interest, accretable purchase discount is recognized as collateral lessinterest income over the aggregatelife of repurchase agreement financing and net interest receivable/payable on all such instruments.the security.
(2)Includes European-based counterparties as well as U.S.-domiciled subsidiariesthe impact of $855,000 of cash proceeds (a one-time payment) received by the European parent entity.Company during the three months ended March 31, 2019 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities.

The following table presents information with respect to the yield components of our Non-Agency MBS for the three months ended March 31, 2020 and 2019. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Legacy Non-Agency MBS:
  Three Months Ended March 31, 2020 Three Months Ended March 31, 2019
  
Legacy
Non-Agency MBS
 RPL/NPL MBS 
Legacy
Non-Agency MBS
 RPL/NPL MBS
Non-Agency MBS        
Coupon Yield (1)
 6.83% 4.96% 6.78% 4.86%
Effective Yield Adjustment (2)
 3.72
 0.25
 3.67
 0.04
Net Yield 10.55% 5.21% 10.45% 4.90%

(1)Reflects the annualized coupon interest income divided by the average amortized cost.  The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate.
(3)(2)Includes London branchThe effective yield adjustment is the difference between the net yield, calculated utilizing management’s estimates of one counterpartytiming and Cayman Islands branchamount of future cash flows for Legacy Non-Agency MBS and RPL/NPL MBS, less the other counterparty.
(4)Includes Canada-based counterparties as well as U.S.-domiciled subsidiaries of Canadian parent entities. In the case of one counterparty, also includes exposure of $411.4 million to Barbados-based affiliate of the Canadian parent entity.
(5)Exposure is to U.S.-domiciled subsidiary of the Japanese or Chinese parent entity, as the case may be.
(6)Includes $500.0 million of repurchase agreements entered into in connection with contemporaneous repurchase and reverse repurchase agreements with a single counterparty.current coupon yield.

At September 30, 2017, we did
Actual maturities of MBS are generally shorter than stated contractual maturities because actual maturities of MBS are affected by the contractual lives of the underlying mortgage loans, periodic payments of principal and prepayments of principal.  The following table presents certain information regarding the amortized costs, weighted average yields and contractual maturities of our MBS at March 31, 2020 and does not use credit default swapsreflect the effect of prepayments or other forms of credit protection to hedge the exposures summarized in the table above.scheduled principal amortization on our MBS:
 
Uncertainty
  Within One Year One to Five Years Five to Ten Years Over Ten Years Total MBS
(Dollars in Thousands) 
Amortized
Cost
 
Weighted
Average
Yield
 
Amortized
Cost
 
Weighted
Average
Yield
 
Amortized
Cost
 
Weighted
Average
Yield
 
Amortized
Cost
 
Weighted
Average
Yield
 
Total
Amortized
Cost
 
Total Fair
Value
 
Weighted
Average
Yield
Agency MBS:      
  
  
  
  
  
  
  
  
Fannie Mae $
 % $5,449
 1.63% $105,646
 2.87% $332,921
 2.77% $444,016
 $448,258
 2.78%
Freddie Mac 
 
 5,903
 
 54,725
 2.34
 38,994
 3.90
 99,622
 101,277
 2.95
Ginnie Mae 
 
 
 
 65
 3.91
 3,753
 3.09
 3,818
 3,878
 3.10
Total Agency MBS $
 % $11,352
 2.00% $160,436
 2.69% $375,668
 2.89% $547,456
 $553,413
 2.81%
Non-Agency MBS $
 % $50,116
 4.81% $1,701
 5.36% $923,591
 11.09% $975,408
 $1,119,940
 10.76%
Total MBS $
 % $61,468
 4.29% $162,137
 2.72% $1,299,259
 8.72% $1,522,864
 $1,673,353
 7.90%


CRT Securities

At March 31, 2020, our total investment in CRT securities was $254.1 million, with a gross unrealized losses of $67.7 million, a weighted average yield of 3.86% and a weighted average time to maturity of 14.3 years. At December 31, 2019, our total investment in CRT securities was $255.4 million, with a net unrealized gain of $6.2 million, a weighted average yield of 5.85% and weighted average time to maturity of 11.1 years.

During three months ended March 31, 2020, we sold certain CRT securities for $35.6 million, realizing losses of $2.0 million. The net income impact of these sales, after reversal of previously unrealized gains on CRT securities on which we had elected the global financialfair value option, was a loss of approximately $2.5 million. Subsequent to March 31, 2020 we significantly reduced our holdings of CRT securities.


MSR-Related Assets

At March 31, 2020 and December 31, 2019, we had $706.6 million and $1.2 billion, respectively, of term notes issued by SPVs that have acquired the rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. At March 31, 2020, these term notes had an amortized cost and fair value of $706.6 million, a weighted average yield of 4.74% and a weighted average term to maturity of 5.1 years. During three months ended March 31, 2020, we sold certain term notes for $136.8 million, realizing losses of $24.6 million. During the last two weeks in March, market and weakvalues of our investments in these term notes fell significantly, primarily due to a lack of liquidity driven by concerns related to the impact of the COVID-19 pandemic on economic conditions generally and residential mortgage markets specifically. This resulted in Europe, including as a resultnumber of our investments being in an unrealized loss position at quarter end. As we had committed to a plan to sell these investments, we were required to recognize an impairment charge in first quarter 2020 net income of approximately $280.8 million. Subsequent to March 31, 2020 we significantly reduced our holdings of MSR-related assets.

At December 31, 2019, these term notes had an amortized cost of $1.2 billion, gross unrealized losses of approximately $5.2 million, a weighted average yield of 4.75% and a weighted average term to maturity of 5.3 years.

During the United Kingdom’s recent voteyear ended December 31, 2019, we participated in a loan where we committed to leavelend $100.0 million of which approximately $33.8 million was drawn at March 31, 2020. At March 31, 2020, the European Union (commonly known as “Brexit”)coupon paid by the borrower on the drawn amount is 3.93%, could potentially impact our major European financial counterparties,the remaining term associated with the possibility that this would also impact the operations of their U.S. domiciled subsidiaries. This could adversely affect our financing and operations as well as those of the entire mortgage sector in general. Management monitors our exposure to our repurchase agreement counterparties on a regular basis, using various methods, including review of recent rating agency actions or other developments and by monitoring the amount of cash and securities collateral pledgedloan is 5 months and the associated loanremaining commitment period on any undrawn amount under repurchase agreements with our counterparties. We intend to make reverse margin calls on our counterparties to recover excess collateral as permitted by the agreements governing our financing arrangements, or take other necessary actions to reduce the amount of our exposure to a counterparty when such actions are considered necessary. is 5 months.



Tax Considerations
 
Current period estimated taxable income and items expected to impact future taxable income


We estimate that for the ninethree months ended September 30, 2017,March 31, 2020, our taxable income was approximately $250.9$47.1 million. Based on dividends paid or declared during the nine months ended September 30, 2017, weWe have undistributed taxable income of approximately $60.7$64.7 million, or $0.15$0.14 per share. We have until the filing of our 20172019 tax return (due not later than October 15, 2018)2020) to declare the distribution of any 20172019 REIT taxable income not previously distributed.

During the first quarter of 2017 we unwound our remaining MBS resecuritization transaction. We currently estimate that the unwind will generate taxable income (but not GAAP income) of an amount in excess of $0.12 per share. During the second

quarter of 2017 we entered into our first securitization of residential whole loans. As part of this transaction, loans deemed to be sold for tax purposes are estimated to generate 2017 taxable income in excess of $0.01 per share.


Key differences between GAAP net income and REIT Taxable Income for Non-Agency MBSResidential Mortgage Securities and Residential Whole Loans
 
Our total Non-Agency MBS portfolio for tax differs from our portfolio reported for GAAP primarily due to the fact that for tax purposes;purposes: (i) certain of the MBS contributed to the VIEs used to facilitate MBS resecuritization transactions were deemed to be sold; and (ii) the tax basis of underlying MBS considered to be re-acquiredreacquired in connection with the unwind of such transactions becomesbecame the fair market value of such securities at the time of the unwind. For GAAP reporting purposes the underlying MBS that were included in these MBS resecuritization transactions were not considered to be sold. Similarly, for tax purposes the residential whole loans contributed to the VIEsVIE used to facilitate our second quarter 2017 loan securitization transaction were deemed to be sold for tax purposes, but not for GAAP reporting purposes. In addition, for our Non-Agency MBS and residential whole loan tax portfolios, potential timing differences arise with respect to the accretion of market discount and amortization of premium into income andas well as the recognition of realized losses for tax purposes as compared to GAAP.  Further, use of fair value accounting for certain residential mortgage securities and residential whole loans for GAAP, but not for tax, also gives rise to potential timing differences. Consequently, our REIT taxable income calculated in a given period may differ significantly from our GAAP net income.
 
The determination of taxable income attributable to Non-Agency MBS and residential whole loans is dependent on a number of factors, including principal payments, defaults, loss mitigation efforts and loss severities.  In estimating taxable income for Non-Agency MBS and residential whole loans during the year, management considers estimates of the amount of discount expected to be accreted.  Such estimates require significant judgment and actual results may differ from these estimates.  Moreover, the deductibility of realized losses from Non-Agency MBS and residential whole loans and their effect on market discount accretion isand premium amortization are analyzed on an asset-by-asset basis and, while they will result in a reduction of taxable income, this reduction tends to occur gradually and, primarily for Non-Agency MBS, in periods after the realized losses are reported. In addition, for MBSsecuritization and resecuritization transactions that were treated as a sale of the underlying MBS or residential whole loans for tax purposes, taxable gain or loss, if any, resulting from the unwind of such transactions is not recognized in GAAP net income.
 
Securitization transactions result in differences between GAAP net income and REIT Taxable Income
 
For tax purposes, depending on the transaction structure, a securitization and/or resecuritization transaction may be treated either as a sale or a financing of the underlying collateral.  Income recognized from securitization and resecuritization transactions will differ for tax and GAAP purposes.  For tax purposes, we own and may in the future acquire interests in securitization and/or resecuritization trusts, in which several of the classes of securities are or will be issued with Original Issue Discountoriginal issue discount (or OID).  As the holder of the retained interests in the trust, we generally will be required to include OID in our current gross interest income over the term of the applicable securities as the OID accrues.  The rate at which the OID is recognized into taxable income is calculated using a constant rate of yield to maturity, with realized losses impacting the amount of OID recognized in REIT taxable income once they are actually incurred.  For tax purposes, REIT taxable income may be recognized in excess of economic income (i.e., OID) or in advance of the corresponding cash flow from these assets, thereby effectingaffecting our dividend distribution requirement to stockholders. In addition, for securitization and/or resecuritization transactions that were treated as a sale of the underlying collateral for tax purposes, the unwindunwinding of any such transaction will likely result in a taxable gain or loss that is likely not recognized in GAAP net income since securitization and resecuritization transactions are typically accounted for as financing transactions for GAAP purposes. The tax basis of underlying residential whole loans or MBS re-acquired in connection with the unwind of such transactions becomes the fair market value of such assets at the time of the unwind.


Taxable income of consolidated TRS subsidiaries is included in GAAP income, but may not be included in REIT Taxable Income
Net income generated by our TRS subsidiaries is included in consolidated GAAP net income, but may not be included in REIT taxable income in the same period. Net income of U.S. domiciled TRS subsidiaries is included in REIT taxable income when distributed by the TRS. Net income of foreign domiciled TRS subsidiaries is included in REIT taxable income as if distributed to the REIT in the taxable year it is earned by the foreign domiciled TRS.


Regulatory Developments
 
The U.S. Congress, Board of Governors of the Federal Reserve, System, U.S. Treasury, Federal Deposit Insurance Corporation, SEC and other governmental and regulatory bodies have taken and continue to consider additional actions in response to the 2007-2008 financial crisis.  In particular, the Dodd-Frank Wall Street Reform and Consumer Protection Act (or the Dodd-Frank Act) created a new regulator, an independent bureau housed within the Federal Reserve System and known as the Consumer Financial Protection Bureau (or the CFPB). The CFPB has broad authority over a wide range of consumer financial products and services, including mortgage lending.lending and servicing.  One portion of the Dodd-Frank Act, the Mortgage Reform and Anti-Predatory Lending Act (or Mortgage Reform Act), contains underwriting and servicing standards for the mortgage industry, restrictions on compensation for mortgage loan originators, and various other requirements related to mortgage origination.origination and servicing.  In addition, the Dodd-Frank Act grants enforcement authority and broad discretionary regulatory authority to the CFPB to prohibit or condition terms, acts or practices relating to residential mortgage loans that the CFPB finds abusive, unfair, deceptive or predatory, as well as to take other actions that the CFPB finds are necessary or proper to ensure responsible affordable mortgage credit remains available to consumers.  The Dodd-Frank Act also affects the securitization of mortgages (and other assets) with requirements for risk retention by securitizers and requirements for regulating Rating Agencies.rating agencies.



TheNumerous regulations have been issued pursuant to the Dodd-Frank Act, requires that numerousincluding regulations be issued, many of which (including those mentioned above regarding mortgage loan servicing, underwriting and mortgage loan originator compensation) have only recently been implementedcompensation and operationalized.others could be issued in the future. As a result, we are unable to fully predict at this time how the Dodd-Frank Act, as well as other laws or regulations that may be adopted in the future, will affect our business, results of operations and financial condition, or the environment for repurchase financing and other forms of borrowing, the investing environment for Agency MBS, Non-Agency MBS and/or residential mortgage loans, the securitization industry, Swaps and other derivatives.  However, at a minimum, weWe believe that the Dodd-Frank Act and the regulations promulgated thereunder are likely to continue to increase the economic and compliance costs for participants in the mortgage and securitization industries, including us.


In addition to the regulatory actions being implemented under the Dodd-Frank Act, on August 31, 2011, the SEC issued a concept release under which it is reviewing interpretive issues related to Section 3(c)(5)(C) of the Investment Company Act.  Section 3(c)(5)(C) excludes from the definition of “investment company” entities that are primarily engaged in, among other things, “purchasing or otherwise acquiring mortgages and other liens on and interests in real estate.”  Many companies that engage in the business of acquiring mortgages and mortgage-related instruments seek to rely on existing interpretations of the SEC Staff with respect to Section 3(c)(5)(C) so as not to be deemed an investment company for the purpose of regulation under the Investment Company Act.  In connection with the concept release, the SEC requested comments on, among other things, whether it should reconsider its existing interpretation of Section 3(c)(5)(C). To date the SEC has not taken or otherwise announced any further action in connection with the concept release.


The FHFAFederal Housing Finance Agency (or FHFA) and both houses of Congress have discussed and considered separate measures intended to restructure the U.S. housing finance system and the operations of Fannie Mae and Freddie Mac. Congress may continue to consider legislation that would significantly reform the country’s mortgage finance system, including, among other things, eliminating Freddie Mac and Fannie Mae and replacing them with a single new MBS insurance agency. Many details remain unsettled, including the scope and costs of the agencies’ guarantee and their affordable housing mission, some of which could be addressed even in the absence of large-scale reform. On March 27, 2019, President Trump issued a memorandum on federal housing finance reform that directed the Secretary of the Treasury to develop a plan for administrative and legislative reforms as soon as practicable to achieve the following housing reform goals: 1) ending the conservatorships of the Government-sponsored enterprises (or GSEs) upon the completion of specified reforms; 2) facilitating competition in the housing finance market; 3) establishing regulation of the GSEs that safeguards their safety and soundness and minimizes the risks they pose to the financial stability of the United States; and 4) providing that the federal government is properly compensated for any explicit or implicit support it provides to the GSEs or the secondary housing finance market. On September 5, 2019, in response to President Trump’s memorandum, the U.S. Department of the Treasury released a plan, developed in conjunction with the FHFA, the Department of Housing and Urban Development, and other government agencies, which includes legislative and administrative reforms to achieve each of these reform goals. At this point, it remains unclear whether any of these legislative or regulatory reforms will be enacted or implemented. The prospects for passage of any of these plans are uncertain, but the proposals underscore the potential for change to Fannie Mae and Freddie Mac. On May 20, 2020, in connection with its stated intention to responsibly end the conservatorship of the GSEs, the FHFA issued a notice of proposed rulemaking and request for comments (“Proposed Rule”) on a new regulatory capital framework for Fannie Mae and Freddie Mac. The Proposed Rule is a re-proposal of the regulatory capital framework originally proposed in 2018 that would have established new risk-based capital requirements for the GSEs and updated the minimum leverage requirements. The re-proposal contains enhancements to establish a post-conservatorship regulatory capital framework that ensures that each Enterprise operates in a safe and sound manner and is positioned to fulfill its statutory mission to provide stability and ongoing assistance to the secondary mortgage market across the economic cycle, in particular during periods of financial stress. Comments on the Proposed Rule are due 60 days after publication in in the Federal Register.

While the likelihood of enactment of major mortgage finance system reform in the short term remains uncertain, it is possible that the adoption of any such reforms could adversely affect the types of assets we can buy, the costs of these assets and our business operations.  As the FHFA and both houses of Congress continue to consider various measures intended to dramatically restructure the U.S. housing finance system and the operations of Fannie Mae and Freddie Mac, we expect debate and discussion on the topic to continue throughout 2017. However,2020, and we cannot be certain whether alternative plans may be proposed by the Trump Administration, if any housing and/or mortgage-related legislation will emerge from committee or be approved by Congress, or the extent to which administrative reforms may be implemented, and if so, what the effect willwould be on our business.

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was signed into law. Among the provisions in this wide-ranging law are protections for homeowners experiencing financial difficulties due to the COVID-19 pandemic, including forbearance provisions and procedures. Borrowers with federally backed mortgage loans, regardless of delinquency status, may request loan forbearance for a six-month period, which could be extended for another six-month period if necessary. Federally backed mortgage loans are loans secured by first- or subordinate-liens on 1-4 family residential real property, including individual units of condominiums and cooperatives, which are insured or guaranteed pursuant to certain government housing programs, such as by the Federal Housing Administration, Federal Housing Administration, or U.S. Department of Agriculture, or are purchased or securitized by Fannie Mae or Freddie Mac. The CARES Act also includes a temporary 60 day foreclosure moratorium that applies to federally backed mortgage loans, which lasted until May 17, 2020. However, the moratorium has been extended to June 30, 2020 by Fannie Mae, Federal Housing Administration, Federal Housing Administration and the U.S. Department of Agriculture. Some states and local jurisdictions have also implemented moratoriums on foreclosures.






Results of Operations


Quarter Ended September 30, 2017March 31, 2020 Compared to the Quarter Ended September 30, 2016March 31, 2019
 
General
 
ForUnprecedented disruption in residential mortgage markets, due to concerns related to the third quarter of 2017, we hadCOVID-19 pandemic, resulted in us generating a net incomeloss available to our common stock and participating securities for the first quarter of $60.12020 of $914.2 million, or $0.15$2.02 per basic and diluted common share, compared to net income available to common stock and participating securities of $79.3$85.1 million, or $0.21$0.19 per basic and diluted common share, for the thirdfirst quarter of 2016.2019. The decrease in net income available to common stock and participating securities and the decrease of this item on a per share basis primarily reflects a decrease in ourlower Other income, which was driven by impairment losses on securities available-for-sale , net interest income, primarilyrealized losses on our Agencysales of residential mortgage securities and Non-Agency MBS portfolios and lower other income, driven primarily byresidential whole loans, unrealized losses on CRTresidential mortgage securities accounted formeasured at fair value partially offset by gainsthrough earnings, net losses on liquidationour residential whole loans measured at fair value through earnings and impairments charges recorded on certain other assets. In addition, under the new accounting standard for estimating credit losses that we were required to adopt during the first quarter of 2020, we recorded a provision for credit losses on residential whole loans held at carrying value of $74.9 million. We also recorded a valuation allowance of $70.2 million to adjust the carrying value of certain residential whole loans accounted forto their estimated fair value as these loans were designated as being held-for-sale at carrying value. In addition, operating and other expenses were higher primarily due to non-recurring expenses in relation to our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer.March 31, 2020.


Net Interest Income

Net interest income represents the difference between income on interest-earning assets and expense on interest-bearing liabilities.  Net interest income depends primarily upon the volume of interest-earning assets and interest-bearing liabilities and the corresponding interest rates earned or paid.  Our net interest income varies primarily as a result of changes in interest rates, the slope of the yield curve (i.e., the differential between long-term and short-term interest rates), borrowing costs (i.e., our interest expense) and prepayment speeds on our MBS.investments.  Interest rates and CPRs (which measure the amount of unscheduled principal prepayment on a bond or loan as a percentage of the bondits unpaid balance) vary according to the type of investment, conditions in the financial markets and other factors, none of which can be predicted with any certainty.
 
The changes in average interest-earning assets and average interest-bearing liabilities and their related yields and costs are discussed in greater detail below under “Interest Income” and “Interest Expense.”
 
For the thirdfirst quarter of 2017,2020, our net interest spread and margin were 2.02%1.82% and 2.54%2.20%, respectively, compared to a net interest spread and margin of 2.13%1.98% and 2.46%2.41%, respectively, for the thirdfirst quarter of 2016.2019. Our net interest income decreased by $8.7 million, or 13.5%, to $55.9 million from $64.5of $61.7 million for the thirdfirst quarter of 2016.  Current2020 was largely unchanged from the first quarter of 2019. For the first quarter of 2020, net interest income from Agency MBS and Legacy Non-Agency MBS declinedfor our residential mortgage securities portfolio decreased by approximately $16.9 million compared to the thirdfirst quarter of 2016 by approximately $11.0 million,2019, primarily due to lower average amounts invested in these securities due primarily to portfolio runoff and highersales, lower yields earned on our Agency MBS and CRT securities, partially offset by lower funding costs partially offset byand higher yields earned on these investments.our RPL/NPL MBS and Legacy Agency MBS portfolios. In addition, we incurred approximately $3.9 million interest expense on our Convertible Senior Notes issued during the first quarter of 2020. The decrease in net interest income on RPL/NPL MBS was $6.8 million lower compared to the third quarter of 2016 primarily due to lower average amounts invested in these securities and higher funding costs partially offset by higher yields earned on these securities. These decreases were partially offset by higher net interest income on MSR related assets, CRT securities andfrom residential whole loans held at carrying value, MSR-related assets and other interest-earning assets of approximately $9.2$19.6 million compared to the thirdfirst quarter of 2016,2019, primarily due to higher average balancesamounts invested in these assets. In addition, net interest income also includes $4.6$9.7 million of interest expense associated with residential whole loans held at fair value, reflecting a $1.3$1.2 million increasedecrease in borrowing costs related to these investments compared to the thirdfirst quarter of 2016.2019. Coupon interest income received from residential whole loans held at fair value is presented as a component of the total income earned on these investments and therefore is included in Other Income, net rather than net interest income.






Analysis of Net Interest Income
 
The following table sets forth certain information about the average balances of our assets and liabilities and their related yields and costs for the three months ended September 30, 2017March 31, 2020 and 20162019Average yields are derived by dividing annualized interest income by the average amortized cost of the related assets, and average costs are derived by dividing annualized interest expense by the daily average balance of the related liabilities, for the periods shown.  The yields and costs include premium amortization and purchase discount accretion which are considered adjustments to interest rates.
 Three Months Ended September 30, Three Months Ended March 31,
 2017 2016 2020 2019
(Dollars in Thousands) Average Balance Interest Average Yield/Cost Average Balance Interest Average Yield/Cost Average Balance Interest Average Yield/Cost Average Balance Interest Average Yield/Cost
Assets:  
  
  
  
  
  
  
  
  
  
  
  
Interest-earning assets:  
  
  
  
  
  
  
  
  
  
  
  
Agency MBS (1)
 $3,154,112
 $15,533
 1.97% $4,143,523
 $18,957
 1.83%
Legacy Non-Agency MBS (1)
 2,182,148
 48,693
 8.93
 2,858,731
 57,818
 8.09
RPL/NPL MBS (1)
 1,315,737
 14,559
 4.43
 2,673,527
 25,820
 3.86
Residential whole loans, at carrying value (1)
 $6,584,538
 $83,486
 5.07% $3,369,301
 $49,620
 5.89%
Agency MBS (2)
 1,527,036
 8,861
 2.32
 2,667,573
 18,441
 2.77
Legacy Non-Agency MBS (2)
 1,011,810
 26,688
 10.55
 1,432,014
 37,416
 10.45
RPL/NPL MBS (2)
 449,789
 5,863
 5.21
 1,353,954
 16,585
 4.90
Total MBS 6,651,997
 78,785
 4.74
 9,675,781
 102,595
 4.24
 2,988,635
 41,412
 5.54
 5,453,541
 72,442
 5.31
CRT securities (1)
 604,322
 8,676
 5.74
 294,704
 3,983
 5.41
MSR related assets (1)
 454,354
 7,194
 6.33
 
 
 
Residential whole loans, at carrying value (2)
 609,538
 9,026
 5.92
 388,601
 5,917
 6.09
CRT securities (2)
 300,069
 2,962
 3.95
 441,528
 6,200
 5.62
MSR-related assets (2)
 1,197,956
 14,207
 4.74
 788,705
 10,620
 5.39
Cash and cash equivalents (3)
 657,331
 1,452
 0.88
 307,147
 221
 0.29
 206,899
 486
 0.94
 156,306
 764
 1.96
Other interest-earning assets 129,947
 2,907
 8.95
 89,648
 1,306
 5.83
Total interest-earning assets 8,977,542
 105,133
 4.68
 10,666,233
 112,716
 4.23
 11,408,044
 145,460
 5.10
 10,299,029
 140,952
 5.47
Total non-interest-earning assets (2)
 2,487,953
     2,146,677
    
Total non-interest-earning assets 2,277,842
  
   2,493,634
    
Total assets $11,465,495
     $12,812,910
     $13,685,886
  
   $12,792,663
    
                        
Liabilities and stockholders’ equity:                        
Interest-bearing liabilities:                        
Total repurchase agreements and other advances (4)
 $7,022,913
 $46,303
 2.58% $8,868,173
 $46,158
 2.04%
Total repurchase agreements (4)
 $9,233,808
 $72,698
 3.11% $8,282,621
 $70,809
 3.42%
Securitized debt 139,276
 962
 2.70
 
 
 
 558,007
 5,161
 3.66
 675,678
 6,206
 3.67
Convertible Senior Notes 224,071
 3,888
 6.94
 
 
 
Senior Notes 96,756
 2,010
 8.31
 96,718
 2,009
 8.31
 96,866
 2,012
 8.31
 96,819
 2,011
 8.31
Total interest-bearing liabilities 7,258,945
 49,275
 2.66
 8,964,891
 48,167
 2.10
 10,112,752
 83,759
 3.28
 9,055,118
 79,026
 3.49
Total non-interest-bearing liabilities 927,877
     842,227
     152,941
    
 320,586
    
Total liabilities 8,186,822
     9,807,118
     10,265,693
    
 9,375,704
    
Stockholders’ equity 3,278,673
     3,005,792
     3,420,193
    
 3,416,959
    
Total liabilities and stockholders’ equity $11,465,495
     $12,812,910
     $13,685,886
    
 $12,792,663
    
                        
Net interest income/net interest rate spread (5)
   $55,858
 2.02%   $64,549
 2.13%   $61,701
 1.82%   $61,926
 1.98%
Net interest-earning assets/net interest margin (6)
 $1,718,597
   2.54% $1,701,342
   2.46% $1,295,292
   2.20% $1,243,911
   2.41%
Ratio of interest-earning assets to
interest-bearing liabilities
 1.24x     1.19x    


(1)Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets. Includes Non-QM loans held-for-sale with a net carrying value of $895.3 million at March 31, 2020.
(2)Yields presented throughout this Quarterly Report on Form 10-Q are calculated using average amortized cost data for securities which excludes unrealized gains and losses and includes principal payments receivable on securities.  For GAAP reporting purposes, purchases and sales are reported on the trade date. Average amortized cost data used to determine yields is calculated based on the settlement date of the associated purchase or sale as interest income is not earned on purchased assets and continues to be earned on sold assets until settlement date.  Includes Non-Agency MBS transferred to consolidated VIEs.
(2)Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets.
(3)Includes average interest-earning cash, cash equivalents and restricted cash.
(4)Average cost of repurchase agreements includes the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration.
(5)Net interest rate spread reflects the difference between the yield on average interest-earning assets and average cost of funds.
(6)Net interest margin reflects annualized net interest income divided by average interest-earning assets.

Rate/Volume Analysis


The following table presents the extent to which changes in interest rates (yield/cost) and changes in the volume (average balance) of interest-earning assets and interest-bearing liabilities have affected our interest income and interest expense during the periods indicated.  Information is provided in each category with respect to: (i) the changes attributable to changes in volume (changes in average balance multiplied by prior rate); (ii) the changes attributable to changes in rate (changes in rate multiplied by prior average balance); and (iii) the net change.  The changes attributable to the combined impact of volume and rate have been allocated proportionately, based on absolute values, to the changes due to rate and volume.
 Three Months Ended September 30, 2017 Three Months Ended March 31, 2020
 Compared to Compared to
 Three Months Ended September 30, 2016 Three Months Ended March 31, 2019
 Increase/(Decrease) due to 
Total Net
Change in
Interest Income/Expense
 Increase/(Decrease) due to 
Total Net
Change in
Interest Income/Expense
(In Thousands) Volume Rate  Volume Rate 
Interest-earning assets:  
  
  
  
  
  
Residential whole loans, at carrying value (1)
 $41,604
 $(7,738) $33,866
Agency MBS (4,790) 1,366
 (3,424) (6,960) (2,620) (9,580)
Legacy Non-Agency MBS (14,688) 5,563
 (9,125) (11,078) 350
 (10,728)
RPL/NPL MBS (14,616) 3,355
 (11,261) (11,712) 990
 (10,722)
CRT securities 4,430
 263
 4,693
 (1,680) (1,558) (3,238)
MSR related assets 7,194
 
 7,194
Residential whole loans, at carrying value (1)
 3,276
 (167) 3,109
MSR-related assets 4,976
 (1,389) 3,587
Cash and cash equivalents 437
 794
 1,231
 198
 (476) (278)
Other interest-earning assets 730
 871
 1,601
Total net change in income from interest-earning assets $(18,757) $11,174
 $(7,583) $16,078
 $(11,570) $4,508
            
Interest-bearing liabilities:            
Agency repurchase agreements and FHLB advances (3,498) 3,767
 269
Residential whole loan at carrying value repurchase agreements $23,874
 $(4,722) $19,152
Residential whole loan at fair value repurchase agreements 905
 (1,286) (381)
Agency repurchase agreements (6,096) (126) (6,222)
Legacy Non-Agency repurchase agreements (3,396) 1,541
 (1,855) (2,242) (543) (2,785)
RPL/NPL MBS repurchase agreements (7,199) 2,760
 (4,439) (4,958) (1,908) (6,866)
CRT securities repurchase agreements 1,242
 316
 1,558
 (820) (721) (1,541)
MSR related assets repurchase agreements 2,408
 
 2,408
Residential whole loan at carrying value repurchase agreements 605
 457
 1,062
Residential whole loan at fair value repurchase agreements 690
 452
 1,142
MSR-related assets repurchase agreements 2,494
 (1,818) 676
Other repurchase agreements (136) (8) (144)
Securitized debt 962
 
 962
 (1,021) (24) (1,045)
Convertible Senior Notes 3,888
 
 3,888
Senior Notes 1
 
 1
 1
 
 1
Total net change in expense of interest-bearing liabilities $(8,185) $9,293
 $1,108
Total net change in expense from interest-bearing liabilities $15,889
 $(11,156) $4,733
Net change in net interest income $(10,572) $1,881
 $(8,691) $189
 $(414) $(225)
 
(1)Excludes residential whole loans held at fair value which are reported as a component of non-interest-earning assets. Includes Non-QM loans held-for-sale with a net carrying value of $895.3 million at March 31, 2020.



The following table presents certain quarterly information regarding our net interest spread and net interest margin for the quarterly periods presented:
  
Total Interest-Earning Assets and Interest-
Bearing Liabilities
 
Net Interest
Spread (1)
 
Net Interest
Margin (2)
Quarter Ended  
September 30, 2017 2.02% 2.54%
June 30, 2017 2.10
 2.58
March 31, 2017 2.27
 2.63
December 31, 2016 2.12
 2.46
September 30, 2016 2.13
 2.46
  
Total Interest-Earning Assets and Interest-
Bearing Liabilities
 
Net Interest
Spread (1)
 
Net Interest
Margin (2)
Quarter Ended  
March 31, 2020 1.82% 2.20%
December 31, 2019 2.33
 2.68
September 30, 2019 1.82
 2.19
June 30, 2019 1.90
 2.29
March 31, 2019 1.98
 2.41
 
(1)Reflects the difference between the yield on average interest-earning assets and average cost of funds.
(2)Reflects annualized net interest income divided by average interest-earning assets.
(1)  Reflects
The following table presents the difference betweencomponents of the yield on average interest-earning assets and average cost of funds.
(2)  Reflects annualized net interest income divided by average interest-earning assets.spread earned on our Residential whole loans, at carrying value for the quarterly periods presented:

  Purchased Performing Loans Purchased Credit Deteriorated Loans Total Residential Whole Loans, at Carrying Value
Quarter Ended 
Net
Yield
(1)
 
Cost of
Funding
(2)
 
Net 
Interest
Spread
(3)
 
Net
Yield
(1)
 
Cost of
Funding
(2)
 
Net 
Interest
Spread
(3)
 
Net
Yield
(1)
 
Cost of
Funding
(2)
 
Net 
Interest
Spread
(3)
March 31, 2020 5.10% 3.44% 1.66% 4.84% 3.39% 1.45% 5.07% 3.43% 1.64%
December 31, 2019 5.24
 3.61
 1.63
 5.79
 3.51
 2.28
 5.31
 3.59
 1.72
September 30, 2019 5.55
 3.92
 1.63
 5.76
 3.79
 1.97
 5.58
 3.90
 1.68
June 30, 2019 5.71
 4.22
 1.49
 5.75
 3.98
 1.77
 5.72
 4.17
 1.55
March 31, 2019 5.93
 4.27
 1.66
 5.77
 4.06
 1.71
 5.89
 4.21
 1.68

(1)Reflects annualized interest income on Residential whole loans, at carrying value divided by average amortized cost of Residential whole loans, at carrying value. Excludes servicing costs.
(2)Reflects annualized interest expense divided by average balance of repurchase agreements and securitized debt. Total Residential whole loans, at carrying value cost of funding includes 3, 5, 3, 5, and 6 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended March 31, 2020, December 31, 2019, September 30, 2019, June 30, 2019 and March 31, 2019, respectively.
(3)Reflects the difference between the net yield on average Residential whole loans, at carrying value and average cost of funds on Residential whole loans, at carrying value.

The following table presents the components of the net interest spread earned on our Agency MBS, Legacy Non-Agency MBS and Non-AgencyRPL/NPL MBS for the quarterly periods presented:
 
  Agency MBS Legacy Non-Agency MBS RPL/NPL MBS Total MBS
Quarter Ended 
Net
Yield 
(1)
 
Cost of
Funding 
(2)
 
Net Interest
Rate
Spread (3)
 
Net
Yield 
(1)
 
Cost of
Funding 
(2)
 
Net Interest
Rate
Spread (3)
 
Net
Yield 
(1)
 
Cost of
Funding 
(2)
 
Net Interest
Rate
Spread (3)
 
Net
Yield 
(1)
 
Cost of
Funding 
(2)
 
Net Interest
Rate
Spread (3)
September 30, 2017 1.97% 1.75% 0.22% 8.93% 3.26% 5.67% 4.43% 2.69% 1.74% 4.74% 2.41% 2.33%
June 30, 2017 1.96
 1.57
 0.39
 8.85
 3.28
 5.57
 4.18
 2.46
 1.72
 4.68
 2.29
 2.39
March 31, 2017 1.98
 1.49
 0.49
 8.90
 3.05
 5.85
 3.87
 2.27
 1.60
 4.58
 2.15
 2.43
December 31, 2016 1.92
 1.41
 0.51
 8.24
 3.01
 5.23
 3.86
 2.14
 1.72
 4.35
 2.07
 2.28
September 30, 2016 1.83
 1.28
 0.55
 8.09
 2.98
 5.11
 3.86
 2.05
 1.81
 4.24
 1.96
 2.28
  Agency MBS Legacy Non-Agency MBS RPL/NPL MBS Total MBS
Quarter Ended 
Net
Yield 
(1)
 
Cost of
Funding 
(2)
 
Net Interest
Rate
Spread (3)
 
Net
Yield 
(1)
 
Cost of
Funding 
(2)
 
Net Interest
Rate
Spread (3)
 
Net
Yield 
(1)
 
Cost of
Funding 
(2)
 
Net Interest
Rate
Spread (3)
 
Net
Yield 
(1)
 
Cost of
Funding 
(2)
 
Net Interest
Rate
Spread (3)
March 31, 2020 2.32% 2.51% (0.19)% 10.55% 3.13% 7.42% 5.21% 2.56% 2.65% 5.54% 2.78% 2.76%
December 31, 2019 2.38
 2.33
 0.05
 14.76
 3.18
 11.58
 5.17
 2.78
 2.39
 6.76
 2.70
 4.06
September 30, 2019 2.32
 2.47
 (0.15) 10.32
 3.24
 7.08
 5.18
 3.18
 2.00
 5.28
 2.86
 2.42
June 30, 2019 2.50
 2.56
 (0.06) 11.30
 3.30
 8.00
 4.98
 3.39
 1.59
 5.45
 2.95
 2.50
March 31, 2019 2.77
 2.53
 0.24
 10.45
 3.30
 7.15
 4.90
 3.43
 1.47
 5.31
 2.95
 2.36
 
(1)Reflects annualized interest income on MBS divided by average amortized cost of MBS.
(2)Reflects annualized interest expense divided by average balance of repurchase agreements, and other advances, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration and securitized debt. Agency MBS cost of funding includes 44, 49, 60, 6578, 36, 1, (9), and 62(13) basis points and Legacy Non-Agency MBS cost of funding includes 45, 58, 58, 69,52, 24, 1, (14), and 74(20) basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended March 31, 2020, December 31, 2019, September 30, 2017,2019, June 30, 2017,2019 and March 31, 2017, December 31, 2016 and September 30, 2016,2019, respectively.
(3)Reflects the difference between the net yield on average MBS and average cost of funds on MBS.
 
Interest Income
 
Interest income on our residential whole loans held at carrying value increased by $33.9 million, or 68.3%, for the first quarter of 2020, to $83.5 million compared to $49.6 million for the first quarter of 2019. This increase primarily reflects a $3.2 billion increase in the average balance of this portfolio to $6.6 billion for the first quarter of 2020 from $3.4 billion for the first quarter of 2019 partially offset by a decrease in the yield (excluding servicing costs) to 5.07% for the first quarter of 2020 from 5.89% for the first quarter of 2019.

Interest income on our Agency MBS for the thirdfirst quarter of 20172020 decreased by $3.4$9.6 million, or 18.1%51.9%, to $15.5$8.9 million from $19.0$18.4 million for the thirdfirst quarter of 2016.2019.  This decrease primarily reflects a $989.4 million$1.1 billion decrease in the average amortized cost of our Agency MBS portfolio, due primarily to $3.2portfolio sales and run-off, to $1.5 billion for the thirdfirst quarter of 20172020 from $4.1$2.7 billion for the thirdfirst quarter of 2016 partially offset by an increase2019 and a decrease in the net yield on our Agency MBS to 1.97%2.32% for the thirdfirst quarter of 20172020 from 1.83%2.77% for the thirdfirst quarter of 2016. At2019. In addition, for the end of the thirdfirst quarter of 2017, the average coupon on mortgages underlying our Agency MBS was higher compared to the end of the third quarter of 2016.  In addition, during the third quarter of 2017,2020, our Agency MBS portfolio experienced a 16.2%12.6% CPR and we recognized $7.9$4.8 million of net premium amortization compared to a CPR of 16.7%13.6% and $10.3$6.2 million of net premium amortization for the thirdfirst quarter of 2016.2019. At September 30, 2017,March 31, 2020, we had net purchase premiums on our Agency MBS of $110.6$18.9 million, or 3.8%3.5% of current par value, compared to net purchase premiums of $135.1$62.8 million, or 3.8%3.9% of par value, at December 31, 2016.2019.
 
Interest income on our Non-Agency MBS decreased $20.4$21.5 million, or 24.4%39.7%, for the thirdfirst quarter of 20172020 to $63.3$32.6 million compared to $83.6$54.0 million for the thirdfirst quarter of 2016.2019. This decrease is primarily due to theportfolio run-off and sales and resulted in a decrease in the average amortized cost of our Non-Agency MBS portfolio of $2.0$1.3 billion, or 36.8%47.5%, to $3.5 billion from $5.5$1.5 billion for the thirdfirst quarter of 2016.2020 from $2.8 billion for the first quarter of 2019.

Interest income on our Legacy Non-Agency MBS for the first quarter of 2020 decreased $10.7 million to $26.7 million from $37.4 million for the first quarter of 2019. This decrease primarily reflects a $420.2 million decrease in the average amortized cost of our Legacy Non-Agency MBS portfolio, due primarily to portfolio sales and run-off, to $1.0 billion for the first quarter of 2020 from $1.4 billion for the first quarter of 2019. This decrease more than offset the impact of the higher yields generated on our Legacy Non-Agency MBS portfolio, which were 8.93%10.55% for the thirdfirst quarter of 20172020 compared to 8.09%10.45% for the thirdfirst quarter of 2016. The2019.

Interest income on our RPL/NPL MBS portfolio decreased $10.7 million to $5.9 million for the first quarter of 2020 from $16.6 million for the first quarter of 2019. This decrease primarily reflects a $904.2 million decrease in the average amortized cost of this portfolio, due primarily to portfolio runoff and sales, to $449.8 million for the first quarter of 2020 from $1.4 billion the first quarter of 2019, partially offset by an increase in the net yield on our Legacy Non-Agency MBS portfolio reflects the impact of the cash proceeds received during 2016 in connection with the settlement of litigation related to certain Countrywide and Citigroup sponsored residential mortgage backed securitization trusts and the improved

performance of loans underlying the Legacy Non-Agency MBS portfolio, which has resulted in credit reserve releases. Our RPL/NPL MBS portfolio yielded 4.43%to 5.21% for the thirdfirst quarter of 20172020 compared to 3.86%4.90% for the thirdfirst quarter of 2016.2019. The increase in the net yield primarily reflects an increase in the average coupon yield to 4.24%4.96% for the thirdfirst quarter of 20172020 from 3.83%4.86% for the thirdfirst quarter of 2016 and higher accretion income recognized in the current quarter due to the impact of redemptions of certain securities that had been previously purchased at a discount.2019.

During the third quarter of 2017, we recognized net purchase discount accretion of $18.6 million on our Non-Agency MBS, compared to $20.2 million for the third quarter of 2016.  At September 30, 2017, we had net purchase discounts of $835.8 million, including Credit Reserve and previously recognized OTTI of $593.1 million, on our Legacy Non-Agency MBS, or 28.7% of par value.  During the third quarter of 2017 we reallocated $14.8 million of purchase discount designated as Credit Reserve to accretable purchase discount.

The following table presents the coupon yield and net yields earned on our Agency MBS, Legacy Non-Agency MBS and Non-AgencyRPL/NPL MBS and weighted average CPRs experienced for such MBS for the quarterly periods presented:
 
  Agency MBS Legacy Non-Agency MBS RPL/NPL MBS
Quarter Ended 
Coupon Yield (1)
 
Net Yield (2)
 
3 Month Average CPR (3)
 
Coupon Yield (1)
 
Net Yield (2)
 
3 Month Average CPR (3)
 
Coupon Yield (1)
 
Net Yield (2)
 
3 Month Average Bond CPR (4)
September 30, 2017 2.98% 1.97% 16.2% 5.63% 8.93% 18.7% 4.24% 4.43% 26.2%
June 30, 2017 2.94
 1.96
 16.3
 5.52
 8.85
 18.2
 4.03
 4.18
 36.2
March 31, 2017 2.90
 1.98
 15.1
 5.50
 8.90
 16.8
 3.84
 3.87
 27.1
December 31, 2016 2.86
 1.92
 15.9
 5.40
 8.24
 17.3
 3.82
 3.86
 25.8
September 30, 2016 2.83
 1.83
 16.7
 5.28
 8.09
 15.9
 3.83
 3.86
 32.2
  Agency MBS Legacy Non-Agency MBS RPL/NPL MBS
Quarter Ended 
Coupon Yield (1)
 
Net Yield (2)
 
3 Month Average CPR (3)
 
Coupon Yield (1)
 
Net Yield (2)
 
3 Month Average CPR (3)
 
Coupon Yield (1)
 
Net Yield (2)
 
3 Month Average Bond CPR (4)
March 31, 2020 3.57% 2.32% 12.6% 6.83% 10.55% 13.6% 4.96% 5.21% 34.4%
December 31, 2019 3.63
 2.38
 18.1
 6.88
 14.76
 16.4
 5.07
 5.17
 18.8
September 30, 2019 3.73
 2.32
 18.6
 6.92
 10.32
 14.9
 5.18
 5.18
 18.2
June 30, 2019 3.76
 2.50
 18.3
 6.91
 11.30
 15.7
 4.98
 4.98
 16.1
March 31, 2019 3.69
 2.77
 13.6
 6.78
 10.45
 12.7
 4.86
 4.90
 11.6
 
(1)Reflects the annualized coupon interest income divided by the average amortized cost. The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate.
(2)Reflects annualized interest income on MBS divided by average amortized cost of MBS.
(3)3 month average CPR weighted by positions as of the beginning of each month in the quarter.
(4)All principal payments are considered to be prepayments for CPR purposes.


Interest income on our MSR-related assets increased by $3.6 million to $14.2 million for the first quarter of 2020 compared to $10.6 million for the first quarter of 2019. This increase primarily reflects a $409.3 million increase in the average balance of these investments for the first quarter of 2020 to $1.2 billion compared to $788.7 million for the first quarter of 2019 partially offset by a decrease in the yield to 4.74% for the first quarter of 2020 from 5.39% for the first quarter of 2019.

Interest Expense
 
Our interest expense for the thirdfirst quarter of 20172020 increased by $1.1$4.7 million, or 2.3%6.0%, to $49.3$83.8 million from $48.2$79.0 million for the thirdfirst quarter of 2016.2019.  This increase primarily reflects an increase in financing rates on our repurchase agreement financings, an increase in our average borrowings to finance our residential whole loans MSR related assetsheld at carrying value and CRT securities, whichMSR-related assets. In addition we incurred interest expense of $3.9 million on our Convertible Senior Notes issued during the first quarter of 2020. The impact of these items on our interest expense was partially offset by a decrease in our average repurchase agreement borrowings and other advances to finance Agency MBSour residential mortgage securities portfolio and Non-Agency MBS.a decrease in financing rates on our repurchase agreement financings. The effective interest rate paid on our borrowings increaseddecreased to 2.66%3.28% for the quarter ended September 30, 2017March 31, 2020 from 2.10%3.49% for the quarter ended September 30, 2016. 
At September 30, 2017, we had repurchase agreement borrowings of $6.9 billion, of which $2.6 billion was hedged with Swaps.  At September 30, 2017, our Swaps designated in hedging relationships had a weighted average fixed-pay rate of 2.04% and extended 30 months on average with a maximum remaining term of approximately 71 months.March 31, 2019. 
 
Payments made and/or received on our Swaps designated as hedges for accounting purposes are a component of our borrowing costs and accounted forresulted in interest expense of $5.3$3.4 million, or 2931 basis points, for the thirdfirst quarter of 2017,2020, as compared to interest expenseincome of $10.2$1.2 million, or 445 basis points, for the thirdfirst quarter of 2016.2019.  The weighted average fixed-pay rate on our Swaps designated as hedges increaseddecreased to 2.04%2.09% for the quarter ended September 30, 2017March 31, 2020 from 1.82%2.31% for the quarter ended and September 30, 2016.March 31, 2019.  The weighted average variable interest rate received on our Swaps increaseddesignated as hedges decreased to 1.23%1.65% for the quarter ended September 30, 2017March 31, 2020 from 0.49%2.49% for the quarter ended September 30, 2016.  DuringMarch 31, 2019. 

Provision for Credit and Valuation Losses on Residential Whole Loans Held at Carrying Value and Held-for-Sale

For the first quarter ended September 30, 2017,of 2020, we did not enter into any new Swapsrecorded a provision for credit and had no Swaps amortize and/or expire.

We expect that our interest expensevaluation losses on residential whole loans held at carrying value and funding costsheld-for-sale of $150.8 million compared to $805,000 for the remainder of 2017 will be impacted by market interest rates, the amount of our borrowings and incremental hedging activity, existing and future interest rates on our hedging instruments and the extent to which we execute additional longer-term structured financing transactions.  As a result of these variables, our borrowing costs cannot be predicted with any certainty.  (See Notes 5(b), 6 and 15 to the accompanying consolidated financial statements, included under Item 1 of this Quarterly Report on Form 10-Q.)
OTTI
We did not recognize any OTTI charges through earnings during the thirdfirst quarter of 2017. During2019. As previously discussed, on January 1, 2020, we adopted the third quarternew accounting standard addressing the measurement of 2016, we recognized OTTI charges through earnings against certain ofcredit losses on financial instruments (CECL). With respect to our Non-Agency MBS of $485,000. These impairment charges reflected changes in ourresidential whole loans held at carrying value, CECL requires that reserves for credit losses are estimated cash flows for such securitiesat the reporting date based on an updated assessmentlife of the estimated future performance of the underlying collateral, including the expected principal loss over the term of the securities and changes in the expected timing of receipt of cash flows. At September 30, 2017, we had 386 Agency MBS with a gross unrealized loss of $32.9 million and 13 Non-Agency MBS with a gross unrealized loss of $390,000.  Impairments on Agency MBS in an unrealized loss position at September 30, 2017 are considered temporary and not credit related.  Unrealized losses on Non-Agency MBS for which no OTTI was recorded during the quarter are considered temporary based on an assessment of changes in theloan expected cash flows, for such securities, which considers recent bond performanceincluding anticipated prepayments and expectedreasonable and supportable forecasts of future performanceeconomic conditions. While the adjustments recorded at the transition date to adopt CECL did not have a material impact on our financial position, given the anticipated impact of the underlying collateral.  Significant judgment is used both in our analysisCOVID-19 pandemic on expected economic conditions for the short to medium term, estimates of expected cash flowscredit losses recorded under CECL for our Legacy Non-Agency MBS and any determinationthe first quarter of the2020 are significantly higher than would have been recorded under prior accounting standards, where reserves for credit component of OTTI.

Other Income, net

losses were recorded only when assessed as being incurred. For the thirdfirst quarter of 2017, Other Income, net decreased by $4.82020, a provision for credit losses of $74.9 million or 14.2%, to $29.1 million compared to $33.9 million for the third quarter of 2016.  Other Income, net for the third quarter of 2017 primarily reflects a $18.7 million net gainwas recorded on residential whole loans held at faircarrying value. In addition, a valuation allowance to reduce the carrying value $14.9of Non-QM loans designated as held-for-sale at quarter-end of $70.2 million was recorded. This valuation allowance is included, along with CECL credit loss estimates, in the provision for credit losses in our income statement.

Other (Loss)/Income, net

For the first quarter of 2020, Other Loss, net gains realized onwas $790.8 million compared to Other Income, net of $51.2 million for the salefirst quarter of $44.5 million2019.  The components of Non-Agency MBS and U.S. Treasury securities primarily offset by $5.2 million of unrealized losses on CRT securities accounted for at fair value. Other (Loss)/Income, net for the thirdfirst quarter of 2016 primarily reflects a $19.6 million net gain recorded on residential whole loans held at fair value, $7.7 million of unrealized gains on CRT securities accounted for at fair value2020 and $7.1 million of gross gains realized on2019 are summarized in the sale of $13.2 million Non-Agency MBS.table below:

  Quarter Ended March 31,
(In Thousands) 2020 2019
Impairment and other losses on securities available-for-sale and other assets $(419,651) $
Net realized (loss)/gain on sales of residential mortgage securities and residential whole loans (238,380) 24,609
Net unrealized (loss)/gain on residential mortgage securities measured at fair value through earnings (77,961) 8,672
Net (loss)/gain on residential whole loans measured at fair value through earnings (52,760) 25,267
Net loss on Swaps not designated as hedges for accounting purposes (4,239) (8,944)
Liquidations gains on Purchased Credit Deteriorated Loans and other loan related income 1,429
 2,807
Other 799
 (1,242)
Total Other (Loss)/Income, net $(790,763) $51,169

Operating and Other Expense


For the thirdfirst quarter of 2017,2020, we had compensation and benefits and other general and administrative expenses of $15.0$13.5 million, or 1.83%1.58% of average equity, compared to $10.8$13.2 million, or 1.44%1.55% of average equity, for the thirdfirst quarter of 2016.2019.  Compensation and benefits expense increased $3.8 millionby approximately $345,000 to $10.9$8.9 million for the thirdfirst quarter of 2017,2020, compared to $7.1$8.6 million for the thirdfirst quarter of 2016, which2019, primarily reflects non-recurring expenses recordedreflecting higher expense in relation to our contractual obligation to accelerateconnection with long term incentive awards in the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer.current year period. Our other general and administrative expenses increasedwere essentially flat, decreasing by $372,000$70,000 to $4.1$4.6 million for the quarter ended September 30, 2017 compared to $3.7March 31, 2020. In addition, professional services and other costs of $4.5 million forwere incurred during the quarter ended September 30, 2016 primarilyrelated to negotiating forbearance arrangements with our lenders, which was required due to higher professional services related costs. the impact of the market disruptions caused by concerns associated with the COVID-19 pandemic.


Operating and Other Expense for the thirdfirst quarter of 20172020 also includes $6.2$11.2 million of loan servicing and other related operating expenses related to our residential whole loan activities. These expenses increased compared to the prior year period by approximately $2.0 million,$930,000, or 9.1%, primarily due to increases in non-recoverable advances onrelated to our REO increasedportfolio, partially offset by lower servicing fees across all of our residential whole loan servicing and modification fees and higher loan acquisition related expenses.portfolios.



Selected Financial Ratios
 
The following table presents information regarding certain of our financial ratios at or for the dates presented:
 
At or for the Quarter Ended 
Return on
Average Total
Assets (1)
 
Return on
Average Total
Stockholders’
Equity (2)
 
Total Average
Stockholders’
Equity to Total
Average Assets (3)
 
Dividend Payout
Ratio (4)
 
Leverage Multiple (5)
 
Book Value
per Share
of Common
Stock (6)
September 30, 2017 2.10% 7.78% 28.60% 1.33 2.4 $7.70
June 30, 2017 2.63
 10.01
 27.59
 1.00 2.5 7.76
March 31, 2017 2.42
 10.19
 24.95
 1.00 2.9 7.66
December 31, 2016 2.18
 9.52
 24.19
 1.11 3.1 7.62
September 30, 2016 2.47
 11.05
 23.46
 0.95 3.1 7.64
At or for the Quarter Ended 
Return on
Average Total
Assets (1)
 
Return on
Average Total
Stockholders’
Equity (2)
 
Total Average
Stockholders’
Equity to Total
Average Assets (3)
 
Dividend Payout
Ratio (4)
 
Leverage Multiple (5)
 
Book Value
per Share
of Common
Stock (6)
 
Economic Book Value per Share of Common Stock (7)
March 31, 2020 (26.72)% (106.31)% 24.99% 0.00 3.4 $4.34
 $4.09
December 31, 2019 2.92
 11.90
 25.48
 0.95 3.0 7.04
 7.44
September 30, 2019 2.79
 11.24
 25.80
 1.00 2.8 7.09
 7.41
June 30, 2019 2.74
 10.91
 26.13
 1.00 2.8 7.11
 7.40
March 31, 2019 2.66
 10.40
 26.71
 1.05 2.7 7.11
 7.32


(1)Reflects annualized net income available to common stock and participating securities divided by average total assets.
(2)Reflects annualized net income divided by average total stockholders’ equity.
(3)Reflects total average stockholders’ equity divided by total average assets.
(4)Reflects dividends declared per share of common stock divided by earnings per share.
(5)Represents the sum of borrowings under repurchase agreements, FHLB advances, securitized debt, payable for unsettled purchases, and obligations to return securities obtained as collateralConvertible Senior Notes and Senior Notes divided by stockholders’ equity.
(6)Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding.


Nine Month Period Ended September 30, 2017 Compared to the Nine Month Period Ended September 30, 2016
General
For the nine months ended September 30, 2017, we had net income available to common stock and participating securities of $210.5 million, or $0.54 per basic and diluted common share, compared to net income available to common stock and participating securities of $228.8 million, or $0.61 per basic and diluted common share, for the nine months ended September 30, 2016. The decrease in net income available to common stock and participating securities, and the decrease of this item on a per share basis primarily reflects a decrease in our net interest income primarily on our Agency and Non-Agency MBS portfolios. This decrease was partially offset by higher other income, driven primarily by higher gains on sales of Legacy Non-Agency MBS, unrealized gains on CRT securities accounted for at fair value and gains on the liquidation of certain residential whole loans accounted for at carrying value. In addition, operating and other expenses where higher primarily due to non-recurring expenses in relation to our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer.
Net Interest Income

For the nine months ended September 30, 2017, our net interest spread and margin were 2.15% and 2.59%, respectively, compared to a net interest spread and margin of 2.16% and 2.49%, respectively, for the nine months ended September 30, 2016. Our net interest income decreased by $17.3 million, or 8.6%, to $183.9 million from $201.2 million for the nine months ended September 30, 2016.  For the nine months ended September 30, 2017, net interest income from Agency MBS and Legacy Non-Agency MBS declined compared to the nine months ended September 30, 2016, by approximately $27.3 million, primarily due to lower average amounts invested in these securities and higher funding costs, partially offset by higher yields earned on Legacy Non-Agency MBS. In addition, net interest income on RPL/NPL MBS was approximately $14.8 million lower compared to the nine months ended September 30, 2016 primarily due to lower average amounts invested in these securities and higher funding costs partially offset by higher yields earned on these securities. These decreases were partially offset by higher net interest income on MSR related assets, CRT securities, and residential whole loans at carrying value of approximately $25.4 million compared to the nine months ended September 30, 2016, primarily due to higher average amounts invested in these assets and higher yields earned on CRT securities. In addition, net interest income for the nine months ended September 30, 2017 also includes $13.2 million of interest expense associated with residential whole loans at fair value, reflecting a $2.9 million increase in borrowing costs related to these investments compared to the nine months ended September 30, 2016. Coupon interest income received from residential whole loans at fair value is presented as a component of the total income earned on these investments and therefore is included in Other Income, net rather than net interest income.



Analysis of Net Interest Income
The following table sets forth certain information about the average balances of our assets and liabilities and their related yields and costs for the nine months ended September 30, 2017 and 2016Average yields are derived by dividing annualized interest income by the average amortized cost of the related assets, and average costs are derived by dividing annualized interest expense by the daily average balance of the related liabilities, for the periods shown.  The yields and costs include premium amortization and purchase discount accretion which are considered adjustments to interest rates.
  Nine Months Ended September 30,
  2017 2016
  Average Balance Interest Average Yield/Cost Average Balance Interest Average Yield/Cost
(Dollars in Thousands)      
Assets:  
  
  
  
  
  
Interest-earning assets:  
  
  
  
  
  
Agency MBS (1)
 $3,383,373
 $50,014
 1.97% $4,389,672
 $64,546
 1.96%
Legacy Non-Agency MBS (1)
 2,350,975
 156,829
 8.89
 3,023,239
 176,890
 7.80
RPL/NPL MBS (1)
 1,813,557
 55,899
 4.11
 2,630,475
 76,665
 3.89
Total MBS 7,547,905
 262,742
 4.64
 10,043,386
 318,101
 4.22
CRT securities (1)
 520,585
 22,898
 5.86
 243,776
 9,897
 5.41
MSR related assets (1)
 376,811
 17,833
 6.31
 
 
 
Residential whole loans, at carrying value (2)
 587,511
 26,219
 5.95
 346,013
 16,112
 6.21
Cash and cash equivalents (3)
 531,722
 2,854
 0.72
 270,297
 531
 0.26
Total interest-earning assets 9,564,534
 332,546
 4.64
 10,903,472
 344,641
 4.21
Total non-interest-earning assets (2)
 2,207,939
  
  
 2,007,033
  
  
Total assets $11,772,473
  
  
 $12,910,505
  
  
             
Liabilities and stockholders’ equity:  
  
  
  
  
  
Interest-bearing liabilities:  
  
  
  
  
  
   Total repurchase agreements and other advances (4)
 7,704,662
 141,444
 2.42
 9,069,065
 137,127
 1.99
Securitized debt (5)
 57,073
 1,173
 2.71
 8,949
 333
 4.89
Senior Notes 96,746
 6,029
 8.31
 96,709
 6,027
 8.31
Total interest-bearing liabilities 7,858,481
 148,646
 2.49
 9,174,723
 143,487
 2.05
Total non-interest-bearing liabilities 734,181
  
  
 799,438
  
  
Total liabilities 8,592,662
  
  
 9,974,161
  
  
Stockholders’ equity 3,179,811
  
  
 2,936,344
  
  
Total liabilities and stockholders’ equity $11,772,473
  
  
 $12,910,505
  
  
             
Net interest income/ net interest rate spread (6)
  
 $183,900
 2.15%  
 $201,154
 2.16%
Net interest-earning assets/ net interest margin (7)
 $1,706,053
  
 2.59% $1,728,749
  
 2.49%
Ratio of interest-earning assets to
    interest-bearing liabilities
 1.22x  
  
 1.19x  
  

(1)Yields presented throughout this Quarterly Report on Form 10-Q are calculated using average amortized cost data for securities which excludes unrealized gains and losses and includes principal payments receivable on securities.  For GAAP reporting purposes, purchases and sales are reported on the trade date. Average amortized cost data used to determine yields is calculated based on the settlement date of the associated purchase or sale as interest income is not earned on purchased assets and continues to be earned on sold assets until settlement date.  Includes Non-Agency MBS transferred to consolidated VIEs.
(2)Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets.
(3)Includes average interest-earning cash, cash equivalents and restricted cash.
(4)Average cost of repurchase agreements includes the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration.
(5)Securitized debt for the nine months ended September 30, 2017 reflects securitized debt from our loan securitization transaction in June 2017. Securitized debt for the nine months ended September 30, 2016 reflects securitized debt from our MBS resecuritization transaction in February 2012.
(6)Net interest rate spread reflects the difference between the yield on average interest-earning assets and average cost of funds.
(7)Net interest margin reflects annualized net interest income divided by average interest-earning assets.“Economic book value” is a non-GAAP financial measure of our financial position. To calculate our Economic book value, our portfolios of Residential whole loans at carrying value are adjusted to their fair value, rather than the carrying value that is required to be reported under the GAAP accounting model applied to these loans. For additional information please refer to page 82 under the heading “Economic Book Value”.



Rate/Volume AnalysisReconciliation of GAAP and Non-GAAP Financial Measures

The following table presentsEconomic Book Value

“Economic book value” is a non-GAAP financial measure of our financial position. To calculate our Economic book value, our portfolios of Residential whole loans at carrying value are adjusted to their fair value, rather than the extentcarrying value that is required to which changes in interest rates (yield/cost) and changesbe reported under the GAAP accounting model applied to these loans. This adjustment is also reflected in the volume (average balance) of interest-earning assets and interest-bearing liabilities have affectedtable below in our interest income and interest expense during the periods indicated.  Information is provided in each category with respect to: (i) the changes attributable to changes in volume (changes in average balance multiplied by prior rate); (ii) the changes attributable to changes in rate (changes in rate multiplied by prior average balance); and (iii) the net change.  The changes attributable to the combined impact of volume and rate have been allocated proportionately, based on absolute values, to the changes due to rate and volume.
  Nine Months Ended September 30, 2017
  Compared to
  Nine Months Ended September 30, 2016
  Increase/(Decrease) due to 
Total Net
Change in
Interest Income/Expense
(In Thousands) Volume Rate 
Interest-earning assets:  
  
  
Agency MBS $(14,842) $310
 $(14,532)
Legacy Non-Agency MBS (42,659) 22,598
 (20,061)
RPL/NPL MBS (24,970) 4,204
 (20,766)
CRT securities 12,111
 890
 13,001
MSR related assets 17,833
 
 17,833
Residential whole loans, at carrying value (1)
 10,804
 (697) 10,107
Cash and cash equivalents 833
 1,490
 2,323
Total net change in income from interest-earning assets $(40,890) $28,795
 $(12,095)
       
Interest-bearing liabilities:  
  
  
Agency repurchase agreements and FHLB advances $(10,361) $8,616
 $(1,745)
Legacy Non-Agency repurchase agreements (10,192) 4,965
 (5,227)
RPL/NPL MBS repurchase agreements (11,447) 5,434
 (6,013)
CRT securities repurchase agreements 3,452
 579
 4,031
MSR related assets repurchase agreements 5,773
 
 5,773
Residential whole loan at carrying value repurchase agreements 3,998
 747
 4,745
Residential whole loan at fair value repurchase agreements 2,071
 682
 2,753
Securitized debt 1,049
 (209) 840
Senior Notes 2
 
 2
Total net change in expense of interest-bearing liabilities $(15,655) $20,814
 $5,159
Net change in net interest income $(25,235) $7,981
 $(17,254)

(1)Excludes residential whole loans held at fair value which are reported as a component of non-interest-earning assets.

The following table presents the components of the net interest spread earned on our Agency MBS and Non-Agency MBS for the periods presented:
  Agency MBS Legacy Non-Agency MBS RPL/NPL MBS Total MBS
Nine Months Ended 
Net Yield 
(1)
 
Cost of Funding 
(2)
 
Net Interest Spread 
(3)
 
Net Yield 
(1)
 
Cost of Funding 
(2)
 
Net Interest Spread 
(3)
 
Net Yield 
(1)
 
Cost of Funding 
(2)
 
Net Interest Spread 
(3)
 
Net Yield 
(1)
 
Cost of Funding 
(2)
 
Net Interest Spread 
(3)
September 30, 2017 1.97% 1.60% 0.37% 8.89% 3.19% 5.70% 4.11% 2.43% 1.68% 4.64% 2.27% 2.37%
September 30, 2016 1.96% 1.26% 0.70% 7.80% 2.89% 4.91% 3.89% 2.03% 1.86% 4.22% 1.91% 2.31%
(1) Reflects annualized interest income on MBS divided by average amortized cost of MBS.
(2) Reflects annualized interest expense divided by average balance of repurchase agreements and other advances, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration, and securitized debt. Agency cost of funding includes 51 and 63 basis points and Legacy Non-Agency cost of funding includes 54 and 69 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the nine months ended September 30, 2017 and 2016, respectively.
(3) Reflects the difference between the net yield on average MBS and average cost of funds on MBS.

Interest Income
Interest income on our Agency MBS for the nine months ended September 30, 2017 decreased by $14.5 million, or 22.5%, to $50.0 million from $64.5 million for the nine months ended September 30, 2016.  This change primarily reflects a $1.0 billion decrease in the average amortized cost of our Agency MBS portfolio to $3.4 billion for the nine months ended September 30, 2017 from $4.4 billion for the nine months ended September 30, 2016 partially offset by a slight increase in the net yield on our Agency MBS to 1.97% for the nine months ended September 30, 2017 from 1.96% for the nine months ended September 30, 2016.  At the end of the third quarter of 2017, the average coupon on mortgages underlyingperiod stockholders’ equity. Management considers that Economic book value provides investors with a useful supplemental measure to evaluate our Agency MBS was higher compared to the end of the third quarter of 2016.  However, during the nine months ended September 30, 2017, our Agency MBS portfolio experienced a 14.4% CPR and we recognized $24.6 million of net premium amortization compared to a CPR of 12.7% and $27.7 million of net premium amortization for the nine months ended September 30, 2016.  At September 30, 2017, we had net purchase premiums on our Agency MBS of $110.6 million, or 3.8% of current par value, compared to net purchase premiums of $135.1 million, or 3.8% of par value at December 31, 2016.
Interest income on our Non-Agency MBS (which includes Non-Agency MBS transferred to consolidated VIEs) decreased by $40.8 million, or 16.1%, for the nine months ended September 30, 2017 to $212.7 million compared to $253.6 million for the nine months ended September 30, 2016. This decrease is primarily due to the decrease in the average amortized cost of our Non-Agency MBS portfolio of $1.5 billion or 26.3%, to $4.2 billion from $5.7 billion for the nine months ended September 30, 2016.  This decrease more than offset the impact of the higher yields generated on our Legacy Non-Agency MBS portfolio, which were 8.89% for the nine months ended September 30, 2017 compared to 7.80% for the nine months ended September 30, 2016.  The increase in the net yield on our Legacy Non-Agency MBS portfoliofinancial position as it reflects the impact of the cash proceeds received during 2016 in connection with the settlementfair value changes for all of litigation related to certain Countrywide and Citigroup sponsoredour residential mortgage backed securitization trusts,investments, irrespective of the improved performanceaccounting model applied for GAAP reporting purposes. Economic book value does not represent and should not be considered as a substitute for Stockholders’ Equity, as determined in accordance with GAAP, and our calculation of loans underlying the Legacy Non-Agency MBS portfolio, which has resulted in credit reserve releases and the impact of redemptions during 2017 of certain securities that had been previously purchased at a discount. Our RPL/NPL MBS portfolio yielded 4.11% for the nine months ended September 30, 2017 comparedthis measure may not be comparable to 3.89% for the nine months ended September 30, 2016. The increase in the net yield reflects an increase in the average coupon yield to 4.01% for the nine months ended September 30, 2017 from 3.79% for the nine months ended September 30, 2016 and higher accretion income recognized in the current nine month period due to the impact of redemptions of certain securities that had been previously purchased at a discount.

During the nine months ended September 30, 2017, we recognized net purchase discount accretion of $60.5 million on our Non-Agency MBS, compared to $61.2 million for the nine months ended September 30, 2016.  At September 30, 2017, we had net purchase discounts of $835.8 million, including Credit Reserve and previously recognized OTTI of $593.1 million, on our Legacy Non-Agency MBS, or 28.7% of par value.  During the nine months ended September 30, 2017 we reallocated $33.8 million of purchase discount designated as Credit Reserve to accretable purchase discount.similarly titled measures reported by other companies.

The following table presentsprovides a reconciliation of our GAAP book value per common share to our non-GAAP Economic book value per common share as of the coupon yield and net yields earned on our Agency MBS and Non-Agency MBS and weighted average CPRs experienced for such MBS for thequarterly periods presented:below:

  Agency MBS Legacy Non-Agency MBS RPL/NPL MBS
Nine Months Ended 
Coupon Yield (1)
 
Net Yield (2)
 
9 Month Average CPR (3)
 
Coupon Yield (1)
 
Net Yield (2)
 
9 Month Average CPR (3)
 
Coupon Yield (1)
 
Net Yield (2)
 
9 Month Average Bond CPR (4)
September 30, 2017 2.94% 1.97% 14.4% 5.55% 8.89% 16.3% 4.01% 4.11% 32.2%
September 30, 2016 2.80
 1.96
 12.7
 5.19
 7.80
 13.7
 3.79
 3.89
 26.9
(In Thousands, Except Per Share Amounts) March 31, 2020 December 31, 2019 September 30, 2019 June 30, 2019 March 31, 2019
GAAP Total Stockholders’ Equity $2,440.7
 $3,384.0
 $3,403.4
 $3,403.4
 $3,404.5
Preferred Stock, liquidation preference (475.0) (200.0) (200.0) (200.0) (200.0)
GAAP Stockholders’ Equity for book value per common share 1,965.7
 3,184.0
 3,203.4
 3,203.4
 3,204.5
Adjustments:          
Fair value adjustment to Residential whole loans, at carrying value (113.5) 182.4
 145.8
 131.2
 92.1
           
Stockholders’ Equity including fair value adjustment to Residential whole loans, at carrying value (Economic book value) $1,852.2
 $3,366.4
 $3,349.2
 $3,334.6
 $3,296.7
           
GAAP book value per common share $4.34
 $7.04
 $7.09
 $7.11
 $7.11
Economic book value per common share $4.09
 $7.44
 $7.41
 $7.40
 $7.32
Number of shares of common stock outstanding 453.1
 452.4
 451.7
 450.6
 450.5
(1)Reflects the annualized coupon interest income divided by the average amortized cost. The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate.
(2)Reflects annualized interest income on MBS divided by average amortized cost of MBS.
(3)9 month average CPR weighted by positions as of the beginning of each month in the quarter.
(4)All principal payments are considered to be prepayments for CPR purposes.

Interest Expense
Our interest expense for the nine months ended September 30, 2017 increased by $5.2 million, or 3.6%, to $148.6 million, from $143.5 million for the nine months ended September 30, 2016.  This increase primarily reflects an increase in financing rates on our repurchase agreement financings, an increase in our average borrowings to finance residential whole loans, MSR related assets and CRT securities, which was partially offset by a decrease in our average repurchase agreement borrowings and other advances to finance Agency MBS and Non-Agency MBS. The effective interest rate paid on our borrowings increased to 2.49% for the nine months ended September 30, 2017, from 2.05% for the nine months ended September 30, 2016. 

Payments made and/or received on our Swaps are a component of our borrowing costs and accounted for interest expense of $19.6 million, or 33 basis points, for the nine months ended September 30, 2017, compared to interest expense of $31.3 million, or 45 basis points, for the nine months ended September 30, 2016.  The weighted average fixed-pay rate on our Swaps designated as hedges increased to 1.96% for the nine months ended September 30, 2017 from 1.82% for the nine months ended September 30, 2016.  The weighted average variable interest rate received on our Swaps designated as hedges increased to 1.00% for the nine months ended September 30, 2017 from 0.45% for the nine months ended September 30, 2016.  During the nine months ended September 30, 2017, we did not enter into any new Swaps and had Swaps with an aggregate notional amount of $350.0 million and a weighted average fixed-pay rate of 0.58% amortize and/or expire.
We expect that our interest expense and funding costs for the remainder of 2017 will be impacted by market interest rates, the amount of our borrowings and incremental hedging activity, existing and future interest rates on our hedging instruments and the extent to which we execute additional longer-term structured financing transactions.  As a result of these variables, our borrowing costs cannot be predicted with any certainty.  (See Notes 5(b), 6 and 15 to the accompanying consolidated financial statements, included under Item 1 of this Quarterly Report on Form 10-Q.)
OTTI
During the nine months ended September 30, 2017 and 2016, we recognized OTTI charges through earnings against certain of our Non-Agency MBS of $1.0 million and $485,000, respectively. These impairment charges reflected changes in our estimated cash flows for such securities based on an updated assessment of the estimated future performance of the underlying collateral, including the expected principal loss over the term of the securities and changes in the expected timing of receipt of cash flows.

Other Income, net
For the nine months ended September 30, 2017, Other Income, net increased by $10.4 million, or 12.4%, to $94.0 million compared to $83.6 million for the nine months ended September 30, 2016.  Other Income, net for the nine months ended September 30, 2017 primarily reflects a $48.7 million net gain recorded on residential whole loans held at fair value, $30.5 million of net gains realized on the sale of $222.1 million Non-Agency MBS and U.S. Treasury securities and $14.2 million of unrealized gains on CRT securities accounted for at fair value. Other Income, net for the nine months ended September 30, 2016 primarily reflects a net gain of $47.7 million on residential whole loans held at fair value, $26.1 million of gains realized on the sale of $65.1 million of Non-Agency MBS and $11.1 million of unrealized gains on CRT securities accounted for at fair value.

Operating and Other Expense

During the nine months ended September 30, 2017, we had compensation and benefits and other general and administrative expenses of $40.3 million, or 1.69% of average equity, compared to $34.0 million, or 1.54% of average equity, for the nine months ended September 30, 2016.  Compensation and benefits expense increased $4.8 million to $26.3 million for the nine months ended September 30, 2017, compared to $21.5 million for the nine months ended September 30, 2016, which primarily reflects non-recurring expenses recorded in relation to our contractual obligation to accelerate the vesting of certain share based awards and to make a death benefit payment to the estate of our former Chief Executive Officer. Our other general and administrative expenses increased by $1.6 million to $14.1 million for the nine months ended September 30, 2017 compared to $12.5 million for the nine months ended September 30, 2016, primarily due to higher costs associated with the loan securitization transaction completed during the second quarter of 2017 and other structured financing transactions, higher costs related to stock-based compensation awards to Directors and higher professional services related costs.

Operating and Other Expense during the nine months ended September 30, 2017 also includes $14.8 million of loan servicing and other related operating expenses related to our residential whole loan activities. These expenses increased compared to the prior year period by approximately $4.5 million, primarily due to increases in non-recoverable advances on REO, increased loan servicing and modification fees and higher loan acquisition related expenses, which were partially offset by a decrease in the provision for loan losses recognized for the nine month period.

Selected Financial Ratios
The following table presents information regarding certain of our financial ratios at or for the dates presented:
At or for the Nine Months Ended 
Return on
Average Total
Assets (1)
 
Return on
Average Total
Stockholders’
Equity (2)
 
Total Average
Stockholders’
Equity to Total
Average Assets (3)
 
Dividend Payout
Ratio (4)
 
Leverage Multiple (5)
 
Book Value
per Share
of Common
Stock (6)
September 30, 2017 2.38% 9.30% 27.01% 1.11 2.4
 $7.70
September 30, 2016 2.36
 10.90
 22.74
 0.98 3.1
 7.64

(1)Reflects annualized net income available to common stock and participating securities divided by average total assets.
(2)Reflects annualized net income divided by average total stockholders’ equity.
(3)Reflects total average stockholders’ equity divided by total average assets.
(4)Reflects dividends declared per share of common stock divided by earnings per share.
(5)Represents the sum of borrowings under repurchase agreements, FHLB advances, securitized debt, payable for unsettled purchases, and obligations to return securities obtained as collateral and Senior Notes divided by stockholders’ equity.
(6)Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding.


Recent Accounting Standards to be Adopted in Future Periods

Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities

In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities (or ASU 2017-12). The amendments in this ASU expand an entity’s ability to hedge non-financial and financial risk components and reduce complexity in fair value hedges of interest rate risk. The new guidance eliminates the requirement to separately measure and report hedge ineffectiveness and requires the entire change in the fair value of a hedging instrument to be presented in the same income statement line as the hedged item. ASU 2017-12 also simplifies certain documentation and assessment requirements and modifies the accounting for components excluded from the assessment of hedge effectiveness. ASU 2017-12 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early application is permitted in any interim period or fiscal year before the effective date. An entity should apply the amendments of this ASU to cash flow and net investment hedge relationships that exist on the date of adoption using a modified retrospective approach. The presentation and disclosure requirements of ASU 2017-12 should be applied prospectively. In addition, certain transition elections may be made by an entity upon adoption to allow for existing hedging relationships to transition to the newly allowable alternatives within this ASU. We are currently evaluating our adoption timing and the effect that ASU 2017-12 will have on our consolidated financial statements and related disclosures.

Compensation - Stock Compensation - Scope of Modification Accounting

In May 2017, the FASB issued ASU 2017-09, Scope of Modification Accounting (or ASU 2017-09). The amendments in ASU 2017-09 provide guidance about which changes to the terms or conditions of a share-based payment award require an entity

to apply modification accounting. Pursuant to this ASU, an entity should account for the effects of a modification unless all of the following are met: (1) the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the modified award is the same as the fair value (or calculated value or intrinsic value, if such an alternative measurement method is used) of the original award immediately before the original award is modified; (2) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified; and (3) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award date is modified. ASU 2017-09 is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. Early adoption is permitted, including adoption in any interim period for which financial statements have not yet been issued or made available for issuance. The amendments of this ASU should be applied prospectively to an award modified on or after the adoption date. We do not expect the adoption of ASU 2017-09 to have a significant impact on our financial position or financial statement disclosures.

Intangibles - Goodwill and Other - Simplifying the Test for Goodwill Impairment

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other - Simplifying the Test for Goodwill Impairment (or ASU 2017-04). The amendments in ASU 2017-04 eliminate the requirement to calculate the implied fair value of goodwill (Step 2 from today’s goodwill impairment test) to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value (i.e., measure the charge based on today’s Step 1). Public business entities should adopt the amendments in ASU 2017-04 for its annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates on or after January 1, 2017. The amendments of this ASU should be applied in a prospective basis. We do not expect the adoption of ASU 2017-04 to have a significant impact on our financial position or financial statement disclosures.

Statement of Cash Flows - Restricted Cash

In November 2016, the FASB issued ASU 2016-18, Restricted Cash (or ASU 2016-18). ASU 2016-18 clarifies how entities should present restricted cash and restricted cash equivalents in the statement of cash flows with the objective of reducing the existing diversity in practice. The amendments in ASU 2016-18 require restricted cash and restricted cash equivalents to be included with cash and cash equivalents when reconciling the beginning-of-period and end-of period total amounts shown on the statement of cash flows. ASU 2016-18 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. Early application is permitted, provided that all of the amendments are adopted in the same period. The amendments of this ASU should generally be applied using a retrospective transition method to each period presented. We do not expect the adoption of ASU 2016-18 to have a significant impact on our financial position or financial statement disclosures.

Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments

In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (or ASU 2016-15). The amendments in ASU 2016-15 provide guidance for eight specific cash flow classification issues, certain cash receipts and cash payments on the statement of cash flows with the objective of reducing the existing diversity in practice. ASU 2016-15 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. Early application is permitted, provided that all of the amendments are adopted in the same period. The amendments of this ASU should generally be applied using a retrospective transition method to each period presented. We do not expect the adoption of ASU 2016-15 to have a significant impact on our financial position or financial statement disclosures.

Financial Instruments - Credit Losses - Measurement of Credit Losses on Financial Instruments

In June 2016, the FASB issued ASU 2016-13, Measurements of Credit Losses on Financial Instruments (or ASU 2016-13). The amendments in ASU 2016-13 require entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Entities will now use forward-looking information to better inform their credit loss estimates. ASU 2016-13 also requires enhanced financial statement disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. Under ASU 2016-13 credit losses for available-for-sale debt securities should be measured in a manner similar to current GAAP. However, the amendments in this ASU require that credit losses be recorded through an allowance for credit losses, which will allow subsequent reversals in credit loss estimates to be recognized in current income. In addition, the allowance on available-for-sale debt securities will be limited to the extent that the fair value is less than the amortized cost.


ASU 2016-13 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for all entities for annual periods beginning after December 15, 2018, and interim periods therein. The amendments in this ASU are required to be applied by recording a cumulative-effect adjustment to equity as of the beginning of the first reporting period in which the guidance is effective. A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. Based on our initial evaluation of the amendments in this ASU, we anticipate being required to make changes to the way we account for credit impairment losses on our available-for-sale debt securities. Under our current accounting, credit impairment losses are generally required to be recorded as OTTI, which directly reduce the carrying amount of impaired securities, and are recorded in earnings and are not reversed if expected cash flows subsequently recover. Under the new guidance, credit impairments on such securities will be recorded as an allowance for credit losses that are also recorded in earnings, but the allowance can be reversed through earnings in a subsequent period if expected cash flows subsequently recover. In addition, we expect that the new guidance will also result in changes to the accounting and presentation of our residential whole loans held at carrying value. We currently anticipate that upon adoption, the guidance will result in an increase in the gross carrying amount of our residential whole loans at carrying value by the amount of the allowance for loan losses calculated under the new guidance. Thereafter, changes in the expected cash flows of such assets are expected to result in the recognition (or reversal) of an allowance for loan losses that will impact earnings. We will continue to monitor and evaluate the potential effects that ASU 2016-13 will have on our consolidated financial statements and related disclosures.

Leases

In February 2016, the FASB issued ASU 2016-02, Leases (or ASU 2016-02). The amendments in this ASU establish a right-of-use model that requires a lessee to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company’s significant lease contracts are discussed in Note 11(a) of the accompanying consolidated financial statements. While we continue to evaluate the potential impact that adoption of ASU 2016-02 will have on our financial reporting, given the relatively limited nature and extent of lease financing transactions that we have entered into, we do not expect that the adoption of ASU 2016-02 will have a significant impact on our financial position or financial statement disclosures.

Financial Instruments - Overall - Recognition and Measurement of Financial Assets and Financial Liabilities

In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (or ASU 2016-01). The amendments in this ASU affect all entities that hold financial assets or owe financial liabilities, and address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments.  The classification and measurement guidance of investments in debt securities and loans are not affected by the amendments in this ASU. ASU 2016-01 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017.  Early adoption is not permitted for public business entities, except for a provision related to financial statements of fiscal years or interim periods that have not yet been issued, to recognize in other comprehensive income, the change in fair value of a liability resulting from a change in the instrument-specific credit risk measured using the fair value option. The amendments in this ASU are required to be applied by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. We do not expect that adoption of ASU 2016-01 will have a significant impact on our financial position or financial statement disclosures.


Revenue from Contracts with Customers

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (or ASU 2014-09).  The ASU requires an entity to recognize revenue in an amount that reflects the consideration to which it expects to be entitled for the transfer of promised goods or services to customers.  ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. ASU 2014-09 originally would have been effective for public business entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2016.  Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. On April 29, 2015, the FASB proposed a one-year deferral of the effective date for ASU 2014-09. On July 9, 2015 the FASB affirmed its proposal to defer the effective date of the new revenue standard for all entities by one year. As a result, public entities would apply the new revenue standard to annual reporting periods beginning after December 15, 2017 and interim periods therein. The FASB would also permit entities to adopt the standard early, but not before the original public entity effective date. Based on our initial evaluation of this ASU, we do not expect its adoption will have a material impact on our financial position or financial statement disclosures as the majority of the Company’s revenues are generated by financial instruments that are explicitly scoped out of this ASU. We will continue to monitor overall industry efforts to implement this ASU, including evaluating recent implementation questions and practice issues that may impact our business. As this monitoring effort continues, we will continue to assess potential impacts to our financial reporting procedures and controls (if any) as well as any impact on our financial position or financial statement disclosures.




Liquidity and Capital Resources
 
General
 
Our principal sources of cash generally consist of borrowings under repurchase agreements and other collateralized financings, payments of principal and interest we receive on our investment portfolio, cash generated from our operating results and, to the extent such transactions are entered into, proceeds from capital market and structured financing transactions. Our most significant uses of cash are generally to pay principal and interest on our financing transactions, to purchase residential mortgage assets, to make dividend payments on our capital stock, to fund our operations, to meet margin calls and to make other investments that we consider appropriate.


We seek to employ a diverse capital raising strategy under which we may issue capital stock and other types of securities. To the extent we raise additional funds through capital market transactions, we currently anticipate using the net proceeds from such transactions to acquire additional residential mortgage-related assets, consistent with our investment policy, and for working capital, which may include, among other things, the repayment of our financing transactions.  There can be no assurance, however, that we will be able to access the capital markets at any particular time or on any particular terms.  We have available for issuance an unlimited amount (subject to the terms and limitations of our charter) of common stock, preferred stock, depositary shares representing preferred stock, warrants, debt securities, rights and/or units pursuant to our automatic shelf registration statement and, at September 30, 2017,March 31, 2020, we had 13.0approximately 8.8 million shares of common stock available for issuance pursuant to our DRSPP shelf registration statement.  During the ninethree months ended September 30, 2017,March 31, 2020, we issued 1,516,307106,949 shares of common stock through our DRSPP, raising net proceeds of approximately $12.2 million.$691,979. During the three months ended March 31, 2020, we did not sell any shares of common stock through the ATM Program.

On March 2, 2020, we completed the issuance of 11.0 million shares of our Series C Preferred Stock with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The total net proceeds we received from the offering were approximately $266.0 million, after deducting offering expenses and the underwriting discount.


Impact of COVID-19 Pandemic; Repurchase Obligations

As discussed above under “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Senior Secured Financing and Exit from Forbearance”, due to the severe market volatility and price dislocations resulting from concerns driven by the COVID-19 pandemic, in March 2020 we were unable to meet all of our margin call obligations with respect to our repurchase obligations. As a result of these events, we initiated forbearance discussions with our financing counterparties and entered into a series of Forbearance Agreements (the Initial FBA, the Second FBA and the Third FBA) whereby certain of our counterparties agreed to forbear from exercising their rights and remedies with respect to an event of default under the applicable financing arrangement for an agreed upon period, including selling collateral to enforce margin calls. The Third FBA was set to expire on June 26, 2020. On June 15, 2020, we and certain of our wholly owned subsidiaries entered into a credit agreement for a $500 million Term Loan Facility. In connection with, and conditioned on, the funding of the Term Loan Facility, the Company also executed on June 15, 2020 a commitment letter to enter into a non-mark-to-market term loan facility for an aggregate amount of up to $1,650,000,000 (the “Asset Level Debt Facility”). Further details related to the Term Loan Facility and the Asset Level Debt Facility are discussed in “Note 16. Subsequent Events” in our interim financial statements as of and for the three months ended March 31, 2020. Following closing and funding of these transactions, we expect to execute a Reinstatement Agreement with our repurchase agreement counterparties that will terminate the Third FBA and provide for our exit from forbearance.

Our borrowings under repurchase agreements are uncommitted and renewable at the discretion of our lenders and, as such, our lenders could determine to reduce or terminate our access to future borrowings at virtually any time.  The terms of the repurchase transaction borrowings under our master repurchase agreements, as such terms relate to repayment, margin requirements and the segregation of all securities that are the subject of repurchase transactions, generally conform to the terms contained in the standard master repurchase agreement published by the Securities Industry and Financial Markets Association (or SIFMA) or the global master repurchase agreement published by SIFMA and the International Capital Market Association.  In addition, each lender typically requires that we include supplemental terms and conditions to the standard master repurchase agreement.  Typical supplemental terms and conditions, which differ by lender, may include changes to the margin maintenance requirements, required haircuts (as defined below), purchase price maintenance requirements, requirements that all controversies related to the repurchase agreement be litigated in a particular jurisdiction and cross default and setoff provisions.
 
With respect to margin maintenance requirements for repurchase agreements secured by harder to value assets, such as residential whole loans, Non-Agency MBS and residential whole loans,MSR-related assets, margin calls are typically determined by our counterparties based on their assessment of changes in the fair value of the underlying collateral and in accordance with the agreed upon haircuts specified in the transaction confirmation with the counterparty.  We address margin call requests in accordance with the required terms specified in the applicable repurchase agreement and such requests are typically satisfied by posting additional cash or collateral on the same business day.  We review margin calls made by counterparties and assess them for reasonableness by comparing the counterparty valuation against our valuation determination.  When we believe that a margin call is unnecessary because our assessment of collateral value differs from the counterparty valuation, we typically hold discussions with the counterparty and are able to resolve the matter.  In the unlikely event that resolution cannot be reached, we will look to resolve the dispute based on the remedies available to us under the terms of the repurchase agreement, which in some instances may include the engagement of a third-party to review collateral valuations.  For certain other agreements that do not include such provisions, we could resolve the matter by substituting collateral as permitted in accordance with the agreement or otherwise request the counterparty to return the collateral in exchange for cash to unwind the financing.
 

The following table presentstables present information regarding the margin requirements, or the percentage amount by which the collateral value is contractually required to exceed the loan amount (this difference is referred to as the “haircut”), on our repurchase agreements at September 30, 2017March 31, 2020 and December 31, 20162019:
 
At September 30, 2017
Weighted
Average
Haircut

Low
High
At March 31, 2020
Weighted
Average
Haircut

Low
High
Repurchase agreement borrowings secured by:
 

 

 

 

 

 
Residential whole loans (1)
 19.17% 8.00% 50.00%
Agency MBS
4.62% 3.00% 5.00%
4.99
 4.00
 6.00
Legacy Non-Agency MBS
22.40
 15.00
 35.00

21.60
 15.00
 50.00
RPL/NPL MBS 21.58
 20.00
 27.50
 20.30
 15.00
 25.00
U.S. Treasury securities
1.39
 1.00
 2.00
CRT securities 22.05
 15.00
 25.00
 20.89
 12.50
 35.00
MSR related assets 33.76
 30.00
 50.00
Residential whole loans 28.35
 20.00
 35.00
MSR-related assets 22.11
 20.00
 30.00
Other 21.88
 20.00
 35.00
            
At December 31, 2016
Weighted
Average
Haircut
 Low High
At December 31, 2019
Weighted
Average
Haircut
 Low High
Repurchase agreement borrowings secured by:
 
  
  
 
  
  
Residential whole loans (2)
 20.07% 8.00% 50.00%
Agency MBS
4.67% 3.00% 6.00%
4.46
 3.00
 5.00
Legacy Non-Agency MBS
24.01
 15.00
 60.00

20.27
 15.00
 35.00
RPL/NPL MBS 20.98
 15.00
 30.00
 21.52
 15.00
 30.00
U.S. Treasury securities
1.60
 1.00
 2.00
CRT securities 23.22
 20.00
 25.00
 18.84
 12.50
 25.00
MSR related assets 41.40
 35.00
 50.00
Residential whole loans 25.03
 20.00
 35.00
MSR-related assets 21.18
 20.00
 30.00
Other 22.01
 20.00
 35.00

(1)At March 31, 2020, includes repurchase agreements with an aggregate balance of $146.3 million secured by RPL/NPL MBS obtained in connection with our loan securitization transactions that are eliminated in consolidation. Such repurchase agreements had a weighted average haircut of 29.7%, a minimum haircut of 15.0%, and a maximum haircut of 50.0%.
(2)At December 31, 2019, includes repurchase agreements with an aggregate balance of $146.3 million secured by RPL/NPL MBS obtained in connection with our loan securitization transactions that are eliminated in consolidation. Such repurchase agreements had a weighted average haircut of 29.7%, a minimum haircut of 15.0%, and a maximum haircut of 50.0%.
 
During the first ninethree months of 2017,2020, the weighted average haircut requirements for the respective underlying collateral types for our repurchase agreements have remained fairly consistent compared to the end of 2016. Weighted average haircuts have decreased on MSR related assets, Legacy Non-Agency MBS and CRT securities and have increased on Residential whole loans and RPL/NPL MBS.2019.
 
RepurchasePrior to the onset of COVID-19-related market disruptions and entry into the several forbearance agreements with our repurchase agreement counterparties, funding for our residential mortgage investments has beenwas available to us at generally attractive market terms from multiple counterparties.  Typically, due to the risks inherent in credit sensitive residential mortgage investments, repurchase agreement funding involving such investments is available at terms requiring higher collateralization and higher interest rates than repurchase agreement funding secured by Agency MBSMBS. In connection with our preparing for an exit from forbearance we are currently renegotiating the terms of our financing arrangements with certain of our existing repurchase agreement counterparties. While the final terms of any renegotiated agreements are not yet known and U.S. Treasury securities.  Therefore,there can be no assurance that we generally expect towill be able to financereach definitive agreements with our acquisitionscounterparties through such ongoing negotiations, the revised terms will likely include changes to terms that exist in our current financing agreements, including increasing the term to maturity, higher haircut levels (and consequently lower advance rates) and higher interest rate charged and changes to the types of Agency MBS on more favorable terms than financing for credit sensitive investments.

We maintain cashcollateral accepted and cash equivalents, unpledged Agency and Non-Agency MBS and collateral in excessthe operation of margin requirements, held byincluding collateral mark-to-market provisions.

We expect that we will continue to pledge residential mortgage assets as part of certain of our counterparties (or collectively, “cashongoing financing arrangements.  Our current financing agreements, and other unpledged collateral”)we anticipate that certain of our future arrangements, will require us to meet routinepledge additional collateral in the event the market value of the assets pledged decreases in order maintain the lenders’ contractually specified collateral cushion, which is measured as the difference between the loan amount and the market value of the asset pledged as collateral. As we experienced in the first quarter of 2020, when the value of our residential mortgage assets pledged as collateral experienced rapid decreases, margin calls and protect against unforeseen reductionsunder our repurchase agreement financing arrangements could increase, causing an

adverse change in our borrowing capabilities.  liquidity position.  Additionally, if one or more of our financing counterparties chose not to provide ongoing funding, our ability to finance our long-maturity assets would decline or otherwise become available on possibly less advantageous terms.  Further, when liquidity tightens, our repurchase agreement counterparties may increase their required collateral cushion (or margin) requirements on new financings, including repurchase agreement financings that we roll with the same counterparty, thereby reducing our ability to use leverage.  Access to financing may also be negatively impacted by the ongoing volatility in financial markets, thereby potentially adversely impacting our current or future lenders’ ability or willingness to provide us with financing. In addition, there is no assurance that favorable market conditions will exist to permit us to consummate additional securitization transactions if we determine to seek that form of financing.

Our ability to meet future margin calls will be impactedaffected by our ability to use cash or obtain financing from unpledged collateral, the amount of which can vary based on the market value of such collateral, our cash position and margin requirements.  Our cash position fluctuates based on the timing of our operating, investing and financing activities and is managed based on our anticipated cash needs.  (See our Consolidated Statements of Cash Flows, included under Item 1 of this Quarterly Report on Form 10-Q and “Interest Rate Risk” included under Item 3 of this Quarterly Report on Form 10-Q.)
 
At September 30, 2017,March 31, 2020, we had a total of $8.5$8.8 billion of MBS, U.S. Treasury securities, CRT securities, residential whole loans, and MSR relatedMBS, CRT securities, MSR-related assets and $15.4other interest-earning assets and $216.9 million of restricted cash pledged against our repurchase agreements andand/or Swaps. At September 30, 2017,March 31, 2020, we havehad access to various sources of liquidity which we estimate exceeds $1.2 billion.estimated exceeded $176.1 million. This amount includes (i) $608.2$116.5 million of cash and cash equivalents; (ii) $186.0$56.1 million in estimated financing available from unpledged Agency MBS and other Agency MBS collateral that is currentlywas pledged in excess of contractual requirements; and (iii) $363.4$3.5 million in estimated financing available from unpledged Non-Agency MBS.MBS and from other Non-Agency MBS and CRT collateral that was pledged in excess of contractual requirements. Our sources of liquidity do not include restricted cash. In addition, we have $682.7 million of unencumbered residential whole loans. We are evaluating potential opportunities to finance our residential whole loans, including loan securitization.



The table below presents certain information about our borrowings under repurchase agreements and other advances, and securitized debt:
  Repurchase Agreements and Other Advances 
Securitized Debt (1)
Quarter Ended (2)
 Quarterly
Average
Balance
 End of Period
Balance
 Maximum
Balance at Any
Month-End
 Quarterly
Average
Balance
 End of Period
Balance
 Maximum
Balance at Any
Month-End
(In Thousands)            
September 30, 2017 $7,022,913
 $6,871,443
 $7,023,702
 $139,276
 $137,327
 $141,088
June 30, 2017 7,612,393
 7,040,844
 7,763,860
 30,414
 143,698
 143,698
March 31, 2017 8,494,853
 8,137,102
 8,564,493
 
 
 
December 31, 2016 8,684,803
 8,687,268
 8,815,846
 
 
 
September 30, 2016 8,868,173
 8,697,756
 8,917,550
 
 
 
  Repurchase Agreements Securitized Debt
Quarter Ended (1)
 Quarterly
Average
Balance
 End of Period
Balance
 Maximum
Balance at Any
Month-End
 Quarterly
Average
Balance
 End of Period
Balance
 Maximum
Balance at Any
Month-End
(In Thousands)            
March 31, 2020 $9,233,808
 $7,768,180
 $9,486,555
 $558,007
 $533,733
 $562,681
December 31, 2019 8,781,646
 9,139,821
 9,139,821
 590,813
 570,952
 594,458
September 30, 2019 8,654,350
 8,571,422
 8,833,159
 617,689
 605,712
 621,071
June 30, 2019 8,621,895
 8,630,642
 8,639,311
 645,972
 627,487
 649,405
March 31, 2019 7,672,309
 7,879,087
 7,879,087
 699,207
 684,420
 702,377


(1)The information presented in the table above excludes $230.0 million of Convertible Senior Notes issued in June 2019 and $100.0 million of Senior Notes issued in April 2012. The outstanding balance of both the Convertible Senior Notes and Senior Notes have been unchanged since issuance.

(1) Reflects securitized debt from our loan securitization transaction in June 2017
(2)  The information presented in the table above excludes Senior Notes issued in April 2012. The outstanding balance of Senior Notes has been unchanged at $100.0 million since issuance.


Cash Flows and Liquidity for the NineThree Months Ended September 30, 2017March 31, 2020
 
Our cash, and cash equivalents and restricted cash increased by $348.1$198.7 million during the ninethree months ended September 30, 2017,March 31, 2020, reflecting: $1.9 billion$822.2 million provided by our investing activities, primarily from payments on$636.8 million used in our MBS; $119.0financing activities and $13.2 million provided by our operating activities; and $1.7 billion used in our financing activities.
 
At September 30, 2017,March 31, 2020, our debt-to-equity multiple was 2.43.4 times compared to 3.13.0 times at December 31, 2016.2019. At September 30, 2017,March 31, 2020, we had borrowings under repurchase agreements of $6.9$7.8 billion, with 31 counterparties, of which $2.7$4.7 billion were secured by residential whole loans, $522.2 million were secured by Agency MBS, $1.4$1.0 billion were secured by Legacy Non-Agency MBS, $798.5$255.4 million were secured by RPL/NPL MBS, $474.7 million were secured by U.S. Treasuries, $413.2$297.6 million were secured by CRT securities, $268.8$929.9 million were secured by MSR relatedMSR-related assets and $883.4$59.8 million were secured by residential whole loans.  We continue to have available capacity under our repurchase agreement credit lines.other interest-earning assets.   In addition, at September 30, 2017,March 31, 2020, we had securitized debt of $137.3$533.7 million in connection with our loan securitization transaction in June 2017.transactions. At December 31, 2016,2019, we had borrowings under repurchase agreements of $8.5$9.1 billion, with 31 counterparties, of which $3.1$4.7 billion were secured by residential whole loans, $1.6 billion were secured by Agency MBS, $1.7$1.1 billion were secured by Legacy Non-Agency MBS, $1.9 billion$495.1 million were secured by RPL/NPL MBS, $504.6 million were secured by U.S. Treasuries, $271.2$203.6 million were secured by CRT securities, $135.1$962.5 million were secured by MSR relatedMSR-related assets and $832.1$57.2 million were secured by residential whole loans.other

interest-earning assets. In addition, at December 31, 2016,2019, we had $215.0securitized debt of $571.0 million in outstanding FHLB advances, secured by Agency MBS, all of which were repaid in January 2017.connection with our loan securitization transactions.


During the ninethree months ended September 30, 2017, $1.9 billionMarch 31, 2020, $822.2 million was provided throughby our investing activities.  We paid $1.1 billion for purchases of residential whole loans, loan related investments and capitalized advances, and purchased $3.9 million of MSR-related assets and $158.7 million of CRT securities funded with cash and repurchase agreement borrowings.  In addition, during the three months ended March 31, 2020, we received cash of $3.4 billion$539.9 million from prepayments and scheduled amortization on our MBS, CRT securities and MSR relatedMSR-related assets, of which $675.6$122.9 million was attributable to Agency MBS, $2.6 billion$383.1 million was from Non-Agency MBS, and $12.1 million was from CRT securities and $140.1$33.2 million was attributable to MSR related assets.  We purchased $718.9 million of Non-Agency MBS, $238.8 million ofMSR-related assets, and approximately $700,000 was attributable to CRT securities, $325.4 millionand we sold certain of MSR relatedour investment securities and MSR-related assets and $3.2 millionfor $1.0 billion, realizing net losses of Agency MBS funded with cash and repurchase agreement borrowings.$92.6 million. While we generally intend to hold our MBS and CRT securities as long-term investments, we may sell certain of our securities in order to manage our interest rate risk and liquidity needs, meet other operating objectives and adapt to market conditions. In addition, duringparticular, subsequent to the nineend of the first quarter, we sold the vast majority of our remaining Agency MBS and Legacy Non-Agency MBS portfolios and substantially reduced our investments in MSR-related assets and CRT securities. During the three months ended September 30, 2017March 31, 2020 we sold certainreceived $508.9 million of our Non-Agency MBSprincipal payments on residential whole loans and U.S. Treasury securities for $222.1$52.0 million realizing net gains of $30.5 million.proceeds on sales of REO. 
 
In connection with our repurchase agreement borrowingsfinancings and Swaps, we routinely receive margin calls/reverse margin calls from our counterparties and make margin calls to our counterparties.  Margin calls and reverse margin calls, which requirements vary over time, may occur daily between us and any of our counterparties when the value of collateral pledged changes from the amount contractually required.  The value of securities pledged as collateral fluctuates reflecting changes in: (i) the face (or par) value of our MBS;assets; (ii) market interest rates and/or other market conditions; and (iii) the market value of our Swaps.  Margin calls/reverse margin calls are satisfied when we pledge/receive additional collateral in the form of additional securitiesassets and/or cash.
 

The table below summarizes our margin activity with respect to our repurchase agreement financings and derivative hedging instruments for the quarterly periods presented.presented:
 
  Collateral Pledged to Meet Margin Calls 
Cash and
Securities Received for
Reverse Margin Calls
 Net Assets
Received/(Pledged) for Margin Activity
For the Quarter Ended Fair Value of
Securities
Pledged
 Cash Pledged Aggregate Assets
Pledged For
Margin Calls
  
(In Thousands)          
September 30, 2017 $83,513
 $
 $83,513
 $53,499
 $(30,014)
June 30, 2017 106,432
 500
 106,932
 75,996
 (30,936)
March 31, 2017 150,264
 1,500
 151,764
 246,168
 94,404
December 31, 2016 337,694
 8,000
 345,694
 357,163
 11,469
September 30, 2016 343,351
 28,700
 372,051
 343,139
 (28,912)
  Collateral Pledged to Meet Margin Calls 
Cash and
Securities Received for
Reverse Margin Calls
 Net Assets
Received/(Pledged) for Margin Activity
For the Quarter Ended (1)
 Fair Value of
Securities
Pledged
 Cash Pledged Aggregate Assets
Pledged For
Margin Calls
  
(In Thousands)          
March 31, 2020 $30,187
 $213,392
 $243,579
 $67,343
 $(176,236)
December 31, 2019 
 26,972
 26,972
 18,311
 (8,661)
September 30, 2019 77,214
 35,271
 112,485
 129,132
 16,647
June 30, 2019 26,037
 1,019
 27,056
 7,295
 (19,761)
March 31, 2019 49,139
 
 49,139
 65,461
 16,322
 
(1) Excludes variation margin payments on the Company’s cleared Swaps which are treated as a legal settlement of the exposure under the Swap contract.

We are subject to various financial covenants under our repurchase agreements and derivative contracts, which include minimum net worth and/or profitability requirements, net worth decline limitations and maximum debt-to-equity ratiosratios.
As a result of the turmoil in the financial markets resulting from the spread of the novel coronavirus and minimum market capitalization requirements.  We have maintained compliance with allthe global COVID-19 virus pandemic, on March 25, 2020, in order to preserve liquidity, we revoked the previously announced first quarter 2020 quarterly cash dividends on each of our financial covenants through September 30, 2017.
During the nine months ended September 30, 2017, we paid $229.0 million forcommon stock and Series B Preferred Stock. The quarterly cash dividendsdividend of $0.20 per share on our common stock had been declared on March 11, 2020, and was to be paid on April 30, 2020, to stockholders of record as of the close of business March 31, 2020. The Series B Preferred Stock dividend equivalentsof $0.46875 per share had been declared on February 14, 2020, and was to be paid cashon March 31, 2020, to stockholders of record as of the close of business March 2, 2020. On June 1, 2020, we announced that we were suspending the second quarter 2020 dividends of $11.3 millionon the Series B Preferred Stock and on our preferred stock. On September 14, 2017, we declared6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock. Our payment of dividends is, with limited exceptions, prohibited under the terms of the Forbearance Agreement currently in place with our third quarter 2017 dividendrepurchase agreement counterparties. Unpaid dividends on our Series B Preferred Stock and Series C Preferred Stock will accumulate without interest. No dividends may be paid or set apart on shares of our common stock of $0.20 per share;unless full cumulative dividends on October 31, 2017,the Series B Preferred

Stock and Series C Preferred Stock for all past dividend periods that have ended have been or contemporaneously are paid in cash, or a sum sufficient for such payment is set apart for payment.

In connection with our anticipated exit from forbearance, we paid this dividend, which totaled approximately $79.6 million, including dividend equivalents of approximately $205,000. 
We believe that we have adequate financial resourcesexpect to meet our current obligations, including margin calls, as they come due, to fundpay all accumulated unpaid dividends we declare and to actively pursue our investment strategies.  However, should the value of our MBS suddenly decrease, significant margin calls on our repurchase agreement borrowings could resultSeries B Preferred Stock and our liquidity position could be materiallySeries C Preferred Stock. We will continue to monitor market conditions and adversely affected.  Further, should market liquidity tighten, our repurchase agreement counterparties may increase our margin requirements on new financings, reducing our ability to use leverage.  Access to financing may also be negatively impacted bythe potential impact the ongoing volatility in the world financial markets, potentially adversely impactingand uncertainty may have on our current or potential lenders’ ability or willingness to provide us with financing. In addition, there is no assurance that favorable market conditionsbusiness. Related thereto, our Board of Directors will continue to permit usevaluate liquidity and the payment of dividends as market conditions evolve, including as related to consummate additional securitization transactions if we determine to seek that form of financing.dividends on common stock.
 

Off-Balance Sheet Arrangements
 
We dohave not participated in transactions that create relationships with unconsolidated entities or financial partnerships which would have any materialbeen established for the purpose of facilitating off-balance sheet arrangements.arrangements or other contractually narrow or limited purposes.


Inflation
 
Substantially all of our assets and liabilities are financial in nature.  As a result, changes in interest rates and other factors impact our performance far more than does inflation.  Our results of operations and reported assets, liabilities and equity are measured with reference to historical cost or fair value without considering inflation.



Item 3.  Quantitative and Qualitative Disclosures About Market Risk.
 
We seek to manage our risks related to interest rates, liquidity, prepayment speeds, market value and the credit quality of our assets while, at the same time, seeking to provide an opportunity to stockholders to realize attractive total returns through ownership of our capital stock.  While we do not seek to avoid risk, we seek, consistent with our investment policies, to:  assume risk that can be quantified based on management’s judgment and experience and actively manage such risk; earn sufficient returns to justify the taking of such risks; and maintain capital levels consistent with the risks that we undertake.




Interest Rate Risk
  
We generally acquire interest-rate sensitive assets and fund them with interest-rate sensitive liabilities, a portion of which are typically hedged with Swaps. We are exposed to interest rate risk on our residential mortgage assets, as well as on our liabilities. Changes in interest rates can affect our net interest income and the fair value of our assets and liabilities. The latter part of the first quarter of 2020 was characterized by volatility in interest rates and pricing dislocations in markets for residential mortgage assets. As our swap hedges did not operate as effective hedges during this turbulent period we unwound all of our Swaps late in the first quarter.
We currently finance the majority of our investments in residential mortgage assets with short-term repurchase agreements. In general, when interest rates change, the borrowing costs of ouron such repurchase agreements (net of the impact of Swaps) will change more quickly than the yield on our assets. In a rising interest rate environment, the borrowing costs of our repurchase agreements may increase faster than the interest income on our assets, thereby reducing our net income. In order to mitigate compression in net income based on such interest rate movements, we use Swaps to lock in a portion of the net interest spread between assets and liabilities.


When interest rates change, the fair value of our residential mortgage assets could change at a different rate than the fair value of our liabilities. We measure the sensitivity of our portfolio to changes in interest rates by estimating the duration of our assets and liabilities. Duration is the approximate percentage change in fair value for a 100 basis point parallel shift in the yield curve. In general, our assets have higher duration than our liabilities and in order to reduce this exposure we use Swaps to reduce the gap in duration between our assets and liabilities.


The key factors that impact valuation and interest rate sensitivity of our residential mortgage assets are discussed below. In addition to these factors, as was observed in the first quarter of 2020, broader macro economic conditions can also impact the residential mortgage asset valuations.

The fair value of our re-performing residential whole loans is dependent on the value of the underlying real estate collateral, past and expected delinquency status of the borrower as well as the level of interest rates. For certain residential whole loans that were purchased as re-performing loans, because the borrower is not delinquent on their mortgage payments but is less likely to prepay the loan due to weak credit history and/or high LTV, we believe these loans exhibit positive duration. We estimate the duration of our re-performing residential whole loans using management’s assumptions.

The fair value of our Non-QM loans and Single-family rental loans are typically dependent on the value of the underlying real estate collateral, as well as the level of interest rates. Because these loans are primarily newly or recently originated performing loans, we believe these investments exhibit positive duration. Given the short duration of our Rehabilitation loans, we believe the fair value of these loans exhibits little sensitivity to changes in interest rates. We estimate the duration of these Purchased Performing Loans held at carrying value using management’s assumptions.
The fair value of our non-performing residential whole loans is typically primarily dependent on the value of the underlying real estate collateral and the time required for collateral liquidation. Since neither the value of the collateral nor the liquidation timeline is generally sensitive to interest rates, we believe their fair value exhibits little sensitivity to interest rates. We estimate the duration of our non-performing residential whole loans using management’s assumptions.

In calculating the duration of our Agency MBS we take into account the characteristics of the underlying mortgage loans including whether the underlying loans are fixed rate, adjustable or hybrid; coupon, expected prepayment rates and lifetime and periodic caps. We use third-party financial models, combined with management’s assumptions and observed empirical data when estimating the duration of our Agency MBS.


In analyzing the interest rate sensitivity of our Legacy Non-Agency MBS we take into account the characteristics of the underlying mortgage loans, including credit quality and whether the underlying loans are fixed-rate, adjustable or hybrid. We estimate the duration of our Legacy Non-Agency MBS using management’s assumptions.


The majority of our RPL/NPL MBS deal structures contain a contractual coupon step-up feature where the coupon increases up tofrom 300 - 400 basis points if the bond is not redeemed by the issuer at 36 - 48 months from issuance or sooner. Therefore, we believe their fair value exhibits little sensitivity to changes in interest rates. We estimate the duration of these securities using management’s assumptions.

The fair value of our re-performing residential whole loans is dependent on the value of the underlying real estate collateral, past and expected delinquency status of the borrower as well as the level of interest rates. Because the borrower is not delinquent on their mortgage payments but is less likely to prepay the loan due to weak credit history and/or high LTV, we believe our re-performing residential whole loans exhibit positive duration. We estimate the duration of our re-performing residential whole loans using management’s assumptions.

The fair value of our non-performing residential whole loans is primarily dependent on the value of the underlying real estate collateral and the time required for collateral liquidation. Since neither the value of the collateral nor the liquidation timeline is generally sensitive to interest rates, we believe their fair value exhibits little sensitivity to interest rates. We estimate the duration of our non-performing residential whole loans using management’s assumptions.


We typically use Swaps as part of our overall interest rate risk management strategy. Such derivative financial instruments are intended to act as a hedge against future interest rate increases on our repurchase agreement financings, which rates are typically highly correlated with LIBOR. While ouruse of such derivatives dodoes not extend the maturities of our borrowings under repurchase agreements, they do, in effect, lock in a fixed rate of interest over their term for a corresponding amount of our repurchase agreement financings that are hedged. 



At September 30, 2017, MFA’s $5.7March 31, 2020, our $1.6 billion of Agency MBS and Legacy Non-Agency MBS were backed by Hybrid, adjustable and fixed-rate mortgages.  Additional information about these MBS, including average months to reset and three-month average CPR, is presented below:below. Subsequent to March 31, 2020, we disposed of the vast majority of our investments in Agency MBS and Legacy Non-Agency MBS:
 
 Agency MBS 
Legacy Non-Agency MBS (1)
 
Total (1)
 Agency MBS 
Legacy Non-Agency MBS (1)
 
Total (1)
Time to Reset 
 Fair
Value (2)
 
Average Months to Reset (3)
 
3 Month 
Average CPR (4)
  Fair Value 
Average Months to Reset (3)
 
3 Month 
Average CPR
(4)
 
 Fair
Value (2)
 
Average Months to Reset (3)
 
3 Month 
Average CPR
(4)
 
 Fair
Value (2)
 
Average Months to Reset (3)
 
3 Month 
Average CPR (4)
  Fair Value 
Average Months to Reset (3)
 
3 Month 
Average CPR
(4)
 
 Fair
Value (2)
 
Average Months to Reset (3)
 
3 Month 
Average CPR
(4)
(Dollars in Thousands)  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
< 2 years (5)
 $1,597,666
 8
 20.4% $1,845,110
 5
 19.0% $3,442,776
 6
 19.6% $290,259
 5
 11.6% $645,380
 4
 13.5% $935,639
 5
 12.7%
2-5 years 144,494
 46
 12.0
 
 
 
 144,494
 46
 12.0
 76,273
 33
 11.8
 
 
 
 76,273
 33
 11.8
> 5 years 60,033
 67
 12.8
 
 
 
 60,033
 67
 12.8
 1,576
 87
 0.2
 
 
 
 1,576
 87
 0.2
ARM-MBS Total $1,802,193
 13
 19.5% $1,845,110
 5
 19.0% $3,647,303
 9
 19.2% $368,108
 11
 11.6% $645,380
 4
 13.5% $1,013,488
 7
 12.6%
15-year fixed (6)
 $1,216,047
  
 11.4% $3,250
  
 12.9% $1,219,297
  
 11.4% $170,290
  
 13.5% $418
  
 12.6% $170,708
  
 13.5%
30-year fixed (6)
 
  
 
 830,457
  
 18.3
 830,457
  
 18.3
 14,499
  
 20.6
 378,228
  
 13.9
 392,727
  
 14.0
40-year fixed (6)
 
  
 
 37,910
  
 15.1
 37,910
  
 15.1
 
  
 
 34,254
  
 12.4
 34,254
  
 12.4
Fixed-Rate Total $1,216,047
  
 11.4% $871,617
  
 18.1% $2,087,664
  
 14.4% $184,789
  
 13.6% $412,900
  
 13.6% $597,689
  
 13.6%
MBS Total $3,018,240
  
 16.2% $2,716,727
  
 18.7% $5,734,967
  
 17.5% $552,897
  
 12.6% $1,058,280
   13.6% $1,611,177
   13.1%
 
(1)Excludes $1.2 billion$80.0 million of RPL/NPL MBS. Refer to table below for further information.
(2)Does not include principal payments receivable of $1.1 million.$516,000.
(3)Months to reset is the number of months remaining before the coupon interest rate resets.  At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic and/or lifetime caps.  The months to reset do not reflect scheduled amortization or prepayments.
(4)3 month average CPR weighted by positions as of the beginning of each month in the quarter.
(5)Amounts presented are based on origination data. Includes floating-rate MBS that may be collateralized by fixed-rate mortgages. In addition, underlying loans may have been modified to be fixed or step rate.
(6)Information presented based on data available at time of loan origination.




The following table presents certain information about our RPL/NPL MBS portfolio at September 30, 2017March 31, 2020:
 Fair Value Net Coupon 
Months to
Step-Up (1)
 
3 Month Average
Bond CPR (2)
(Dollars in Thousands)         Fair Value Net Coupon 
Months to
Step-Up (1)
 
3 Month Average
Bond CPR (2)
Re-Performing loans $84,012
 3.65% 32
 43.0% $
 % 
 %
Non-Performing loans 1,110,920
 4.25
 21
 22.6
 79,464
 4.82
 27
 34.4
Total RPL/NPL MBS $1,194,932
 4.21% 22
 26.2% $79,464
 4.82% 27
 34.4%


(1)Months to step-up is the weighted average number of months remaining before the coupon interest rate increases pursuant to the first coupon reset. We anticipate that the securities will be redeemed prior to the step-up date.
(2)All principal payments are considered to be prepayments for CPR purposes.


At September 30, 2017,March 31, 2020, our CRT securities and MSR relatedMSR-related assets had a fair value of $653.6$254.1 million and $411.8$738.1 million, respectively, and their coupons reset monthly based on one-month LIBOR. Subsequent to March 31, 2020 we significantly reduced our holdings of CRT securities and MSR-related assets.



The interest rates for the vast majority of our investments, financings and hedging transactions are either explicitly or indirectly based on LIBOR. On July 27, 2017, the United Kingdom Financial Conduct Authority announced that it intends to stop persuading or compelling banks to submit LIBOR rates after 2021. At this time, it is not possible to predict the effect of such change, including the establishment of potential alternative reference rates, on the economy or markets we are active in either currently or in the future, or on any of our assets or liabilities whose interest rates are based on LIBOR. We are in the process of evaluating the potential impact of a discontinuation of LIBOR after 2021 on our portfolio, as well as the related accounting impact. However, we expect that during the remainder of 2020, we will work closely with the Trustee companies and/or other entities that are involved in calculating the interest rates for our residential mortgage securities and securitized debt, our loan servicers for our hybrid and floating rate loans, and with the various counterparties to our financing and hedging transactions in order to determine what changes, if any, are required to made to existing agreements for these transactions.
Shock Table


The information presented in the following “Shock Table” projects the potential impact of sudden parallel changes in interest rates on our net interest income and portfolio value including the impact of Swaps, over the next 12 months based on the assets in our investment portfolio at September 30, 2017March 31, 2020.  All changes in income and value are measured as the percentage change from the projected net interest income and portfolio value under the base interest rate scenario at September 30, 2017March 31, 2020.

It should be noted that as we have disposed of a significant portfolio of our investments in residential mortgage securities and MSR-related assets subsequent to the end of the first quarter of 2020, the interest rate sensitivity of our remaining portfolio may not be reflective of the results implied in the table below.
Change in Interest Rates 
Estimated
Value
of Assets 
(1)
 Estimated
Value of
Swaps
 Estimated
Value of
Financial
Instruments
 
Change in
Estimated
Value
 Percentage
Change in Net
Interest
Income
 Percentage
Change in
Portfolio
Value
 
Estimated
Value
of Assets 
(1)
 Estimated
Value of Securitized and Other Fixed Rate Debt
 Estimated
Value of
Financial
Instruments
 
Change in
Estimated
Value
 Percentage
Change in Net
Interest
Income
 Percentage
Change in
Portfolio
Value
(Dollars in Thousands)                        
+100 Basis Point Increase $10,411,914
 $27,911
 $10,439,825
 $(85,728) (3.08)% (0.81)% $10,326,036
 $(41,223) $10,284,813
 $(218,692) (19.12)% (2.08)%
+ 50 Basis Point Increase $10,485,268
 $(1,070) $10,484,198
 $(41,355) (1.80)% (0.39)% $10,451,785
 $(48,805) $10,402,980
 $(100,525) (10.28)% (0.96)%
Actual at September 30, 2017 $10,555,603
 $(30,050) $10,525,553
 $
 
 
Actual at March 31, 2020 $10,559,892
 $(56,387) $10,503,505
 $
  %  %
- 50 Basis Point Decrease $10,622,921
 $(59,030) $10,563,891
 $38,338
 (1.41)% 0.36 % $10,650,358
 $(63,969) $10,586,389
 $82,884
 8.35 % 0.79 %
-100 Basis Point Decrease $10,687,220
 $(88,011) $10,599,209
 $73,656
 (1.68)% 0.70 % $10,723,183
 $(71,551) $10,651,632
 $148,127
 16.00 % 1.41 %


(1)  Such assets include MBS and CRT securities, residential whole loans and REO, MSR relatedMBS and CRT securities, MSR-related assets, cash and cash equivalents and restricted cash.


Certain assumptions have been made in connection with the calculation of the information set forth in the Shock Table and, as such, there can be no assurance that assumed events will occur or that other events will not occur that would affect the outcomes.  The base interest rate scenario assumes interest rates at September 30, 2017.March 31, 2020.  The analysis presented utilizes assumptions and estimates based on management’s judgment and experience.  Furthermore, while we generally expect to retain the majority of our assets and the associated interest rate risk to maturity, future purchases and sales of assets could materially change our interest rate risk profile.  It should be specifically noted that the information set forth in the above table and all related disclosure constitute forward-looking statements within the meaning of Section 27A of the 1933 Act and Section 21E of the 1934 Act.  Actual results could differ significantly from those estimated in the Shock Table above.
 
The Shock Table quantifies the potential changes in net interest income and portfolio value, which includes the value of our Swapssecuritized and other fixed rate date (which are carried at fair value), should interest rates immediately change (i.e., are shocked).  The Shock Table presents the estimated impact of interest rates instantaneously rising 50 and 100 basis points, and falling 50 and 100 basis points.  The cash flows associated with our portfolio of MBS for each rate shock are calculated based on assumptions, including, but not limited to, prepayment speeds, yield on replacement assets, the slope of the yield curve and composition of our portfolio.  Assumptions made with respect to the interest rate sensitive liabilities include anticipated interest rates, collateral requirements as a percent of repurchase agreement financings, and the amounts and terms of borrowing.  At September 30, 2017,March 31, 2020, we applied a floor of 0% for all anticipated interest rates included in our assumptions.  Due to this floor, it is anticipated that any hypothetical interest rate shock decrease would have a limited positive impact on our funding costs; however, because prepayments speeds are unaffected by this floor, it is expected that any increase in our prepayment speeds (occurring as a result of any interest rate shock decrease or otherwise) could result in an acceleration of premium amortization on our Agency MBS and discount accretion on our Non-Agency MBS and in the reinvestment of principal repayments in lower yielding assets.  As a result, because the presence of this floor limits the positive impact of interest rate decrease on our funding costs, hypothetical interest rate shock decreases could cause a decline in the fair value of our financial instruments and our net interest income.

 
At September 30, 2017,March 31, 2020, the impact on portfolio value was approximated using estimated net effective duration (i.e., the price sensitivity to changes in interest rates), including the effect of Swaps,securitized and other fixed rate debt, of 0.761.70 which is the weighted average of 1.682.36 for our Residential whole loans, 1.18 for our Agency MBS, 1.281.07 for our Non-Agency investments, (2.30)(1.87) for our Swaps,securitized debt, and 0.05other fixed rate debt, and 0.20 for our Other assets and cash and cash equivalents. Estimated convexity (i.e., the approximate change in duration relative to the change in interest rates) of the portfolio was (0.11)(0.66), which is the weighted average of (0.40)(0.90) for our Residential whole loans, (0.61) for our Agency MBS, zero for our Swaps, zerosecuritized and other fixed rate debt, (0.15) for our Non-Agency MBS and zero for our Other assets and cash and cash equivalents. The impact on our net interest income is driven mainly by the difference between portfolio yield and cost of funding of our repurchase agreements, which includes the cost and/or benefit from Swaps.agreements.  Our asset/liability structure is generally such that an increase in interest rates would be expected to result in a decrease in net interest income, as our borrowings are generally shorter in term than our interest-earning assets. When interest rates are shocked, prepayment assumptions are adjusted based on management’s expectations along with the results from the prepayment model.



Credit Risk
 
Although we do not believe that we are exposed to credit risk in our Agency MBS portfolio, we are exposed to credit risk through our credit-sensitivecredit sensitive residential mortgage investments, in particular residential whole loans, Legacy Non-Agency MBS and residential whole loansCRT securities and to a lesser extent our investments in RPL/NPL MBS and MSR-related assets. As discussed above, since the end of the first quarter we have engaged in asset sales and taken other actions that significantly changed our asset composition subsequent to March 31, 2020. In particular, subsequent to the end of the first quarter, we sold the vast majority of our remaining Agency MBS and Legacy Non-Agency MBS portfolios and substantially reduced our investments in MSR-related assets and CRT securities and MSR related assets. securities. As a result, our primary credit risk currently relates to our residential whole loans.

Our exposure to credit risk from our credit sensitive investments is discussed in more detail below:

Residential Whole Loans

We are exposed to credit risk from our investments in residential whole loans. Our investment process for non-performing and Purchased Credit Deteriorated Loans is generally similar to that used for Legacy Non-Agency MBS (as discussed below) and is likewise focused on quantifying and pricing credit risk. Non-Performing and Purchased Credit Deteriorated Loans are acquired at purchase prices that are generally discounted to the contractual loan balances based on a number of factors, including the impaired credit history of the borrower and the value of the collateral securing the loan. In addition, as we generally own the mortgage-servicing rights associated with these loans, our process is also focused on selecting a sub-servicer with the appropriate expertise to mitigate losses and maximize our overall return. This involves, among other things, performing due diligence on the sub-servicer prior to their engagement as well as ongoing oversight and surveillance. To the extent that delinquencies and defaults on these loans are higher than our expectation at the time the loans were purchased, the discounted purchase price at which the asset is acquired is intended to provide a level of protection against financial loss.

Credit risk on Purchased Performing Loans is mitigated through our process to underwrite the loan before it is purchased and includes an assessment of the borrower’s financial condition and ability to repay the loan, nature of the collateral and relatively low LTV, including after-repair LTV for the majority of our Rehabilitation loans.


The following table presents certain information about our Residential whole loans, at carrying value at March 31, 2020:

  Purchased Performing Loans Purchased Credit Deteriorated Loans  
  Loans with an LTV: Loans with an LTV:  
(Dollars in Thousands) 80% or Below Above 80% 80% or Below Above 80% Total
Amortized cost $4,845,142
 $344,492
 $434,506
 $309,901
 $5,934,041
Unpaid principal balance (UPB) $4,749,863
 $336,094
 $477,667
 $380,455
 $5,944,079
Weighted average coupon (1)
 6.1% 6.3% 4.5% 4.4% 5.9%
Weighted average term to maturity (months) 279
 349
 269
 322
 285
Weighted average LTV (2)
 63.7% 86.9% 57.4% 108.9% 67.3%
Loans 90+ days delinquent (UPB) $115,212
 $4,733
 $44,426
 $62,234
 $226,605

(1)
Weighted average is calculated based on the interest bearing principal balance of each loan within the related category. For loans acquired with servicing rights released by the seller, interest rates included in the calculation do not reflect loan servicing fees. For loans acquired with servicing rights retained by the seller, interest rates included in the calculation are net of servicing fees.
(2)LTV represents the ratio of the total unpaid principal balance of the loan to the estimated value of the collateral securing the related loan as of the most recent date available, which may be the origination date. For Rehabilitation loans, the LTV presented is the ratio of the maximum unpaid principal balance of the loan, including unfunded commitments, to the estimated “after repaired” value of the collateral securing the related loan, where available. For certain Rehabilitation loans, totaling $259.4 million, an after repaired valuation was not obtained and the loan was underwritten based on an “as is” valuation. The LTV of these loans based on the current unpaid principal balance and the valuation obtained during underwriting, is 68%. Excluded from the calculation of weighted average LTV are certain low value loans secured by vacant lots, for which the LTV ratio is not meaningful.

The following table presents the five largest geographic concentrations by state of our residential whole loan portfolio at March 31, 2020:
Property LocationPercent of Interest-Bearing Unpaid Principal Balance
California36.2%
Florida12.6%
New York8.0%
New Jersey5.6%
Georgia3.2%

Legacy Non-Agency MBS


In the event of the return of less than 100% of par on our Legacy Non-Agency MBS, credit support contained in the MBS deal structures and the discounted purchase prices we paid mitigate our risk of loss on these investments.  Over time, we expect the level of credit support remaining in certain MBS deal structures to decrease, which will result in an increase in the amount of realized credit loss experienced by our Legacy Non-Agency MBS portfolio.  Our investment process for Legacy Non-Agency MBS involves analysis focused primarily on quantifying and pricing credit risk.  When we purchase Legacy Non-Agency MBS, we assign certain assumptions to each of the MBS, including but not limited to, future interest rates, voluntary prepayment rates, mortgage modifications, default rates and loss severities, and generally allocate a portion of the purchase discount as a Credit Reserve which provides credit protection for such securities.  As part of our surveillance process, we review our Legacy Non-Agency MBS by tracking their actual performance compared to the securities’ expected performance at purchase or, if we have modified our original purchase assumptions, compared to our revised performance expectations.  To the extent that actual performance of a Legacy Non-Agency MBS is less favorable than its expected performance, we may revise our performance expectations.  As a result, we could reduce the accretable discount on the security and/or recognize an other-than-temporary impairment charges through earnings, either of which could have a material adverse impact on our operating results. 


In evaluating our asset/liability management and Legacy Non-Agency MBS credit performance, we consider the credit characteristics of the mortgage loans underlying our Legacy Non-Agency MBS.  The following table presents certain information aboutSubsequent to March 31, 2020, we disposed of the vast majority of our investments in Legacy Non-Agency MBS portfolio at September 30, 2017.  Information presented with respect to the weighted average FICO scores and other information aggregated based on information reported at the time of mortgage origination are historical and, as such, do not reflect the impact of the general changes in home prices or changes in borrowers’ credit scores or the current use of the mortgaged properties.

The information in the table below is presented as of September 30, 2017:
  
Securities with Average Loan FICO
of 715 or Higher
(1)
 
Securities with Average Loan FICO
Below 715
(1)
  
Year of Securitization (2)
 2007 2006 2005
and Prior
 2007 2006 2005
and Prior
 Total
(Dollars in Thousands)  
  
  
  
  
  
  
Number of securities 84
 65
 90
 29
 57
 61
 386
MBS current face (3)
 $776,217
 $505,156
 $580,846
 $171,088
 $446,942
 $428,426
 $2,908,675
Total purchase discounts, net (3)
 $(229,043) $(143,950) $(107,878) $(56,606) $(169,151) $(129,206) $(835,834)
Purchase discount designated as Credit Reserve and OTTI (3)(4)
 $(145,118) $(74,508) $(57,820) $(46,116) $(165,468) $(104,104) $(593,134)
Purchase discount designated as Credit Reserve and OTTI as percentage of current face 18.7% 14.7% 10.0% 27.0% 37.0% 24.3% 20.4%
MBS amortized cost (3)
 $547,174
 $361,206
 $472,968
 $114,482
 $277,791
 $299,220
 $2,072,841
MBS fair value (3)
 $729,689
 $472,395
 $562,202
 $157,543
 $393,568
 $401,330
 $2,716,727
Weighted average fair value to current face 94.0% 93.5% 96.8% 92.1% 88.1% 93.7% 93.4%
Weighted average coupon (5)
 3.97% 3.45% 3.69% 4.93% 4.97% 4.74% 4.15%
Weighted average loan age (months) (5)(6)
 126
 135
 149
 131
 137
 148
 137
Weighted average current loan size (5)(6)
 $503
 $491
 $300
 $345
 $249
 $236
 $373
Percentage amortizing (7)
 99% 100% 100% 99% 99% 100% 100%
Weighted average FICO score at origination (5)(8)
 729
 729
 726
 705
 702
 703
 719
Owner-occupied loans 90.7% 90.9% 86.5% 84.8% 86.3% 84.4% 88.0%
Rate-term refinancings 29.8% 21.8% 14.9% 22.3% 15.7% 14.4% 20.5%
Cash-out refinancings 35.2% 35.2% 27.7% 44.5% 44.4% 39.5% 36.3%
3 Month CPR (6)
 23.0% 17.8% 20.2% 16.5% 16.7% 17.6% 19.4%
3 Month CRR (6)(9)
 19.5% 15.1% 17.3% 13.9% 12.6% 14.5% 16.2%
3 Month CDR (6)(9)
 4.5% 3.3% 3.5% 3.3% 5.5% 4.0% 4.1%
3 Month loss severity 61.5% 41.6% 45.8% 51.9% 55.8% 54.2% 53.4%
60+ days delinquent (8)
 11.5% 11.4% 8.5% 15.1% 15.1% 12.8% 11.8%
Percentage of always current borrowers (Lifetime) (10)
 32.6% 32.3% 39.8% 27.2% 23.4% 28.2% 31.6%
Percentage of always current borrowers (12M) (11)
 76.4% 76.9% 79.3% 69.2% 68.2% 70.4% 74.5%
Weighted average credit enhancement (8)(12)
 0.2% 0.2% 4.7% 0.0% 1.3% 2.8% 1.6%


(1)FICO score is used by major credit bureaus to indicate a borrower’s creditworthiness at time of loan origination.
(2)Information presented based on the initial year of securitization of the underlying collateral. Certain of our Non-Agency MBS have been resecuritized.  The historical information presented in the table is based on the initial securitization date and data available at the time of original securitization (and not the date of resecuritization). No information has been updated with respect to any MBS that have been resecuritized.
(3)Excludes Non-Agency MBS issued since 2012 in which the underlying collateral consists of RPL/NPL MBS. These Non-Agency MBS have a current face of $1.2 billion, amortized cost of $1.2 billion, fair value of $1.2 billion and purchase discounts of $2.0 million at September 30, 2017.
(4)Purchase discounts designated as Credit Reserve and OTTI are not expected to be accreted into interest income.
(5)Weighted average is based on MBS current face at September 30, 2017.
(6)Information provided is based on loans for individual groups owned by us.
(7)Percentage of face amount for which the original mortgage note contractually calls for principal amortization in the current period.
(8)Information provided is based on loans for all groups that provide credit enhancement for MBS with credit enhancement.
(9)CRR represents voluntary prepayments and CDR represents involuntary prepayments.
(10)Percentage of face amount of loans for which the borrower has not been delinquent since origination.
(11)Percentage of face amount of loans for which the borrower has not been delinquent in the last twelve months.
(12)Credit enhancement for a particular security is expressed as a percentage of all outstanding mortgage loan collateral.  A particular security will not be subject to principal loss as long as its credit enhancement is greater than zero. 


The mortgages securing our Legacy Non-Agency MBS are located in many geographic regions across the United States.  The following table presents the five largest geographic concentrations by state of the mortgages collateralizing our Legacy Non-Agency MBS at September 30, 2017:
Property LocationPercent of Unpaid Principal Balance
California42.9%
Florida7.8%
New York6.5%
New Jersey4.0%
Virginia3.9%

RPL/NPL MBS


These securities are backed by re-performing and non-performing loans, were purchased primarily through new issue at prices at or around par and represent the senior and mezzanine tranches of the related securitizations. The majority of these securities are structured with significant credit enhancement (typically approximately 50%) and the subordinate tranches absorb all credit losses (until those tranches are extinguished) and typically receive no cash flow (interest or principal) until the senior tranche is paid off. Prior to purchase, we analyze the deal structure in order to assess the associated credit risk. Subsequent to purchase, the ongoing credit risk associated with the deal is evaluated by analyzing the extent to which actual credit losses occur that result in a reduction in the amount of subordination enjoyed by our bond.


CRT Securities


We are exposed to potential credit losses from our investments in CRT securities issued by or sponsored by Fannie Mae and Freddie Mac. While CRT securities are debt obligations ofissued by or sponsored by these GSEs, payment of principal on these securities is not guaranteed. As an investor in a CRT security, we may incur a loss if losses on the mortgage loans in the associated reference pool exceed the credit enhancement on the underlying CRT security owned by us or if an actual pool of loans experience delinquencies exceeding specified thresholds or other specified credit events occur.losses. We assess the credit risk associated with our investments in CRT securities by assessing the current and expected future performance of the loans in the associated referenceloan pool. Subsequent to March 31, 2020, we substantially reduced our holdings of CRT securities.


MSR RelatedMSR-Related Assets


Term Notes


We have invested in certain term notes that are issued by SPVs that have acquired rights to receive cash flows representing the servicing fees and/or excess servicing spread associated with certain MSRs. Payment of principal and interest on these term notes is considered by us to be largely dependent on the cash flows generated by the underlying MSRs as this impacts the cash flows available to the SPV that issued the term notes. Credit risk borne by the holders of the term notes is also mitigated by structural credit support in the form of over-collateralization. In addition, credit support is also provided by a corporate guarantee from the ultimate parent or sponsor of the SPV that is intended to provide for payment of interest and principal to the holders of the term notes should cash flows generated by the underlying MSRs be insufficient. Subsequent to March 31, 2020, we have substantially reduced our investments in MSR-related assets.
Corporate Loan


We have entered intoparticipated in a loan agreement withto provide financing to an entity that originates residential whole loans and owns the related MSRs. We assess the credit risk associated with this loan participation by considering various factors, including the current status of the loan, changes in fair value of the MSRs that secure the loan and the recent financial performance of the borrower.

Credit Spread Risk
Residential Whole Loans

We are also exposed toCredit spreads measure the additional yield demanded by investors in financial instruments based on the credit risk from our investments in residential whole loans. Our investment processassociated with an instrument relative to benchmark interest rates. They are impacted by the available supply and demand for residential whole loans is generally similar to that used for Legacy Non-Agency MBS and is likewise focused on quantifying and pricinginstruments with various levels of credit risk. Consequently, these loans are acquired at purchase prices that areWidening credit spreads would result in higher yields being required by investors in financial instruments. Credit spread widening generally discounted (often substantially) to the contractual loan balances based on a number of factors, including the impaired credit historyresults in lower values of the borrowerfinancial instruments we hold at that time, but will generally result in a higher yield on future investments with similar credit risk. It is possible that the credit spreads on our assets and the value of the collateral securing the loan. In addition, as the owner of the servicing rights,liabilities, including hedges, will not always move in tandem. Consequently, changes in credit spreads can result in volatility in our process is also focused on selecting a sub-servicer with the appropriate expertise to mitigate lossesfinancial results and maximize our overall return. This involves, among other things, performing due diligence on the sub-servicer prior to their engagement as well as ongoing oversight and surveillance. To the extent that loanreported book value.

delinquencies and defaults are higher than our expectation at the time the loans were purchased, the discounted purchase price at which the asset is acquired is intended to provide a level of protection against financial loss.

The following table presents the five largest geographic concentrations by state of our credit sensitive residential whole loan portfolio at September 30, 2017:
Property Location
Percent of Interest-Bearing Unpaid Principal Balance (1)
California20.7%
New York15.0%
Florida8.6%
New Jersey7.1%
Maryland5.0%

(1) Excludes approximately $120.4 million of residential whole loans for which the closing of the purchase transaction had not occurred as of September 30, 2017.



Liquidity Risk


The primary liquidity risk we face arises from financing long-maturity assets with shorter-term borrowings primarily in the form of repurchase agreement financings.  This risk was particularly pronounced during the first quarter of 2020, as conditions created by the COVID-19 pandemic resulted in us receiving an usually high number of margin calls, negatively impacting our overall liquidity and ultimately leading to us enter into the Forbearance Agreements. For more information, see Note 16 to our consolidated financial statements and “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Senior Secured Financing and Exit from Forbearance.”

We pledge residential mortgage assets and cash to secure our repurchase agreements and Swaps.  At September 30, 2017, we had accessOur Repurchase agreements require us to various sourcespledge additional collateral in the event the market value of liquiditythe assets pledged decreases, in order maintain the lenders contractually specified collateral cushion, which we estimate to be in excessis measured as the difference between the loan amount and the market value of $1.2 billion, an amount which includes: (i) $608.2 million of cash and cash equivalents, (ii) $186.0 million in estimated financing available from unpledged Agency MBS and other Agency MBS collateral that are currentlythe asset pledged in excess of contractual requirements, and (iii) $363.4 million in estimated financing available from currently unpledged Non-Agency MBS.  Our sources of liquidity do not include restricted cash.as collateral. Should the value of our residential mortgage assets pledged as collateral suddenly decrease, margin calls under our repurchase agreements would likely increase, causing an adverse change in our liquidity position.  Additionally, if one or more of our financing counterparties chose not to provide ongoing funding, our ability to finance our long-maturity assets would decline or be available on possibly less advantageous terms.  As such, we cannot assure you that we will always be able to roll over our repurchase agreement financings and other advances.  Further, should marketwhen liquidity tighten,tightens, our repurchase agreement counterparties may increase our margincollateral cushion (or margin) requirements on new financings, including repurchase agreement borrowings that we roll with the same counterparty, reducing our ability to use leverage.


At March 31, 2020, we had access to various sources of liquidity which we estimate to be in excess of $176.1 million, an amount which includes: (i) $116.5 million of cash and cash equivalents, (ii) $56.1 million in estimated financing available from unpledged Agency MBS and other Agency MBS collateral that were pledged in excess of contractual requirements, and (iii) $3.5 million in estimated financing available from then unpledged Non-Agency MBS and from other Non-Agency MBS and CRT collateral that was pledged in excess of contractual requirements. Our sources of liquidity do not include restricted cash. In addition, March 31, 2020 we had $682.7 million of unencumbered residential whole loans.

Prepayment Risk


Premiums arise when we acquire an MBS or loan at a price in excess of the aggregate principal balance of the mortgages securing the MBS (i.e., par value). or when we acquire residential whole loans at a price in excess of their aggregate principal balance.  Conversely, discounts arise when we acquire an MBS or loan at a price below the aggregate principal balance of the mortgages securing the MBS or when we acquire residential whole loans at a price below their aggregate principal balance.  Premiums paid on our MBS are amortized against interest income and accretable purchase discounts on these investments are accreted to interest income.  Purchase premiums, which are primarily carried on our Non-QM loans, Agency MBS, and certain CRT securities, are amortized against interest income over the life of each securitythe investment using the effective yield method, adjusted for actual prepayment activity.  An increase in the prepayment rate, as measured by the CPR, will typically accelerate the amortization of purchase premiums, thereby reducing the IRR/interest income earned on these assets.  Generally, if prepayments on Non-Agency MBS and residential whole loans purchased at significant discounts and not accounted for at fair value are less than anticipated, we expect that the income recognized on these assets will be reduced and impairments and/or loancredit loss reserves may result.


In addition, increased prepayments are generally associated with decreasing market interest rates as borrowers are able to refinance their mortgages at lower rates. Therefore, increased prepayments on our investments may accelerate the redeployment of our capital to generally lower yielding investments. Similarly, decreased prepayments are generally associated with increasing market interest rates and may slow our ability to redeploy capital to generally higher yielding investments.



Item 4.  Controls and Procedures
 
(a) Evaluation of Disclosure Controls and Procedures
 
Management, under the direction of its Chief Executive Officer and Chief Financial Officer, is responsible for maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the 1934 Act) that are designed to ensure that information required to be disclosed in reports filed or submitted under the 1934 Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.
 
In connection with the preparation of this Quarterly Report on Form 10-Q, management reviewed and evaluated the Company’s disclosure controls and procedures.  The evaluation was performed under the direction of the Company’s Chief Executive Officer and Chief Financial Officer to determine the effectiveness, as of September 30, 2017March 31, 2020, of the design and operation of the Company’s disclosure controls and procedures.  Based on that review and evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that the Company’s current disclosure controls and procedures, as designed and implemented, were effective as of September 30, 2017March 31, 2020. Notwithstanding the foregoing, a control system, no matter how well designed, implemented and operated, can provide only reasonable, not absolute, assurance that it will detect or uncover failures within the Company to disclose material information otherwise required to be set forth in the Company’s current periodic reports.
  
(b) Changes in Internal Control over Financial Reporting


There have been no changes in the Company’s internal control over financial reporting that occurred during the quarter ended September 30, 2017March 31, 2020 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

PART II. OTHER INFORMATION
 
Item 1.  Legal Proceedings
 
There are no material pending legal proceedings to which we are a party or any of our assets are subject.


Item 1A. Risk Factors
 
For a discussion of the Company’s risk factors, see Part 1, Item 1A. “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.2019. There are no material changes from the risk factors set forth in such Annual Report on Form 10-K.10-K, except as noted below. However, the risks and uncertainties that the Company faces are not limited to those set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.2019. Additional risks and uncertainties not currently known to the Company (or that it currently believes to be immaterial) may also adversely affect the Company’s business and the trading price of our securities.

The Company is supplementing the risk factors described under “Item 1A. Risk Factors” in its Annual Report on Form 10-K for the year ended December 31, 2019, with the additional risk factors set forth below. These supplemental risk factors should be read in conjunction with the other risk factors described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.
The term of the Third Forbearance Agreement is limited and may be terminated prior to its expiration upon certain events.
The term of the current forbearance agreement between the Company and its repurchase agreement counterparties, which was entered into on June 1, 2020, is limited and, unless extended by the parties, will expire on June 26, 2020. Further, the Forbearance Agreement may terminate earlier than June 26, 2020, upon the occurrence of specified triggering events. Therefore, we cannot predict the full length of the forbearance term. Any early termination of the forbearance agreement, our inability to extend, if necessary, the term of the forbearance agreement, or our inability to fully come to an agreement with our counterparties with respect to an exit from forbearance related to our remaining outstanding repurchase agreement obligations could have a material adverse effect on our business.
The recent global COVID-19 pandemic has adversely affected, and will likely continue to adversely affect, our business, financial condition, liquidity and results of operations.
We believe the worldwide COVID-19 pandemic has negatively affected our business and is likely to continue to do so. The outbreak has caused significant volatility and disruption in the financial markets both in the United States and globally. If COVID-19, or another highly infectious or contagious disease, continues to spread or the response to contain it is unsuccessful, we could continue to experience material adverse effects on our business, financial condition, liquidity, and results of operations. The extent of such effects will depend on future developments which are highly uncertain and cannot be predicted, including the geographic spread of the novel coronavirus, the overall severity of the disease, the duration of the outbreak, the measures that may be taken by various governmental authorities in response to the outbreak (such as quarantines and travel restrictions) and the possible further impacts on the global economy. The continued spread of COVID-19 could also negatively impact the availability of key personnel who are necessary to conduct our business.

Any significant decrease in economic activity or resulting decline in the housing market could have an adverse effect on our investments in mortgage real estate assets. In addition, as interest rates continue to decline as a result of demand for U.S. Treasury securities and the activities of the Federal Reserve, prepayments on our assets are likely to increase due to refinancing activity, which could have a material adverse effect on our result of operations.

Further, in light of the current environment related to the COVID-19 pandemic on the overall economy, such as rising unemployment levels or changes in consumer behavior related to loans as well as government policies and pronouncements, borrowers may experience difficulties meeting their obligations or seek to forbear payment on or refinance their mortgage loans to avail themselves of lower rates, which may adversely affect our result of operations.
We cannot predict the effect that government policies, laws and plans adopted in response to the COVID-19 pandemic and global recessionary economic conditions will have on us.

Governments have adopted, and we expect will continue to adopt, policies, laws and plans intended to address the COVID-19 pandemic and adverse developments in the credit, financial and mortgage markets. We cannot assure you that these programs will be effective, sufficient or otherwise have a positive impact on our business.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds
 
Purchases of Equity Securities
 
As previously disclosed, in August 2005, the Company’s Board authorized a Repurchase Program, to repurchase up to 4.0 million shares of the Company’s outstanding common stock under the Repurchase Program.  The Board reaffirmed such authorization in May 2010.  In December, 2013, the Company’s Board increased the number of shares authorized for repurchase to an aggregate of 10.0 million shares (under which approximately 6.6 million shares remain available for repurchase). Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization.  Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as we deemthe Company deems appropriate (including, in ourits discretion, through the use of one or more plans adopted under Rule 10b-5-1 promulgated under the 1934 Act), using available cash resources.  Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock.  The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice.


The Company engaged in no share repurchase activity during the thirdfirst quarter of 20172020 pursuant to the Repurchase Program. The Company did, however, withhold restricted shares (under the terms of grants under ourits Equity Plan) to offset tax withholding obligations that occur upon the vesting and release of restricted stock awards and/or RSUs. The following table presents information with respect to (i) such withheld restricted shares and (ii) eligible shares remaining for repurchase under the Repurchase Program:

Month  Total
Number of
Shares
Purchased
 
Weighted
Average Price
Paid Per
Share 
(1)
 Total Number of
Shares Repurchased as
Part of Publicly
Announced
Repurchase Program
or Employee Plan
 Maximum Number of
Shares that May Yet be
Purchased Under the
Repurchase Program or
Employee Plan
 Total
Number of
Shares
Purchased
 
Weighted
Average Price
Paid Per
Share 
(1)
 Total Number of
Shares Repurchased as
Part of Publicly
Announced
Repurchase Program
or Employee Plan
 Maximum Number of
Shares that May Yet be
Purchased Under the
Repurchase Program or
Employee Plan
July 1-31, 2017:  
  
  
  
January 1-31, 2020:  
  
  
  
Repurchase Program(2)
 $
 
 6,616,355
(2)
 $
 
 6,616,355
Employee Transactions(3)552
 8.53
 N/A
 N/A
(3)337,026
 7.87
 N/A
 N/A
August 1-31, 2017:  
  
  
  
February 1-29, 2020:        
Repurchase Program(2)
 
 
 6,616,355
(2)
 
 
 6,616,355
Employee Transactions(3)3,676
 8.79
 N/A
 N/A
(3)
 
 N/A
 N/A
September 1-30, 2017:  
  
  
  
March 1-31, 2020:        
Repurchase Program(2)
 
 
 6,616,355
(2)
 
 
 6,616,355
Employee Transactions(3)140,195
 $8.77
 N/A
 N/A
(3)
 $
 N/A
 N/A
Total Repurchase Program(2)
 $
 
 6,616,355
(2)
 $
 
 6,616,355
Total Employee Transactions(3)144,423
 $8.77
 N/A
 N/A
(3)337,026
 $7.87
 N/A
 N/A

(1)Includes brokerage commissions.
(2)As of March 31, 2020, the Company had repurchased an aggregate of 3,383,645 shares under the Repurchase Program.
(3)The Company’s Equity Plan provides that the value of the shares delivered or withheld be based on the price of its common stock on the date the relevant transaction occurs.

(1)  Includes brokerage commissions.
(2)  As of September 30, 2017, the Company had repurchased an aggregate of 3,383,645 shares under the Repurchase Program.
(3)  The Company’s Equity Plan provides that the value of the shares delivered or withheld be based on the price of its common stock on the date the relevant transaction occurs.

Item 3.  Defaults Upon Senior Securities
 
None.As a result of the turmoil in the financial markets resulting from the spread of the novel coronavirus and the global COVID-19 pandemic, on March 25, 2020, in order to preserve liquidity, we revoked our previously announced first quarter 2020 quarterly cash dividends on our Series B Preferred Stock. The Series B Preferred Stock dividend of $0.46875 per share had been declared on February 14, 2020 and was to be paid on March 31, 2020 to stockholders of record as of the close of business March 2, 2020.  On June 3, 2020, we announced that we had likewise determined to suspend our second quarter 2020 quarterly cash dividend on the Series B Preferred Stock and on our 6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock. The payment by us of dividends, with limited exceptions, has been prohibited under the terms of each of the three forbearance agreements that we have entered into with our repurchase agreement counterparties since April 10, 2020. Unpaid dividends on our Series B and Series C Preferred Stock accumulate without interest. No dividends may be paid or set apart on shares of our common stock unless full cumulative dividends on the Series B Preferred Stock and Series C Preferred Stock for all past dividend periods that have ended have been or contemporaneously are paid in cash, or a sum sufficient for such payment is set apart for payment.


As of May 31, 2020, the amount of accrued and unpaid dividends on our Series B and Series C Preferred Stock is $6.3 million and $4.4 million, respectively.

Item 4.  Mine Safety Disclosures
 
None.


Item 5.  Other Information
 
None.


Item 6. Exhibits
 
The list of exhibits required to be filed as exhibits to this report are listed on page E-1 hereof, under “Exhibit Index,” which is incorporated herein by reference.

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: November 2, 2017June 22, 2020MFA FINANCIAL, INC.
 (Registrant)
   
   
 By:/s/ Stephen D. Yarad
  Stephen D. Yarad
  Chief Financial Officer
  (Principal Financial Officer)

EXHIBIT INDEX


The following exhibits are filed as part of this Quarterly Report:


Exhibit Description
   
   
Articles Supplementary designating the Registrant’s 6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, liquidation preference $25.00 per share (incorporated herein by reference to Exhibit 3.10 to the Company’s Registration Statement on Form 8-A, filed February 28, 2020 (Commission File No. 1-13991)).
Specimen of certificate representing the 6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (incorporated herein by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 8-A, filed February 28, 2020 (Commission File No. 1-13991)).
Forbearance Agreement, dated as of April 10, 2020, by and among the Company and the several Participating Counterparties thereto (incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K, filed April 13, 2020 (Commission File No. 1-13991)).
Second Forbearance Agreement, dated as of April 27, 2020, by and among the Company and the several Secondary Participating Counterparties thereto (incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K, filed April 29, 2020 (Commission File No. 1-13991)).
Agreement, entered into as of May 6, 2020, by and between the Company and Stephen D. Yarad (incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K, filed May 8, 2020 (Commission File No. 1-13991)).
Form of Indemnification Agreement (incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K, filed May 19, 2020 (Commission File No. 1-13991)).
Third Forbearance Agreement, dated as of June 1, 2020, by and among the Company and the several Secondary Participating Counterparties thereto (incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K, filed June 3, 2020 (Commission File No. 1-13991)).

 Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
 Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
 Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
 Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS*101 XBRL Instance Document
Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in iXBRL (Inline Extensible Business Reporting Language): (i) our Consolidated Balance Sheets as of March 31, 2020 (Unaudited) and December 31, 2019; (ii) our Consolidated Statements of Operations (Unaudited) for the three months ended March 31, 2020 and 2019; (iii) our Consolidated Statements of Comprehensive Income / (Loss) (Unaudited) for the three months ended March 31, 2020 and 2019; (iv) Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) for the three months ended March 31, 2020 and 2019; (v) our Consolidated Statements of Cash Flows (Unaudited) for the three months ended March 31, 2020 and 2019; and (vi) the notes to our Unaudited Consolidated Financial Statements.
   
101.SCH*104 Cover Page Interactive Data File (formatted as Inline XBRL Taxonomy Extension Schema Documentand contained in Exhibit 101).
   
101.CAL*XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*XBRL Taxonomy Extension Label Linkbase Document
101.PRE*XBRL Taxonomy Extension Presentation Linkbase Document
 
*These interactive data files are furnished and deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of  the Securities Act of 1933, as amended, deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.


E-1